
<html lang="en"     class="pb-page"  data-request-id="60476315-d3b2-4592-a71e-45e19c8abee3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b00588;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2018.61.issue-24;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses" /></meta><meta name="dc.Creator" content="Vrajesh B.  Pandya" /></meta><meta name="dc.Creator" content="Sanjay  Kumar" /></meta><meta name="dc.Creator" content=" Sachchidanand" /></meta><meta name="dc.Creator" content="Rajiv  Sharma" /></meta><meta name="dc.Creator" content="Ranjit C.  Desai" /></meta><meta name="dc.Description" content="The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the production of pro-inflammatory cytokines implicated in the pathogenesi..." /></meta><meta name="Description" content="The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the production of pro-inflammatory cytokines implicated in the pathogenesi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 16, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00588" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00588" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00588" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00588" /></link>
        
    
    

<title>Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00588" /></meta><meta property="og:title" content="Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0012.jpeg" /></meta><meta property="og:description" content="The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the production of pro-inflammatory cytokines implicated in the pathogenesis of autoimmune diseases. Recently, small molecule inhibitors of RORc drew the enormous attention of the research community worldwide as a possible therapy for autoimmune diseases, mediated by the IL-17 cytokine. With the clinical proof-of-concept inferred from a small molecule inhibitor VTP-43742 for psoriasis and recent inflow of several RORc inhibitors into the clinic for therapeutic interventions in autoimmune diseases, this field continues to evolve. This review briefly summarizes the RORc inhibitors disclosed in the literature and discusses the progress made by these inhibitors in combating autoimmune diseases." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the production of pro-inflammatory cytokines implicated in the pathogenesis of autoimmune diseases. Recently, small molecule inhibitors of RORc drew the enormous attention of the research community worldwide as a possible therapy for autoimmune diseases, mediated by the IL-17 cytokine. With the clinical proof-of-concept inferred from a small molecule inhibitor VTP-43742 for psoriasis and recent inflow of several RORc inhibitors into the clinic for therapeutic interventions in autoimmune diseases, this field continues to evolve. This review briefly summarizes the RORc inhibitors disclosed in the literature and discusses the progress made by these inhibitors in combating autoimmune diseases." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0012.jpeg" /></meta><meta name="twitter:title" content="Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00588"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00588">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00588&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00588&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00588&amp;href=/doi/10.1021/acs.jmedchem.8b00588" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10976-10995</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00541" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b00876" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Vrajesh B. Pandya</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vrajesh B. Pandya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +912717665555. Fax: +91-2717-665355. E-mail: <a href="/cdn-cgi/l/email-protection#bfc9cdded5daccd7cfded1dbc6deffc5c6dbcaccdcdedbd6d3de91dcd0d2"><span class="__cf_email__" data-cfemail="cbbdb9aaa1aeb8a3bbaaa5afb2aa8bb1b2afbeb8a8aaafa2a7aae5a8a4a6">[email protected]</span></a></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vrajesh+B.++Pandya">Vrajesh B. Pandya</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9004-4514" title="Orcid link">http://orcid.org/0000-0001-9004-4514</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sanjay Kumar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sanjay Kumar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sanjay++Kumar">Sanjay Kumar</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"> Sachchidanand</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name"> Sachchidanand</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=+Sachchidanand"> Sachchidanand</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rajiv Sharma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajiv Sharma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajiv++Sharma">Rajiv Sharma</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ranjit C. Desai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ranjit C. Desai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ranjit+C.++Desai">Ranjit C. Desai</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00588&amp;href=/doi/10.1021%2Facs.jmedchem.8b00588" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10976–10995</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 16, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 April 2018</li><li><span class="item_label"><b>Published</b> online</span>16 July 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 December 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00588" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00588</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10976%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DVrajesh%2BB.%2BPandya%252C%2BSanjay%2BKumar%252C%2B%2BSachchidanand%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D24%26contentID%3Dacs.jmedchem.8b00588%26title%3DCombating%2BAutoimmune%2BDiseases%2BWith%2BRetinoic%2BAcid%2BReceptor-Related%2BOrphan%2BReceptor-%25CE%25B3%2B%2528ROR%25CE%25B3%2Bor%2BRORc%2529%2BInhibitors%253A%2BHits%2Band%2BMisses%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10995%26publicationDate%3DDecember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00588"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2522</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00588" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Vrajesh&quot;,&quot;last_name&quot;:&quot;B. Pandya&quot;},{&quot;first_name&quot;:&quot;Sanjay&quot;,&quot;last_name&quot;:&quot;Kumar&quot;},{&quot;first_name&quot;:&quot;&quot;,&quot;last_name&quot;:&quot;Sachchidanand&quot;},{&quot;first_name&quot;:&quot;Rajiv&quot;,&quot;last_name&quot;:&quot;Sharma&quot;},{&quot;first_name&quot;:&quot;Ranjit&quot;,&quot;last_name&quot;:&quot;C. Desai&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;16&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;10976-10995&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00588&quot;},&quot;abstract&quot;:&quot;The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the production of pro-inflammatory cytokines implicated in the pathogenesis of autoimmune diseases. Recently, small molecule inhibitors of RORc drew the enormous attention of the research community worldwide as a possible therapy for autoimmune diseases, mediated by the IL-17 cytokine. With the clinical proof-of-concept inferred from a small molecule inhibitor VTP-43742 for psoriasis and recent inflow of several RORc inhibitors into the clinic for therapeutic interventions in autoimmune diseases, this field continues to evolve. This review briefly summarizes the RORc inhibitors disclosed in the literature and discusses the progress made by these inhibitors in combating autoimmune diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00588&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00588" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00588&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00588" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00588&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00588" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00588&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00588&amp;href=/doi/10.1021/acs.jmedchem.8b00588" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00588" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00588" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00588%26sid%3Dliteratum%253Aachs%26pmid%3D30010338%26genre%3Darticle%26aulast%3DPandya%26date%3D2018%26atitle%3DCombating%2BAutoimmune%2BDiseases%2BWith%2BRetinoic%2BAcid%2BReceptor-Related%2BOrphan%2BReceptor-%25CE%25B3%2B%2528ROR%25CE%25B3%2Bor%2BRORc%2529%2BInhibitors%253A%2BHits%2Band%2BMisses%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D24%26spage%3D10976%26epage%3D10995%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291763" title="Noncovalent interactions">Noncovalent interactions</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/24" title="Go to Volume 61, Issue 24"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/jmcmar.2018.61.issue-24/20181227/jmcmar.2018.61.issue-24.largecover.jpg" alt="Go to Volume 61, Issue 24"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The nuclear receptor retinoic acid receptor-related orphan receptor gamma (RORγ or RORc) is a key transcription factor for the production of pro-inflammatory cytokines implicated in the pathogenesis of autoimmune diseases. Recently, small molecule inhibitors of RORc drew the enormous attention of the research community worldwide as a possible therapy for autoimmune diseases, mediated by the IL-17 cytokine. With the clinical proof-of-concept inferred from a small molecule inhibitor VTP-43742 for psoriasis and recent inflow of several RORc inhibitors into the clinic for therapeutic interventions in autoimmune diseases, this field continues to evolve. This review briefly summarizes the RORc inhibitors disclosed in the literature and discusses the progress made by these inhibitors in combating autoimmune diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65503" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65503" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Autoimmune diseases represent chronic inflammatory conditions that occur as a consequence of genetic susceptibility, environmental factors, and immune dysregulation. The immune system is a highly regulated defense mechanism capable of differentiating the “good” and “bad” substances encountered in the body. The breakdown of this system as a result of the destruction of body’s own cells leads to “autoimmunity” defined as a disturbance in the process of antigenic recognition and elimination.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The imbalance of protective immune responses and overexpression of the pro-inflammatory cytokines triggers autoimmune diseases and are one of the leading causes of morbidity and mortality worldwide. Autoimmune diseases may localize to a particular organ, e.g., type 1 diabetes, inflammatory bowel diseases (IBD), multiple sclerosis (MS), uveitis, and psoriasis. However, other autoimmune diseases such as rheumatoid arthritis (RA), ankylosing spondylitis (AS), Behcet’s disease, and systemic lupus erythematosus have systemic manifestation.</div><div class="NLM_p">The pro-inflammatory cytokines interleukin-17 (IL-17) and IL-23 have received substantial attention over the past decade for their involvement in the autoimmune inflammatory diseases and are currently being targeted by several biologics in the clinic.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> The antibodies directed against IL-17 (e.g., Secukinumab, Ixekizumab) and IL-17 receptor (e.g., Brodalumab) have recently demonstrated clinical efficacy in psoriasis, RA, and uveitis (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The IL-23 antibodies such as Ustekinumab, Briakinumab, Tildrakizumab, and Guselkumab have also been evaluated clinically demonstrating efficacy in several autoimmune disorders, especially in psoriasis (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The antibodies against both IL-17 and IL-23 have now established roles in psoriasis. However, in Crohn’s disease, IL-17 antibodies further worsen the disease, unlike IL-23 antibody’s attenuating effect by decreasing colonic inflammation and increasing regulatory T cell (Treg) accumulation. Significant weakening of the intestinal epithelial barrier and increased colonic inflammation in a murine colitis model occurred following IL-17A or IL-17A receptor inhibition. On the basis of this, it appears that IL-17A acts on the intestinal epithelium to promote barrier function and partly explains the mechanisms underlying exacerbation of Crohn’s disease by IL-17 antibodies.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Therapeutic targeting of the IL-23-Th17 axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Cytokines IL-17 (IL-17A and IL-17F), IL-21, IL-22, and granulocyte–macrophage colony stimulating factor (GM-CSF) are produced by a subset of T-cells called Th17 cells differentiated from naïve CD4<sup>+</sup>T cells. The differentiation process requires the presence of cytokines IL-6 and transforming growth factor (TGF)-β, while cytokine IL-23 assists in amplification and stabilization of these cells (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The nuclear receptor (NR) retinoic acid receptor-related orphan receptor gamma (RORγ, murine form or RORc, human form) is a key transcriptional factor for the differentiation of Th17 cells. This was evident by comparing wild-type and RORγ null mice for the development of Th17 cells.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> RORγ signature genes have been characterized in both mouse and human Th17 cells.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> In addition to Th17 cells, RORγ controls the production of these cytokines from other immune cells including Th1/17 cells, CD8<sup>+</sup> Tc17 cells, natural killer T cells, innate lymphoid cells (ILC), and γ/δ T cells. RORγ inhibition, therefore, provides a strategy to control proinflammatory cytokines produced by Th17 cells. In fact, it has now become a very important therapeutic target for the small molecule inhibitors that affect IL-17 production (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">In addition to RORγ, ROR family has two more members, RORα and RORβ, encoded by separate genes and are homologous. RORα is widely expressed in many tissues, including testis, kidney, adipose, liver, and brain, while RORβ is expressed in brain and retina.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The mice lacking RORα and RORβ are characterized by severe ataxia and motor defects, respectively.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> RORγ and its splice variant RORγt (shortened by 24 amino acids at N-terminal) have a distinct expression, while RORγ is present in liver, adipose tissue, skeletal muscle, and kidney, RORγt is present only in the thymus.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> RORγt-deficient mice show significantly decreased susceptibility to experimental autoimmune encephalomyelitis (EAE) as well as the intestinal and skin inflammation.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Furthermore, mice deficient in RORγ exhibited improved insulin sensitivity and glucose tolerance.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> However, mice deficient in RORγ expression lack lymph nodes and Peyer’s patches.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The lack of these lymphoid structures is the outcome of the absence of lymphoid tissue inducer (LTi) cells in RORγt-deficient mice, as RORγt is required for the differentiation of LTi cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Thymic tissue in RORγ<sup>–/–</sup> mice had fewer thymocytes when compared with wild-type animals due to the massive apoptosis of double negative thymocytes.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> RORγt<sup>+/−</sup> mice with enhanced green fluorescent protein gene heterozygously knocked-in at the RORγt gene locus showed increase mortality after myocardial infarction (MI).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This result suggests a cardioprotective role of the RORγt-expressing cells in cardiac remodeling after MI.</div><div class="NLM_p">The structure of RORγ is modular and has a variable N-terminal activation function (AF-1) domain, a highly conserved central DNA binding domain (DBD), a flexible hinge region, and a C-terminal ligand binding domain (LBD) with the ligand-dependent activation function helix 2 (AF-2).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It is the LBD where the entire focus of discovery and design of small molecule modulators is directed. Multiple structures of LBD in apo- and holo-NRs (with an agonist or inverse agonist occupying the ligand binding pocket (LBP)) have been studied with peptides from coregulatory proteins bound to its surface. A typical NR LBD consists of 12 α-helices (H1–H12) organized in three layers, with two or three β-strands forming a short sheet structure. The LBP is mainly hydrophobic where ligands interact with the receptor through extensive van der Waals contacts and few polar interactions. The ligand-bound LBP is packed against H12 on one side and H5 on the other side.</div><div class="NLM_p">One of the X-ray crystal structures of the RORc agonist, 25-hydroxycholesterol, bound to the LBD of RORc (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0L">3L0L</a>), was shown to have mainly hydrophobic LBP with some polar residues Arg364, Arg367, Gln286, His479, and Tyr502 lining the LBP.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The RORc-LBD comprises the 12 α-helices (H1–H12) along with three β-strands. The LBD interacts with the coregulators to regulate gene transcription. The coregulators bind to LBD using one or more LXXLL motifs and associate with H12 via a charge clamp (supporting this motif’s binding as a short α-helix) to the surface of the LBD. Activation by a coactivator complex in RORc is believed to involve the movement of H12 (AF-2) into a hydrophobic pocket of the LBD.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> 25-Hydroxycholesterol indirectly stabilizes the agonist position of Tyr502 (on H12) via a water-mediated hydrogen bond, while 25-hydroxy group makes a direct hydrogen bond with the His479 on H11.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">Comparison of multiple cocrystal structures of RORc with agonists and inverse agonists has highlighted the important structural features associated with the active and inactive conformation of RORc. Therefore, agonist and inverse agonist of RORc may be defined with respect to conformational changes it caused. An agonist of RORc is any molecule that enhances the interactions of LBD with one or more coactivator LXXLL motifs (leading to transcriptional activation). The hydrogen bond between His479 (on H11) and Tyr502 (on H12) has been shown to be critical for RORγ agonist activity. An inverse agonist is any molecule which positions H12 to physically compete with and block the site of coactivators or stabilizes the inactive conformation of RORc. In other words, upon binding of an inverse agonist, the interaction of the LBD with the coactivator will change as H12 would have perturbed conformation and position relative to the LBD core, abrogating the interaction with either a coactivator or a corepressor.</div><div class="NLM_p">A recent publication by Novartis scientists proposed a new molecular mechanism to explain inverse agonism in RORc, where an inverse agonist is cocrystallized with a coactivator peptide and H12 in an agonist position.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It proposes that H12 is destabilized by a gain of free energy upon liberation of an unstable water molecule (trapped in a partially hydrophobic environment interacting with Tyr502) into bulk solvent. It was named as “water trapping” mechanism.</div><div class="NLM_p last">The process of identifying small molecule RORc inhibitors has made significant progress with several small molecules entering into the clinic, including VTP-43742 (phase II, Vitae/Allergan),<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> GSK-2981278 (phase II, GSK),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> ARN-6039 (phase I, Arrien),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> TAK-828 (phase I, Takeda),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> ABBV-553 (phase I, AbbVie),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> JNJ-3534 (phase I, Janssen/Phenex),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> AZD-0284 (phase I, AstraZeneca),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> JTE-451 (phase I, Japan Tobacco/Orphagen),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> JTE-151 (phase I, Japan Tobacco),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and RTA-1701 (phase I, Reata),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> again reemphasizing the emerging role of RORc inhibitors in autoimmune disorders.<a onclick="showRef(event, 'ref8 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref8 ref28 ref29 ref30">(8,28−30)</a> A recent review summarized the discovery and development of RORc agonists as a potential small molecule therapeutics for cancer.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Structural classes of many of these agonists are overlapping with those described for RORc inverse agonists.<a onclick="showRef(event, 'ref8 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref8 ref28 ref29 ref30">(8,28−30)</a> The scope of the present review is limited to the RORc inhibitors and their role in autoimmune diseases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">RORc Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The journey of RORc inhibitors can be credited to the discovery of the compound <b>1</b> (T0901317), reported initially by Tularik as a potent liver X receptor (LXR) agonist and later as a RORc inverse agonist by Scripps Florida (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The team at Scripps Florida showed compound <b>1</b> as a dual inverse agonist of RORc (IC<sub>50</sub> = 1.7 μM) and RORα (IC<sub>50</sub> = 2.0 μM) in GAL4-LBD assays. Further efforts led to the discovery of SR2211 (<b>2</b>, GAL4 IC<sub>50</sub> = 0.32 μM)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and SR1555 (<b>3</b>, GAL4 IC<sub>50</sub> = 1.5 μM)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> as selective RORc inhibitors devoid of LXR liability and efficacious in a collagen-induced arthritis (CIA) mouse model (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Furthermore, Genentech reported a 2.9 Å X-ray cocrystal structure of <b>1</b> with RORc-LBD (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NB6">4NB6</a>), where it mainly occupies the hydrophobic pocket.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In contrast with LXR, the hexafluoroisopropanol group of <b>1</b> does not make any strong hydrogen bond to the protein. The phenyl-sulfonamide group of <b>1</b> was involved in a π–π stacking interaction with Phe367 in RORc-LBD. Interestingly, another cocrystal structure of <b>1</b> with RORγt [264–499, devoid of helix 12] construct at 2.26 Å revealed that the OH group of <b>1</b> makes a strong hydrogen bond with His479 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NTQ">5NTQ</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This difference was attributed to the use of different RORγt construct ([262–507] in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NB6">4NB6</a> vs [264–499] in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NTQ">5NTQ</a>) or different resolutions.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Early inhibitors of RORc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The last five years have witnessed a great acceleration in identifying potent and selective RORc inhibitors derived from a variety of scaffolds. There are 68 crystal structures of RORc deposited in the Protein Data Bank (PDB). On the basis of the similarity in their binding interactions with RORc and the chemotype resemblance of the inhibitors, we have classified them into six types as follows.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.  Sulfonamides of Cyclic Amines</h3><div class="NLM_p">The high throughput screening (HTS) campaign at Bristol-Myers Squibb and subsequent structure–activity relationship (SAR) investigation led to the series of sulfonamide derivatives (<b>4</b>–<b>6</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The X-ray cocrystal structure of <b>4</b> bound to LBD of RORγt at 2.40 Å (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BN6">6BN6</a>) revealed destabilization of helix 12. The hexafluoroisopropanol group occupies a hydrophobic pocket and the hydroxyl moiety forms a hydrogen bond with the side chain of His479. One of the sulfone oxygen atoms forms a hydrogen bond with the side chain of Cys320. The tetrahedral sulfone group is crucial because it projects the 4-fluorophenyl moiety to have favorable hydrophobic interaction. The sulfone group, when replaced with a carbonyl (not shown) afforded a compound with poor activity. The hydroxyl group of 2-hydroxy-2-methylpropyl acetamide moiety forms water-mediated hydrogen bonds to the side chain of Arg367 and the backbone carbonyl of Arg364. These interactions are crucial for RORγt potency and selectivity against LXRβ. The poor selectivity of compound <b>4</b> (RORγt EC<sub>50</sub> = 12 nM in GAL4 assay) against pregnane X receptor (PXR) (PXR EC<sub>50</sub> = 144 nM in transactivation assay using HepG2 cells) was addressed by moving acetamide side chain of <b>4</b> adjacent to nitrogen atom of the ring (e.g., <b>5</b>, EC<sub>50</sub> = 15 nM (RORγt), 1830 nM (PXR)). The most optimized compound <b>6</b> (EC<sub>50</sub> = 39 nM (RORγt), 2000 nM (PXR)) was identified by introducing fluoro atom on <b>5</b> to increase metabolic stability in mice. To evaluate in vivo efficacy, IL-17 mouse model of efficacy was developed. Naive mice were challenged three times with IL-2 and IL-23 (at 0, 7, and 23 h) after IL-2-alone priming (−24 h). Serum IL-17 was measured 7 h after last IL-2/IL-23 administration. Oral dosing of compound <b>6</b> inhibited IL-17 response by 74% and 98% at 25 and 100 mg/kg doses, respectively.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sulfonamides of cyclic amines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The HTS campaign and subsequent SAR study at Genentech resulted in the identification of tetrahydroquinoline derivatives substituted with a carboxamide group (e.g., <b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Compound <b>7</b> was shown to inhibit recruitment of the SRC1 coactivator peptide to the RORc-LBD with an EC<sub>50</sub> value of 26 nM. In the RORc binding assay, it has shown the IC<sub>50</sub> value of 50 nM and displayed 63-fold selectivity over the other ROR isoforms and 13-fold selectivity over the other NRs in the cell assay panel. Further, it inhibited IL-17 production in the human peripheral blood mononuclear cell (PBMC) assay with an EC<sub>50</sub> value of 1400 nM. A molecular modeling study of <b>7</b> suggested a very similar binding mode as that of <b>1</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NB6">4NB6</a>). The benzamide group in <b>7</b> projected toward the C-terminus of the helix 11 in a similar vector as the hexafluoroisopropanol group in <b>1</b>.</div><div class="NLM_p last">HTS campaign at AstraZeneca resulted in the identification of benzoxazepine carboxamides (e.g., <b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) as RORγ inverse agonists.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The SAR studies were directed to improve potency and physiochemical properties of their earlier hits. The optimized compound <b>8</b> was shown to bind with RORγ-LBD in SPA (scintillation proximity assay) with an IC<sub>50</sub> value of 0.04 μM. In the TR-FRET assay, despite having an IC<sub>50</sub> value of 0.04 μM, the % efficacy was only −69, suggesting a partial inverse agonist nature of this compound. The ortho-substituted halogens and presence of a carboxamide group and its point of attachment had a significant effect in improving potency. Compound <b>8</b> inhibited IL-17 production from human Th17 cells with an IC<sub>50</sub> value of 0.18 μM (−73% efficacy). The corresponding benzazepine derivative of <b>8</b> displayed comparable activity (i.e., <b>9</b>, IC<sub>50</sub> = 0.02 μM (SPA), 0.03 μM (TR-FRET)) in biochemical assays. In IL-17 production assay, <b>9</b> had an improved activity (IC<sub>50</sub> = 0.04 μM (<b>9</b>) vs 0.18 μM (<b>8</b>)). Both the compounds were found to be selective against ROR isoforms and related NRs, however, they suffered from low metabolic stability in human liver microsomes (HLM). The cocrystallization of <b>8</b> with the RORγ-LBD (native construct, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APK">5APK</a>) revealed the hydrogen bond of His479 with the NH of the benzamide moiety, disrupting the His-Tyr agonist lock. Also, an induced fit was observed around benzamide moiety in a pocket formed by the key residues from the helix 11.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The chemotypes described in this section were also explored by many researchers to identify RORc agonists with trivial modifications.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.  Acyclic Sulfonamides and Sultam Derivatives</h3><div class="NLM_p">Biochemical screening campaign at Genentech identified a series of tertiary sulfonamides and sultam derivatives (e.g., <b>10</b>–<b>13</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) as RORc modulators.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The piperazine derivative <b>10</b> was shown to inhibit RORc with EC<sub>50</sub> values of 57 and 120 nM in RORc-SRC1 and GAL4 assays, respectively. A publication from Genentech described the reversal of biological activity regarding agonist/inverse agonist on minor variation in the structure.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In a RORc-LBD recruitment assay using SRC1 coactivator peptide, <b>11</b> having a benzyl group was found to be an inverse agonist (EC<sub>50</sub> = 11 nM, −99% efficacy), while the corresponding phenyl analogue <b>12</b> revealed agonistic behavior (EC<sub>50</sub> = 69 nM, +35% efficacy). Further confirmation was achieved using a human IL-17 PBMC assay where inverse agonist <b>11</b> has shown decreased production of IL-17 (EC<sub>50</sub> = 0.35 μM, −79% efficacy) and agonist <b>12</b> has shown increased production of IL-17 (EC<sub>50</sub> = 0.78 μM, +77% efficacy).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Acyclic sulfonamides and sultam derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding mode of these compounds was studied by solving cocrystal structures of inverse agonist <b>10</b> (close analogue of <b>11</b>, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP">4WQP</a>) and agonist <b>12</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF">4WPF</a>) with RORc-LBD (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The agonist ligand <b>12</b> stabilizes the agonist conformation of helix 12 by aligning itself against Trp317, His479, and Tyr502 and recruited the coactivator peptide. On the other hand, the benzyl moiety of the inverse agonist ligand <b>10</b> prevented the formation of the hydrogen bond with Tyr502 of helix 12 through displacement of His479. The disruption of the hydrogen bond between His479 and Tyr502 dislodged helix 12 entirely in the costructure with <b>10</b>. This prevents the binding site for coregulator proteins and imparts an inverse agonist activity (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Both <b>10</b> and <b>12</b> formed a water-mediated hydrogen bond with Arg367 through the terminal acetyl groups. One of the sulfonamide oxygen atoms forms a hydrogen bond with His479, while remaining interactions were mostly hydrophobic in nature.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of agonist ligand <b>12</b> (orange ribbon, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF">4WPF</a>) and inverse agonist ligand <b>10</b> (yellow ribbon, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP">4WQP</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further efforts to address metabolic stability issues in compounds (<b>10</b>–<b>12</b>) were reported as conformationally restricted sultam derivatives (e.g., <b>13</b>, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), mainly to prevent metabolism in the form of N-dealkylation.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Compound <b>11</b> discussed above has been shown to suffer from the low metabolic stability in liver microsomes of both human (HLM) and rat (RLM) species (CL<sub>hep</sub> (mL/min/kg): 19 (HLM) and 50 (RLM)). The sultam derivative <b>13</b> (RORc SRC1 EC<sub>50</sub> = 12 nM) has shown improved metabolic stability (CL<sub>hep</sub> (mL/min/kg): 10 (HLM), 21 (RLM)), and also improved rat pharmacokinetic (PK) properties (<i>F</i>(%) = 55, <i>T</i><sub>1/2</sub> = 3.5 h).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The <i>R</i>-stereochemistry of the phenyl ring was found to be crucial for the in vitro potency and improved metabolic stability. Furthermore, compound <b>13</b> was shown to reduce homodimeric IL-17FF levels by 54% when dosed orally at 30 mg/kg in mice pretreated with a pan-CYP inhibitor (1-aminobenzotriazole) and subsequent stimulation with IL-1β and IL-23.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In their previous patent publication, the SAR around <i>N</i>-acetyl piperazine group, which is involved in a hydrogen- bonding with the Arg367 residue of RORc-LBD was described.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Few potential bioisosteric replacements of <i>N</i>-acetyl piperazine group disclosed in it are shown in the box (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><div class="NLM_p">A team from GSK disclosed reverse sulfonamide derivatives exemplified by <b>14</b> (GSK-2981278, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) as RORγ inverse agonist.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> It was shown to inhibit SRC1 coactivator recruitment and IL-17 production in hPBMCs with IC<sub>50</sub> values of 20 and 63 nM, respectively.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The tetrahydropyran group as discussed above may serve as a hydrogen bond acceptor group for Arg367 residue interaction (see box, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compound <b>14</b> is their clinical candidate being evaluated for the topical treatment of psoriasis. The in vivo efficacy of <b>14</b> was demonstrated in the mouse model of psoriasis.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Mice were treated topically with <b>14</b> (1% ointment) for 13 days (day −3 to day +9). Starting on day 0, mice were challenged topically with 5% imiquimod (IMQ) cream for up to 10 days (day 0 to day +9). On the last day of treatment, the skin was imaged and clinically assessed. Mice treated with <b>14</b> exhibited a reduced skin redness, scaling, and decreased hyperplasia, which was evident from a 23% reduction in epidermal thickness when compared to the placebo + IMQ-treated group.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The ex vivo efficacy was also demonstrated in the diseased human skin in which compound treatment reduced levels of IL-17A, IL-17F, IL-22, and IL-19 transcript levels by >50% compared to vehicle-treated psoriatic explants.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p last">A recent publication by Galderma/Nestlé disclosed preclinical characterization of <b>15</b> (CD12681), a structurally related RORγ inverse agonist to <b>14</b> for the topical treatment of psoriasis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> In RORγ GAL4 cellular assay, <b>15</b> displayed an IC<sub>50</sub> value of 19 nM and was found to be selective against related NRs. Compound <b>15</b> was topically applied (3% w/w in acetone) twice a daily for 16 days in a mouse model of IL-23-induced skin inflammation. Significant reduction in ear thickness and IL-17 inflammatory cell recruitment was observed for <b>15</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.  Aryl Sulfonyl Compounds</h3><div class="NLM_p">Compounds of this type possess characteristic sulfonyl group attached to aryl/heteroaryl ring and involved in key hydrogen bond interactions contributing to high RORc inhibitory potency (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The HTS campaign at GSK followed by initial SAR led to the identification of aminothiazole derivative <b>16</b>, a partial agonist (RORγt FRET IC<sub>50</sub> = 160 nM, 56% inhibition) for which cocrystal structure with RORγt-LBD was reported (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XT9">4XT9</a>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> The signature group (i.e., sulfonyl) was involved in hydrogen-bonding interactions with Arg367 and backbone NH of Leu287. The NH from linker amide of ligand formed a hydrogen bond with the backbone carbonyl of Phe377. Two ligand phenyl rings are in π–π stacking with Phe377 and Phe388. The phenyl group at the 5-position of the thiazole ring occupies the hydrophobic pocket, contributing to the activation of RORγt by stabilizing the H12 (AF-2 domain) toward SRC recruitment. However, compound <b>17</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) with a carbonyl spacer was found to be an inverse agonist (FRET IC<sub>50</sub> = 16 nM, IL-17 IC<sub>50</sub> = 200 nM).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The X-ray structure of <b>17</b> with RORγt [264–518] construct and RIP140 coactivator peptide at 1.85 Å (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NU1">5NU1</a>) revealed a trapped water molecule that forms a hydrogen bonds with Tyr502 and His479.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This may lead to the destabilization of helix 12 by a gain of free energy upon liberation of a water molecule into the bulk solvent (“water trapping” mechanism), explaining the inverse agonist nature of this ligand. Furthermore, in vivo efficacy was demonstrated in the mouse EAE and CIA models upon oral dosing at 100 mg/kg bid.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Compound <b>17</b> was independently evaluated by Phenex and found to be a potent inhibitor of RORβ (FRET IC<sub>50</sub> = 79 nM).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Aryl sulfonyl compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additional efforts by researchers of GSK to improve central nervous system (CNS) penetrability by removing carbonyl group of <b>17</b> led to the series of biaryl amides exemplified by <b>18</b> and <b>19</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Compounds <b>18</b> (GSK805) and its methyl analogue <b>19</b> showed an excellent in vitro potency in RORγ FRET (IC<sub>50</sub> = 4 nM (<b>18</b>), 5 nM (<b>19</b>)) and Th17 cell differentiation (IC<sub>50</sub> = < 6.3 nM (<b>18</b>), 40 nM (<b>19</b>)) assays. The CNS permeability was impressive as reflected in their brain-to-blood ratio (0.78 (<b>18</b>), 0.79 (<b>19</b>)). Compound <b>19</b> displayed an excellent PK profile (<i>F</i>(%) = 100, <i>T</i><sub>1/2</sub> = 9.7 h) in mouse. Furthermore, both of the compounds were found to be efficacious in a mouse model of EAE with the highest effect observed at 10 mg/kg po.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> In a very recent publication by GSK, compound <b>20</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) has been shown as a long inverse agonist that dispels both a corepressor peptide (NCOR2) and a coactivator peptide (SRC1) in a dual FRET assay.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The short inverse agonist (e.g., a close analogue of <b>18</b>), on the other hand, dispels a coactivator peptide only. Compound <b>20</b> was shown to have an IC<sub>50</sub> value of ∼31 nM in both RORγ FRET and RORγ dual FRET assays. This difference in the mechanism of action needs further attention to derive additional insights into the new design of the RORc inhibitors.</div><div class="NLM_p">Our group recently identified cyclopropyl derivatives exemplified by <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) as potent RORγt inhibitors.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The unique 1,1-disubstituted cyclopropyl ring may project aryl/heteroaryl rings attached with it for the better occupancy in the hydrophobic pocket of RORγt-LBD. Compound <b>21</b> inhibited RORγt with an IC<sub>50</sub> value of 2.1 nM in luciferase assay and also IL-17 production in human PBMC cells (IC<sub>50</sub> = 6.6 nM). Furthermore, undisclosed compounds of the invention have demonstrated excellent in vivo efficacy in three disease models in mouse, including the EAE model of MS (>90% reduction in the clinical score at 50 mg/kg bid, po), CIA model of RA (75% reduction in the clinical score at 30 mg/kg bid, po), and IMQ-induced psoriasis model (40% reduction in ear weight at 3 mg/kg bid, po).</div><div class="NLM_p">The compound <b>22</b> (VTP-43742, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was evaluated by Vitae in phase II clinical trial for psoriasis.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In preclinical studies, <b>22</b> was shown as a potent inhibitor of RORγ in both the binding assay (RORγ IC<sub>50</sub> = 3.7 nM) and a cell-based assay (RORγt IC<sub>50</sub> = 17 nM) with more than 1000-fold selectivity against other ROR isoforms.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> It potently inhibits the secretion of IL-17A from activated human PBMCs (IC<sub>50</sub> = 21 nM) and human whole blood from healthy (IC<sub>50</sub> = 207 nM) and psoriatic donors (IC<sub>50</sub> = 250 nM). The PK profile in rat (<i>F</i>(%) = 64, <i>T</i><sub>1/2</sub> = 6 h) and dog (<i>F</i>(%) = 66, <i>T</i><sub>1/2</sub> = 15 h) was shown as favorable to go for once-daily dosing in humans. In the mouse EAE model, at 15 mg/kg (twice daily) oral dosage, a decrease in clinical score and suppression of inflammatory markers in the spinal cord was observed. At 100 mg/kg (twice daily) oral dosage, the compound completely suppressed the EAE clinical score (>95%), while the corresponding effect of anti-IL-17A mABs was at ∼60% reduction in clinical score.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The X-ray structure of <b>22</b> with RORγt [264–518] construct and RIP140 coactivator peptide revealed that the terminal CF<sub>3</sub> group makes close contacts with His479 and Trp317, leading to the destabilization of helix 12 in agonist position (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NTW">5NTW</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, further cocrystallization with RIP140 was possible and also there was a water molecule trapped making a hydrogen bond with Tyr502. Hence, it appears that <b>22</b> works by a combination of mechanisms (i.e., both by the steric clash with helix 12 and “water trapping”).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In a follow-up patent from Vitae, <b>22</b> was shown to inhibit hERG by 45.4% at 3 μM, however, no cardiac abnormalities were reported for this compound.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The same application described compound <b>23</b> (RORγ <i>K</i><sub>i</sub> = <100 nM in the binding assay) with improved hERG profile (7.7% inhibition at 3 μM) and also improved potency (IC<sub>50</sub> < 100 nM) in human whole blood assay. This effect may be assigned to a polar hydroxymethyl group. An additional feature in compounds <b>22</b> and <b>23</b> is the inverted connectivity of the carboxamide group to the central core unlike compounds <b>18</b>–<b>21</b> described earlier.</div><div class="NLM_p">A team from Glenmark disclosed a series of ether derivatives exemplified by <b>24</b> (RORc TR-FRET IC<sub>50</sub> = 4.3 nM) for their intended use in respiratory indications (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Intranasal delivery of compound <b>24</b> has demonstrated a significant inhibition of pulmonary inflammation and emphysema induced by cigarette smoke in male C57/BL6 mice. Compound <b>24</b> also inhibited IL-17 production from the lung BAL cells (IC<sub>50</sub> = 350 nM) and PBMCs (IC<sub>50</sub> = 147 nM) of chronic obstructive pulmonary disease (COPD) patients. A spirocyclic modification of the central core (e.g., <b>25</b>, RORγt <i>K</i><sub>i</sub> = 16.6 nM in the binding assay) was recently disclosed by Lilly.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Compound <b>25</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) displayed more than 700-fold selectivity against RORα and RORβ isoforms. In a HEK293 RORc LBD-GAL4 assay and a hPBMC-IL-17 assay, it was shown to have IC<sub>50</sub> values of 21.8 and 20 nM, respectively. In glucose-6-phosphate isomerase-induced arthritis model in mice, compound <b>25</b> displayed 75% reduction in the clinical score at an unusually high dose of 1000 mg/kg po.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">Researchers at AstraZeneca reported isoindoline derivatives exemplified by <b>26</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The key feature of this compound is the conformational restriction applied at the methylene group of linker amide with the neighboring phenyl ring constructing an isoindoline core. Recently, discovery efforts for the identification of their clinical candidate AZD-0284 (<b>26</b>) were described.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The early SAR involve structural optimization of compound <b>17</b>, eyeing improved cellular potency and better physiochemical properties. Reduced lipophilicity and improved solubility were achieved by employing hexafluoroisopropanol moiety as an optimized group in the left portion of <b>17</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Further improvement in potency and physiochemical properties was achieved by introducing polar groups at the methylene group of the central linker. These groups allow more polar interactions in the LBD of RORγ. Compound <b>26</b> was finally shortlisted as their clinical candidate, the profile of which was compared with <b>22</b> (VTP-43742, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). It inhibited RORc in FRET assay with an IC<sub>50</sub> value of 40 nM. The cell potency measured in human Th17 cells was better when compared with <b>22</b> (IC<sub>50</sub> = 16 nM (<b>26</b>) vs 40 nM (<b>22</b>)). Compound <b>26</b> showed an improve solubility (380 μM (<b>26</b>) vs 17 μM (<b>22</b>)) and appreciable free fraction in human plasma (16% (<b>26</b>) vs 0.5% (<b>22</b>)). The oral bioavailability in rats was moderate (<i>F</i>(%): 34 (<b>26</b>), 72 (<b>22</b>)), however, it has shown excellent bioavailability in the dog (<i>F</i>(%) = 96). Compound <b>26</b> was reported to inhibit IL-17 production in all CCR6<sup>+</sup> subsets and reduced skin inflammation in vivo. Cocrystal structure of <b>26</b> bound to the RORγ-LBD revealed an additional hydrogen bond interaction through an oxygen atom of the <i>N</i>-acetyl group. Other three hydrogen bond interactions are similar as expected for this class of compounds (e.g., <b>16</b>, <b>22</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The hexafluoroisopropanol moiety interacts with helices 11/12 via water-mediated hydrogen bonds (crystal structure not deposited in the PDB).</div><div class="NLM_p last">A team from Boehringer recently described a series of pteridine derivatives as RORγ inhibitors (e.g., <b>27</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) with the unique nonamide linker different from the compounds discussed above.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> However, compounds have free NH group, which may still involve in the hydrogen-bonding with Phe377. Compound <b>27</b> (RORγ IC<sub>50</sub> = 60 nM in reporter gene assay) was shown as a potent inhibitor with favorable metabolic stability in HLM.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">4.  Amide/Bis-amide Derivatives</h3><div class="NLM_p">The RORc inhibitors discussed in this section have the presence of one or two amide groups each involved in key hydrogen bond interactions either directly or water-mediated with Glu379, His479, and Phe377 and imparts to them a very good potency (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Researchers at Biogen reported one of the first of its kind. Structure-based approach with an intention to incorporate polar groups into the molecule to allow more hydrogen-bonding interactions led to the identification of biarylamide derivative <b>28</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> The IC<sub>50</sub> value in RORc FRET assay and EC<sub>50</sub> value in the RORc GAL4 cellular assay were found to be 29 and 97 nM, respectively. The cocrystal structure of compound <b>28</b> with RORγ protein (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZJR">4ZJR</a>) revealed a prominent hydrogen bond through carbonyl of head amide group with the backbone residue Glu379 at the pocket entrance. The OCH<sub>2</sub>CF<sub>3</sub> group occupies a nearby small pocket and twisted the internal amide group for the second hydrogen bond interaction with His479 on H11. This second hydrogen bond interaction disrupts the agonist lock between His479 (on H11) and Tyr502 (on H12), resulting in inverse agonistic activity. The incorporation of N-CD<sub>3</sub> group improved PK properties in rats, especially reduced clearance was observed over corresponding N-CH<sub>3</sub> derivative by lowering <i>N</i>-demethylation metabolism (<i>F</i>(%) = 41, <i>T</i><sub>1/2</sub> = 9.6 h). Reduction in lipophilicity to improve solubility was achieved by synthesizing pyrazole analogue <b>29</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In addition to improved solubility, compound <b>29</b> has shown excellent potency in RORγ FRET (IC<sub>50</sub> = 3 nM) and RORγ GAL4 (EC<sub>50</sub> = 8.1 nM) assays and suppress IL-17 production in splenocytes (EC<sub>50</sub> = 38 nM). The cocrystal structure of <b>29</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZOM">4ZOM</a>) with RORc-LBD showed similar binding interactions as observed for <b>28</b>.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Amide/Bis-amide derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A team from GSK disclosed a series of diamide derivatives (e.g., <b>30</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) containing piperazine carboxamide functionality.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The SAR involved exploration of a variety of substituents at both the amide terminus. The cyclopentyl group was one of the highly explored substituents at the piperazine amide terminus, while the majority of substituents explored at the aryl amide terminus have hydrogen bond acceptor functionality. Compound <b>30</b> was shown to have RORγ inhibitory activity in both dual FRET (IC<sub>50</sub><b>=</b> 97 nM) and Th17 cell differentiation (IC<sub>50</sub> = 31 nM) assays. In a mouse EAE model of MS, compound <b>30</b> delayed onset of EAE and also lowered clinical score at doses of 3, 10, or 30 mg/kg bid, po.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> In a recent publication by Novartis, compound <b>31</b> (RORc IC<sub>50</sub> = 1.2 nM in the TR-FRET assay) was tested in rats to show reduced delayed-type hypersensitivity ear swelling response at 3 mg/kg bid, po.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> However, oral administration of <b>31</b> at 10 mg/kg bid for 13 weeks showed thymic aberrations including early lymphocytolysis. The above result suggests a possible risk of T cell lymphoma with RORc inhibitors upon chronic therapy.</div><div class="NLM_p">A series of structurally similar piperazine derivatives with the imidazopyridine core (e.g., <b>32</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) was further disclosed by Novartis.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> In a RIP140 coactivator peptide displacement assay and IL-17 production assay in human whole blood, <b>32</b> displayed IC<sub>50</sub> values of 13 and 168 nM, respectively. Compound <b>32</b> showed moderate oral bioavailability in rats (<i>F</i>(%) = 23) and showed appreciable free fraction in the rat (25.6%) and human (31.2%) blood. The X-ray structure of compound <b>32</b> with RORγt [264–491] construct (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M96">5M96</a>) revealed that the two nitrogen atoms of the pyrimidine ring formed water-mediated hydrogen bonds to residues Arg367, Leu287, and Glu379. The adjacent amide NH group in <b>32</b> makes a hydrogen bond with the carbonyl of the backbone of Phe377 similar to that observed for arylsulfonyl class of compounds through the NH of linker amide (e.g., <b>16</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The imidazopyridine core occupies a pocket formed by Met365, Val376, Leu400, Phe401, and Ser404. The carbonyl group from the second amide group present at the piperazine core provides a hydrogen bond contact with His479, similar to that observed for <b>28</b> through internal amide group. The terminal cyclopentyl group will clash with Trp317 if helix 12 is in the agonist position.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">A structurally related sulfonamide modification (<b>33</b>) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) was disclosed by Daiichi Sankyo.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> In the binding assay with RORγt-LBD, <b>33</b> displayed an IC<sub>50</sub> value of 89 nM and was found to be selective against RORα, RORβ, and PPARγ in luciferase reporter assay. In an IL-23-induced mouse model of psoriasis, significant reductions in epidermal thickness and IL-17A levels were observed for <b>33</b> when dosed orally at 100 mg/kg. A second confirmation of efficacy was achieved in K5.Stat3C transgenic mouse, which resembles human psoriasis. Oral administration of <b>33</b> attenuated 12-<i>O</i>-tetradecanoylphorbol-13-acetate-induced psoriasis-like lesions by improving scaly and erythematous change with attenuation of ear thickness.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">Pfizer disclosed a series of azaindole derivatives exemplified by compound <b>34</b> and <b>35</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> The striking feature of this molecule is the presence of rigid azaindole core unlike flexible methylene linker present in molecules <b>30</b>–<b>32</b>. The other noticeable change is the presence of piperidine heterocycle instead of piperazine. Compounds of this invention are always substituted with CF<sub>3</sub> (<b>34</b>), OCH<sub>3</sub> (<b>35</b>), and CH<sub>3</sub> (not shown) groups at the para-position of the pyridine from the azaindole core. RORγ inhibitory activity was confirmed in both TR-FRET assay (IC<sub>50</sub> = 4.7 nM (<b>34</b>), 11.8 nM (<b>35</b>)) and in the IL-17 production assay (IC<sub>50</sub> = 9.4 nM (<b>34</b>), 29.8 nM (<b>35</b>)).</div><div class="NLM_p">A recent publication by Takeda described the trimethylsilyl analogues (<b>36</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>)<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> with conformationally restricted bis-amide linker modification to their previously disclosed aliphatic linker derived bis-amides.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The selection of an unusual trimethylsilyl group was based on the finding that the silyl compounds have shown improved functional activity when compared with their <i>tert</i>-butyl counterparts (not shown).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The increase lipophilicity of the trimethylsilyl group over <i>tert</i>-butyl could be the reason for this phenomenon. A similar observation was earlier reported by Hashimoto’s group, where they have shown increased ROR inhibitory activity for silylated compounds.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Compound <b>36</b> with tetrahydroisoquinoline core inhibited RORγt with IC<sub>50</sub> values of 3 and 23 nM in the binding assay and a cell-based reporter gene assay, respectively. The X-ray cocrystal structure of a closely related analogue with RORγt-LBD revealed that the trimethylsilylphenyl group was extended toward the hydrophobic pocket (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B30">6B30</a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Amide groups, one with NH group and other with the carbonyl group, formed hydrogen bonds with the backbones of Phe377 and Glu379 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Compound <b>36</b> was shown to have excellent oral bioavailability in mice (<i>F</i>(%) = 94). Furthermore, <b>36</b> had shown excellent in vivo efficacy with an ED<sub>50</sub> value of 2.8 mg/kg po in reducing IL-17A gene expression in IL-23 treated mice.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><div class="NLM_p">Takeda recently described the discovery efforts and pharmacological profile of their clinical candidate <b>37</b> (TAK-828F, free form of TAK-828, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(74,75)</a> The SAR was directed to reduce lipophilicity of compound <b>36</b> (clogP = 5.8) with three significant changes: first, to replace trimethylsilyl group with dimethylindanyl group, second, core modification with tetrahydronaphthyridine, and third, replacement of the flexible carboxylic acid linker with a rigid structure. The optimized compound <b>37</b> (clogP = 3.9) was identified with improved RORγt IC<sub>50</sub> values of 1.9, 6.1, and 102 nM in a binding assay, cell-based reporter gene assay, and human PBMCs, respectively.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> It was found to be highly selective against related ROR isoforms and a panel of 20 NRs.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> In Th17 and Th1 cells differentiation assay from human CD4<sup>+</sup> T cells, it selectively suppressed Th17 polarization (IC<sub>50</sub> = 28 nM) and also decreased Tc17 cells differentiation from human CD8<sup>+</sup>T cells (IC<sub>50</sub> = 9.5 nM).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> In human whole blood assay, it inhibited IL-17, IL-17F, and IL-22 production with IC<sub>50</sub> values of 120, 430, and 1600 nM, respectively.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Compound <b>37</b> suppressed the Th17 cells differentiation and simultaneously increase the expression of Treg transcriptional factor Foxp3 in CD4<sup>+</sup> T cells in Th17-skewing condition improving Th17/Treg cells imbalance.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Owing to the good PK in mice (<i>F</i>(%) = 96, <i>T</i><sub>1/2</sub> = > 4 h), it was further evaluated in EAE model where it displayed 50% reduction of the clinical score upon oral dosing at 1 mg/kg bid in mice.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Furthermore, <b>37</b> was also shown to have in vivo efficacy in the activated T cell transfer colitis model and IL-23-induced mouse psoriasis model upon oral dosing.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The cocrystal structure of <b>37</b> with RORγt (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BR3">6BR3</a>) revealed similar interactions as described for <b>36</b> with an additional water-mediated hydrogen bond interaction observed for nitrogen atom of the pyridine ring with Gln286.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The methoxy group was involved in a water-mediated interaction with Arg364. However, Takeda recently announced the discontinuation of <b>37</b> based on the critical toxicological findings in both monkey and rats.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p last">The HTS campaign at Japan Tobacco followed by ligand efficiency (LE), and a fraction of saturated carbons (Fsp<sup>3</sup>) guided SAR led to the identification of compound <b>38</b> (human GAL4 EC<sub>50</sub> = 34 nM, LE = 0.29, Fsp<sup>3</sup> = 0.64) as an orally active RORγ inhibitor (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> The X-ray structure of an analogue (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AYG">5AYG</a>) revealed the U-shape binding in the LBP of human RORγ. The NH from linker amide group made a direct hydrogen bond with the backbone carbonyl of Phe377, while the water-mediated hydrogen bond was observed with Arg364 through the carbonyl. A second water-mediated hydrogen bond was observed to Glu379 through a nitrogen atom from the triazole ring serving a role of the carbonyl from a second amide group. Furthermore, the compound <b>38</b> (<i>F</i>(%) = 78 in mouse), when administered at 30 mg/kg po to mice treated with MOG/PTX and a CD3 antibody suppressed IL-17 production by 45% after 8 h.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">5.  Allosteric Inhibitors</h3><div class="NLM_p">The RORc inhibitors discussed so far were shown to occupy orthosteric-binding pocket in RORc. Researchers at Merck identified a novel allosteric binding site adjacent to it with a series of allosteric ligands <b>39</b>–<b>42</b> (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The cocrystal of RORγt-LBD and <b>39</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPQ">4YPQ</a>) revealed a new binding site different from the canonical orthosteric NR ligand-binding site and is formed by helices 4, 5, 11, and the reoriented flexible H12 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). The ortho-substituted trifluoromethyl and chloro moieties impart a specific rotation to the phenyl group of <b>39</b> and address hydrophobic sites near helix-11 and helix-3 in the allosteric pocket (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). The carboxylic acid group of <b>39</b> involved in hydrogen-bonding interactions with the backbone NH of Aln497 and Phe498 and also with the side chain of Gln329, suggesting the importance of the carboxylic group in this class of compounds. The unique conformation induced by the binding of <b>39</b> prevents interaction with coactivator peptides, which usually bind RORγt at the AF-2 domain.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Allosteric inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cocrystal structure of allosteric ligand <b>39</b> (MRL-871) and orthosteric ligand <b>1</b> (T0901317) with RORγt-LBD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The potency of compounds has been evaluated in the biochemical assay (RORγt FRET IC<sub>50</sub> = 6.1 nM (<b>39</b>), 3.8 nM (<b>40</b>), 1.9 nM (<b>41</b>), 2 nM (<b>42</b>)) and functional assay of IL-17 production (hPBMC IC<sub>50</sub> = 39.6 nM (<b>39</b>), 9.4 nM (<b>40</b>), 13 nM (<b>41</b>)).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The additional fluoro groups and polar functionalities in <b>40</b> and <b>41</b> showed a positive impact in improving potency. Compounds <b>40</b> and <b>42</b> were found to be >100-fold selective when tested against ROR isoforms and panel of NRs. At 1 μM concentration, compounds <b>39</b> and <b>42</b> were shown to suppress IL-17A secretion by 70% in cells derived from patients with AS. Furthermore, they were shown to reduce the number of IL-17A<sup>+</sup> cells within the CD4<sup>+</sup> T-cell compartment by 50% in cluster of autoimmune inflammatory diseases, including AS, psoriatic arthritis, RA, and IBD.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> A recent patent from Merck described a cyclopropyl modification of compound <b>42</b> (i.e., <b>43</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) in order to improve PK profile.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Compound <b>43</b> (RORγt FRET IC<sub>50</sub> = 2.5 nM) was shown to have low plasma clearance (5 mL/min/kg) in comparison with <b>42</b> (76 mL/min/kg) in rat.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">To address the potential metabolic liability of the 1-acyl-indazole moiety, researchers at Genentech came up with the imidazo[1,5-<i>a</i>]pyridine (e.g., <b>44</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) central core that has a benzoyl group attached to a carbon atom.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Compound <b>44</b> (RORc SRC1 EC<sub>50</sub> = 2 nM) suppressed IL-17 production in hPBMCs with an IC<sub>50</sub> value of 17 nM and displayed 250-fold selectivity against ROR isoforms. The structural modification also facilitated compound <b>44</b> and related analogues to improve their selectivity over PPARγ in comparison with compound <b>39</b>. However, in a rat PK experiment, <b>44</b> demonstrated a high plasma clearance (CLp = 130 mL/min/kg) exceeding rodent liver blood flow (55 mL/min/kg), indicating that extrahepatic clearance mechanisms may also be participating in the metabolism of <b>44</b>.</div><div class="NLM_p last">Galderma disclosed a series of phenoxyindazoles (e.g., <b>45</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) in line with their interest in developing RORγ inhibitor suitable for topical application.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> In a recombinant RORγt/GAL4 cellular assay, <b>45</b> displayed an IC<sub>50</sub> value of 31 nM and inhibited IL-17 production in human CD4 cells with an IC<sub>50</sub> value of 40 nM. The presence of a <i>N</i>,<i>N</i>-dimethylamide group was crucial for its selectivity against retinoic acid receptor gamma (RARγ). Although high intrinsic clearance in human hepatocytes was suitable for its use as a topical agent, phototoxicity in the cellular assay prevented its further evaluation. The X-ray structure of <b>45</b> bound to RORγ (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWP">5LWP</a>) offered a further confirmation for the compound to be an allosteric ligand.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">6.  Miscellaneous Inhibitors</h3><div class="NLM_p">The isooxazole derivative <b>46</b> (TMP778, IC<sub>50</sub> = 5 nM (FRET) and 17 nM (GAL4) assays, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) was earlier reported to have antipsoriatic activity in mice.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> It was shown to reduce ear thickness, epidermal hyperplasia, and inflammatory cell influx in the IMQ-induced mouse model of psoriasis at 20 mg/kg bid, sc, by a team from Tempero.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Miscellaneous inhibitors (part 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A team from Innovimmune published several patent applications on a common pyrazole motif (e.g., <b>47</b>–<b>49</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref84 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref84 ref85 ref86">(84−86)</a> In a separate disclosure, a series of compounds with pyrazole moiety linked to indole (e.g., <b>47</b>),<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> azaindole (e.g., <b>48</b>),<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and pyrazole (e.g., <b>49</b>)<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> central cores were described. Selected compounds of the invention were evaluated for their ability to inhibit cytokine production in human PBMCs. All exemplified compounds have inhibited IL-17A, IL-17F, IL-21, and IL-22 production with an IC<sub>50</sub> value of <10 μM. Recently, a preclinical profile of their RORγ inhibitor (INV-17) was disclosed.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> The compound was assessed for its therapeutic efficacy in IMQ-induced mouse model of psoriasis. INV-17 was dosed orally at 15 mg/kg od in BALB/c mice for 5 days. A significant reduction of ear thickness was observed which was more pronounced than Tofacitinib citrate, a Janus kinase inhibitor (JAK 1 and 3) used as a comparator at 30 mg/kg bid, po.</div><div class="NLM_p">Nuevolution and Almirall have collaborated for discovering RORγt inverse agonists.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> While Nuevolution would evaluate RORγt inverse agonists for IBD indication, Almirall would develop them for dermatological indications including psoriatic arthritis.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Pyrimidine derivatives exemplified by <b>50</b> were earlier disclosed by Nuevolution as RORγ inverse agonists (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Several examples from the Nuevolution patent contained polar groups such as acid, alcohol, amide, and sulfonyl at one end, while the other end of the molecule usually has phenyl ring substituted with lipophilic substituents such as trifluoromethyl and alkyl. Compound <b>50</b> inhibited RORγ activity in the Gal4 assay by more than 80% at 1 μM. Furthermore, it was assessed in both EAE and CIA mouse model of autoimmune diseases where oral administration of <b>50</b> at 10 and 30 mg/kg bid doses displayed a disease attenuating effect.</div><div class="NLM_p">A team from Esalier Bioscience disclosed a series of biaryl derivatives (e.g., <b>51</b> and <b>52</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) as soft drugs for the topical treatment of psoriasis.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Structurally they are similar to <b>2</b> (SR2211) disclosed earlier by Scripps Florida.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The ester derivative <b>51</b> was shown as a potent inhibitor of RORγt in the Gal4 assay (IC<sub>50</sub> < 1 μM). The corresponding carboxylic acid derivative <b>52</b>, which may have been observed in systemic circulation upon enzymatic hydrolysis of ester, was inactive with an IC<sub>50</sub> value of >10 μM. The design of such inhibitors may provide a safe delivery of a topical RORγt inhibitor with a minimal systemic toxicity.</div><div class="NLM_p">A team from Arrien disclosed structurally distinct indanone derivatives exemplified by <b>53</b> as RORγt antagonists (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> The preferred compounds in this publication have a methoxy group on the phenyl ring of the central core and a benzyl group on 5-membered cyclopentanone ring. Trifluoromethyl group was extensively used as a substituent on the benzyl group. The representative compound <b>53</b> displayed IC<sub>50</sub> values less than 500 nM in FRET assay, RORγt-activated IL-17A assay in HEK 293 cell lines, and a CD4+ T cell IL-17 production assay. The preclinical profile of their clinical candidate ARN-6039 (structure not disclosed) was recently described.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The activity of ARN-6039 was demonstrated in a RORγt-activated IL-17A Prom/LUCPorter assay in HEK 293 cells (IC<sub>50</sub> = 360 nM) and in IL-17 production from CD4<sup>+</sup> T cell assay (IC<sub>50</sub> = 220 nM).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> It was found to be selective against related isoforms and has moderate oral bioavailability (<i>F</i>(%) = 37) and has no hERG liability. The uptake data indicated that ARN-6039 might act in the CNS as well as the blood to inhibit inflammation and demyelination. Oral administration of ARN-6039 (10 mg/kg) before anti-CD3e antibody administration in mice resulted in a 50% reduction of IL-17 production. In a mouse model of EAE, once a day dosing of ARN-6039 for 28 days protected mice from EAE development at 40 mg/kg dose. ARN-6039 showed no signs of toxicities up to doses of 2000 mg/kg from their toxicity studies.</div><div class="NLM_p">A structurally distinct series of indole derivative exemplified by <b>54</b> (IC<sub>50</sub> < 100 nM in RORγ GAL4 assay) was disclosed by AbbVie (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> The key SAR in patent examples was directed to the variations at amide portion of the molecule. The piperazine ring shown in <b>54</b> was frequently replaced with morpholine and piperidine. A large number of examples have piperidine ring substituted with the carboxylic acid group. AbbVie was successful in identifying its clinical candidate (ABBV-553), however, clinical development was later ceased.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_p">Pyridazine derivatives exemplified by <b>55</b> and <b>56</b> were disclosed by Genentech as modulators of RORc (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Majority of examples have 2,6-difluorophenyl ring substituted at the third position of the pyridazine ring. The chemotype optimization was mainly focused on the pyrimidine ring attached with a central core and was substituted with a variety of groups. In the binding assay, compound <b>55</b> with an unsubstituted pyrimidine ring displayed an IC<sub>50</sub> value of 15.8 nM, while <b>56</b> with the piperidinyl substituent showed improved binding with an IC<sub>50</sub> value of 2 nM.</div><div class="NLM_p">Researchers at Phenex previously described a series of pyrrole derivatives (e.g., <b>57</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) as RORγ modulators.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> The subsequent replacement of the pyrrole ring with oxazole,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> thiazole,<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and pyrazole<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> rings was reported in separate publications. Recently, biological evaluation of thiazole-based inverse agonists of RORγt (e.g., <b>58</b>, <b>59</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) derived from <b>57</b> was published by a team from Phenex and Janssen.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> During SAR, compounds were initially evaluated in a ThermoFluor binding assay using RORγ. Selected compounds were then tested in the RORc LBD-GAL4 assay in HEK293T cells and analyzed for their ability to inhibit IL-17 production in human whole blood. Compounds were further evaluated for their liability of PXR and RORβ inhibition associated with this chemotype. The initial SAR led to the identification of compound <b>58</b> (RORc IC<sub>50</sub> = 1.2 nM) with a moderate EC<sub>50</sub> value of 505 nM in human whole blood assay (efficacy compared to <b>62</b>, JNJ-54271074, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Compound <b>58</b> has shown limited potential for PXR inhibition, however, it was found to inhibit RORβ (IC<sub>50</sub> = 83 nM) in the similar assay as described for RORc. Additional optimization resulted in the identification of compound <b>59</b> (RORc IC<sub>50</sub> = 1.6 nM) with high selectivity over PXR and RORβ. The EC<sub>50</sub> value in human whole blood was found to be 98 nM. The X-ray structure of <b>58</b> bound to LBD of RORγt was prepared to understand the binding mode of this series of compounds (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CVH">6CVH</a>). Compound <b>58</b> almost entirely occupied LBD, while the carboxylic group was shown to project out of the LBP and was partially solvent-exposed. These results explain the broad tolerance of the polar groups at C-2 amide region of thiazole ring. The amide and terminal alkyl-CF<sub>3</sub> moieties projects toward the AF-2 region of LBD and approached helix 10/11. Despite extensive SAR efforts, the entire drug like parameters could not be achieved in this series and further SAR evaluation is warranted.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Miscellaneous inhibitors (part 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additional work based on the thiazole chemotype was published by Janssen in a recent patent disclosing a series of 6-aminopyridin-3-yl thiazole derivatives exemplified by <b>60</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> The amino group at sixth position on the pyridine ring was found to be crucial for the biological activity, while CF<sub>3</sub> group was desirable for high potency. Compound <b>60</b> in RORγt ThermoFluor binding assay displayed a <i>K</i><sub>d</sub> value of 0.17 nM, and in a human Th17 cell assay, it showed the IC<sub>50</sub> value of 2.8 nM.</div><div class="NLM_p">Quinolinyl derivatives as RORγt inhibitors were extensively evaluated by Janssen.<a onclick="showRef(event, 'ref100 ref101 ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref100 ref101 ref102 ref103">(100−103)</a> The SAR of quinoline tertiary alcohol modulators of RORγt (e.g., <b>61</b> and <b>62</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) was recently described by the team from Janssen.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The HTS using ThermoFluor assay followed by thorough optimization of 2-, 3-, and 4-positions on the quinoline core led to the identification of compound <b>61</b> (IC<sub>50</sub> = 170 nM in cell-based reporter assay). The cocrystal structure of <b>61</b> bound to LBD of RORγt revealed that the 4-chloro-2-methoxyquinoline core positioned itself between the side chains of Met365 and Phe378, forming an edge-to-face π–π interaction with the latter (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W4V">5W4V</a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The trifluoromethylpyridine ring is sandwiched between three aromatic side chains, making face-to-face contact with His323 and edge-to-face interactions with Phe377 and Phe378. The pyridine nitrogen accepts a hydrogen bond from the backbone amide of Glu379. The nitrogen from <i>N</i>-methylimidazole core was shown to make a water-mediated hydrogen bond with the Arg367. The antiarthritic activity of compound <b>62</b> (JNJ-54271074) was reported in a separate publication.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It was shown to have IC<sub>50</sub>s of 8 nM in a RORγt FRET assay, 9 nM in a one-hybrid reporter assay, and 30 nM in a two-hybrid corepressor peptide NCoR assay.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> A dose-dependent reduction in the arthritic score was demonstrated in a mouse model of CIA with 32%, 46%, and 78% reductions observed at 10, 30, and 60 mg/kg bid, po doses, respectively. It inhibited IL-17A production in PBMCs from RA subjects with an IC<sub>50</sub> value of 5 nM. In an IL-23-induced mouse model of dermatitis, oral administration of <b>62</b> showed significant reduction of total skin histology score, skin abscesses, and acanthosis at 30 and 60 mg/kg bid doses.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Janssen in collaboration with Phenex is developing JNJ-3534 (structure not disclosed) for psoriasis indication. Currently, the molecule is undergoing phase I clinical evaluation.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">In a recent press release, Reata Pharmaceuticals announced the initiation of phase I trial of their oral inhibitor of RORγt (RTA-1701, structure not disclosed).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Preclinical profile of RTA-1701 was recently described.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> It was shown as an isoform-selective, potent inhibitor of RORγt and inhibits IL-17 production in human PBMCs. Furthermore, RTA-1701 was reported to have efficacy in animal models of autoimmune disease, including the CIA mouse model of RA and the EAE mouse model of MS. In a separate report, PK of RTA-1701 and its effects on ex vivo stimulation of IL-17A production in the whole blood after oral administration to cynomolgus monkeys were described.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Monkeys received a single administration of RTA-1701 (0.3, 3, 30, or 300 mg/kg), and after a one-week washout, the same doses of RTA-1701 were given once daily for 14 consecutive days. RTA-1701 exhibited oral bioavailability in monkeys and produces significant and dose-dependent suppression of ex vivo stimulation of IL-17A secretion in whole blood at 24 and 30 h after single and repeat dosing. IL-17A levels normalized within 72 h after a single dose.</div><div class="NLM_p last">Reata disclosed their RORγt inhibitors in two separate patent publications. The first disclosure was C-4 modified oleanolic acid derivatives (e.g., <b>63</b>, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) reported as inhibitors of IL-17.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Compounds in this series are close analogues of Bardoxolone methyl, an NRF2 (nuclear factor erythroid-derived 2-related factor 2) activator, evaluated in a phase III trial for the treatment of chronic kidney disease.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> The C-4 position in this series was modified with groups such as substituted alkyl, cycloalkyl, heterocyclyl, hydroxy, and amino. In RORγ GAL4 cellular assay, <b>63</b> displayed an IC<sub>50</sub> value of 115 nM and inhibited IL-17 production from human CD4<sup>+</sup> T cells with an IC<sub>50</sub> value of 18 nM. In an AREc32 luciferase reporter assay, which allows assessment of the endogenous activity of NRF2 transcriptional factor in cultured cells, <b>63</b> doubles the NRF2-ARE (antioxidant response element) luciferase activity at 56 nM concentration. In a very recent patent, Reata disclosed pyrimidine-based tricyclic enone derivatives exemplified by <b>64</b>–<b>69</b> as inhibitors of RORγ.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> The compounds of the invention were evaluated for their biological activity using similar assays as described above. The major structural modifications were reported on the pyrimidine ring. The group at R<sup>1</sup> was 2-fluorophenyl in the majority of examples (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). The other R<sup>1</sup> substituents such as cycloalkyloxy and 5-membered heteroaryls have displayed appreciable activity in few examples. The 6-–10-membered N-containing heteroaryl rings especially pyridine and quinoline as R<sup>2</sup> substituents (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) have shown relatively better activity compare to its phenyl counterpart (not shown). The other R<sup>2</sup> modifications such as substituted alkyl and saturated heterocycles were not tolerated (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). The compound <b>64</b> with phenyl as R<sup>1</sup> substituent and 3-methyl-4-pyridyl as R<sup>2</sup> substituent displayed excellent potency (RORγ IC<sub>50</sub> = 40 nM, hIL-17 IC<sub>50</sub> = 39 nM, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Compound <b>65</b> with 2-fluorophenyl as R<sup>1</sup> and 4-quinolyl as R<sup>2</sup> showed similar potency (RORγ IC<sub>50</sub> = 52 nM, hIL-17 IC<sub>50</sub> = 32 nM) as that of <b>64</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). The C-4 position in the enone-containing ring was also modified. Changing the methyl to <i>n</i>-propyl group in <b>65</b> gave compound <b>66</b> with improved potency (<b>66</b>, RORγ IC<sub>50</sub> = 36 nM, hIL-17 IC<sub>50</sub> = 16 nM). Compound <b>67</b> with <i>gem</i>-dimethyl modification of <b>65</b> displayed slightly lower RORγ inhibitory activity but comparable IL-17 potency (<b>67</b>, RORγ IC<sub>50</sub> = 71 nM, hIL-17 IC<sub>50</sub> = 28 nM). The presence of cyano and the alkene group was a prerequisite for the potency as changing it to amide and saturating double bond, respectively, furnished compounds with the diminished potency (not shown). The central ring contraction from cyclohexyl (i.e., <b>65</b>) to cyclopentyl (i.e., <b>68</b>) was found to be detrimental for the potency (<b>68</b>, RORγ IC<sub>50</sub> = 245 nM, hIL-17 IC<sub>50</sub> = 147 nM). However, ring expansion from cyclohexyl (i.e., <b>64</b>) to cycloheptyl (i.e., <b>69</b>) was done with the retention of activity (<b>69</b>, RORγ IC<sub>50</sub> = 37 nM, hIL-17 IC<sub>50</sub> = 44 nM). The R stereochemistry of the C–H at the fusion of the enone-containing ring and the central ring is favored for the enhancement of potency (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Compounds have also been tested for their potential to activate NRF2 and found to double NRF2-ARE at 5–10-fold higher concentration than their RORγ IC<sub>50</sub> values. For example, compound <b>64</b> (RORγ IC<sub>50</sub> = 40 nM) doubles NRF2-ARE at ∼7-fold higher concentration (278 nM). Importantly, compound <b>69</b> (RORγ IC<sub>50</sub> = 37 nM) with cycloheptane central ring doubles it at a much higher concentration (892 nM, ∼24-fold). Reata has claimed their clinical candidate to be an allosteric ligand. Structurally, this class of inhibitors is quite different from the earlier allosteric inhibitors. Hence, cocrystal data are required to substantiate their classification into an allosteric class of inhibitors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Clinical Update</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Vitae/Allergan disclosed the clinical data of the most advanced molecule (<b>22</b>, VTP-43742/AGN 242428, phase II). Compound <b>22</b> was evaluated in two, randomized, double-blind, placebo-controlled studies in healthy volunteers.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Compound <b>22</b> in both single ascending dose (SAD) study (seven dose levels, 30–2000 mg) and multiple ascending dose (MAD) study (five dose levels, 100–1400 mg, od, 10 days) was safe and well tolerated at all dose levels. In the SAD study, it had a terminal half-life of ∼30 h suitable for once a day dosing. In an ex vivo whole blood assay of IL-17A secretion, <b>22</b> suppressed IL-17A secretion in a dose-dependent manner with >90% inhibition observed at the higher doses. Compound <b>22</b> was then evaluated in a randomized, double-blind placebo-controlled phase IIa trial in psoriasis patients over a four-week period. A significant reduction in the psoriasis area severity index (PASI) score relative to the placebo was observed in the 350 mg (24%) and 700 mg (30%) dose groups.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> The rate of reduction in PASI score showed an increasing trend between weeks three and four, suggesting the potential for greater reductions in PASI scores with the longer duration of treatment. No serious adverse events were reported in this study, however, in the 700 mg dose group, reversible transaminase elevations were observed in four patients. In a recent press release, the discontinuation of <b>22</b> was reported because of unknown safety concerns.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a></div><div class="NLM_p">Compound <b>14</b> (GSK-2981278, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) was evaluated in the clinic for the topical treatment of psoriasis by GSK. The clinical outcome of phase I randomized controlled trial to evaluate the safety and clinical effect of topically applied ointment of <b>14</b> in a psoriasis plaque test was recently disclosed.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> Subjects (<i>n</i> = 15) were treated with 200 μL of <b>14</b> ointment (0.03%, 0.1%, 0.8%, or 4%), vehicle, and betamethasone valerate 0.1% cream (positive control) once daily over 19 days. However, clinical assessment results showed no improvement in psoriatic lesions following treatment with <b>14</b> or vehicle ointment. The lack of efficacy is attributed to the insufficient drug exposure at the target site, small treatment area, and the need for systemic inhibition of RORγ. GSK recently announced that it may terminate, partner or divest <b>14</b>.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div class="NLM_p last">Development of clinical molecules TAK-828 (<b>37</b>), ABBV-553, and JTE-151 was ceased, while the outcome of other clinical molecules, including ARN-6039 (phase I), JNJ-3534 (phase I), AZD-0284 (<b>26</b>, phase I), and JTE-451 (phase I) has not been reported so far. RTA-1701 is an allosteric inhibitor of RORγt for which initiation of a phase I trial has been recently reported.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of RORc inhibitors for the treatment of autoimmune disorders has received much attention in the past five years. With several molecules currently in the clinical and preclinical evaluation, this area of research continues to evolve. The broad consensus among highly diverse RORc inhibitors is the presence of lipophilic motif on one end attached to a polar moiety (most often hydrogen bond acceptor) on the other end via a variety of linkers or central cores. Availability of crystal structures with ligands offers significant insight on how to modulate RORc inverse agonistic activity. In general, ligands that stabilize helix 12 of protein are agonists, while those which destabilize are inverse agonists. Even minor variation in the structure is found to reverse the biological nature of the ligand. For example, compound <b>12</b> with benzenesulfonamide moiety displayed agonist nature, while compounds <b>10</b> and <b>11</b> with benzyl sulfonamide moiety were inverse agonist (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Current inhibitors of RORc have shown high selectivity over related NRs. As many of them are derived from the HTS campaign, SAR was directed to achieve selectivity against their primary biological target in parallel to improve RORc inverse agonist activity. Compounds <b>2</b>–<b>4</b> and <b>5</b> illustrate the SAR studies in which the selectivity was achieved against LXR and PXR, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Compound <b>43</b> illustrates the SAR exploration in which C-acylated imidazo[1,5-<i>a</i>]pyridine derivatives have shown improved PPARγ selectivity when compared with <i>N</i>-acylated indazole derivative (<b>39</b>) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><div class="NLM_p">Isoform selectivity in RORc inhibitors initially remained an issue, but that has been mostly resolved, as current inhibitors possess excellent isoform selectivity. As described in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, compounds <b>2</b> and <b>3</b> have hexafluoroisopropanol-substituted phenyl ring similar to <b>1</b> but differ in having a biaryl core in place of sulfonamide group and an additional piperazine moiety bearing a hydrogen bond acceptor groups at the terminal position. The above structural changes offered compounds <b>2</b> and <b>3</b> an improved selectivity for RORc, unlike <b>1</b>, which is a nonselective RORα/c inverse agonist. Compound <b>17</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), one of the earliest compounds in aryl sulfonyl class of RORc inhibitors, was described as a dual inhibitor of RORβ/c.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> However, few inhibitors from the same class having variations at the lipophilic portion and having similar hydrogen bond acceptor aryl sulfonyl moiety are reported to be selective RORc inverse agonists (e.g., <b>22</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and <b>25</b>,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). This has led to the inference that modulating a lipophilic portion of the molecule may improve RORβ selectivity. The solubility is another critical issue with these significant lipophilic RORc inhibitors. Discovery of <b>26</b> (AZD-0284, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was dominated by the structural modifications that improve solubility by reducing log <i>D</i>.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> To achieve this as discussed, polar groups were introduced at the linker which has served to improve both potency and solubility.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p">The identification of selective RORγ inhibitor against related isoforms addressed the toxicities associated with RORα inhibition (ataxia) and RORβ inhibition (motor defects). RORγ and its isoform RORγt have identical LBDs. This makes selective inhibition of RORγt, which is present only in the thymus, a challenging goal to achieve. The undesired inhibition of RORγ in nonimmune cells poses a concern for potential side effects. Besides its beneficial effect in regulating IL-17-mediated diseases, its excessive inhibition may have several theoretical concerns. Recent studies with RORγt inverse agonist (<b>42</b>, MRL-248, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>) revealed that the pharmacological inhibition of RORγt decreases double-positive CD4<sup>+</sup>CD8<sup>+</sup> thymocyte life span, skews TCRα gene rearrangement, and limits T cell repertoire diversity.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> The chronic study in rats with RORc inhibitor showed thymic aberrations, suggesting a possible risk of T cell lymphoma with RORc inhibitors upon chronic therapy.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Furthermore, a conditional RORγ/γt knockout mouse (RORc CKO), where the RORc locus can be deleted in adult animals, was designed to understand whether lymphomas observed in the RORc KO mice<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> would develop in an animal with an intact, fully developed immune system.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The study confirmed findings that RORc CKO animals also develop lymphoma in a similar time frame as embryonic RORc knockouts. Interestingly, in animals where the gene deletion is incomplete, the thymus undergoes a rapid selection process which replaces RORc-deficient cells with remnant thymocytes carrying a functional RORc locus. Subsequently, these animals did not develop lymphoblastic lymphoma. These observations have raised a notion that RORc partial inverse agonists (e.g., <b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) may have a better safety profile than full inverse agonists. However, the balance between safety and the desired therapeutic efficacy with the partial inverse agonists needs to be demonstrated. RORγ loss of function mutations have been identified in humans.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Seven patients from three ethnic groups were shown to lack functional RORγ and RORγt.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Importantly, only a mild T-cell lymphopenia was observed, and these patients were free from any lymphomas. However, they have shown increased susceptibility to candidiasis and mycobacteriosis.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Long-term toxicological evaluation of RORc inhibitors is therefore needed to preclude any toxicity that may arise in humans upon chronic use.</div><div class="NLM_p">Despite potential concerns of RORc inhibition, it is still a viable approach for some, if not all, of the autoimmune diseases. The preclinical data of current RORc inhibitors endorse their use for the treatment of psoriasis and MS. Although a few molecules have shown efficacy in a mouse CIA model, clinical usage of these inhibitors for RA is still a forward-looking goal. However, there may be a more immediate application in combination therapy for RA. So far, the majority of molecules advanced into the clinical trials found psoriasis as their primary indication through topical as well as systemic administration. The initial data of the most advanced molecule <b>22</b> (VTP-43742, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) in psoriatic patients upon oral dosing were encouraging, however, safety concerns prevented further development of this molecule. Furthermore, the lack of efficacy of topically applied <b>14</b> (GSK-2981278) in a psoriasis plaque suggests that systemic inhibition of RORc would be more desirable.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> As discussed previously, IL-17 antibodies exacerbate Crohn’s disease, which may be due to undesired inhibition of RORγt in innate lymphoid cells (ILC). However, a recent investigation with RORγt inverse agonist (<b>18</b>, GSK805, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) in mice infected with <i>Citrobacter rodentium</i> demonstrated that transient inhibition of RORγt provides therapeutic benefit in mouse models of intestinal inflammation by selective targeting of Th17 cells but not ILCs.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> TAK-828 (<b>37</b>, its free base) was advanced into the clinic with the intended use for the treatment of Crohn’s disease. Unfortunately, before valuable insight was derived, the trial was discontinued based on the critical toxicological findings in both monkey and rats combined with its potential for teratogenicity in humans.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The discontinuation of VTP-43742 and TAK-828 due to safety concerns reaffirm the importance of a critical evaluation of preclinical toxicity in animals. The LBP of RORc is mainly hydrophobic and allows binding of inhibitors with substantially high lipophilicity. Consequently, these inhibitors have shown excellent efficacy in a preclinical model of MS, possibly as a result of their appreciable CNS penetrability.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> On the basis of these findings, Arrien has advanced its candidate ARN-6039 in a phase I trial for MS indication. Another application of RORc inhibitors is in respiratory indications. As discussed earlier, RORc inhibitor <b>24</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was shown to inhibit pulmonary inflammation and emphysema induced by cigarette smoke in male C57/BL6 mice. Moreover, <b>24</b> also inhibits the IL-17 production from lung BAL cells and PBMCs of COPD patients.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Recently, it was shown that IL-17 was expressed in the lymphocytes associated with tuberculosis (TB) granulomas and in the bronchoalveolar lavage fluid from patients with pulmonary TB.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> IL-17 drives airway stromal cell-derived matrix metalloproteinase-3, a mediator of tissue destruction in TB, suggesting a possible role of RORc inhibitors in improving outcomes in TB therapy.</div><div class="NLM_p last">In our opinion, RORc is a potential target for therapeutic interventions in autoimmune diseases through its inhibition or in cancer through its activation. Disclosure of additional clinical data will further strengthen the therapeutic potential of RORc inhibitors in diseases like psoriasis, MS, and Crohn’s disease. The use of RORc inhibitors for respiratory indications and metabolic disorders is another area that requires attention. As a result, continued investigation into the discovery of new, selective RORc inhibitors and subsequent investigation in autoimmune disease models will contribute to future advances in the field.</div></div><div class="NLM_back"><div class="NLM_notes" id="notes-1"><p class="first last">The authors declare no competing financial interest.</p></div><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00588" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vrajesh B. Pandya</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9004-4514" title="Orcid link">http://orcid.org/0000-0001-9004-4514</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#99efebf8f3fceaf1e9f8f7fde0f8d9e3e0fdeceafaf8fdf0f5f8b7faf6f4"><span class="__cf_email__" data-cfemail="8ff9fdeee5eafce7ffeee1ebf6eecff5f6ebfafceceeebe6e3eea1ece0e2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanjay Kumar</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong"> Sachchidanand</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajiv Sharma</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ranjit C. Desai</span> - <span class="hlFld-Affiliation affiliation">Zydus Research Centre, Cadila Healthcare Limited, Sarkhej Bavla NH8A, Moraiya, Ahmedabad 382210, India</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Vrajesh B. Pandya</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=BIO-d7e2752-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Vrajesh B. Pandya</b> is a medicinal chemist at Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India. He obtained his Ph.D. degree from The Maharaja Sayajirao University of Baroda, Vadodara, India, studying novel compounds for the treatment of thrombotic and related disorders. He is actively involved in the discovery of new chemical entities in anti-inflammatory and antibacterial therapeutic areas.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Sanjay Kumar</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=BIO-d7e2757-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sanjay Kumar</b> is currently working as General Manager in the Medicinal Chemistry Department at Zydus Research Center, Ahmedabad India, where he is involved in preclinical drug discovery in various therapeutic areas viz., metabolic disorders, infectious diseases, etc. Prior to Zydus, he worked at Piramal Life Sciences Mumbai on proliferative, metabolic, and inflammatory disorders for a decade, and as a team delivered multiple clinical candidates to treat oncological and metabolic disorders. He obtained his Ph.D. degree from University of Allahabad and completed his postdoctoral research at the Indian Institute of Science (IISc) Bangalore and the Complex Carbohydrate Research Center (CCRC), University of Georgia at Athens, Georgia, USA.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Sachchidanand</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=BIO-d7e2762-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sachchidanand</b> is currently heading Bioinformatics Department at Zydus Research Center, Ahmedabad, India. Prior to Zydus, he worked as Associate Professor at NIPER Hajipur in the Department of Pharmacoinformatics, as Senior Scientist at Lupin Research Park, Pune, in the Molecular Modeling Group and Senior Research Scientist at the Institute of Life Sciences, Hyderabad. He obtained his D.Phil. degree from the University of Oxford, UK, and did his postdoctoral research at Mount Sinai School of Medicine, New York, USA.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Rajiv Sharma</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=BIO-d7e2767-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rajiv Sharma</b> is the senior vice president and head of chemistry at Zydus Research Center, Ahmedabad, where he is involved in the discovery and development of NCE’s in the field of inflammation, anemia, and antibacterials for resistant infections. Dr. Sharma received his Ph.D. in organic chemistry from University of Delhi and obtained postdoctorate training in Medicinal chemistry in National Institutes of Health at Bethesda, Maryland. Prior to Zydus, he has worked in leadership positions at Piramal, Amgen, Tularik, and Boehringer Ingelheim.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Ranjit C. Desai</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=BIO-d7e2772-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ranjit C. Desai</b> is a current Senior Consultant (January 2016–present) and former Senior Vice President and Head of Chemistry for Zydus Research Center, Cadila Healthcare Ltd., in Ahmedabad, India. Dr. Desai has been with Zydus since July 2012 and during his tenure has led the development of four IND candidates in various therapeutic areas, ranging from the metabolic diseases to pain and oncology. In his current role with Zydus, he runs projects in the anti-infective area. Dr. Desai received his Ph.D. from the MS University of Baroda in Gujurat, India, where he worked with Dr. Sukh Dev at the Malti-Chem Research Centre. After working as a postdoctoral associate at Clemson University, Purdue University and the University of Montreal, he held roles at Sanofi-Winthrop, Hoechst Celanese, and Merck Research Laboratories.</p></figure></div><div class="ack" id="ACK-d7e2777-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Amit Joharapurkar and Jeevan Kumar for their help in preparing manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AF</td><td class="NLM_def"><p class="first last">activation function helix</p></td></tr><tr><td class="NLM_term">ARE</td><td class="NLM_def"><p class="first last">antioxidant response element</p></td></tr><tr><td class="NLM_term">AS</td><td class="NLM_def"><p class="first last">ankylosing spondylitis</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">collagen-induced arthritis</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">Fsp3</td><td class="NLM_def"><p class="first last">fraction of saturated carbons</p></td></tr><tr><td class="NLM_term">GM-CSF</td><td class="NLM_def"><p class="first last">granulocyte-macrophage colony stimulating factor</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">inflammatory bowel disease</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">ILC</td><td class="NLM_def"><p class="first last">innate lymphoid cells</p></td></tr><tr><td class="NLM_term">IMQ</td><td class="NLM_def"><p class="first last">Imiquimod</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand-binding domain</p></td></tr><tr><td class="NLM_term">LBP</td><td class="NLM_def"><p class="first last">ligand-binding pocket</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LTi</td><td class="NLM_def"><p class="first last">lymphoid tissue inducer</p></td></tr><tr><td class="NLM_term">LXR</td><td class="NLM_def"><p class="first last">liver X receptor</p></td></tr><tr><td class="NLM_term">MAD</td><td class="NLM_def"><p class="first last">multiple ascending dose</p></td></tr><tr><td class="NLM_term">MI</td><td class="NLM_def"><p class="first last">myocardial infarction</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">nuclear receptor</p></td></tr><tr><td class="NLM_term">NRF2</td><td class="NLM_def"><p class="first last">nuclear factor erythroid-derived 2-related factor 2</p></td></tr><tr><td class="NLM_term">PASI</td><td class="NLM_def"><p class="first last">psoriasis area severity index</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">PXR</td><td class="NLM_def"><p class="first last">pregnane X receptor</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">RARγ</td><td class="NLM_def"><p class="first last">retinoic acid receptor gamma</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">ROR</td><td class="NLM_def"><p class="first last">retinoic acid receptor-related orphan receptor</p></td></tr><tr><td class="NLM_term">SAD</td><td class="NLM_def"><p class="first last">single ascending dose</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SPA</td><td class="NLM_def"><p class="first last">scintillation proximity assay</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">steroid receptor coactivator</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tuberculosis</p></td></tr><tr><td class="NLM_term">Tc</td><td class="NLM_def"><p class="first last">cytotoxic T cell</p></td></tr><tr><td class="NLM_term">Th</td><td class="NLM_def"><p class="first last">T helper cell</p></td></tr><tr><td class="NLM_term">Treg</td><td class="NLM_def"><p class="first last">regulatory T cells</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 120 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balagué, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godessart, N.</span></span> <span> </span><span class="NLM_article-title">Understanding autoimmune disease: new targets for drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.drudis.2009.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=19596080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFygs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=926-934&author=C.+Balagu%C3%A9author=S.+L.+Kunkelauthor=N.+Godessart&title=Understanding+autoimmune+disease%3A+new+targets+for+drug+discovery&doi=10.1016%2Fj.drudis.2009.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding autoimmune disease: new targets for drug discovery</span></div><div class="casAuthors">Balague, Cristina; Kunkel, Steven L.; Godessart, Nuria</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">926-934</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A more complete understanding of the mechanisms that drive autoimmune diseases has begun to be translated into therapeutic options with significant clin. consequences.  A clear example of this is the introduction of biol. therapies, which have provided new therapeutic avenues, as well as validated the mediators (TNFα, IL-6), mechanisms (T cell costimulation, leukocyte migration), and cellular players (T and B lymphocytes) of the disease process itself.  New discoveries into the role of Th17 and regulatory T cells and the epigenetic regulation of cytokine expression may offer novel intervention strategies to satisfy the unmet medical needs that still exist in these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrE52gnwKpXrVg90H21EOLACvtfcHk0lgu4-fcx5VcoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFygs7fJ&md5=9716694fad8a281ab56c36cb48c47411</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DBalagu%25C3%25A9%26aufirst%3DC.%26aulast%3DKunkel%26aufirst%3DS.%2BL.%26aulast%3DGodessart%26aufirst%3DN.%26atitle%3DUnderstanding%2520autoimmune%2520disease%253A%2520new%2520targets%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D926%26epage%3D934%26doi%3D10.1016%2Fj.drudis.2009.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansouri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menter, A.</span></span> <span> </span><span class="NLM_article-title">A review of biologic therapies targeting IL-23 and IL-17 for use in moderate-to-severe plaque psoriasis</span>. <i>Dermatol Ther (Heidelb)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1007/s13555-015-0092-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1007%2Fs13555-015-0092-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26714681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A280%3ADC%252BC28rlslejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1-12&author=M.+Campaauthor=B.+Mansouriauthor=R.+Warrenauthor=A.+Menter&title=A+review+of+biologic+therapies+targeting+IL-23+and+IL-17+for+use+in+moderate-to-severe+plaque+psoriasis&doi=10.1007%2Fs13555-015-0092-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis</span></div><div class="casAuthors">Campa Molly; Menter Alan; Mansouri Bobbak; Warren Richard</div><div class="citationInfo"><span class="NLM_cas:title">Dermatology and therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn">2193-8210</span>.
    </div><div class="casAbstract">The development of several highly effective biologic drugs in the past decade has revolutionized the treatment of moderate-to-severe plaque psoriasis.  With increased understanding of the immunopathogenesis of psoriasis, the emphasis has turned toward more specific targets for psoriasis drugs.  Although the complex immunological pathway of psoriasis is not yet completely understood, current models emphasize the significant importance of interleukin (IL)-23 and IL-17.  Several biologic drugs targeting these cytokines are now in various stages of drug development.  Drugs targeting IL-23 include BI-655066, briakinumab, guselkumab, tildrakizumab, and ustekinumab.  Drugs targeting IL-17 include brodalumab, ixekizumab, and secukinumab.  While many of these have shown safety and good efficacy in clinical trials of moderate-to-severe plaque psoriasis, long-term safety is still to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6JaFL9P83pNiNltV31zlfW6udTcc2eZqDbziTafnXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rlslejtA%253D%253D&md5=3937d9a24e1587e1d04d24f3dad6f48a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs13555-015-0092-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13555-015-0092-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampa%26aufirst%3DM.%26aulast%3DMansouri%26aufirst%3DB.%26aulast%3DWarren%26aufirst%3DR.%26aulast%3DMenter%26aufirst%3DA.%26atitle%3DA%2520review%2520of%2520biologic%2520therapies%2520targeting%2520IL-23%2520and%2520IL-17%2520for%2520use%2520in%2520moderate-to-severe%2520plaque%2520psoriasis%26jtitle%3DDermatol%2520Ther%2520%2528Heidelb%2529%26date%3D2016%26volume%3D6%26spage%3D1%26epage%3D12%26doi%3D10.1007%2Fs13555-015-0092-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caiazzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Caprio, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monfrecola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lembo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, F.</span></span> <span> </span><span class="NLM_article-title">Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders</span>. <i>Expert Opin. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1374</span>, <span class="refDoi"> DOI: 10.1080/14712598.2017.1363884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1080%2F14712598.2017.1363884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28791896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSrt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=1363-1374&author=A.+Balatoauthor=E.+Scalaauthor=N.+Balatoauthor=G.+Caiazzoauthor=R.+D.+Di+Caprioauthor=G.+Monfrecolaauthor=A.+Raimondoauthor=S.+Lemboauthor=F.+Ayala&title=Biologics+that+inhibit+the+Th17+pathway+and+related+cytokines+to+treat+inflammatory+disorders&doi=10.1080%2F14712598.2017.1363884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders</span></div><div class="casAuthors">Balato, Anna; Scala, Emanuele; Balato, Nicola; Caiazzo, Giuseppina; Di Caprio, Roberta; Monfrecola, Giuseppe; Raimondo, Annunziata; Lembo, Serena; Ayala, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1363-1374</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Advances in the understanding of TNF-α and IL-17 synergistic functions have recently led to the concept that patients who do not respond or who respond inadequately to TNF-α inhibitors may have IL-17-driven diseases, opening up the way for a new class of therapeutic development: Th17-inhibitors.  In this review, the authors discuss the central role that the IL-23/Th17 axis plays in the pathogenesis of several inflammatory diseases, such as psoriasis, highlighting its position as a relevant therapeutic target.  In particular, the authors start by giving a brief historical excursus on biol. agent development up until the success of TNF-α inhibitors, and continue with an overview of IL12/23 pathway inhibition.  Next, they describe Th17 cell biol., focusing on the role of IL-17 in host defense and in human immune-inflammatory diseases, discussing the use and side effects of IL-17 inhibitors.  The IL-23/Th17 signaling pathway plays a central role in the pathogenesis of several inflammatory diseases, such as psoriasis.  Recent data has demonstrated that biologics neutralizing IL-17 (ixekizumab, secukinumab) or its receptor (brodalumab) are highly effective with a pos. safety profile in treating moderate to severe psoriasis, offering new treatment possibilities, esp. for patients who do not respond adequately to anti-TNF-α therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppe7x_eAazOLVg90H21EOLACvtfcHk0li39Xlu86nzQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSrt73E&md5=2f344e96219286494f71e4aece68c52a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F14712598.2017.1363884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14712598.2017.1363884%26sid%3Dliteratum%253Aachs%26aulast%3DBalato%26aufirst%3DA.%26aulast%3DScala%26aufirst%3DE.%26aulast%3DBalato%26aufirst%3DN.%26aulast%3DCaiazzo%26aufirst%3DG.%26aulast%3DDi%2BCaprio%26aufirst%3DR.%2BD.%26aulast%3DMonfrecola%26aufirst%3DG.%26aulast%3DRaimondo%26aufirst%3DA.%26aulast%3DLembo%26aufirst%3DS.%26aulast%3DAyala%26aufirst%3DF.%26atitle%3DBiologics%2520that%2520inhibit%2520the%2520Th17%2520pathway%2520and%2520related%2520cytokines%2520to%2520treat%2520inflammatory%2520disorders%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2017%26volume%3D17%26spage%3D1363%26epage%3D1374%26doi%3D10.1080%2F14712598.2017.1363884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budelsky, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towne, J. E.</span></span> <span> </span><span class="NLM_article-title">Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2015.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.immuni.2015.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26431947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFyqt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=739-750&author=J.+R.+Maxwellauthor=Y.+Zhangauthor=W.+A.+Brownauthor=C.+L.+Smithauthor=F.+R.+Byrneauthor=M.+Fiorinoauthor=E.+Stevensauthor=J.+Biglerauthor=J.+A.+Davisauthor=J.+B.+Rottmanauthor=A.+L.+Budelskyauthor=A.+Symonsauthor=J.+E.+Towne&title=Differential+roles+for+interleukin-23+and+interleukin-17+in+intestinal+immunoregulation&doi=10.1016%2Fj.immuni.2015.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation</span></div><div class="casAuthors">Maxwell, Joseph R.; Zhang, Yu; Brown, William A.; Smith, Carole L.; Byrne, Fergus R.; Fiorino, Mike; Stevens, Erin; Bigler, Jeannette; Davis, John A.; Rottman, James B.; Budelsky, Alison L.; Symons, Antony; Towne, Jennifer E.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">739-750</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Interleukin-23 (IL-23) and IL-17 are cytokines currently being targeted in clin. trials.  Although inhibition of both of these cytokines is effective for treating psoriasis, IL-12 and IL-23 p40 inhibition attenuates Crohn's disease, whereas IL-17A or IL-17 receptor A (IL-17RA) inhibition exacerbates Crohn's disease.  This dichotomy between IL-23 and IL-17 was effectively modeled in the multidrug resistance-1a-ablated (Abcb1a-/-) mouse model of colitis.  IL-23 inhibition attenuated disease by decreasing colonic inflammation while enhancing regulatory T (Treg) cell accumulation.  Exacerbation of colitis by IL-17A or IL-17RA inhibition was assocd. with severe weakening of the intestinal epithelial barrier, culminating in increased colonic inflammation and accelerated mortality.  These data show that IL-17A acts on intestinal epithelium to promote barrier function and provide insight into mechanisms underlying exacerbation of Crohn's disease when IL-17A or IL-17RA is inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3yYoQqeahMrVg90H21EOLACvtfcHk0li39Xlu86nzQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFyqt7vI&md5=8108b2db081ce238b76827b938bbffbe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2015.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2015.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DJ.%2BR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BL.%26aulast%3DByrne%26aufirst%3DF.%2BR.%26aulast%3DFiorino%26aufirst%3DM.%26aulast%3DStevens%26aufirst%3DE.%26aulast%3DBigler%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DJ.%2BA.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBudelsky%26aufirst%3DA.%2BL.%26aulast%3DSymons%26aufirst%3DA.%26aulast%3DTowne%26aufirst%3DJ.%2BE.%26atitle%3DDifferential%2520roles%2520for%2520interleukin-23%2520and%2520interleukin-17%2520in%2520intestinal%2520immunoregulation%26jtitle%3DImmunity%26date%3D2015%26volume%3D43%26spage%3D739%26epage%3D750%26doi%3D10.1016%2Fj.immuni.2015.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17<sup>+</sup> T helper cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=I.+I.+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+orphan+nuclear+receptor+ROR%CE%B3t+directs+the+differentiation+program+of+proinflammatory+IL-17%2B+T+helper+cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0li39Xlu86nzQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DI.%2BI.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3t%2520directs%2520the%2520differentiation%2520program%2520of%2520proinflammatory%2520IL-17%252B%2520T%2520helper%2520cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yosef, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahl, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Small molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.immuni.2014.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=477-489&author=S.+Xiaoauthor=N.+Yosefauthor=J.+Yangauthor=Y.+Wangauthor=L.+Zhouauthor=C.+Zhuauthor=C.+Wuauthor=E.+Balogluauthor=D.+Schmidtauthor=R.+Rameshauthor=M.+Loberaauthor=M.+S.+Sundrudauthor=P.+Y.+Tsaiauthor=Z.+Xiangauthor=J.+Wangauthor=Y.+Xuauthor=X.+Linauthor=K.+Kretschmerauthor=P.+B.+Rahlauthor=R.+A.+Youngauthor=Z.+Zhongauthor=D.+A.+Haflerauthor=A.+Regevauthor=S.+Ghoshauthor=A.+Marsonauthor=V.+K.+Kuchroo&title=Small+molecule+ROR%CE%B3t+antagonists+inhibit+T+helper+17+cell+transcriptional+network+by+divergent+mechanisms&doi=10.1016%2Fj.immuni.2014.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DYosef%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DTsai%26aufirst%3DP.%2BY.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKretschmer%26aufirst%3DK.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DMarson%26aufirst%3DA.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DSmall%2520molecule%2520ROR%25CE%25B3t%2520antagonists%2520inhibit%2520T%2520helper%252017%2520cell%2520transcriptional%2520network%2520by%2520divergent%2520mechanisms%26jtitle%3DImmunity%26date%3D2014%26volume%3D40%26spage%3D477%26epage%3D489%26doi%3D10.1016%2Fj.immuni.2014.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna-Roman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span> <span> </span><span class="NLM_article-title">RORγt and RORα signature genes in human Th17 cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0181868</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0181868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1371%2Fjournal.pone.0181868" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0181868&author=G.+Castroauthor=X.+Liuauthor=K.+Ngoauthor=A.+De+Leon-Tabaldoauthor=S.+Zhaoauthor=R.+Luna-Romanauthor=J.+Yuauthor=T.+Caoauthor=R.+Kuhnauthor=P.+Wilkinsonauthor=K.+Hermanauthor=M.+I.+Nelenauthor=J.+Blevittauthor=X.+Xueauthor=A.+Fourieauthor=W.+P.+Fung-Leung&title=ROR%CE%B3t+and+ROR%CE%B1+signature+genes+in+human+Th17+cells&doi=10.1371%2Fjournal.pone.0181868"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0181868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0181868%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DDe%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLuna-Roman%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DT.%26aulast%3DKuhn%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DP.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DFourie%26aufirst%3DA.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26atitle%3DROR%25CE%25B3t%2520and%2520ROR%25CE%25B1%2520signature%2520genes%2520in%2520human%2520Th17%2520cells%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0181868%26doi%3D10.1371%2Fjournal.pone.0181868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0lhnTnL_Y74eXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism</span>. <i>Nucl. Recept. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e003</span>, <span class="refDoi"> DOI: 10.1621/nrs.07003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1621%2Fnrs.07003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=19381306" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e003&author=A.+M.+Jetten&title=Retinoid-related+orphan+receptors+%28RORs%29%3A+critical+roles+in+development%2C+immunity%2C+circadian+rhythm%2C+and+cellular+metabolism&doi=10.1621%2Fnrs.07003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1621%2Fnrs.07003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1621%252Fnrs.07003%26sid%3Dliteratum%253Aachs%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoid-related%2520orphan%2520receptors%2520%2528RORs%2529%253A%2520critical%2520roles%2520in%2520development%252C%2520immunity%252C%2520circadian%2520rhythm%252C%2520and%2520cellular%2520metabolism%26jtitle%3DNucl.%2520Recept.%2520Signaling%26date%3D2009%26volume%3D7%26spage%3De003%26doi%3D10.1621%2Fnrs.07003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna-Roman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria-Babi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlueter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budelsky, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37977</span>, <span class="refDoi"> DOI: 10.1038/srep37977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fsrep37977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27905482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=37977&author=X.+Xueauthor=P.+Sorooshauthor=A.+De+Leon-Tabaldoauthor=R.+Luna-Romanauthor=M.+Sabladauthor=N.+Rozenkrantsauthor=J.+Yuauthor=G.+Castroauthor=H.+Banieauthor=W.-P.+Fung-Leungauthor=L.+Santamaria-Babiauthor=T.+Schlueterauthor=M.+Albersauthor=K.+Leonardauthor=A.+L.+Budelskyauthor=A.+M.+Fourie&title=Pharmacologic+modulation+of+ROR%CE%B3t+translates+to+efficacy+in+preclinical+and+translational+models+of+psoriasis+and+inflammatory+arthritis&doi=10.1038%2Fsrep37977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span></div><div class="casAuthors">Xue, Xiaohua; Soroosh, Pejman; De Leon-Tabaldo, Aimee; Luna-Roman, Rosa; Sablad, Marciano; Rozenkrants, Natasha; Yu, Jingxue; Castro, Glenda; Banie, Homayon; Fung-Leung, Wai-Ping; Santamaria-Babi, Luis; Schlueter, Thomas; Albers, Michael; Leonard, Kristi; Budelsky, Alison L.; Fourie, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37977</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The IL-23/IL-17 pathway is implicated in autoimmune diseases, particularly psoriasis, where biologics targeting IL-23 and IL-17 have shown significant clin. efficacy.  Retinoid-related orphan nuclear receptor gamma t (RORγt) is required for Th17 differentiation and IL-17 prodn. in adaptive and innate immune cells.  We identified JNJ-54271074, a potent and highly-selective RORγt inverse agonist, which dose-dependently inhibited RORγt-driven transcription, decreased co-activator binding and promoted interaction with co-repressor protein.  This compd. selectively blocked Th17 differentiation, significantly reduced IL-17A prodn. from memory T cells, and decreased IL-17A- and IL-22-producing human and murine γδ and NKT cells.  In a murine collagen-induced arthritis model, JNJ-54271074 dose-dependently suppressed joint inflammation.  Furthermore, JNJ-54271074 suppressed IL-17A prodn. in human PBMC from rheumatoid arthritis patients.  RORγt-deficient mice showed decreased IL-23-induced psoriasis-like skin inflammation and cytokine gene expression, consistent with dose-dependent inhibition in wild-type mice through oral dosing of JNJ-54271074.  In a translational model of human psoriatic epidermal cells and skin-homing T cells, JNJ-54271074 selectively inhibited streptococcus ext.-induced IL-17A and IL-17F.  JNJ-54271074 is thus a potent, selective RORγt modulator with therapeutic potential in IL-23/IL-17 mediated autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6V70xff8x77Vg90H21EOLACvtfcHk0liTPc0Rshi4xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F&md5=2dea294b5db93b110af4818dbfcb589b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsrep37977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep37977%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DDe%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DLuna-Roman%26aufirst%3DR.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DFung-Leung%26aufirst%3DW.-P.%26aulast%3DSantamaria-Babi%26aufirst%3DL.%26aulast%3DSchlueter%26aufirst%3DT.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DBudelsky%26aufirst%3DA.%2BL.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26atitle%3DPharmacologic%2520modulation%2520of%2520ROR%25CE%25B3t%2520translates%2520to%2520efficacy%2520in%2520preclinical%2520and%2520translational%2520models%2520of%2520psoriasis%2520and%2520inflammatory%2520arthritis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D37977%26doi%3D10.1038%2Fsrep37977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corzo, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Antiobesity effect of a small molecule repressor of RORγ</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1124/mol.114.097485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1124%2Fmol.114.097485" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=48-56&author=M.+R.+Changauthor=Y.+Heauthor=T.+M.+Khanauthor=D.+S.+Kuruvillaauthor=R.+Garcia-Ordonezauthor=C.+A.+Corzoauthor=T.+J.+Ungerauthor=D.+W.+Whiteauthor=S.+Khanauthor=L.+Linauthor=M.+D.+Cameronauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Antiobesity+effect+of+a+small+molecule+repressor+of+ROR%CE%B3&doi=10.1124%2Fmol.114.097485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.097485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.097485%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%26aulast%3DCorzo%26aufirst%3DC.%2BA.%26aulast%3DUnger%26aufirst%3DT.%2BJ.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DAntiobesity%2520effect%2520of%2520a%2520small%2520molecule%2520repressor%2520of%2520ROR%25CE%25B3%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D48%26epage%3D56%26doi%3D10.1124%2Fmol.114.097485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unutmaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner-Morton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mebius, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Requirement of RORγ in thymocyte survival and lymphoid organ development</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">2369</span>– <span class="NLM_lpage">2373</span>, <span class="refDoi"> DOI: 10.1126/science.288.5475.2369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1126%2Fscience.288.5475.2369" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2000&pages=2369-2373&author=Z.+Sunauthor=D.+Unutmazauthor=Y.-R.+Zouauthor=M.+J.+Sunshineauthor=A.+Pieraniauthor=S.+Brenner-Mortonauthor=R.+E.+Mebiusauthor=D.+R.+Littman&title=Requirement+of+ROR%CE%B3+in+thymocyte+survival+and+lymphoid+organ+development&doi=10.1126%2Fscience.288.5475.2369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.288.5475.2369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.288.5475.2369%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DUnutmaz%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DY.-R.%26aulast%3DSunshine%26aufirst%3DM.%2BJ.%26aulast%3DPierani%26aufirst%3DA.%26aulast%3DBrenner-Morton%26aufirst%3DS.%26aulast%3DMebius%26aufirst%3DR.%2BE.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DRequirement%2520of%2520ROR%25CE%25B3%2520in%2520thymocyte%2520survival%2520and%2520lymphoid%2520organ%2520development%26jtitle%3DScience%26date%3D2000%26volume%3D288%26spage%3D2369%26epage%3D2373%26doi%3D10.1126%2Fscience.288.5475.2369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1038/ni1022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fni1022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=14691482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=64-73&author=G.+Eberlauthor=S.+Marmonauthor=M.-J.+Sunshineauthor=P.+D.+Rennertauthor=Y.+Choiauthor=D.+R.+Littman&title=An+essential+function+for+the+nuclear+receptor+ROR%CE%B3t+in+the+generation+of+fetal+lymphoid+tissue+inducer+cells&doi=10.1038%2Fni1022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells</span></div><div class="casAuthors">Eberl, Gerard; Marmon, Shana; Sunshine, Mary-Jean; Rennert, Paul D.; Choi, Yongwon; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-73</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lymphoid tissue inducer (LTi) cells are assocd. with early development of lymph nodes and Peyer's patches.  The authors show here that during fetal life the nuclear hormone receptor RORγt is expressed exclusively in and is required for the generation of LTi cells.  RORγt+ LTi cells provide essential factors, among which lymphotoxin-α1β2 is necessary but not sufficient for activation of the mesenchyma in lymph node and Peyer's patch anlagen.  This early LTi cell-mediated activation of lymph node and Peyer's patch mesenchyma forms the necessary platform for the subsequent development of mature lymphoid tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5WJaoOUVHLVg90H21EOLACvtfcHk0liTPc0Rshi4xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N&md5=537f5f89b071b5b5a710d80a476d1b52</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fni1022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1022%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DG.%26aulast%3DMarmon%26aufirst%3DS.%26aulast%3DSunshine%26aufirst%3DM.-J.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DAn%2520essential%2520function%2520for%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3t%2520in%2520the%2520generation%2520of%2520fetal%2520lymphoid%2520tissue%2520inducer%2520cells%26jtitle%3DNat.%2520Immunol.%26date%3D2004%26volume%3D5%26spage%3D64%26epage%3D73%26doi%3D10.1038%2Fni1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medvedev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptor γ (RORγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">10132</span>– <span class="NLM_lpage">10137</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.18.10132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1073%2Fpnas.97.18.10132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10132-10137&author=S.+Kurebayashiauthor=E.+Uedaauthor=M.+Sakaueauthor=D.+D.+Patelauthor=A.+Medvedevauthor=F.+Zhangauthor=A.+M.+Jetten&title=Retinoid-related+orphan+receptor+%CE%B3+%28ROR%CE%B3%29+is+essential+for+lymphoid+organogenesis+and+controls+apoptosis+during+thymopoiesis&doi=10.1073%2Fpnas.97.18.10132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.18.10132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.18.10132%26sid%3Dliteratum%253Aachs%26aulast%3DKurebayashi%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DE.%26aulast%3DSakaue%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DMedvedev%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoid-related%2520orphan%2520receptor%2520%25CE%25B3%2520%2528ROR%25CE%25B3%2529%2520is%2520essential%2520for%2520lymphoid%2520organogenesis%2520and%2520controls%2520apoptosis%2520during%2520thymopoiesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D10132%26epage%3D10137%26doi%3D10.1073%2Fpnas.97.18.10132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enomoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujio, Y.</span></span> <span> </span><span class="NLM_article-title">RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0183584</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0183584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1371%2Fjournal.pone.0183584" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0183584&author=D.+Enomotoauthor=K.+Matsumotoauthor=T.+Yamashitaauthor=A.+Kobayashiauthor=M.+Maedaauthor=H.+Nakayamaauthor=M.+Obanaauthor=Y.+Fujio&title=ROR%CE%B3t-expressing+cells+attenuate+cardiac+remodeling+after+myocardial+infarction&doi=10.1371%2Fjournal.pone.0183584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0183584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0183584%26sid%3Dliteratum%253Aachs%26aulast%3DEnomoto%26aufirst%3DD.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DObana%26aufirst%3DM.%26aulast%3DFujio%26aufirst%3DY.%26atitle%3DROR%25CE%25B3t-expressing%2520cells%2520attenuate%2520cardiac%2520remodeling%2520after%2520myocardial%2520infarction%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0183584%26doi%3D10.1371%2Fjournal.pone.0183584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martynowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hydroxycholesterols a natural ligands of orphan nuclear receptor RORγ</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1210%2Fme.2009-0507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=20203100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=923-929&author=L.+Jinauthor=D.+Martynowskiauthor=S.+Zhengauthor=T.+Wadaauthor=W.+Xieauthor=Y.+Li&title=Structural+basis+for+hydroxycholesterols+a+natural+ligands+of+orphan+nuclear+receptor+ROR%CE%B3&doi=10.1210%2Fme.2009-0507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span></div><div class="casAuthors">Jin, Lihua; Martynowski, Dariusz; Zheng, Songyang; Wada, Taira; Xie, Wen; Li, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The retinoic acid-related orphan receptor γ (RORγ) has important roles in development and metabolic homeostasis.  Although the biol. functions of RORγ have been studied extensively, no ligands for RORγ have been identified, and no structure of RORγ has been reported.  In this study, we showed that hydroxycholesterols promote the recruitment of coactivators by RORγ using biochem. assays.  We also report the crystal structures of the RORγ ligand-binding domain bound with hydroxycholesterols.  The structures reveal the binding modes of various hydroxycholesterols in the RORγ pocket, with the receptors all adopting the canonical active conformation.  Mutations that disrupt the binding of hydroxycholesterols abolish the constitutive activity of RORγ.  Our observations suggest an important role for the endogenous hydroxycholesterols in modulating RORγ-dependent biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-ndP3ZSYebVg90H21EOLACvtfcHk0lhaARH_UOoOLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D&md5=1651fa21702f2a06451377fa11aa80bc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0507%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMartynowski%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520hydroxycholesterols%2520a%2520natural%2520ligands%2520of%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D923%26epage%3D929%26doi%3D10.1210%2Fme.2009-0507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izaac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Be, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arista, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span> <span> </span><span class="NLM_article-title">Structural states of RORγt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1014</span>– <span class="NLM_lpage">1021</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201700278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28590087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1014-1021&author=J.+Kallenauthor=A.+Izaacauthor=C.+Beauthor=L.+Aristaauthor=D.+Orainauthor=K.+Kaupmannauthor=C.+Guntermannauthor=K.+Hoegenauerauthor=S.+Hintermann&title=Structural+states+of+ROR%CE%B3t%3A+X-ray+elucidation+of+molecular+mechanisms+and+binding+interactions+for+natural+and+synthetic+compounds&doi=10.1002%2Fcmdc.201700278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural States of RORγt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds</span></div><div class="casAuthors">Kallen, Joerg; Izaac, Aude; Be, Celine; Arista, Luca; Orain, David; Kaupmann, Klemens; Guntermann, Christine; Hoegenauer, Klemens; Hintermann, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1014-1021</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The T-cell-specific retinoic acid receptor (RAR)-related orphan receptor-γ (RORγt) is a key transcription factor for the prodn. of pro-inflammatory Th17 cytokines, which are implicated in the pathogenesis of autoimmune diseases.  Over the years, several structurally diverse RORγt inverse agonists have been reported, but combining high potency and good physicochem. properties has remained a challenging task.  We recently reported a new series of inverse agonists based on an imidazopyridine core with good physicochem. properties and excellent selectivity.  Herein we report eight new X-ray crystal structures for different classes of natural and synthetic compds., including examples selected from the patent literature.  Anal. of their resp. binding modes revealed insight into the mol. mechanisms that lead to agonism, antagonism, or inverse agonism.  We report new mol. mechanisms for RORγt agonism and propose a sepn. of the inverse agonists into two classes: those that act via steric clash and those that act via other mechanisms (for the latter, co-crystn. with a co-activator peptide and helix 12 in the agonist position is still possible).  For the non-steric clash inverse agonists, we propose a new mechanism ("water trapping") which can be combined with other mechanisms (e.g., close contacts with H479).  In addn., we compare the interactions made for selected compds. in the "back pocket" near S404 and in the "sulfate pocket" near R364 and R367.  Taken together, these new mechanistic insights should prove useful for the design and optimization of further RORγt modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2bJdGLB1okrVg90H21EOLACvtfcHk0lhaARH_UOoOLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK&md5=c49d7d9710f6c4f7baed7e7b207a0bf7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700278%26sid%3Dliteratum%253Aachs%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DIzaac%26aufirst%3DA.%26aulast%3DBe%26aufirst%3DC.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DHintermann%26aufirst%3DS.%26atitle%3DStructural%2520states%2520of%2520ROR%25CE%25B3t%253A%2520X-ray%2520elucidation%2520of%2520molecular%2520mechanisms%2520and%2520binding%2520interactions%2520for%2520natural%2520and%2520synthetic%2520compounds%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D1014%26epage%3D1021%26doi%3D10.1002%2Fcmdc.201700278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span>Vitae Pharmaceuticals, Inc. <span> </span><span class="NLM_article-title">An Ascending
Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic
Patients</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2016</span>;<a href="https://clinicaltrials.gov/ct2/show/NCT02555709?term=VTP43742&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02555709?term=VTP43742&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vitae+Pharmaceuticals%2C+Inc.+An+Ascending%0AMultiple+Dose+Study+With+VTP-43742+in+Healthy+Volunteers+and+Psoriatic%0APatients.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes+of+Health%3A+Bethesda%2C+MD%2C+2016%3Bhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02555709%3Fterm%3DVTP43742%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAn%2520Ascending%250AMultiple%2520Dose%2520Study%2520With%2520VTP-43742%2520in%2520Healthy%2520Volunteers%2520and%2520Psoriatic%250APatients%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%2520of%2520Health%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span>GlaxoSmithKline. <span> </span><span class="NLM_article-title">A Study of GSK2981278
Ointment in Subjects With Plaque Psoriasis</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes
of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2018</span>;<a href="https://clinicaltrials.gov/ct2/show/NCT03004846?term=GSK2981278&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03004846?term=GSK2981278&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GlaxoSmithKline.+A+Study+of+GSK2981278%0AOintment+in+Subjects+With+Plaque+Psoriasis.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes%0Aof+Health%3A+Bethesda%2C+MD%2C+2018%3Bhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03004846%3Fterm%3DGSK2981278%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%2520of%2520GSK2981278%250AOintment%2520in%2520Subjects%2520With%2520Plaque%2520Psoriasis%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%250Aof%2520Health%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span>Arrien Pharmaceuticals. <span> </span><span class="NLM_article-title">A Phase 1 Study
of ARN-6039 (ARN-6039)</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>;<a href="https://clinicaltrials.gov/ct2/show/NCT03237832?term=ARN-6039&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03237832?term=ARN-6039&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arrien+Pharmaceuticals.+A+Phase+1+Study%0Aof+ARN-6039+%28ARN-6039%29.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3Bhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03237832%3Fterm%3DARN-6039%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%25201%2520Study%250Aof%2520ARN-6039%2520%2528ARN-6039%2529%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span>Takeda. <span> </span><span class="NLM_article-title">Safety, Tolerability and Pharmacokinetics
of Escalating Single Doses of TAK-828 in Healthy Participants</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National
Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2016</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT02706834?term=TAK828&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02706834?term=TAK828&rank=2</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Takeda.+Safety%2C+Tolerability+and+Pharmacokinetics%0Aof+Escalating+Single+Doses+of+TAK-828+in+Healthy+Participants.+ClinicalTrials.Gov%3B+U.S.+National%0AInsitutes+of+Health%3A+Bethesda%2C+MD%2C+2016%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02706834%3Fterm%3DTAK828%26rank%3D2+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DSafety%252C%2520Tolerability%2520and%2520Pharmacokinetics%250Aof%2520Escalating%2520Single%2520Doses%2520of%2520TAK-828%2520in%2520Healthy%2520Participants%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%250AInsitutes%2520of%2520Health%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span>AbbVie. <span> </span><span class="NLM_article-title">A Study to Evaluate the Pharmacokinetics,
Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects
With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National
Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03145948?term=ABBV-553&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03145948?term=ABBV-553&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AbbVie.+A+Study+to+Evaluate+the+Pharmacokinetics%2C%0ASafety+and+Tolerability+of+ABBV-553+in+Healthy+Volunteers+and+in+Subjects%0AWith+Psoriasis+and+Efficacy+of+ABBV-553+in+Subjects+With+Psoriasis.+ClinicalTrials.Gov%3B+U.S.+National%0AInsitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03145948%3Fterm%3DABBV-553%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%2520to%2520Evaluate%2520the%2520Pharmacokinetics%252C%250ASafety%2520and%2520Tolerability%2520of%2520ABBV-553%2520in%2520Healthy%2520Volunteers%2520and%2520in%2520Subjects%250AWith%2520Psoriasis%2520and%2520Efficacy%2520of%2520ABBV-553%2520in%2520Subjects%2520With%2520Psoriasis%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%250AInsitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span> <i>Phenex AG Announces Milestone
Payment from Janssen for the Entry
of RORgt Inhibitor into Phase I</i>; <span class="NLM_publisher-name">Phenex Pharmaceuticals
AG</span>: <span class="NLM_publisher-loc">Ludwigshafen, Germany</span>, July 10, <span class="NLM_year">2017</span>; press release, <a href="http://www.phenex-pharma.com/pdf/Phenex_Janssen_Ph1_eng_2017_final.pdf" class="extLink">http://www.phenex-pharma.com/pdf/Phenex_Janssen_Ph1_eng_2017_final.pdf</a> (accessed on July 10, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Phenex+AG+Announces+Milestone%0APayment+from+Janssen+for+the+Entry%0Aof+RORgt+Inhibitor+into+Phase+I%3B+Phenex+Pharmaceuticals%0AAG%3A+Ludwigshafen%2C+Germany%2C+July+10%2C+2017%3B+press+release%2C+http%3A%2F%2Fwww.phenex-pharma.com%2Fpdf%2FPhenex_Janssen_Ph1_eng_2017_final.pdf+%28accessed+on+July+10%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DPhenex%2520AG%2520Announces%2520Milestone%250APayment%2520from%2520Janssen%2520for%2520the%2520Entry%250Aof%2520RORgt%2520Inhibitor%2520into%2520Phase%2520I%26pub%3DPhenex%2520Pharmaceuticals%250AAG%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>AstraZeneca. <span> </span><span class="NLM_article-title">Study to Determine if AZD0284
is Effective and Safe in Treating Plaque Psoriasis (DERMIS)</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National
Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2018</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03310320?term=AZD-0284&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03310320?term=AZD-0284&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AstraZeneca.+Study+to+Determine+if+AZD0284%0Ais+Effective+and+Safe+in+Treating+Plaque+Psoriasis+%28DERMIS%29.+ClinicalTrials.Gov%3B+U.S.+National%0AInsitutes+of+Health%3A+Bethesda%2C+MD%2C+2018%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03310320%3Fterm%3DAZD-0284%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520to%2520Determine%2520if%2520AZD0284%250Ais%2520Effective%2520and%2520Safe%2520in%2520Treating%2520Plaque%2520Psoriasis%2520%2528DERMIS%2529%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%250AInsitutes%2520of%2520Health%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span>Akros Pharma (subsidiary
of Japan Tobacco). <span> </span><span class="NLM_article-title">Study to Evaluate Safety,
Tolerability, Pharmacodynamics & Pharmacokinetics
of JTE-451 in Active Plaque Psoriasis Subjects</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes
of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03018509?term=JTE-451&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03018509?term=JTE-451&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Akros+Pharma+%28subsidiary%0Aof+Japan+Tobacco%29.+Study+to+Evaluate+Safety%2C%0ATolerability%2C+Pharmacodynamics+%26+Pharmacokinetics%0Aof+JTE-451+in+Active+Plaque+Psoriasis+Subjects.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes%0Aof+Health%3A+Bethesda%2C+MD%2C+2017%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03018509%3Fterm%3DJTE-451%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520to%2520Evaluate%2520Safety%252C%250ATolerability%252C%2520Pharmacodynamics%2520%2526%2520Pharmacokinetics%250Aof%2520JTE-451%2520in%2520Active%2520Plaque%2520Psoriasis%2520Subjects%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%250Aof%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span> <i>Clinical Development as
of July 30, 2013</i>; <span class="NLM_publisher-name">Japan Tobacco Inc.</span>, <span class="NLM_year">2013</span>; <a href="http://www.jt.com/investors/results/S_information/pharmaceuticals/" class="extLink">http://www.jt.com/investors/results/S_information/pharmaceuticals/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Clinical+Development+as%0Aof+July+30%2C+2013%3B+Japan+Tobacco+Inc.%2C+2013%3B+http%3A%2F%2Fwww.jt.com%2Finvestors%2Fresults%2FS_information%2Fpharmaceuticals%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Development%2520as%250Aof%2520July%252030%252C%25202013%26pub%3DJapan%2520Tobacco%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span> <i>Reata Announces Initiation of a Phase 1 Trial of
RTA 1701, a Selective,
Oral Allosteric Inhibitor of RORγt</i>; <span class="NLM_publisher-name">Reata Pharmaceuticals</span>: <span class="NLM_publisher-loc">Irving, TX</span>, June 20, <span class="NLM_year">2018</span>; <a href="http://investors.reatapharma.com/news-releases/news-release-details/reata-announces-initiation-phase-1-trial-rta-1701-selective-oral" class="extLink">http://investors.reatapharma.com/news-releases/news-release-details/reata-announces-initiation-phase-1-trial-rta-1701-selective-oral</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Reata+Announces+Initiation+of+a+Phase+1+Trial+of%0ARTA+1701%2C+a+Selective%2C%0AOral+Allosteric+Inhibitor+of+ROR%CE%B3t%3B+Reata+Pharmaceuticals%3A+Irving%2C+TX%2C+June+20%2C+2018%3B+http%3A%2F%2Finvestors.reatapharma.com%2Fnews-releases%2Fnews-release-details%2Freata-announces-initiation-phase-1-trial-rta-1701-selective-oral."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DReata%2520Announces%2520Initiation%2520of%2520a%2520Phase%25201%2520Trial%2520of%250ARTA%25201701%252C%2520a%2520Selective%252C%250AOral%2520Allosteric%2520Inhibitor%2520of%2520ROR%25CE%25B3t%26pub%3DReata%2520Pharmaceuticals%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbieg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">RORγ antagonists and inverse agonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1236918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1080%2F13543776.2017.1236918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27629281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=101-112&issue=1&author=S.+M.+Bronnerauthor=J.+R.+Zbiegauthor=J.+J.+Crawford&title=ROR%CE%B3+antagonists+and+inverse+agonists%3A+a+patent+review&doi=10.1080%2F13543776.2017.1236918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">RORγ antagonists and inverse agonists: a patent review</span></div><div class="casAuthors">Bronner, Sarah M.; Zbieg, Jason R.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The transcription factor RORγ plays a crit. role in the expression of pro-inflammatory cytokine interleukin IL-17 and is therefore an attractive target for the treatment of inflammatory diseases.  Interest in this mol. target has been heightened by the advancement of orally and topically administered RORγ modulators into clin. trials.  The present review seeks to summarize published patent applications from assignee companies that have disclosed Investigational New Drug (IND) filings for small mol. RORγ/RORγt antagonists and inverse agonists.  The field of RORγ research is extremely competitive, with the majority of companies targeting psoriasis as the primary disease indication.  Vitae Pharmaceuticals is currently the most advanced, with a potential first-in-class oral RORγ-modulator for the treatment of psoriasis.  Future efforts will likely expand into potential applications of RORγ-modulators in the lesser explored immune-related areas of rheumatoid arthritis, type 1 diabetes, lupus, and irritable bowel disorder, as well as cancer immunotherapy and castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj8lMzWsYVA7Vg90H21EOLACvtfcHk0lhi6Su88QBMlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP&md5=d80db6c4c948bc12c5d0ce4b41edd2fb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1236918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1236918%26sid%3Dliteratum%253Aachs%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DZbieg%26aufirst%3DJ.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DROR%25CE%25B3%2520antagonists%2520and%2520inverse%2520agonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26issue%3D1%26spage%3D101%26epage%3D112%26doi%3D10.1080%2F13543776.2017.1236918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">764</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1039/c3md00005b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1039%2Fc3md00005b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=764-776&author=T.+M.+Kameneckaauthor=B.+Lydaauthor=M.+R.+Changauthor=P.+R.+Griffin&title=Synthetic+modulators+of+the+retinoic+acid+receptor-related+orphan+receptors&doi=10.1039%2Fc3md00005b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span></div><div class="casAuthors">Kamenecka, Theodore M.; Lyda, Brent; Chang, Mi Ra; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">764-776</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NR) are ligand-regulated transcription factors that control the expression of target genes involved in a range of physiol. processes such as development, metab., and immunity.  The retinoic acid receptor-related orphan receptors alpha, beta, and gamma (RORA, RORB, and RORC) comprise a distinct subfamily of nuclear receptors and are considered orphan' receptors, as they have no known generally agreed upon endogenous ligands, although these receptors do bind to and are modulated by oxysterols.  Several recent reports have highlighted the potential role for RORs in human disease, and more importantly, studies have demonstrated that these receptors can be modulated by exogenous synthetic ligands.  The identification of potent and selective ROR ligands will allow for a better understanding of the roles of the ROR receptors in human disease, and potentially pave the way for development of novel therapeutics.  Here we review the current status of synthetic ligand development from both the primary and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOh7XjR1TYObVg90H21EOLACvtfcHk0ljbo9Szm1V-gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D&md5=1985ee3df0c0476b65bcd68f7e9bc126</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fc3md00005b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00005b%26sid%3Dliteratum%253Aachs%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DSynthetic%2520modulators%2520of%2520the%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D764%26epage%3D776%26doi%3D10.1039%2Fc3md00005b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress on nuclear receptor RORc modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4387</span>– <span class="NLM_lpage">4393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27542308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4387-4393&author=P.+Cyrauthor=S.+M.+Bronnerauthor=J.+J.+Crawford&title=Recent+progress+on+nuclear+receptor+RORc+modulators&doi=10.1016%2Fj.bmcl.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress on nuclear receptor RORγ modulators</span></div><div class="casAuthors">Cyr, Patrick; Bronner, Sarah M.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4387-4393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The retinoic acid receptor-related orphan receptor RORγ plays key roles in the development and differentiation of TH17 cells, and thus in IL-17 expression, thymocyte development and regulation of metab.  With the recent progression into phase 2 clin. trials of both oral and topically administered inverse agonists, and with others close behind, there is significant interest in the discovery of RORγ modulators.  This digest covers key developments around RORγ agonists, antagonists and inverse agonists; orthosteric and allosteric binders; and aims to summarize the available information concerning the potential utility of RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6nrse0GiBLVg90H21EOLACvtfcHk0ljbo9Szm1V-gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL&md5=688885fc5c71ce01b86df6c9703b51ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DP.%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520on%2520nuclear%2520receptor%2520RORc%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4387%26epage%3D4393%26doi%3D10.1016%2Fj.bmcl.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid receptor-related orphan receptor γt (RORγt) agonists as potential small molecule therapeutics for cancer immunotherapy</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01314</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+Qiu&author=Y.+Wang&title=Retinoic+acid+receptor-related+orphan+receptor+%CE%B3t+%28ROR%CE%B3t%29+agonists+as+potential+small+molecule+therapeutics+for+cancer+immunotherapy&doi=10.1021%2Facs.jmedchem.7b01314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01314%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DR.%26atitle%3DRetinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%25CE%25B3t%2520%2528ROR%25CE%25B3t%2529%2520agonists%2520as%2520potential%2520small%2520molecule%2520therapeutics%2520for%2520cancer%2520immunotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.7b01314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conkright, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istrate, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busby, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">The benzenesulfonamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-(trifluoromethyl)ethyl]phenyl] benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-α/γ inverse agonist</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1124/mol.109.060905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1124%2Fmol.109.060905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=228-236&author=N.+Kumarauthor=L.+A.+Soltauthor=J.+J.+Conkrightauthor=Y.+Wangauthor=M.+A.+Istrateauthor=S.+A.+Busbyauthor=R.+D.+Garcia-Ordonezauthor=T.+P.+Burrisauthor=P.+R.+Griffin&title=The+benzenesulfonamide+T0901317+%5BN-%282%2C2%2C2-trifluoroethyl%29-N-%5B4-%5B2%2C2%2C2-trifluoro-1-hydroxy-%28trifluoromethyl%29ethyl%5Dphenyl%5D+benzenesulfonamide%5D+is+a+novel+retinoic+acid+receptor-related+orphan+receptor-%CE%B1%2F%CE%B3+inverse+agonist&doi=10.1124%2Fmol.109.060905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.060905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.060905%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DConkright%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DIstrate%26aufirst%3DM.%2BA.%26aulast%3DBusby%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DThe%2520benzenesulfonamide%2520T0901317%2520%255BN-%25282%252C2%252C2-trifluoroethyl%2529-N-%255B4-%255B2%252C2%252C2-trifluoro-1-hydroxy-%2528trifluoromethyl%2529ethyl%255Dphenyl%255D%2520benzenesulfonamide%255D%2520is%2520a%2520novel%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B1%252F%25CE%25B3%2520inverse%2520agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D228%26epage%3D236%26doi%3D10.1124%2Fmol.109.060905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Identification of SR2211: a potent synthetic RORγ-selective modulator</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">672</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1021/cb200496y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200496y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=672-677&author=N.+Kumarauthor=B.+Lydaauthor=M.+R.+Changauthor=J.+L.+Lauerauthor=L.+A.+Soltauthor=T.+P.+Burrisauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Identification+of+SR2211%3A+a+potent+synthetic+ROR%CE%B3-selective+modulator&doi=10.1021%2Fcb200496y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator</span></div><div class="casAuthors">Kumar, Naresh; Lyda, Brent; Chang, Mi Ra; Lauer, Janelle L.; Solt, Laura A.; Burris, Thomas P.; Kamenecka, Theodore M.; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">672-677</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nuclear receptors (NRs) are ligand-regulated transcription factors that display canonical domain structure with highly conserved DNA-binding and ligand-binding domains.  The identification of the endogenous ligands for several receptors remains elusive or is controversial, and thus these receptors are classified as orphans.  One such orphan receptor is the retinoic acid receptor-related orphan receptor γ (RORγ).  An isoform of RORγ, RORγt, has been shown to be essential for the expression of Interleukin 17 (IL-17) and the differentiation of Th17 cells.  Th17 cells have been implicated in the pathol. of several autoimmune diseases, including multiple sclerosis (MS) and rheumatoid arthritis (RA).  Genetic ablation of RORγ alone or in combination with RORα in mice led to impaired Th17 differentiation and protected the mice from development of exptl. autoimmune encephalomyelitis (EAE), a mouse model of MS.  Here we describe SR2211 (I), a selective RORγ modulator that potently inhibits prodn. of IL-17 in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUNURhZdOLSLVg90H21EOLACvtfcHk0ljj6af-sBmWSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGlsLo%253D&md5=3ef8a34687651a8fb7b3ab5a9b188abf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcb200496y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200496y%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DLauer%26aufirst%3DJ.%2BL.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DIdentification%2520of%2520SR2211%253A%2520a%2520potent%2520synthetic%2520ROR%25CE%25B3-selective%2520modulator%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D672%26epage%3D677%26doi%3D10.1021%2Fcb200496y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Identification of a selective RORγ ligand that suppresses TH17 cells and stimulates T-regulatory cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1021/cb3002649</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb3002649" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1515-1519&author=L.+A.+Soltauthor=N.+Kumarauthor=Y.+Heauthor=T.+M.+Kameneckaauthor=P.+R.+Griffinauthor=T.+P.+Burris&title=Identification+of+a+selective+ROR%CE%B3+ligand+that+suppresses+TH17+cells+and+stimulates+T-regulatory+cells&doi=10.1021%2Fcb3002649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcb3002649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3002649%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DIdentification%2520of%2520a%2520selective%2520ROR%25CE%25B3%2520ligand%2520that%2520suppresses%2520TH17%2520cells%2520and%2520stimulates%2520T-regulatory%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D1515%26epage%3D1519%26doi%3D10.1021%2Fcb3002649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological repression of RORγ is therapeutic in the collagen-induced arthritis experimental model</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1002/art.38272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fart.38272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24574218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtl2gt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=579-588&author=M.+R.+Changauthor=B.+Lydaauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Pharmacological+repression+of+ROR%CE%B3+is+therapeutic+in+the+collagen-induced+arthritis+experimental+model&doi=10.1002%2Fart.38272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model</span></div><div class="casAuthors">Chang, Mi Ra; Lyda, Brent; Kamenecka, Theodore M.; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: The nuclear receptor retinoic acid receptor-related orphan nuclear receptor γ (RORγ; T cell-specific isoform RORγt) is a key regulator of Th17 cell differentiation, controlling the prodn. of the inflammatory cytokine interleukin-17 (IL-17).  Lipopolysaccharide (LPS) stimulation of monocytes leads to the induction of RORγ.  We previously showed that the potent and selective inverse agonist of RORγ, SR2211, was effective at suppressing IL-17 prodn. in EL4 cells.  The aim of this study was to examine the effects of SR2211 treatment on proinflammatory cytokine expression in LPS-stimulated RAW 264.7 cells as well as on joint inflammation in vivo in mice with collagen-induced arthritis (CIA).  Methods: Collagen was injected into the tail of DBA mice, followed by a booster inoculation 21 days later.  Three days prior to the booster inoculation, SR2211 was administered twice daily for 15 days.  Thymus, spleen, and draining lymph nodes (DLNs) were then harvested, and Th17 cell differentiation and DLN stimulation were performed.  Results: Treatment of Th17 cells with SR2211 suppressed the expression and prodn. of inflammatory cytokines.  Likewise, SR2211 reduced inflammatory cytokine prodn. in LPS-stimulated RAW 264.7 cells.  Mice with CIA that received SR2211 twice daily for 15 days exhibited a statistically significant redn. in joint inflammation as compared to mice that received only vehicle.  Interestingly, systemic Th1 cell activation was detected in SR2211-treated mice with CIA, as indicated by an increase in interferon-γ levels.  Conclusion: The findings of this study support the idea of targeting RORγ to therapeutically repress inflammatory T cell function and macrophage activation in humans with rheumatoid arthritis.  Compds. such as SR2211 have potential utility for the treatment of inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppuyw_Wu3pGbVg90H21EOLACvtfcHk0lhJaHgjx5V-GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtl2gt73M&md5=f58ea5bdd8276926161fee78e0c4f4a2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fart.38272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.38272%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DPharmacological%2520repression%2520of%2520ROR%25CE%25B3%2520is%2520therapeutic%2520in%2520the%2520collagen-induced%2520arthritis%2520experimental%2520model%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2014%26volume%3D66%26spage%3D579%26epage%3D588%26doi%3D10.1002%2Fart.38272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6604</span>– <span class="NLM_lpage">6609</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2013.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24239186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslygtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6604-6609&author=B.+P.+Fauberauthor=G.+de+Leon+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+Johnsonauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=O.+Ren%C3%A9author=H.+Wong&title=Structure-based+design+of+substituted+hexafluoroisopropanol-arylsulfonamides+as+modulators+of+RORc&doi=10.1016%2Fj.bmcl.2013.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc</span></div><div class="casAuthors">Fauber, Benjamin P.; de Leon Boenig, Gladys; Burton, Brenda; Eidenschenk, Celine; Everett, Christine; Gobbi, Alberto; Hymowitz, Sarah G.; Johnson, Adam R.; Liimatta, Marya; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Rene, Olivier; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6604-6609</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structure-activity relationships of T0901317 analogs were explored as RORc inverse agonists using the principles of property- and structure-based drug design.  An X-ray co-crystal structure of T0901317 and RORc was obtained and provided mol. insight into why T0901317 functioned as an inverse agonist of RORc; whereas, the same ligand functioned as an agonist of FXR, LXR, and PXR.  The structural data was also used to design inhibitors with improved RORc biochem. and cellular activities.  The improved inhibitors possessed enhanced selectivity profiles (rationalized using the X-ray crystallog. data) against other nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxTcPky8JCMbVg90H21EOLACvtfcHk0lhJaHgjx5V-GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslygtrzL&md5=fb0331ebb12017c746f1a4f791e21637</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520of%2520substituted%2520hexafluoroisopropanol-arylsulfonamides%2520as%2520modulators%2520of%2520RORc%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6604%26epage%3D6609%26doi%3D10.1016%2Fj.bmcl.2013.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmakar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemagiri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raut, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pudzianowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somerville, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murali
Dhar, T. G.</span></span> <span> </span><span class="NLM_article-title">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29233651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=85-93&author=H.+Gongauthor=D.+S.+Weinsteinauthor=Z.+Luauthor=J.+J.+Duanauthor=S.+Stachuraauthor=L.+Haqueauthor=A.+Karmakarauthor=H.+Hemagiriauthor=D.+K.+Rautauthor=A.+K.+Guptaauthor=J.+Khanauthor=D.+Camacauthor=J.+S.+Sackauthor=A.+Pudzianowskiauthor=D.+R.+Wuauthor=M.+Yardeauthor=D.+R.+Shenauthor=V.+Borowskiauthor=J.+H.+Xieauthor=H.+Sunauthor=C.+D%E2%80%99Arienzoauthor=M.+Dabrosauthor=M.+A.+Galellaauthor=F.+Wangauthor=C.+A.+Weigeltauthor=Q.+Zhaoauthor=W.+Fosterauthor=J.+E.+Somervilleauthor=L.+M.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=T.+G.+Murali%0ADhar&title=Identification+of+bicyclic+hexafluoroisopropyl+alcohol+sulfonamides+as+retinoic+acid+receptor-related+orphan+receptor+gamma+%28ROR%CE%B3%2FRORc%29+inverse+agonists.+Employing+structure-based+drug+design+to+improve+pregnane+X+receptor+%28PXR%29+selectivity&doi=10.1016%2Fj.bmcl.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span></div><div class="casAuthors">Gong, Hua; Weinstein, David S.; Lu, Zhonghui; Duan, James J.-W.; Stachura, Sylwia; Haque, Lauren; Karmakar, Ananta; Hemagiri, Hemalatha; Raut, Dhanya Kumar; Gupta, Arun Kumar; Khan, Javed; Camac, Dan; Sack, John S.; Pudzianowski, Andrew; Wu, Dauh-Rurng; Yarde, Melissa; Shen, Ding-Ren; Borowski, Virna; Xie, Jenny H.; Sun, Huadong; D'Arienzo, Celia; Dabros, Marta; Galella, Michael A.; Wang, Faye; Weigelt, Carolyn A.; Zhao, Qihong; Foster, William; Somerville, John E.; Salter-Cid, Luisa M.; Barrish, Joel C.; Carter, Percy H.; Dhar, T. G. Murali</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-93</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We disclose the optimization of a high throughput screening hit to yield benzothiazine and tetrahydroquinoline sulfonamides as potent RORγt inverse agonists.  However, a majority of these compds. showed potent activity against pregnane X receptor (PXR) and modest activity against liver X receptor α (LXRα).  Structure-based drug design (SBDD) led to the identification of benzothiazine and tetrahydroquinoline sulfonamide analogs which completely dialed out LXRα activity and were less potent at PXR.  Pharmacodynamic (PD) data for compd. 35 in an IL-23 induced IL-17 mouse model is discussed along with the implications of a high Ymax in the PXR assay for long term preclin. pharmacokinetic (PK) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFyMm8wpiSbVg90H21EOLACvtfcHk0lhJaHgjx5V-GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ&md5=be0dfef2d7494dca1979711a03ac7878</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DH.%26aulast%3DWeinstein%26aufirst%3DD.%2BS.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%26aulast%3DStachura%26aufirst%3DS.%26aulast%3DHaque%26aufirst%3DL.%26aulast%3DKarmakar%26aufirst%3DA.%26aulast%3DHemagiri%26aufirst%3DH.%26aulast%3DRaut%26aufirst%3DD.%2BK.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPudzianowski%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DD.%2BR.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DBorowski%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDabros%26aufirst%3DM.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DFoster%26aufirst%3DW.%26aulast%3DSomerville%26aufirst%3DJ.%2BE.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DMurali%2BDhar%26aufirst%3DT.%2BG.%26atitle%3DIdentification%2520of%2520bicyclic%2520hexafluoroisopropyl%2520alcohol%2520sulfonamides%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma%2520%2528ROR%25CE%25B3%252FRORc%2529%2520inverse%2520agonists.%2520Employing%2520structure-based%2520drug%2520design%2520to%2520improve%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D85%26epage%3D93%26doi%3D10.1016%2Fj.bmcl.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4109</span>– <span class="NLM_lpage">4113</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.08.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4109-4113&author=B.+P.+Fauberauthor=A.+Gobbiauthor=P.+Savyauthor=B.+Burtonauthor=Y.+Dengauthor=C.+Everettauthor=H.+Laauthor=A.+R.+Johnsonauthor=P.+Lockeyauthor=M.+Normanauthor=H.+Wong&title=Identification+of+N-sulfonyl-tetrahydroquinolines+as+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.08.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DSavy%26aufirst%3DP.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520N-sulfonyl-tetrahydroquinolines%2520as%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4109%26epage%3D4113%26doi%3D10.1016%2Fj.bmcl.2015.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPheat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grindebacke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">Benzoxazepines achieve potent suppression of IL-17 release in human T-helper 17 (TH17) cells through an induced-fit binding mode to the nuclear receptor RORγ</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201500432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26553345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=207-216&author=R.+I.+Olssonauthor=Y.+Xueauthor=S.+von+Bergauthor=A.+Aagaardauthor=J.+McPheatauthor=E.+L.+Hanssonauthor=J.+Bernstr%C3%B6mauthor=P.+Hanssonauthor=J.+Jirholtauthor=H.+Grindebackeauthor=A.+Lefflerauthor=R.+Chenauthor=Y.+Xiongauthor=H.+Geauthor=T.+G.+Hanssonauthor=F.+Narjes&title=Benzoxazepines+achieve+potent+suppression+of+IL-17+release+in+human+T-helper+17+%28TH17%29+cells+through+an+induced-fit+binding+mode+to+the+nuclear+receptor+ROR%CE%B3&doi=10.1002%2Fcmdc.201500432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span></div><div class="casAuthors">Olsson, Roine I.; Xue, Yafeng; von Berg, Stefan; Aagaard, Anna; McPheat, Jane; Hansson, Eva L.; Bernstroem, Jenny; Hansson, Pia; Jirholt, Johan; Grindebacke, Hanna; Leffler, Agnes; Chen, Rongfeng; Xiong, Yao; Ge, Hongbin; Hansson, Thomas G.; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">RORγt, an isoform of the retinoic acid-related orphan receptor gamma (RORc, RORγ), has been identified as the master regulator of T-helper 17 (TH17) cell function and development, making it an attractive target for the treatment of autoimmune diseases.  Validation for this target comes from antibodies targeting interleukin-17 (IL-17), the signature cytokine produced by TH17 cells, which have shown impressive results in clin. trials.  Through focused screening of our compd. collection, we identified a series of N-sulfonylated benzoxazepines, which displayed micromolar affinity for the RORγ ligand-binding domain (LBD) in a radioligand binding assay.  Optimization of these initial hits resulted in potent binders, which dose-dependently decreased the ability of the RORγ-LBD to interact with a peptide derived from steroid receptor coactivator 1, and inhibited the release of IL-17 secretion from isolated and cultured human TH17 cells with nanomolar potency.  A cocrystal structure of inverse agonist 15 (2-chloro-6-fluoro-N-(4-{[3-(trifluoromethyl)phenyl]sulfonyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)benzamide) bound to the RORγ-LBD illustrated that both hydrophobic interactions, leading to an induced fit around the substituted benzamide moiety of 15, as well as a hydrogen bond from the amide NH to His479 seemed to be important for the mechanism of action.  This structure is compared with the structure of agonist 25 (N-(2-fluorophenyl)-4-[(4-fluorophenyl)sulfonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-6-amine ) and structures of other known RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorSpjXrs3zSrVg90H21EOLACvtfcHk0lhrYlJQLQBiPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N&md5=ed6fa69d887818da7acd4f9abbd2ff93</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500432%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DR.%2BI.%26aulast%3DXue%26aufirst%3DY.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DMcPheat%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DE.%2BL.%26aulast%3DBernstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJirholt%26aufirst%3DJ.%26aulast%3DGrindebacke%26aufirst%3DH.%26aulast%3DLeffler%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DHansson%26aufirst%3DT.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DBenzoxazepines%2520achieve%2520potent%2520suppression%2520of%2520IL-17%2520release%2520in%2520human%2520T-helper%252017%2520%2528TH17%2529%2520cells%2520through%2520an%2520induced-fit%2520binding%2520mode%2520to%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D207%26epage%3D216%26doi%3D10.1002%2Fcmdc.201500432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3891</span>– <span class="NLM_lpage">3897</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2014.06.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3891-3897&author=B.+P.+Fauberauthor=O.+Ren%C3%A9author=G.+de+Leon+Boenigauthor=B.+Burtonauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=W.+Wangauthor=H.+Wong&title=Reduction+in+lipophilicity+improved+the+solubility%2C+plasma-protein+binding%2C+and+permeability+of+tertiary+sulfonamide+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2014.06.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DReduction%2520in%2520lipophilicity%2520improved%2520the%2520solubility%252C%2520plasma-protein%2520binding%252C%2520and%2520permeability%2520of%2520tertiary%2520sulfonamide%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3891%26epage%3D3897%26doi%3D10.1016%2Fj.bmcl.2014.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boenig, G.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Minor structural change to tertiary sulfonamide RORc ligands led to opposite mechanisms of action</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1021/ml500420y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500420y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276-281&author=O.+Ren%C3%A9author=B.+P.+Fauberauthor=G.-L.+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=J.+R.+Kieferauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=H.+A.+Wallweberauthor=H.+Wong&title=Minor+structural+change+to+tertiary+sulfonamide+RORc+ligands+led+to+opposite+mechanisms+of+action&doi=10.1021%2Fml500420y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action</span></div><div class="casAuthors">Rene, Olivier; Fauber, Benjamin P.; Boenig, Gladys de Leon; Burton, Brenda; Eidenschenk, Celine; Everett, Christine; Gobbi, Alberto; Hymowitz, Sarah G.; Johnson, Adam R.; Kiefer, James R.; Liimatta, Marya; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Wallweber, Heidi A.; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-281</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A minor structural change to tertiary sulfonamide RORc ligands led to distinct mechanisms of action.  Co-crystal structures of two compds. revealed mechanistically consistent protein conformational changes.  Optimized phenylsulfonamides were identified as RORc agonists while benzylsulfonamides exhibited potent inverse agonist activity.  Compds. behaving as agonists in our biochem. assay also gave rise to an increased prodn. of IL-17 in human PBMCs whereas inverse agonists led to significant suppression of IL-17 under the same assay conditions.  The most potent inverse agonist compd. showed >180-fold selectivity over the ROR isoforms as well as all other nuclear receptors that were profiled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI70iMUrA6ILVg90H21EOLACvtfcHk0li_q9j8vIbUfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegurfP&md5=0b4f24456aacce42db9f7a1843bb050b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fml500420y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500420y%26sid%3Dliteratum%253Aachs%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBoenig%26aufirst%3DG.-L.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DMinor%2520structural%2520change%2520to%2520tertiary%2520sulfonamide%2520RORc%2520ligands%2520led%2520to%2520opposite%2520mechanisms%2520of%2520action%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D276%26epage%3D281%26doi%3D10.1021%2Fml500420y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5308</span>– <span class="NLM_lpage">5322</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5308-5322&author=B.+P.+Fauberauthor=O.+Ren%C3%A9author=Y.+Dengauthor=J.+DeVossauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=A.+Gobbiauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=J.+Leschauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+1-%7B4-%5B3-fluoro-4-%28%283s%2C6r%29-3-methyl-1%2C1-dioxo-6-phenyl-%5B1%2C2%5Dthiazinan-2-ylmethyl%29-phenyl%5D-piperazin-1-yl%7D-ethanone+%28GNE-3500%29%3A+a+potent%2C+selective%2C+and+orally+bioavailable+retinoic+acid+receptor-related+orphan+receptor+C+%28RORc+or+ROR%CE%B3%29+inverse+agonist&doi=10.1021%2Facs.jmedchem.5b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist</span></div><div class="casAuthors">Fauber, Benjamin P.; Rene, Olivier; Deng, Yuzhong; DeVoss, Jason; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Gobbi, Alberto; Hawkins, Julie; Johnson, Adam R.; La, Hank; Lesch, Justin; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Summerhill, Susan; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5308-5322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor C (RORc, RORγ, or NR1F3) is a nuclear receptor that plays a major role in the prodn. of interleukin (IL)-17.  Considerable efforts have been directed toward the discovery of selective RORc inverse agonists as potential treatments of inflammatory diseases such as psoriasis and rheumatoid arthritis.  Using the previously reported tertiary sulfonamide as a starting point, the authors engineered structural modifications that significantly improved human and rat metabolic stabilities while maintaining a potent and highly selective RORc inverse agonist profile.  The most advanced δ-sultam compd. I possessed favorable RORc cellular potency with 75-fold selectivity for RORc over other ROR family members and >200-fold selectivity over 25 addnl. nuclear receptors in a cell assay panel.  The favorable potency, selectivity, in vitro ADME properties, in vivo PK, and dose-dependent inhibition of IL-17 in a PK/PD model support the evaluation of I in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSG0WeUAvc7Vg90H21EOLACvtfcHk0li_q9j8vIbUfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M&md5=86f291aa61281c4ec98a34cdd31963e0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00597%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%25201-%257B4-%255B3-fluoro-4-%2528%25283s%252C6r%2529-3-methyl-1%252C1-dioxo-6-phenyl-%255B1%252C2%255Dthiazinan-2-ylmethyl%2529-phenyl%255D-piperazin-1-yl%257D-ethanone%2520%2528GNE-3500%2529%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520C%2520%2528RORc%2520or%2520ROR%25CE%25B3%2529%2520inverse%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5308%26epage%3D5322%26doi%3D10.1021%2Facs.jmedchem.5b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodil Van Niel, M.</span>; <span class="NLM_string-name">Fauber, B.</span>; <span class="NLM_string-name">Gaines, S.</span>; <span class="NLM_string-name">Gobbi, A.</span>; <span class="NLM_string-name">Rene, O.</span>; <span class="NLM_string-name">Vesey, D.</span>; <span class="NLM_string-name">Ward, S.</span></span> <span> </span><span class="NLM_article-title">Aryl Sultam Derivatives as RORc Modulators</span>. WO Patent <span class="NLM_patent">WO2014009447A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Bodil+Van+Niel&author=B.+Fauber&author=S.+Gaines&author=A.+Gobbi&author=O.+Rene&author=D.+Vesey&author=S.+Ward&title=Aryl+Sultam+Derivatives+as+RORc+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBodil%2BVan%2BNiel%26aufirst%3DM.%26atitle%3DAryl%2520Sultam%2520Derivatives%2520as%2520RORc%2520Modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birault, V.</span>; <span class="NLM_string-name">Campbell, A. J.</span>; <span class="NLM_string-name">Harrison, S. A.</span>; <span class="NLM_string-name">Le, J.</span></span> <span> </span><span class="NLM_article-title">Novel Compounds</span>. WO Patent <span class="NLM_patent">WO2015061515A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=V.+Birault&author=A.+J.+Campbell&author=S.+A.+Harrison&author=J.+Le&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBirault%26aufirst%3DV.%26atitle%3DNovel%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birault, V.</span>; <span class="NLM_string-name">Campbell, A. J.</span>; <span class="NLM_string-name">Harrison, S. A.</span>; <span class="NLM_string-name">Le, J.</span>; <span class="NLM_string-name">Shukla, L.</span></span> <span> </span><span class="NLM_article-title">Novel Compounds</span>. WO Patent <span class="NLM_patent">WO2013160418A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=V.+Birault&author=A.+J.+Campbell&author=S.+A.+Harrison&author=J.+Le&author=L.+Shukla&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBirault%26aufirst%3DV.%26atitle%3DNovel%2520Compounds%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peredo, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusq, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birault, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viviani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofland, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote-Sierra, J.</span></span> <span> </span><span class="NLM_article-title">Development of a topical treatment for psoriasis targeting RORγ: From bench to skin</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0147979</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0147979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1371%2Fjournal.pone.0147979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26870941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XotlGltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0147979&author=S.+H.+Smithauthor=C.+E.+Peredoauthor=Y.+Takedaauthor=T.+Buiauthor=J.+Neilauthor=D.+Rickardauthor=E.+Millermanauthor=J.+P.+Therrienauthor=E.+Nicodemeauthor=J.+M.+Brusqauthor=V.+Biraultauthor=F.+Vivianiauthor=H.+Hoflandauthor=A.+M.+Jettenauthor=J.+Cote-Sierra&title=Development+of+a+topical+treatment+for+psoriasis+targeting+ROR%CE%B3%3A+From+bench+to+skin&doi=10.1371%2Fjournal.pone.0147979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a topical treatment for psoriasis targeting RORγ: from bench to skin</span></div><div class="casAuthors">Smith, Susan H.; Peredo, Carlos E.; Takeda, Yukimasa; Bui, Thi; Neil, Jessica; Rickard, David; Millerman, Elizabeth; Therrien, Jean-Philippe; Nicodeme, Edwige; Brusq, Jean-Marie; Birault, Veronique; Viviani, Fabrice; Hofland, Hans; Jetten, Anton M.; Cote-Sierra, Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0147979/1-e0147979/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Psoriasis is a chronic inflammatory skin disorder involving marked immunol. changes.  IL-17-targeting biologics have been successful in reducing the disease burden of psoriasis patients with moderate-to-severe disease.  Unfortunately, the stratum corneum prevents penetration of large mol. wt. proteins, including monoclonal antibodies.  Thus, for the majority of psoriasis patients ineligible for systemic treatments, a small mol. targeting RORγt, the master regulator of IL-17 family cytokines, may represent an alternative topical medicine with biol.-like efficacy.  Methods and Findings: The preclin. studies described in this manuscript bridge the gap from bench to bedside to provide the scientific foundation for a compd. entering clin. trials for patients with mild to moderate psoriasis.  In addn. to several ex vivo reporter assays, primary T cell cultures, and the imiquimod mouse model, we demonstrate efficacy in a newly developed human ex vivo skin assay, where Th17-skewed cytokine expression is induced from skin-resident immune cells.  Importantly, the skin barrier remains intact allowing for the demonstration of topical drug delivery.  With the development of this novel assay, we demonstrate potent compd. activity in the target tissue: human skin.  Finally, target engagement by this small mol. was confirmed in ex vivo lesional psoriatic skin.  Conclusions: Our work describes a progressive series of assays to demonstrate the potential clin. value of a novel RORγ inverse agonist small mol. with high potency and selectivity, which will enter clin. trials in late 2015 for psoriasis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokk_sPVo8crbVg90H21EOLACvtfcHk0lg-68anFGiGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotlGltLs%253D&md5=75b3d12e090eab85b79fa55312798dd1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0147979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0147979%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BH.%26aulast%3DPeredo%26aufirst%3DC.%2BE.%26aulast%3DTakeda%26aufirst%3DY.%26aulast%3DBui%26aufirst%3DT.%26aulast%3DNeil%26aufirst%3DJ.%26aulast%3DRickard%26aufirst%3DD.%26aulast%3DMillerman%26aufirst%3DE.%26aulast%3DTherrien%26aufirst%3DJ.%2BP.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DBirault%26aufirst%3DV.%26aulast%3DViviani%26aufirst%3DF.%26aulast%3DHofland%26aufirst%3DH.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26aulast%3DCote-Sierra%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520topical%2520treatment%2520for%2520psoriasis%2520targeting%2520ROR%25CE%25B3%253A%2520From%2520bench%2520to%2520skin%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0147979%26doi%3D10.1371%2Fjournal.pone.0147979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrux-Tallau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihl, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlavan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Defoin-Platel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forissier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froude, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacini-Rachinel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervouet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huguet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafitte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozello, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peluchon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiesse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatinel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vial, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of CD12681, a potent RORγ inverse agonist, preclinical candidate for the topical treatment of psoriasis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201700758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29327456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=321-337&author=G.+Ouvryauthor=N.+Atrux-Tallauauthor=F.+Bihlauthor=A.+Bonduauthor=C.+Bouix-Peterauthor=I.+Carlavanauthor=O.+Christinauthor=M.+J.+Cuadradoauthor=C.+Defoin-Platelauthor=S.+Deretauthor=D.+Duvertauthor=C.+Feretauthor=M.+Forissierauthor=J.+F.+Fournierauthor=D.+Froudeauthor=F.+Hacini-Rachinelauthor=C.+S.+Harrisauthor=C.+Hervouetauthor=H.+Huguetauthor=G.+Lafitteauthor=A.+P.+Luzyauthor=B.+Musickiauthor=D.+Orfilaauthor=B.+Ozelloauthor=C.+Pascauauthor=J.+Pascauauthor=V.+Parnetauthor=G.+Peluchonauthor=R.+Pierreauthor=D.+Piwnicaauthor=C.+Raffinauthor=P.+Rossioauthor=D.+Spiesseauthor=N.+Taquetauthor=E.+Thoreauauthor=R.+Vatinelauthor=E.+Vialauthor=L.+F.+Hennequin&title=Discovery+and+characterization+of+CD12681%2C+a+potent+ROR%CE%B3+inverse+agonist%2C+preclinical+candidate+for+the+topical+treatment+of+psoriasis&doi=10.1002%2Fcmdc.201700758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis</span></div><div class="casAuthors">Ouvry, Gilles; Atrux-Tallau, Nicolas; Bihl, Franck; Bondu, Aline; Bouix-Peter, Claire; Carlavan, Isabelle; Christin, Olivier; Cuadrado, Marie-Josee; Defoin-Platel, Claire; Deret, Sophie; Duvert, Denis; Feret, Christophe; Forissier, Mathieu; Fournier, Jean-Francois; Froude, David; Hacini-Rachinel, Feriel; Harris, Craig Steven; Hervouet, Catherine; Huguet, Helene; Lafitte, Guillaume; Luzy, Anne-Pascale; Musicki, Branislav; Orfila, Danielle; Ozello, Benjamin; Pascau, Coralie; Pascau, Jonathan; Parnet, Veronique; Peluchon, Guillaume; Pierre, Romain; Piwnica, David; Raffin, Catherine; Rossio, Patricia; Spiesse, Delphine; Taquet, Nathalie; Thoreau, Etienne; Vatinel, Rodolphe; Vial, Emmanuel; Hennequin, Laurent Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-337</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With possible implications in multiple autoimmune diseases, the retinoic acid receptor-related orphan receptor RORγ has become a sought-after target in the pharmaceutical industry.  Herein are described the efforts to identify a potent RORγ inverse agonist compatible with topical application for the treatment of skin diseases.  These efforts culminated in the discovery of N-(2,4-dimethylphenyl)-N-isobutyl-2-oxo-1-[(tetrahydro-2H-pyran-4-yl)methyl]-2,3-dihydro-1H-benzo[d]imidazole-5-sulfonamide (CD12681), a potent inverse agonist with in vivo activity in an IL-23-induced mouse skin inflammation model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-4rMWerixL7Vg90H21EOLACvtfcHk0lg-68anFGiGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aksL4%253D&md5=443fc01d790536a34918f1b33f8fdba2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700758%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DAtrux-Tallau%26aufirst%3DN.%26aulast%3DBihl%26aufirst%3DF.%26aulast%3DBondu%26aufirst%3DA.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DCarlavan%26aufirst%3DI.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DCuadrado%26aufirst%3DM.%2BJ.%26aulast%3DDefoin-Platel%26aufirst%3DC.%26aulast%3DDeret%26aufirst%3DS.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DFeret%26aufirst%3DC.%26aulast%3DForissier%26aufirst%3DM.%26aulast%3DFournier%26aufirst%3DJ.%2BF.%26aulast%3DFroude%26aufirst%3DD.%26aulast%3DHacini-Rachinel%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DHervouet%26aufirst%3DC.%26aulast%3DHuguet%26aufirst%3DH.%26aulast%3DLafitte%26aufirst%3DG.%26aulast%3DLuzy%26aufirst%3DA.%2BP.%26aulast%3DMusicki%26aufirst%3DB.%26aulast%3DOrfila%26aufirst%3DD.%26aulast%3DOzello%26aufirst%3DB.%26aulast%3DPascau%26aufirst%3DC.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DParnet%26aufirst%3DV.%26aulast%3DPeluchon%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DPiwnica%26aufirst%3DD.%26aulast%3DRaffin%26aufirst%3DC.%26aulast%3DRossio%26aufirst%3DP.%26aulast%3DSpiesse%26aufirst%3DD.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DThoreau%26aufirst%3DE.%26aulast%3DVatinel%26aufirst%3DR.%26aulast%3DVial%26aufirst%3DE.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520CD12681%252C%2520a%2520potent%2520ROR%25CE%25B3%2520inverse%2520agonist%252C%2520preclinical%2520candidate%2520for%2520the%2520topical%2520treatment%2520of%2520psoriasis%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D321%26epage%3D337%26doi%3D10.1002%2Fcmdc.201700758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5293</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2015.07.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5293-5302&author=Y.+Wangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Maauthor=L.+Yangauthor=L.+Zhouauthor=Z.+Xiangauthor=Z.+Chengauthor=S.+Luauthor=L.+A.+Orband-Millerauthor=W.+Zhangauthor=Q.+Wuauthor=K.+Zhangauthor=Y.+Liauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+N-%284-aryl-5-aryloxy-thiazol-2-yl%29-amides+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmc.2015.07.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520N-%25284-aryl-5-aryloxy-thiazol-2-yl%2529-amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5293%26epage%3D5302%26doi%3D10.1016%2Fj.bmc.2015.07.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2013.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=692-702&author=Y.+Wangauthor=W.+Caiauthor=G.+Zhangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=L.+Zhouauthor=Y.+Maauthor=Z.+Chengauthor=S.+Luauthor=Y.+G.+Zhaoauthor=W.+Zhangauthor=Z.+Xiangauthor=S.+Wangauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=Y.+Xuauthor=J.+Zhangauthor=R.+Gaoauthor=M.+Huxdorfauthor=J.+N.+Xiangauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=S.+Leungauthor=X.+Lin&title=Discovery+of+novel+N-%285-%28arylcarbonyl%29thiazol-2-yl%29amides+and+N-%285-%28arylcarbonyl%29thiophen-2-yl%29amides+as+potent+ROR%CE%B3t+inhibitors&doi=10.1016%2Fj.bmc.2013.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%2BG.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DR.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%2520N-%25285-%2528arylcarbonyl%2529thiazol-2-yl%2529amides%2520and%2520N-%25285-%2528arylcarbonyl%2529thiophen-2-yl%2529amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D692%26epage%3D702%26doi%3D10.1016%2Fj.bmc.2013.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlüter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5265</span>– <span class="NLM_lpage">5267</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2014.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5265-5267&author=C.+Gegeauthor=T.+Schl%C3%BCterauthor=T.+Hoffmann&title=Identification+of+the+first+inverse+agonist+of+retinoid-related+orphan+receptor+%28ROR%29+with+dual+selectivity+for+ROR%CE%B2+and+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2014.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26aulast%3DSchl%25C3%25BCter%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520the%2520first%2520inverse%2520agonist%2520of%2520retinoid-related%2520orphan%2520receptor%2520%2528ROR%2529%2520with%2520dual%2520selectivity%2520for%2520ROR%25CE%25B2%2520and%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5265%26epage%3D5267%26doi%3D10.1016%2Fj.bmcl.2014.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of biaryl amides as potent, orally bioavailable, and CNS penetrant RORγt inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00122</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=787-792&author=Y.+Wangauthor=W.+Caiauthor=Y.+Chengauthor=T.+Yangauthor=Q.+Liuauthor=G.+Zhangauthor=Q.+Mengauthor=F.+Hanauthor=Y.+Huangauthor=L.+Zhouauthor=Z.+Xiangauthor=Y.+G.+Zhaoauthor=Y.+Xuauthor=Z.+Chengauthor=S.+Luauthor=Q.+Wuauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+biaryl+amides+as+potent%2C+orally+bioavailable%2C+and+CNS+penetrant+ROR%CE%B3t+inhibitors&doi=10.1021%2Facsmedchemlett.5b00122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors</span></div><div class="casAuthors">Wang, Yonghui; Cai, Wei; Cheng, Yaobang; Yang, Ting; Liu, Qian; Zhang, Guifeng; Meng, Qinghua; Han, Fangbin; Huang, Yafei; Zhou, Ling; Xiang, Zhijun; Zhao, Yong-Gang; Xu, Yan; Cheng, Ziqiang; Lu, Sijie; Wu, Qianqian; Xiang, Jia-Ning; Elliott, John D.; Leung, Stewart; Ren, Feng; Lin, Xichen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">787-792</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of biaryl amides was identified as RORγt inhibitors through core replacement of a starting hit 1.  Structure-activity relation exploration on the biaryl moiety led to discovery of potent RORγt inhibitors with good oral bioavailability and CNS penetration.  Compds. 9a and 9g demonstrated excellent in vivo efficacy in EAE mice dose dependently with once daily oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRg-_IJY0l47Vg90H21EOLACvtfcHk0liiwLQRRe1Zfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D&md5=0011aa5b6e6952ef2f7cfced6ee1b7fc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DY.%2BG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520biaryl%2520amides%2520as%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520CNS%2520penetrant%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D787%26epage%3D792%26doi%3D10.1021%2Facsmedchemlett.5b00122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yosef, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahl, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.immuni.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24745332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=477-489&author=S.+Xiaoauthor=N.+Yosefauthor=J.+Yangauthor=Y.+Wangauthor=L.+Zhouauthor=C.+Zhuauthor=C.+Wuauthor=E.+Balogluauthor=D.+Schmidtauthor=R.+Rameshauthor=M.+Loberaauthor=M.+S.+Sundrudauthor=P.+Y.+Tsaiauthor=Z.+Xiangauthor=J.+Wangauthor=Y.+Xuauthor=X.+Linauthor=K.+Kretschmerauthor=P.+B.+Rahlauthor=R.+A.+Youngauthor=Z.+Zhongauthor=D.+A.+Haflerauthor=A.+Regevauthor=S.+Ghoshauthor=A.+Marsonauthor=V.+K.+Kuchroo&title=Small-molecule+ROR%CE%B3t+antagonists+inhibit+T+helper+17+cell+transcriptional+network+by+divergent+mechanisms&doi=10.1016%2Fj.immuni.2014.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms</span></div><div class="casAuthors">Xiao, Sheng; Yosef, Nir; Yang, Jianfei; Wang, Yonghui; Zhou, Ling; Zhu, Chen; Wu, Chuan; Baloglu, Erkan; Schmidt, Darby; Ramesh, Radha; Lobera, Mercedes; Sundrud, Mark S.; Tsai, Pei-Yun; Xiang, Zhijun; Wang, Jinsong; Xu, Yan; Lin, Xichen; Kretschmer, Karsten; Rahl, Peter B.; Young, Richard A.; Zhong, Zhong; Hafler, David A.; Regev, Aviv; Ghosh, Shomir; Marson, Alexander; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We identified three retinoid-related orphan receptor gamma t (RORγt)-specific inhibitors that suppress T helper 17 (Th17) cell responses, including Th17-cell-mediated autoimmune disease.  We systemically characterized RORγt binding in the presence and absence of drugs with corresponding whole-genome transcriptome sequencing.  RORγt acts as a direct activator of Th17 cell signature genes and a direct repressor of signature genes from other T cell lineages; its strongest transcriptional effects are on cis-regulatory sites contg. the RORα binding motif.  RORγt is central in a densely interconnected regulatory network that shapes the balance of T cell differentiation.  Here, the three inhibitors modulated the RORγt-dependent transcriptional network to varying extents and through distinct mechanisms.  Whereas one inhibitor displaced RORγt from its target loci, the other two inhibitors affected transcription predominantly without removing DNA binding.  Our work illustrates the power of a system-scale anal. of transcriptional regulation to characterize potential therapeutic compds. that inhibit pathogenic Th17 cells and suppress autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23p8R83CDDbVg90H21EOLACvtfcHk0lgcz9KKsqI0TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D&md5=940074c565211bc00832179574e5231a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DYosef%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DTsai%26aufirst%3DP.%2BY.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKretschmer%26aufirst%3DK.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DMarson%26aufirst%3DA.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DSmall-molecule%2520ROR%25CE%25B3t%2520antagonists%2520inhibit%2520T%2520helper%252017%2520cell%2520transcriptional%2520network%2520by%2520divergent%2520mechanisms%26jtitle%3DImmunity%26date%3D2014%26volume%3D40%26spage%3D477%26epage%3D489%26doi%3D10.1016%2Fj.immuni.2014.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span> <span> </span><span class="NLM_article-title">From RORγt agonist to two types of RORγt inverse agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00476</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00476" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=120-124&author=Y.+Wangauthor=W.+Caiauthor=T.+Tangauthor=Q.+Liuauthor=T.+Yangauthor=L.+Yangauthor=Y.+Maauthor=G.+Zhangauthor=Y.+Huangauthor=X.+Songauthor=L.+A.+Orband-Millerauthor=Q.+Wuauthor=L.+Zhouauthor=Z.+Xiangauthor=J.+N.+Xiangauthor=S.+Leungauthor=L.+Shaoauthor=X.+Linauthor=M.+Loberaauthor=F.+Ren&title=From+ROR%CE%B3t+agonist+to+two+types+of+ROR%CE%B3t+inverse+agonists&doi=10.1021%2Facsmedchemlett.7b00476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00476%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DFrom%2520ROR%25CE%25B3t%2520agonist%2520to%2520two%2520types%2520of%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Facsmedchemlett.7b00476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R.</span>; <span class="NLM_string-name">Kumar, S.
S.</span>; <span class="NLM_string-name">Pandya, V.</span>; <span class="NLM_string-name">Desai, J.</span>; <span class="NLM_string-name">Raval, S.</span></span> <span> </span><span class="NLM_article-title">Cyclopropyl Derivatives as ROR-gamma Modulators</span>. WO Patent<span class="NLM_patent">WO2018011746A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+Desai&author=S.%0AS.+Kumar&author=V.+Pandya&author=J.+Desai&author=S.+Raval&title=Cyclopropyl+Derivatives+as+ROR-gamma+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%26atitle%3DCyclopropyl%2520Derivatives%2520as%2520ROR-gamma%2520Modulators%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of VTP-43742, a RORγt inverse agonist for the treatment of psoriasis</span>.  <i>13th Winter Conference on Medicinal and Bioorganic Chemistry, Steamboat Springs, CO. January 22–26</i>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Zhuang&title=Discovery+of+VTP-43742%2C+a+ROR%CE%B3t+inverse+agonist+for+the+treatment+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520VTP-43742%252C%2520a%2520ROR%25CE%25B3t%2520inverse%2520agonist%2520for%2520the%2520treatment%2520of%2520psoriasis%26jtitle%3D13th%2520Winter%2520Conference%2520on%2520Medicinal%2520and%2520Bioorganic%2520Chemistry%252C%2520Steamboat%2520Springs%252C%2520CO.%2520January%252022%25E2%2580%259326%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGeehan, G. M.</span></span> <span> </span><span class="NLM_article-title">The RORγt blocker, VTP-43742, suppresses Th17 activity providing greater benefit than IL-17A blockade in an EAE model of autoimmunity</span>. Poster presented at  <i>Keystone Symposia on Mechanisms of Pro-Inflammatory Diseases, 23rd April</i>, <span class="NLM_year">2015</span>. <a href="http://www.keystonesymposia.org/15Z4" class="extLink">http://www.keystonesymposia.org/15Z4</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=G.+M.+McGeehan&title=The+ROR%CE%B3t+blocker%2C+VTP-43742%2C+suppresses+Th17+activity+providing+greater+benefit+than+IL-17A+blockade+in+an+EAE+model+of+autoimmunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26atitle%3DThe%2520ROR%25CE%25B3t%2520blocker%252C%2520VTP-43742%252C%2520suppresses%2520Th17%2520activity%2520providing%2520greater%2520benefit%2520than%2520IL-17A%2520blockade%2520in%2520an%2520EAE%2520model%2520of%2520autoimmunity%26jtitle%3DKeystone%2520Symposia%2520on%2520Mechanisms%2520of%2520Pro-Inflammatory%2520Diseases%252C%252023rd%2520April%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claremon, D. A.</span>; <span class="NLM_string-name">Dillard, L. W.</span>; <span class="NLM_string-name">Dong, C.</span>; <span class="NLM_string-name">Fan, Y.</span>; <span class="NLM_string-name">Jia, L.</span>; <span class="NLM_string-name">Lotesta, S. D.</span>; <span class="NLM_string-name">Marcus, A.</span>; <span class="NLM_string-name">Singh, S.
B.</span>; <span class="NLM_string-name">Tice, C.
M.</span>; <span class="NLM_string-name">Yuan, J.</span>; <span class="NLM_string-name">Zhao, W.</span>; <span class="NLM_string-name">Zheng, Y.</span>; <span class="NLM_string-name">Zhuang, L.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrrolopyridine Inhibitors of ROR-gamma</span>. WO Patent <span class="NLM_patent">WO2016061160A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+A.+Claremon&author=L.+W.+Dillard&author=C.+Dong&author=Y.+Fan&author=L.+Jia&author=S.+D.+Lotesta&author=A.+Marcus&author=S.%0AB.+Singh&author=C.%0AM.+Tice&author=J.+Yuan&author=W.+Zhao&author=Y.+Zheng&author=L.+Zhuang&title=Dihydropyrrolopyridine+Inhibitors+of+ROR-gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DDihydropyrrolopyridine%2520Inhibitors%2520of%2520ROR-gamma%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khairatkar-Joshi, N.</span>; <span class="NLM_string-name">Kulkarni, A.</span>; <span class="NLM_string-name">Shah, D. M.</span>; <span class="NLM_string-name">Bhosale, V. M.</span>; <span class="NLM_string-name">Lodhiya, B. J.</span>; <span class="NLM_string-name">Thiraviam, A. M.</span>; <span class="NLM_string-name">Marathe, M.</span>; <span class="NLM_string-name">Hadambar, A. A.</span></span> <span> </span><span class="NLM_article-title">Treatment of Respiratory Disorders Using ROR-gamma Inhibitors</span>. WO Patent<span class="NLM_patent">WO2016193894A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Khairatkar-Joshi&author=A.+Kulkarni&author=D.+M.+Shah&author=V.+M.+Bhosale&author=B.+J.+Lodhiya&author=A.+M.+Thiraviam&author=M.+Marathe&author=A.+A.+Hadambar&title=Treatment+of+Respiratory+Disorders+Using+ROR-gamma+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKhairatkar-Joshi%26aufirst%3DN.%26atitle%3DTreatment%2520of%2520Respiratory%2520Disorders%2520Using%2520ROR-gamma%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, J. R.</span></span> <span> </span><span class="NLM_article-title">Compounds Useful For Inhibiting ROR-Gamma-T</span>. WO Patent<span class="NLM_patent">WO2017044410A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+R.+Morphy&title=Compounds+Useful+For+Inhibiting+ROR-Gamma-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26atitle%3DCompounds%2520Useful%2520For%2520Inhibiting%2520ROR-Gamma-T%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lever, S.</span>; <span class="NLM_string-name">Narjes, F.</span>; <span class="NLM_string-name">Olsson, R. I.</span>; <span class="NLM_string-name">Von Berg, S.</span></span> <span> </span><span class="NLM_article-title">Isoindole Compounds</span>. WO Patent <span class="NLM_patent">WO2017102784A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+Lever&author=F.+Narjes&author=R.+I.+Olsson&author=S.+Von+Berg&title=Isoindole+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLever%26aufirst%3DS.%26atitle%3DIsoindole%2520Compounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">The discovery of AZD0284, an inverse agonist of the nuclear receptor RORγ</span>.  <i>Drug Design and Delivery Symposium, October 26, 2017</i>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington DC</span>, <span class="NLM_year">2017</span>. <a href="https://www.acs.org/content/acs/en/acs-webinars/drug-discovery/psoriasis.html" class="extLink">https://www.acs.org/content/acs/en/acs-webinars/drug-discovery/psoriasis.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=F.+Narjes&title=The+discovery+of+AZD0284%2C+an+inverse+agonist+of+the+nuclear+receptor+ROR%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DThe%2520discovery%2520of%2520AZD0284%252C%2520an%2520inverse%2520agonist%2520of%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DDrug%2520Design%2520and%2520Delivery%2520Symposium%252C%2520October%252026%252C%25202017%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunette, S. R.</span>; <span class="NLM_string-name">Csengery, J.</span>; <span class="NLM_string-name">Hughes, R. O.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Sibley, R.</span>; <span class="NLM_string-name">Turner, M. R.</span>; <span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Pteridine Derivatives as Modulators of ROR Gamma</span>. WO Patent <span class="NLM_patent">WO2017058831A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+R.+Brunette&author=J.+Csengery&author=R.+O.+Hughes&author=X.+Li&author=R.+Sibley&author=M.+R.+Turner&author=Z.+Xiong&title=Pteridine+Derivatives+as+Modulators+of+ROR+Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrunette%26aufirst%3DS.%2BR.%26atitle%3DPteridine%2520Derivatives%2520as%2520Modulators%2520of%2520ROR%2520Gamma%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vloten, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guertin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viney, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of biaryl carboxylamides as potent RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2991</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26048806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFGhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2991-2997&author=J.+Chaoauthor=I.+Enyedyauthor=K.+V.+Van+Vlotenauthor=D.+Marcotteauthor=K.+Guertinauthor=R.+Hutchingsauthor=N.+Powellauthor=H.+Jonesauthor=T.+Bohnertauthor=C.+C.+Pengauthor=L.+Silvianauthor=V.+S.+Hongauthor=K.+Littleauthor=D.+Banerjeeauthor=L.+Pengauthor=A.+Taverasauthor=J.+L.+Vineyauthor=J.+Fontenot&title=Discovery+of+biaryl+carboxylamides+as+potent+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of biaryl carboxylamides as potent RORγ inverse agonists</span></div><div class="casAuthors">Chao, Jianhua; Enyedy, Istvan; Van Vloten, Kurt; Marcotte, Douglas; Guertin, Kevin; Hutchings, Richard; Powell, Noel; Jones, Howard; Bohnert, Tonika; Peng, Chi-Chi; Silvian, Laura; Hong, Victor Sukbong; Little, Kevin; Banerjee, Daliya; Peng, Liaomin; Taveras, Arthur; Viney, Joanne L.; Fontenot, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2991-2997</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathol. of several major human immune-mediated diseases.  Evidence from mouse models demonstrates that genetic or pharmacol. inhibition of RORγ activity can block the prodn. of pathogenic cytokines, including IL-17, and convey therapeutic benefit.  We have identified and developed a biaryl-carboxylamide series of RORγ inverse agonists via a structure based design approach.  Co-crystal structures of compds. 16 and 48 supported the design approach and confirmed the key interactions with RORγ protein; the hydrogen bonding with His479 was key to the significant improvement in inverse agonist effect.  The results have shown this is a class of potent and selective RORγ inverse agonists, with demonstrated oral bioavailability in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8cho8P_anmrVg90H21EOLACvtfcHk0lgDqhKqGyt44g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFGhtLs%253D&md5=6c8dc3982ef7203c3ae7390cccce99e4</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DVan%2BVloten%26aufirst%3DK.%2BV.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DGuertin%26aufirst%3DK.%26aulast%3DHutchings%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DN.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DC.%2BC.%26aulast%3DSilvian%26aufirst%3DL.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DLittle%26aufirst%3DK.%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DTaveras%26aufirst%3DA.%26aulast%3DViney%26aufirst%3DJ.%2BL.%26aulast%3DFontenot%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520biaryl%2520carboxylamides%2520as%2520potent%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2991%26epage%3D2997%26doi%3D10.1016%2Fj.bmcl.2015.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guertin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talreja, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vloten, K. V.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2985</span>– <span class="NLM_lpage">2990</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.05.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2985-2990&author=T.+Wangauthor=D.+Banerjeeauthor=T.+Bohnertauthor=J.+Chaoauthor=I.+Enyedyauthor=J.+Fontenotauthor=K.+Guertinauthor=H.+Jonesauthor=E.+Y.+Linauthor=D.+Marcotteauthor=T.+Talrejaauthor=K.+V.+Van+Vloten&title=Discovery+of+novel+pyrazole-containing+benzamides+as+potent+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.028%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DFontenot%26aufirst%3DJ.%26aulast%3DGuertin%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DE.%2BY.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DVan%2BVloten%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520novel%2520pyrazole-containing%2520benzamides%2520as%2520potent%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2985%26epage%3D2990%26doi%3D10.1016%2Fj.bmcl.2015.05.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span>; <span class="NLM_string-name">Lei, H.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Meng, Q.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Modulators of The Retinoid-Related Orphan Receptor Gamma (ROR-Gamma) For Use in The Treatment of Autoimmune and Inflammatory Diseases</span>. WO Patent <span class="NLM_patent">WO2014086894A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=F.+Han&author=H.+Lei&author=X.+Lin&author=Q.+Meng&author=Y.+Wang&title=Modulators+of+The+Retinoid-Related+Orphan+Receptor+Gamma+%28ROR-Gamma%29+For+Use+in+The+Treatment+of+Autoimmune+and+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DF.%26atitle%3DModulators%2520of%2520The%2520Retinoid-Related%2520Orphan%2520Receptor%2520Gamma%2520%2528ROR-Gamma%2529%2520For%2520Use%2520in%2520The%2520Treatment%2520of%2520Autoimmune%2520and%2520Inflammatory%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubic-Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rio-Espinola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doelemeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deurinck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schümann, J.</span></span> <span> </span><span class="NLM_article-title">Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations</span>. <i>JCI Insight</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e91127</span>, <span class="refDoi"> DOI: 10.1172/jci.insight.91127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1172%2Fjci.insight.91127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28289717" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=e91127&author=C.+Guntermannauthor=A.+Piaiaauthor=M.+L.+Hamelauthor=D.+Theilauthor=T.+Rubic-Schneiderauthor=A.+Del+Rio-Espinolaauthor=L.+Dongauthor=A.+Billichauthor=K.+Kaupmannauthor=J.+Dawsonauthor=K.+Hoegenauerauthor=D.+Orainauthor=S.+Hintermannauthor=R.+Stringerauthor=D.+D.+Patelauthor=A.+Doelemeyerauthor=M.+Deurinckauthor=J.+Sch%C3%BCmann&title=Retinoic-acid-orphan-receptor-C+inhibition+suppresses+Th17+cells+and+induces+thymic+aberrations&doi=10.1172%2Fjci.insight.91127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1172%2Fjci.insight.91127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci.insight.91127%26sid%3Dliteratum%253Aachs%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DPiaia%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DM.%2BL.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DRubic-Schneider%26aufirst%3DT.%26aulast%3DDel%2BRio-Espinola%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DDoelemeyer%26aufirst%3DA.%26aulast%3DDeurinck%26aufirst%3DM.%26aulast%3DSch%25C3%25BCmann%26aufirst%3DJ.%26atitle%3DRetinoic-acid-orphan-receptor-C%2520inhibition%2520suppresses%2520Th17%2520cells%2520and%2520induces%2520thymic%2520aberrations%26jtitle%3DJCI%2520Insight%26date%3D2017%26volume%3D2%26spage%3De91127%26doi%3D10.1172%2Fjci.insight.91127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new triazolo- and imidazolopyridine RORγt inverse agonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2640</span>– <span class="NLM_lpage">2648</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201600500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27902884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFKnu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2640-2648&author=S.+Hintermannauthor=C.+Guntermannauthor=H.+Mattesauthor=D.+A.+Carcacheauthor=J.+Wagnerauthor=A.+Vulpettiauthor=A.+Billichauthor=J.+Dawsonauthor=K.+Kaupmannauthor=J.+Kallenauthor=R.+Stringerauthor=D.+Orain&title=Synthesis+and+biological+evaluation+of+new+triazolo-+and+imidazolopyridine+ROR%CE%B3t+inverse+agonists&doi=10.1002%2Fcmdc.201600500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists</span></div><div class="casAuthors">Hintermann, Samuel; Guntermann, Christine; Mattes, Henri; Carcache, David A.; Wagner, Juergen; Vulpetti, Anna; Billich, Andreas; Dawson, Janet; Kaupmann, Klemens; Kallen, Joerg; Stringer, Rowan; Orain, David</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2640-2648</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Retinoic-acid-related orphan receptor γt (RORγt) is a key transcription factor implicated in the prodn. of pro-inflammatory Th17 cytokines, which drive a no. of autoimmune diseases.  Despite diverse chem. series having been reported, combining high potency with a good physicochem. profile has been a very challenging task in the RORγt inhibitor field.  Based on available chem. structures and incorporating inhouse knowledge, a new series of triazolo- and imidazopyridine RORγt inverse agonists was designed.  In addn., replacement of the terminal cyclopentylamide metabolic soft spot by five-membered heterocycles was investigated.  From the efforts, the authors identified an optimal 6,7,8-substituted imidazo[1,2-a]pyridine core system and a 5-tert-butyl-1,2,4-oxadiazole as cyclopentylamide replacement leading to compds. I and II.  Both derivs. showed good pharmacol. potencies in biochem. and cell-based assays combined with excellent physicochem. properties, including low to medium plasma protein binding across species.  Finally, I and II were shown to be active in a rodent pharmacokinetic/pharmacodynamic (PK/PD) model after oral gavage at 15 mg kg-1, lowering IL-17 cytokine prodn. in ex vivo antigen recall assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWpnWp_eiIk7Vg90H21EOLACvtfcHk0lg9qmX_3eCisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFKnu77O&md5=8840fecf0dd72fb225ed6686c673a35d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600500%26sid%3Dliteratum%253Aachs%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DCarcache%26aufirst%3DD.%2BA.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DOrain%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520triazolo-%2520and%2520imidazolopyridine%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2640%26epage%3D2648%26doi%3D10.1002%2Fcmdc.201600500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimozato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, S.</span></span> <span> </span><span class="NLM_article-title">Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.jdermsci.2016.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.jdermsci.2016.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27726924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=12-19&author=M.+Takaishiauthor=M.+Ishizakiauthor=K.+Suzukiauthor=T.+Isobeauthor=T.+Shimozatoauthor=S.+Sano&title=Oral+administration+of+a+novel+ROR%CE%B3t+antagonist+attenuates+psoriasis-like+skin+lesion+of+two+independent+mouse+models+through+neutralization+of+IL-17&doi=10.1016%2Fj.jdermsci.2016.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17</span></div><div class="casAuthors">Takaishi, Mikiro; Ishizaki, Masayuki; Suzuki, Keisuke; Isobe, Takashi; Shimozato, Takaichi; Sano, Shigetoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-19</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Targeting the IL-17 pathway represents a highly effective strategy for the treatment of psoriasis, using antibodies against IL-17A and IL-17 receptor, suggesting that Th17 cells essentially contribute to development of psoriasis.  Th17 differentiation depends on the key transcription factor, RORγt.  To develop a novel RORγt antagonist which is effective on psoriasis via oral administration.  A chem. library was screened using cell-based high-throughput methods, luciferase reporter assay, competitive binding assay, and T cell differentiation assay.  To evaluate in vivo effects of a novel RORγt antagonist, A213, we orally administrated it to two independent mouse models of psoriasis; IL-23-injection model and K5.Stat3C transgenic mouse.  Oral administration of A213 resulted in attenuation of skin inflammation in the both mouse models.  At the same time, increased levels of IL-17A expression were significantly reduced in the skin lesions and skin-draining lymph nodes.  These results implicate a new therapeutic application of RORγt antagonist for the treatment of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ-UL1F-id0bVg90H21EOLACvtfcHk0lg9qmX_3eCisg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsbvO&md5=e96213dec5048167e63a283d4cbe7a48</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2016.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2016.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DTakaishi%26aufirst%3DM.%26aulast%3DIshizaki%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DS.%26atitle%3DOral%2520administration%2520of%2520a%2520novel%2520ROR%25CE%25B3t%2520antagonist%2520attenuates%2520psoriasis-like%2520skin%2520lesion%2520of%2520two%2520independent%2520mouse%2520models%2520through%2520neutralization%2520of%2520IL-17%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2017%26volume%3D85%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.jdermsci.2016.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flick, A. C.</span>; <span class="NLM_string-name">Jones, P.</span>; <span class="NLM_string-name">Kaila, N.</span>; <span class="NLM_string-name">Mente, S. R.</span>; <span class="NLM_string-name">Schnute, M. E.</span>; <span class="NLM_string-name">Trzupek, J. D.</span>; <span class="NLM_string-name">Vazquez, M. L.</span>; <span class="NLM_string-name">Xing, L.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">Wennerstål, G.
M.</span>; <span class="NLM_string-name">Zamaratski, E.</span></span> <span> </span><span class="NLM_article-title">Methyl-And Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof</span>. WO Patent <span class="NLM_patent">WO2016046755A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+C.+Flick&author=P.+Jones&author=N.+Kaila&author=S.+R.+Mente&author=M.+E.+Schnute&author=J.+D.+Trzupek&author=M.+L.+Vazquez&author=L.+Xing&author=L.+Zhang&author=G.%0AM.+Wennerst%C3%A5l&author=E.+Zamaratski&title=Methyl-And+Trifluoromethyl-Substituted+Pyrrolopyridine+Modulators+of+RORC2+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlick%26aufirst%3DA.%2BC.%26atitle%3DMethyl-And%2520Trifluoromethyl-Substituted%2520Pyrrolopyridine%2520Modulators%2520of%2520RORC2%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2017.12.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=470-482&author=M.+Konoauthor=T.+Odaauthor=M.+Tawadaauthor=T.+Imadaauthor=Y.+Bannoauthor=N.+Tayaauthor=T.+Kawamotoauthor=H.+Tokuharaauthor=Y.+Tomataauthor=N.+Ishiiauthor=A.+Ochidaauthor=Y.+Fukaseauthor=T.+Yukawaauthor=S.+Fukumotoauthor=H.+Watanabeauthor=K.+Ugaauthor=A.+Shibataauthor=H.+Nakagawaauthor=M.+Shirasakiauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=J.+Shiraiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists.+Part+2%3A+Design%2C+synthesis%2C+and+biological+evaluation+of+novel+tetrahydroisoquinoline+derivatives&doi=10.1016%2Fj.bmc.2017.12.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DYukawa%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists.%2520Part%25202%253A%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520tetrahydroisoquinoline%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D470%26epage%3D482%26doi%3D10.1016%2Fj.bmc.2017.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span>; <span class="NLM_string-name">Shirai, J.</span>; <span class="NLM_string-name">Fukase, Y.</span>; <span class="NLM_string-name">Tomata, Y.</span>; <span class="NLM_string-name">Sato, A.</span>; <span class="NLM_string-name">Ochida, A.</span>; <span class="NLM_string-name">Yonemori, K.</span>; <span class="NLM_string-name">Nakagawa, H.</span></span> <span> </span><span class="NLM_article-title">Condensed Heterocyclic Compound</span>. WO Patent <span class="NLM_patent">WO 2013042782A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Yamamoto&author=J.+Shirai&author=Y.+Fukase&author=Y.+Tomata&author=A.+Sato&author=A.+Ochida&author=K.+Yonemori&author=H.+Nakagawa&title=Condensed+Heterocyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DCondensed%2520Heterocyclic%2520Compound%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonemori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29262987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=483-500&author=J.+Shiraiauthor=Y.+Tomataauthor=M.+Konoauthor=A.+Ochidaauthor=Y.+Fukaseauthor=A.+Satoauthor=S.+Masadaauthor=T.+Kawamotoauthor=K.+Yonemoriauthor=R.+Koyamaauthor=H.+Nakagawaauthor=M.+Nakayamaauthor=K.+Ugaauthor=A.+Shibataauthor=K.+Kogaauthor=T.+Okuiauthor=M.+Shirasakiauthor=R.+Skeneauthor=B.+Sangauthor=I.+Hoffmanauthor=W.+Laneauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists%2C+part+1%3A+Identification+of+novel+phenylglycinamides+as+lead+scaffolds&doi=10.1016%2Fj.bmc.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span></div><div class="casAuthors">Shirai, Junya; Tomata, Yoshihide; Kono, Mitsunori; Ochida, Atsuko; Fukase, Yoshiyuki; Sato, Ayumu; Masada, Shinichi; Kawamoto, Tetsuji; Yonemori, Kazuko; Koyama, Ryoukichi; Nakagawa, Hideyuki; Nakayama, Masaharu; Uga, Keiko; Shibata, Akira; Koga, Keiko; Okui, Toshitake; Shirasaki, Mikio; Skene, Robert; Sang, Bi Ching; Hoffman, Isaac; Lane, Wes; Fujitani, Yasushi; Yamasaki, Masashi; Yamamoto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">483-500</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel phenylglycinamides as retinoic acid receptor-related orphan receptor-gamma t (RORγt) inverse agonists were discovered through optimization of a high-throughput screen hit 1.  (R)-N-(2-((3,5-Difluoro-4-(trimethylsilyl)phenyl) amino)-1-(4-methoxyphenyl)-2-oxoethyl)-3-hydroxy-N-methylisoxazole-5-carboxamide (22) was identified as one of the best of these compds.  It displayed higher subtype selectivity and specificity over other nuclear receptors and demonstrated in vivo potency to suppress the transcriptional activity of RORγt in a mouse PD (pharmacodynamic) model upon oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIW-zVUDTjKLVg90H21EOLACvtfcHk0lhb9WTepxOJyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ&md5=649c3527a6f7e383456dd59551e35628</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYonemori%26aufirst%3DK.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DOkui%26aufirst%3DT.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DI.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists%252C%2520part%25201%253A%2520Identification%2520of%2520novel%2520phenylglycinamides%2520as%2520lead%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D483%26epage%3D500%26doi%3D10.1016%2Fj.bmc.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagomi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2014.01.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1948-1959&author=H.+Toyamaauthor=M.+Nakamuraauthor=M.+Nakamuraauthor=Y.+Matsumotoauthor=M.+Nakagomiauthor=Y.+Hashimoto&title=Development+of+novel+silicon-containing+inverse+agonists+of+retinoic+acid+receptor-related+orphan+receptors&doi=10.1016%2Fj.bmc.2014.01.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DToyama%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DNakagomi%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520novel%2520silicon-containing%2520inverse%2520agonists%2520of%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1948%26epage%3D1959%26doi%3D10.1016%2Fj.bmc.2014.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonemori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchimori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of [cis-3-({(5R)-5-[(7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic acid (TAK-828F) as a potent, selective, and orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2973</span>– <span class="NLM_lpage">2988</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00061</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00061" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvFWns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2973-2988&author=M.+Konoauthor=A.+Ochidaauthor=T.+Odaauthor=T.+Imadaauthor=Y.+Bannoauthor=N.+Tayaauthor=S.+Masadaauthor=T.+Kawamotoauthor=K.+Yonemoriauthor=Y.+Naraauthor=Y.+Fukaseauthor=T.+Yukawaauthor=H.+Tokuharaauthor=R.+Skeneauthor=B.+C.+Sangauthor=I.+D.+Hoffmanauthor=G.+P.+Snellauthor=K.+Ugaauthor=A.+Shibataauthor=K.+Igakiauthor=Y.+Nakamuraauthor=H.+Nakagawaauthor=N.+Tsuchimoriauthor=M.+Yamasakiauthor=J.+Shiraiauthor=S.+Yamamoto&title=Discovery+of+%5Bcis-3-%28%7B%285R%29-5-%5B%287-fluoro-1%2C1-dimethyl-2%2C3-dihydro-1H-inden-5-yl%29carbamoyl%5D-2-methoxy-7%2C8-dihydro-1%2C6-naphthyridin-6%285H%29-yl%7Dcarbonyl%29cyclobutyl%5Dacetic+acid+%28TAK-828F%29+as+a+potent%2C+selective%2C+and+orally+available+novel+retinoic+acid+receptor-related+orphan+receptor+%CE%B3t+inverse+agonist&doi=10.1021%2Facs.jmedchem.8b00061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of [cis-3-({(5R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist</span></div><div class="casAuthors">Kono, Mitsunori; Ochida, Atsuko; Oda, Tsuneo; Imada, Takashi; Banno, Yoshihiro; Taya, Naohiro; Masada, Shinichi; Kawamoto, Tetsuji; Yonemori, Kazuko; Nara, Yoshi; Fukase, Yoshiyuki; Yukawa, Tomoya; Tokuhara, Hidekazu; Skene, Robert; Sang, Bi-Ching; Hoffman, Isaac D.; Snell, Gyorgy P.; Uga, Keiko; Shibata, Akira; Igaki, Keiko; Nakamura, Yoshiki; Nakagawa, Hideyuki; Tsuchimori, Noboru; Yamasaki, Masashi; Shirai, Junya; Yamamoto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2973-2988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tetrahydronaphthyridine derivs. as novel RORγt inverse agonists were designed and synthesized.  We reduced the lipophilicity of tetrahydroisoquinoline compd. 1 by replacement of the trimethylsilyl group and SBDD-guided scaffold exchange, which successfully afforded compd. 7 (VII) with a lower log D value and tolerable in vitro activity.  Consideration of LLE (lipophilic ligand efficiency) values in the subsequent optimization of the carboxylate tether led to the discovery of [cis-3-({(5R)-5-[(7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic acid, TAK-828F (10), which showed potent RORγt inverse agonistic activity, excellent selectivity against other ROR isoforms and nuclear receptors, and a good pharmacokinetic profile.  In animal studies, oral administration of compd. 10 exhibited robust and dose-dependent inhibition of IL-17A cytokine expression in a mouse IL23-induced gene expression assay.  Furthermore, development of clin. symptoms in a mouse exptl. autoimmune encephalomyelitis model was significantly reduced.  Compd. 10 was selected as a clin. compd. for the treatment of Th17-driven autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqraNPFfTkC1rVg90H21EOLACvtfcHk0lhbTYbpKeJvig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvFWns7Y%253D&md5=966c20bbdf825d1ff6eb91c5950a33c8</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00061%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DOda%26aufirst%3DT.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYonemori%26aufirst%3DK.%26aulast%3DNara%26aufirst%3DY.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DYukawa%26aufirst%3DT.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DIgaki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DTsuchimori%26aufirst%3DN.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520%255Bcis-3-%2528%257B%25285R%2529-5-%255B%25287-fluoro-1%252C1-dimethyl-2%252C3-dihydro-1H-inden-5-yl%2529carbamoyl%255D-2-methoxy-7%252C8-dihydro-1%252C6-naphthyridin-6%25285H%2529-yl%257Dcarbonyl%2529cyclobutyl%255Dacetic%2520acid%2520%2528TAK-828F%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520novel%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%25CE%25B3t%2520inverse%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2973%26epage%3D2988%26doi%3D10.1021%2Facs.jmedchem.8b00061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchimori, N.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bcp.2018.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29369782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVentr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=35-45&author=A.+Shibataauthor=K.+Ugaauthor=T.+Satoauthor=M.+Sagaraauthor=K.+Igakiauthor=Y.+Nakamuraauthor=A.+Ochidaauthor=M.+Konoauthor=J.+Shiraiauthor=S.+Yamamotoauthor=M.+Yamasakiauthor=N.+Tsuchimori&title=Pharmacological+inhibitory+profile+of+TAK-828F%2C+a+potent+and+selective+orally+available+ROR%CE%B3t+inverse+agonist&doi=10.1016%2Fj.bcp.2018.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist</span></div><div class="casAuthors">Shibata, Akira; Uga, Keiko; Sato, Takayuki; Sagara, Masaki; Igaki, Keiko; Nakamura, Yoshiki; Ochida, Atsuko; Kono, Mitsunori; Shirai, Junya; Yamamoto, Satoshi; Yamasaki, Masashi; Tsuchimori, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-45</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Retinoic acid-related orphan receptor γt (RORγt) is a key master regulator of the differentiation and activation of IL-17 producing CD4+ Th17, CD8+ Tc17 and IL-17/IFN-γ co-producing cells (Th1/17 cells).  These cells play crit. roles in the pathogenesis of autoimmune diseases such as inflammatory bowel disease and multiple sclerosis.  Thus, RORγt is an attractive target for the treatment of these diseases.  The authors discovered TAK-828F, an orally available potent and selective RORγt inverse agonist.  The inhibitory effect on the activation and differentiation of Th17 cells by TAK-828F was evaluated in mouse and human primary cells.  TAK-828F inhibited IL-17 prodn. from mouse splenocytes and human peripheral blood mononuclear cells dose-dependently at concns. of 0.01-10 μM without affecting the prodn. of IFN-γ.  Addnl., TAK-828F strongly inhibited Th17, Tc17 and Th1/17 cells' differentiation from naive T cells and memory CD4+ T cells at 100 nM without affecting Th1 cells' differentiation.  In addn., TAK-828F improved Th17/Treg cells' population ratio by inhibiting Th17 cells' differentiation and up-regulating Treg cells.  Furthermore, TAK-828F, at 100 nM, reduced the prodn. of Th17-related cytokines (IL-17, IL-17F and IL-22) without affecting IFN-γ prodn. in whole blood.  These results demonstrate that TAK-828F has the potent and selective inhibitory activity against RORγt both in mouse and human cells.  Addnl., oral administration of TAK-828F showed promising efficacy in naive T cell transfer mouse colitis model.  TAK-828F may provide a novel therapeutic option to treat immune diseases by inhibiting Th17 and Th1/17 cells' differentiation and improving imbalance between Th17 and Treg cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ1ymVu1K7nbVg90H21EOLACvtfcHk0lhbTYbpKeJvig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVentr8%253D&md5=50e15bf2fbe1809db5d34d6f10ea77e7</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DSagara%26aufirst%3DM.%26aulast%3DIgaki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DKono%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DTsuchimori%26aufirst%3DN.%26atitle%3DPharmacological%2520inhibitory%2520profile%2520of%2520TAK-828F%252C%2520a%2520potent%2520and%2520selective%2520orally%2520available%2520ROR%25CE%25B3t%2520inverse%2520agonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D150%26spage%3D35%26epage%3D45%26doi%3D10.1016%2Fj.bcp.2018.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span> </span><span class="NLM_article-title">FY2016 Full Year Results (released on May
10, 2017), Data Book</span>.  <i>Quarterly Results, Broker
Conferences, Special IR Events</i>; <span class="NLM_publisher-name">Takeda</span>: <span class="NLM_publisher-loc">Tokyo</span>, <span class="NLM_year">2017</span>; <a href="https://www.takeda.com/investors/reports/quarterly-announcements/" class="extLink">https://www.takeda.com/investors/reports/quarterly-announcements/</a> (accessed March 26, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FY2016+Full+Year+Results+%28released+on+May%0A10%2C+2017%29%2C+Data+Book.+Quarterly+Results%2C+Broker%0AConferences%2C+Special+IR+Events%3B+Takeda%3A+Tokyo%2C+2017%3B+https%3A%2F%2Fwww.takeda.com%2Finvestors%2Freports%2Fquarterly-announcements%2F+%28accessed+March+26%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DFY2016%2520Full%2520Year%2520Results%2520%2528released%2520on%2520May%250A10%252C%25202017%2529%252C%2520Data%2520Book%26jtitle%3DQuarterly%2520Results%252C%2520Broker%250AConferences%252C%2520Special%2520IR%2520Events%26pub%3DTakeda%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aratsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiozaki, M.</span></span> <span> </span><span class="NLM_article-title">SAR exploration guided by LE and Fsp3: Discovery of a selective and orally efficacious RORγ Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00253</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00253" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=23-27&author=K.+Hirataauthor=M.+Kotokuauthor=N.+Sekiauthor=T.+Maebaauthor=K.+Maedaauthor=S.+Hirashimaauthor=T.+Sakaiauthor=S.+Obikaauthor=A.+Horiauthor=Y.+Haseauthor=T.+Yamaguchiauthor=Y.+Katsudaauthor=T.+Hataauthor=N.+Miyagawaauthor=K.+Aritaauthor=Y.+Nomuraauthor=K.+Asahinaauthor=Y.+Aratsuauthor=M.+Kamadaauthor=T.+Adachiauthor=M.+Noguchiauthor=S.+Doiauthor=P.+Croweauthor=E.+Bradleyauthor=R.+Steensmaauthor=H.+Taoauthor=M.+Fennauthor=R.+Babineauthor=X.+Liauthor=S.+Thacherauthor=H.+Hashimotoauthor=M.+Shiozaki&title=SAR+exploration+guided+by+LE+and+Fsp3%3A+Discovery+of+a+selective+and+orally+efficacious+ROR%CE%B3+Inhibitor&doi=10.1021%2Facsmedchemlett.5b00253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor</span></div><div class="casAuthors">Hirata, Kazuyuki; Kotoku, Masayuki; Seki, Noriyoshi; Maeba, Takaki; Maeda, Katsuya; Hirashima, Shintaro; Sakai, Takayuki; Obika, Shingo; Hori, Akimi; Hase, Yasunori; Yamaguchi, Takayuki; Katsuda, Yoshiaki; Hata, Takahiro; Miyagawa, Naoki; Arita, Kojo; Nomura, Yukihiro; Asahina, Kota; Aratsu, Yusuke; Kamada, Masafumi; Adachi, Tsuyoshi; Noguchi, Masato; Doi, Satoki; Crowe, Paul; Bradley, Erin; Steensma, Ruo; Tao, Haiyan; Fenn, Morgan; Babine, Robert; Li, Xiaolin; Thacher, Scott; Hashimoto, Hiromasa; Shiozaki, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of RORγ inhibitors was identified starting with the HTS hit compd. 2-(5-(2,3-dihydro-1H-inden-2-yl)-4-ethyl-4-H-1,2,4-triazol-3-ylthio)-N-(naphthalen-1-yl)acetamide.  After SAR investigation based on a prospective consideration of two drug-likeness metrics, ligand efficiency (LE) and fraction of Sp3 carbon atoms (Fsp3), significant improvement of metabolic stability as well as redn. of CYP inhibition was obsd., which finally led to discovery of a selective and orally efficacious RORγ inhibitor (3R,4R)-1-acetyl-4-(4-cyclopropyl-5-(cis-3-isobutylcyclobutyl)-4H-1,2,4-triazol-3-yl)-M-(2,4-dimethylphenyl) pyrrolidine-3-carboxamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojA7KFHVtsOrVg90H21EOLACvtfcHk0li6ZtgtMPXuIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P&md5=fc2736f8baafee2084bb3adce7bb1a2e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00253%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DKotoku%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DMaeba%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DObika%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DKatsuda%26aufirst%3DY.%26aulast%3DHata%26aufirst%3DT.%26aulast%3DMiyagawa%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DK.%26aulast%3DAratsu%26aufirst%3DY.%26aulast%3DKamada%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DCrowe%26aufirst%3DP.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DFenn%26aufirst%3DM.%26aulast%3DBabine%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DThacher%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DShiozaki%26aufirst%3DM.%26atitle%3DSAR%2520exploration%2520guided%2520by%2520LE%2520and%2520Fsp3%253A%2520Discovery%2520of%2520a%2520selective%2520and%2520orally%2520efficacious%2520ROR%25CE%25B3%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D23%26epage%3D27%26doi%3D10.1021%2Facsmedchemlett.5b00253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheepstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Almen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesvaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutilek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eenennaam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagpal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soisson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornienko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotter, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oubrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Identification of an allosteric binding site for RORγt inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8833</span>, <span class="refDoi"> DOI: 10.1038/ncomms9833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fncomms9833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26640126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8833&author=M.+Scheepstraauthor=S.+Leysenauthor=G.+C.+van+Almenauthor=J.+R.+Millerauthor=J.+Piesvauxauthor=V.+Kutilekauthor=H.+van+Eenennaamauthor=H.+Zhangauthor=K.+Barrauthor=S.+Nagpalauthor=S.+M.+Soissonauthor=M.+Kornienkoauthor=K.+Wileyauthor=N.+Elsenauthor=S.+Sharmaauthor=C.+C.+Correllauthor=B.+W.+Trotterauthor=M.+van+der+Steltauthor=A.+Oubrieauthor=C.+Ottmannauthor=G.+Parthasarathyauthor=L.+Brunsveld&title=Identification+of+an+allosteric+binding+site+for+ROR%CE%B3t+inhibition&doi=10.1038%2Fncomms9833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an allosteric binding site for RORγt inhibition</span></div><div class="casAuthors">Scheepstra, Marcel; Leysen, Seppe; van Almen, Geert C.; Miller, J. Richard; Piesvaux, Jennifer; Kutilek, Victoria; van Eenennaam, Hans; Zhang, Hongjun; Barr, Kenneth; Nagpal, Sunil; Soisson, Stephen M.; Kornienko, Maria; Wiley, Kristen; Elsen, Nathaniel; Sharma, Sujata; Correll, Craig C.; Trotter, B. Wesley; van der Stelt, Mario; Oubrie, Arthur; Ottmann, Christian; Parthasarathy, Gopal; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8833/1-8833/10</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">RORγt is crit. for the differentiation and proliferation of Th17 cells assocd. with several chronic autoimmune diseases.  We report the discovery of a novel allosteric binding site on the nuclear receptor RORγt.  Co-crystn. of the ligand binding domain (LBD) of RORγt with a series of small-mol. antagonists demonstrates occupancy of a previously unreported allosteric binding pocket.  Binding at this non-canonical site induces an unprecedented conformational reorientation of helix 12 in the RORγt LBD, which blocks cofactor binding.  The functional consequence of this allosteric ligand-mediated conformation is inhibition of function as evidenced by both biochem. and cellular studies.  RORγt function is thus antagonized in a manner molecularly distinct from that of previously described orthosteric RORγt ligands.  This brings forward an approach to target RORγt for the treatment of Th17-mediated autoimmune diseases.  The elucidation of an unprecedented modality of pharmacol. antagonism establishes a mechanism for modulation of nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNcktcUUFl77Vg90H21EOLACvtfcHk0li6ZtgtMPXuIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL&md5=409b08232ecdd3f3e82fa660585c989d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms9833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9833%26sid%3Dliteratum%253Aachs%26aulast%3DScheepstra%26aufirst%3DM.%26aulast%3DLeysen%26aufirst%3DS.%26aulast%3Dvan%2BAlmen%26aufirst%3DG.%2BC.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DPiesvaux%26aufirst%3DJ.%26aulast%3DKutilek%26aufirst%3DV.%26aulast%3Dvan%2BEenennaam%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DNagpal%26aufirst%3DS.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DWiley%26aufirst%3DK.%26aulast%3DElsen%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DOttmann%26aufirst%3DC.%26aulast%3DParthasarathy%26aufirst%3DG.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520an%2520allosteric%2520binding%2520site%2520for%2520ROR%25CE%25B3t%2520inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8833%26doi%3D10.1038%2Fncomms9833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Wit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mossawi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huhn, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancibia-Carcamo, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanahan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powrie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowness, P. J.</span></span> <span> </span><span class="NLM_article-title">RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">960</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2015.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.jaci.2015.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26611672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVygs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2016&pages=960-963&author=J.+de%0AWitauthor=M.+H.+Al-Mossawiauthor=M.+H.+Huhnauthor=C.+V.+Arancibia-Carcamoauthor=K.+Doigauthor=B.+Kendrickauthor=R.+Gundleauthor=P.+Taylorauthor=T.+McClanahanauthor=E.+Murphyauthor=H.+Zhangauthor=K.+Barrauthor=J.+R.+Millerauthor=X.+Huauthor=T.+D.+Aicherauthor=R.+W.+Morganauthor=G.+D.+Glickauthor=D.+Zallerauthor=C.+Correllauthor=F.+Powrieauthor=P.+J.+Bowness&title=ROR%CE%B3t+inhibitors+suppress+T%28H%2917+responses+in+inflammatory+arthritis+and+inflammatory+bowel+disease&doi=10.1016%2Fj.jaci.2015.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease</span></div><div class="casAuthors">de Wit, Jelle; Al-Mossawi, M. Hussein; Huhn, Michael H.; Arancibia-Carcamo, Carolina V.; Doig, Karen; Kendrick, Benjamin; Gundle, Roger; Taylor, Peter; Mcclanahan, Terri; Murphy, Erin; Zhang, Hongjun; Barr, Ken; Miller, J. Richard; Hu, Xiao; Aicher, Thomas D.; Morgan, Rodney W.; Glick, Gary D.; Zaller, Dennis; Correll, Craig; Powrie, Fiona; Bowness, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">960-963</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The article investigated the role of MRL-248, MRL-367 as RORγt inhibitors suppressed TH17 responses in inflammatory arthritis and inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyjAsdh0dNRrVg90H21EOLACvtfcHk0lhtsnQICGqzfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVygs7vP&md5=5671b3ecee05ca5a6c0faed3ce883478</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2015.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2015.09.048%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3DAl-Mossawi%26aufirst%3DM.%2BH.%26aulast%3DHuhn%26aufirst%3DM.%2BH.%26aulast%3DArancibia-Carcamo%26aufirst%3DC.%2BV.%26aulast%3DDoig%26aufirst%3DK.%26aulast%3DKendrick%26aufirst%3DB.%26aulast%3DGundle%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DMcClanahan%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DC.%26aulast%3DPowrie%26aufirst%3DF.%26aulast%3DBowness%26aufirst%3DP.%2BJ.%26atitle%3DROR%25CE%25B3t%2520inhibitors%2520suppress%2520T%2528H%252917%2520responses%2520in%2520inflammatory%2520arthritis%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2016%26volume%3D137%26spage%3D960%26epage%3D963%26doi%3D10.1016%2Fj.jaci.2015.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Barr, K.
J.</span>; <span class="NLM_string-name">Lapointe, B. T.</span>; <span class="NLM_string-name">Gunaydin, H.</span>; <span class="NLM_string-name">Liu, K.</span>; <span class="NLM_string-name">Trotter, B. W.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl Substituted Benzoic Acids as RORgammaT Inhibitors and Uses Thereof</span>. WO Patent <span class="NLM_patent">WO2017075185A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=H.+Zhang&author=K.%0AJ.+Barr&author=B.+T.+Lapointe&author=H.+Gunaydin&author=K.+Liu&author=B.+W.+Trotter&title=Heteroaryl+Substituted+Benzoic+Acids+as+RORgammaT+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DHeteroaryl%2520Substituted%2520Benzoic%2520Acids%2520as%2520RORgammaT%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2907</span>– <span class="NLM_lpage">2912</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26048793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2907-2912&author=B.+P.+Fauberauthor=A.+Gobbiauthor=K.+Robargeauthor=A.+Zhouauthor=A.+Barnardauthor=J.+Caoauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=W.+Ouyangauthor=W.+Tangauthor=H.+Wong&title=Discovery+of+imidazo%5B1%2C5-a%5Dpyridines+and+-pyrimidines+as+potent+and+selective+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span></div><div class="casAuthors">Fauber, Benjamin P.; Gobbi, Alberto; Robarge, Kirk; Zhou, Aihe; Barnard, Adrian; Cao, Jianhua; Deng, Yuzhong; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Hawkins, Julie; Johnson, Adam R.; La, Hank; Norman, Maxine; Salmon, Gary; Summerhill, Susan; Ouyang, Wenjun; Tang, Wei; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2907-2912</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nuclear receptor (NR) retinoic acid receptor-related orphan receptor gamma (RORγ, RORc, or NR1F3) is a promising target for the treatment of autoimmune diseases.  RORc is a crit. regulator in the prodn. of the pro-inflammatory cytokine interleukin-17.  We discovered a series of potent and selective imidazo[1,5-a]pyridine and -pyrimidine RORc inverse agonists.  The most potent compds. displayed >300-fold selectivity for RORc over the other ROR family members, PPARγ, and NRs in our cellular selectivity panel.  The favorable potency, selectivity, and physiochem. properties of GNE-0946 (9) and GNE-6468 (28), in addn. to their potent suppression of IL-17 prodn. in human primary cells, support their use as chem. biol. tools to further explore the role of RORc in human biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIQTYB5nafXLVg90H21EOLACvtfcHk0lhtsnQICGqzfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D&md5=d0e89e186488a9db8f7629fd86ed7ea0</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C5-a%255Dpyridines%2520and%2520-pyrimidines%2520as%2520potent%2520and%2520selective%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2907%26epage%3D2912%26doi%3D10.1016%2Fj.bmcl.2015.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciesielski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rival, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5802</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2016.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27815118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5802-5808&author=G.+Ouvryauthor=C.+Bouix-Peterauthor=F.+Ciesielskiauthor=L.+Chantalatauthor=O.+Christinauthor=C.+Cominoauthor=D.+Duvertauthor=C.+Feretauthor=C.+S.+Harrisauthor=L.+Lamyauthor=A.+P.+Luzyauthor=B.+Musickiauthor=D.+Orfilaauthor=J.+Pascauauthor=V.+Parnetauthor=A.+Perrinauthor=R.+Pierreauthor=G.+Polgeauthor=C.+Raffinauthor=Y.+Rivalauthor=N.+Taquetauthor=E.+Thoreauauthor=L.+F.+Hennequin&title=Discovery+of+phenoxyindazoles+and+phenylthioindazoles+as+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2016.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span></div><div class="casAuthors">Ouvry, Gilles; Bouix-Peter, Claire; Ciesielski, Fabrice; Chantalat, Laurent; Christin, Olivier; Comino, Catherine; Duvert, Denis; Feret, Christophe; Harris, Craig S.; Lamy, Laurent; Luzy, Anne-Pascale; Musicki, Branislav; Orfila, Danielle; Pascau, Jonathan; Parnet, Veronique; Perrin, Agnes; Pierre, Romain; Polge, Gaelle; Raffin, Catherine; Rival, Yves; Taquet, Nathalie; Thoreau, Etienne; Hennequin, Laurent F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5802-5808</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the IL17 pathway and more specifically the nuclear receptor RORγ is thought to be beneficial in multiple skin disorders.  The Letter describes the discovery of phenoxyindazoles and thiophenoxy indazoles as potent RORγ inverse agonists.  Optimization of the potency and efforts to mitigate the phototoxic liability of the series are presented.  Finally, crystn. of the lead compd. revealed that the series bound to an allosteric site of the nuclear receptor.  Such compds. could be useful as tool compds. for understanding the impact of topical treatment on skin disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7Dguvi_h8LVg90H21EOLACvtfcHk0lghc0woEn-s7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM&md5=cd3aa2c246cfa35c98306096d823dccc</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DCiesielski%26aufirst%3DF.%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DComino%26aufirst%3DC.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DFeret%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DLuzy%26aufirst%3DA.%2BP.%26aulast%3DMusicki%26aufirst%3DB.%26aulast%3DOrfila%26aufirst%3DD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DParnet%26aufirst%3DV.%26aulast%3DPerrin%26aufirst%3DA.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DPolge%26aufirst%3DG.%26aulast%3DRaffin%26aufirst%3DC.%26aulast%3DRival%26aufirst%3DY.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DThoreau%26aufirst%3DE.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%2520phenoxyindazoles%2520and%2520phenylthioindazoles%2520as%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5802%26epage%3D5808%26doi%3D10.1016%2Fj.bmcl.2016.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trocha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudjelal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1302190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.4049%2Fjimmunol.1302190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24516202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2014&pages=2564-2575&author=J.+Skepnerauthor=R.+Rameshauthor=M.+Trochaauthor=D.+Schmidtauthor=E.+Balogluauthor=M.+Loberaauthor=T.+Carlsonauthor=J.+Hillauthor=L.+A.+Orband-Millerauthor=A.+Barnesauthor=M.+Boudjelalauthor=M.+Sundrudauthor=S.+Ghoshauthor=J.+Yang&title=Pharmacologic+inhibition+of+ROR%CE%B3t+regulates+Th17+signature+gene+expression+and+suppresses+cutaneous+inflammation+in+vivo&doi=10.4049%2Fjimmunol.1302190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo</span></div><div class="casAuthors">Skepner, Jill; Ramesh, Radha; Trocha, Mark; Schmidt, Darby; Baloglu, Erkan; Lobera, Mercedes; Carlson, Thaddeus; Hill, Jonathan; Orband-Miller, Lisa A.; Barnes, Ashley; Boudjelal, Mohamed; Sundrud, Mark; Ghosh, Shomir; Yang, Jianfei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2564-2575</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">IL-17-producing CD4+Th17 cells, CD8+Tc17 cells, and γδ T cells play crit. roles in the pathogenesis of autoimmune psoriasis.  RORγt is required for the differentiation of Th17 cells and expression of IL-17.  In this article, we describe a novel, potent, and selective RORγt inverse agonist (TMP778), and its inactive diastereomer (TMP776).  This chem., for the first time to our knowledge, provides a unique and powerful set of tools to probe RORγt-dependent functions.  TMP778, but not TMP776, blocked human Th17 and Tc17 cell differentiation and also acutely modulated IL-17A prodn. and inflammatory Th17-signature gene expression (Il17a, Il17f, Il22, Il26, Ccr6, and Il23) in mature human Th17 effector/memory T cells.  In addn., TMP778, but not TMP776, inhibited IL-17A prodn. in both human and mouse γδ T cells.  IL-23-induced IL-17A prodn. was also blocked by TMP778 treatment.  In vivo targeting of RORγt in mice via TMP778 administration reduced imiquimod-induced psoriasis-like cutaneous inflammation.  Further, TMP778 selectively regulated Th17-signature gene expression in mononuclear cells isolated from both the blood and affected skin of psoriasis patients.  In summary, to our knowledge, we are the first to demonstrate that RORγt inverse agonists: (1) inhibit Tc17 cell differentiation, as well as IL-17 prodn. by γδ T cells and CD8+ Tc17 cells; (2) block imiquimod-induced cutaneous inflammation; (3) inhibit Th17 signature gene expression by cells isolated from psoriatic patient samples; and (4) block IL-23-induced IL-17A expression.  Thus, RORγt is a tractable drug target for the treatment of cutaneous inflammatory disorders, which may afford addnl. therapeutic benefit over existing modalities that target only IL-17A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu4CFK2lBK6bVg90H21EOLACvtfcHk0lghc0woEn-s7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslGls7w%253D&md5=d72bc88b09a34874cf7b89f993977d35</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1302190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1302190%26sid%3Dliteratum%253Aachs%26aulast%3DSkepner%26aufirst%3DJ.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DTrocha%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DBarnes%26aufirst%3DA.%26aulast%3DBoudjelal%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DPharmacologic%2520inhibition%2520of%2520ROR%25CE%25B3t%2520regulates%2520Th17%2520signature%2520gene%2520expression%2520and%2520suppresses%2520cutaneous%2520inflammation%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D192%26spage%3D2564%26epage%3D2575%26doi%3D10.4049%2Fjimmunol.1302190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span>; <span class="NLM_string-name">Tilley, J.</span>; <span class="NLM_string-name">Blinn, J.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Retinoic Acid Receptor-Related Orphan Receptor Modulators And Uses</span>. WO Patent <span class="NLM_patent">WO2016014910A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gaweco&author=J.+Tilley&author=J.+Blinn&title=Sulfonamide+Retinoic+Acid+Receptor-Related+Orphan+Receptor+Modulators+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26atitle%3DSulfonamide%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520Modulators%2520And%2520Uses%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span>; <span class="NLM_string-name">Tilley, J.</span>; <span class="NLM_string-name">Blinn, J.</span></span> <span> </span><span class="NLM_article-title">Azaindole Retinoic Acid Receptor-Related Orphan Receptor Modulators And Uses</span>. WO Patent <span class="NLM_patent">WO2016014916A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gaweco&author=J.+Tilley&author=J.+Blinn&title=Azaindole+Retinoic+Acid+Receptor-Related+Orphan+Receptor+Modulators+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26atitle%3DAzaindole%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520Modulators%2520And%2520Uses%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span>; <span class="NLM_string-name">Tilley, J.</span>; <span class="NLM_string-name">Blinn, J.</span></span> <span> </span><span class="NLM_article-title">Indazole Retinoic Acid Receptor-Related Orphan Receptor Modulators And Uses</span>. WO Patent<span class="NLM_patent">WO2016014913A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gaweco&author=J.+Tilley&author=J.+Blinn&title=Indazole+Retinoic+Acid+Receptor-Related+Orphan+Receptor+Modulators+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26atitle%3DIndazole%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520Modulators%2520And%2520Uses%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic efficacy of a promising oral INV-17 ROR gamma inverse agonist clinical lead compound in a mouse IMQ-psoriasis model</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">AB259</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2017.04.1006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.jaad.2017.04.1006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=AB259&author=A.+Gawecoauthor=K.+Adamauthor=O.+Herbinauthor=J.+Tilley&title=Therapeutic+efficacy+of+a+promising+oral+INV-17+ROR+gamma+inverse+agonist+clinical+lead+compound+in+a+mouse+IMQ-psoriasis+model&doi=10.1016%2Fj.jaad.2017.04.1006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2017.04.1006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2017.04.1006%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26aulast%3DAdam%26aufirst%3DK.%26aulast%3DHerbin%26aufirst%3DO.%26aulast%3DTilley%26aufirst%3DJ.%26atitle%3DTherapeutic%2520efficacy%2520of%2520a%2520promising%2520oral%2520INV-17%2520ROR%2520gamma%2520inverse%2520agonist%2520clinical%2520lead%2520compound%2520in%2520a%2520mouse%2520IMQ-psoriasis%2520model%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2017%26volume%3D76%26spage%3DAB259%26doi%3D10.1016%2Fj.jaad.2017.04.1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span> <i>Almirall and Nuevolution Enter into a Strategic
Collaboration to
Develop RORγt Inhibitors for Treatment of Dermatology Diseaes
and Psoriatic Arthritis</i>; <span class="NLM_publisher-name">Nuevolution</span>: <span class="NLM_publisher-loc">Copenhagen</span>, December 12, <span class="NLM_year">2016</span>; press release <a href="https://nuevolution.com/almirall-and-nuevolution-enter-into-a-strategic-collaboration" class="extLink">https://nuevolution.com/almirall-and-nuevolution-enter-into-a-strategic-collaboration</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Almirall+and+Nuevolution+Enter+into+a+Strategic%0ACollaboration+to%0ADevelop+ROR%CE%B3t+Inhibitors+for+Treatment+of+Dermatology+Diseaes%0Aand+Psoriatic+Arthritis%3B+Nuevolution%3A+Copenhagen%2C+December+12%2C+2016%3B+press+release+https%3A%2F%2Fnuevolution.com%2Falmirall-and-nuevolution-enter-into-a-strategic-collaboration."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DAlmirall%2520and%2520Nuevolution%2520Enter%2520into%2520a%2520Strategic%250ACollaboration%2520to%250ADevelop%2520ROR%25CE%25B3t%2520Inhibitors%2520for%2520Treatment%2520of%2520Dermatology%2520Diseaes%250Aand%2520Psoriatic%2520Arthritis%26pub%3DNuevolution%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder Glad, S.</span>; <span class="NLM_string-name">Birkebäk
Jensen, K.</span>; <span class="NLM_string-name">Grön
Nörager, N.</span>; <span class="NLM_string-name">Sarvary, I.</span>; <span class="NLM_string-name">Vestergaard, M.</span>; <span class="NLM_string-name">Haahr Gouliaev, A.</span>; <span class="NLM_string-name">Teuber, L.</span>; <span class="NLM_string-name">Stasi, L. P.</span></span> <span> </span><span class="NLM_article-title">Optionally Fused Heterocyclyl-Sustituted Derivatives of Pyrimidine Useful For the Treatment of Inflammatory, Metabolic, Oncologic And Autoimmune Diseases</span>. WO Patent <span class="NLM_patent">WO2016020295A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Schr%C3%B6der+Glad&author=K.+Birkeb%C3%A4k%0AJensen&author=N.+Gr%C3%B6n%0AN%C3%B6rager&author=I.+Sarvary&author=M.+Vestergaard&author=A.+Haahr+Gouliaev&author=L.+Teuber&author=L.+P.+Stasi&title=Optionally+Fused+Heterocyclyl-Sustituted+Derivatives+of+Pyrimidine+Useful+For+the+Treatment+of+Inflammatory%2C+Metabolic%2C+Oncologic+And+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%2BGlad%26aufirst%3DS.%26atitle%3DOptionally%2520Fused%2520Heterocyclyl-Sustituted%2520Derivatives%2520of%2520Pyrimidine%2520Useful%2520For%2520the%2520Treatment%2520of%2520Inflammatory%252C%2520Metabolic%252C%2520Oncologic%2520And%2520Autoimmune%2520Diseases%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J.</span>; <span class="NLM_string-name">Harris, J.</span>; <span class="NLM_string-name">Mohan, R.</span></span> <span> </span><span class="NLM_article-title">ROR-Gamma Modulators</span>. WO Patent <span class="NLM_patent">WO2018081558A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Nuss&author=J.+Harris&author=R.+Mohan&title=ROR-Gamma+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%26atitle%3DROR-Gamma%2520Modulators%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vankayalapati, H.</span>; <span class="NLM_string-name">Yerramreddy, V.</span></span> <span> </span><span class="NLM_article-title">Substituted 2,3-Dihydro-1<i>H</i>-Inden-1-one Retinoic Acid-Related Orphan Nuclear Receptor Antagonists For Treating Multiple Sclerosis</span>. WO Patent <span class="NLM_patent">WO2015038350A2</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Vankayalapati&author=V.+Yerramreddy&title=Substituted+2%2C3-Dihydro-1H-Inden-1-one+Retinoic+Acid-Related+Orphan+Nuclear+Receptor+Antagonists+For+Treating+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVankayalapati%26aufirst%3DH.%26atitle%3DSubstituted%25202%252C3-Dihydro-1H-Inden-1-one%2520Retinoic%2520Acid-Related%2520Orphan%2520Nuclear%2520Receptor%2520Antagonists%2520For%2520Treating%2520Multiple%2520Sclerosis%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J. W.</span>; <span class="NLM_string-name">Carlson, N. G.</span>; <span class="NLM_string-name">Yerramreddy, V.</span>; <span class="NLM_string-name">Appalaneni, R. P.</span>; <span class="NLM_string-name">Handler, J. A.</span>; <span class="NLM_string-name">Kancherla, R. R.</span>; <span class="NLM_string-name">Vankayalapati, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of ARN-6039 as a potent, orally available inverse agonist of RORγt for autoimmune neuroinflammatory demyelinating disease</span>. Poster presented at the  <i>68th AAN (American Academy of Neurology) Annual Meeting on April 15–21, 2016</i>; <span class="NLM_publisher-name">American Academy of Neurology</span>, <span class="NLM_year">2016</span>; <a href="https://tools.aan.com/annualmeeting/search/index.cfm?fuseaction=home.detail&amp;id=5109&amp;keyword=&amp;topic=81&amp;type=all" class="extLink">https://tools.aan.com/annualmeeting/search/index.cfm?fuseaction=home.detail&id=5109&keyword=&topic=81&type=all</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+W.+Rose&author=N.+G.+Carlson&author=V.+Yerramreddy&author=R.+P.+Appalaneni&author=J.+A.+Handler&author=R.+R.+Kancherla&author=H.+Vankayalapati&title=Discovery+of+ARN-6039+as+a+potent%2C+orally+available+inverse+agonist+of+ROR%CE%B3t+for+autoimmune+neuroinflammatory+demyelinating+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BW.%26atitle%3DDiscovery%2520of%2520ARN-6039%2520as%2520a%2520potent%252C%2520orally%2520available%2520inverse%2520agonist%2520of%2520ROR%25CE%25B3t%2520for%2520autoimmune%2520neuroinflammatory%2520demyelinating%2520disease%26jtitle%3D68th%2520AAN%2520%2528American%2520Academy%2520of%2520Neurology%2529%2520Annual%2520Meeting%2520on%2520April%252015%25E2%2580%259321%252C%25202016%26pub%3DAmerican%2520Academy%2520of%2520Neurology%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Argiriadi, M. A.</span>; <span class="NLM_string-name">Breinlinger, E.</span>; <span class="NLM_string-name">Cusack, K. P.</span>; <span class="NLM_string-name">Hobson, A. D.</span>; <span class="NLM_string-name">Potin, D.</span>; <span class="NLM_string-name">Barth, M.</span>; <span class="NLM_string-name">Amaudrut, J.</span>; <span class="NLM_string-name">Poupardin, O.</span>; <span class="NLM_string-name">Mounier, L.</span>; <span class="NLM_string-name">Kort, M. E.</span></span> <span> </span><span class="NLM_article-title">ROR Nuclear Receptor Modulators</span>. WO Patent <span class="NLM_patent">WO2016198908A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+A.+Argiriadi&author=E.+Breinlinger&author=K.+P.+Cusack&author=A.+D.+Hobson&author=D.+Potin&author=M.+Barth&author=J.+Amaudrut&author=O.+Poupardin&author=L.+Mounier&author=M.+E.+Kort&title=ROR+Nuclear+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26atitle%3DROR%2520Nuclear%2520Receptor%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B.</span>; <span class="NLM_string-name">Bodil Van Niel, M.</span>; <span class="NLM_string-name">Cridland, A.</span>; <span class="NLM_string-name">Hurley, C.</span>; <span class="NLM_string-name">Killen, J.</span>; <span class="NLM_string-name">Ward, S.</span></span> <span> </span><span class="NLM_article-title">Pyridazine Derivatives as RORc Modulators</span>. WO Patent <span class="NLM_patent">WO2016177686A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+Fauber&author=M.+Bodil+Van+Niel&author=A.+Cridland&author=C.+Hurley&author=J.+Killen&author=S.+Ward&title=Pyridazine+Derivatives+as+RORc+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%26atitle%3DPyridazine%2520Derivatives%2520as%2520RORc%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steeneck, C.</span>; <span class="NLM_string-name">Kinzel, O.</span>; <span class="NLM_string-name">Gege, C.</span>; <span class="NLM_string-name">Kleymann, G.</span>; <span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Pyrrolo Carboxamides As Modulators of Orphan Nuclear Receptor RAR-Related Orphan Receptor-Gamma (RORγ, NR1F3) Activity and for the Treatment of Chronic Inflammatory and Autoimmune Diseases</span>. WO Patent <span class="NLM_patent">WO2013079223A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Steeneck&author=O.+Kinzel&author=C.+Gege&author=G.+Kleymann&author=T.+Hoffmann&title=Pyrrolo+Carboxamides+As+Modulators+of+Orphan+Nuclear+Receptor+RAR-Related+Orphan+Receptor-Gamma+%28ROR%CE%B3%2C+NR1F3%29+Activity+and+for+the+Treatment+of+Chronic+Inflammatory+and+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSteeneck%26aufirst%3DC.%26atitle%3DPyrrolo%2520Carboxamides%2520As%2520Modulators%2520of%2520Orphan%2520Nuclear%2520Receptor%2520RAR-Related%2520Orphan%2520Receptor-Gamma%2520%2528ROR%25CE%25B3%252C%2520NR1F3%2529%2520Activity%2520and%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Inflammatory%2520and%2520Autoimmune%2520Diseases%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span>; <span class="NLM_string-name">Steeneck, C.</span>; <span class="NLM_string-name">Kinzel, O.</span>; <span class="NLM_string-name">Kleymann, G.</span>; <span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Carboxamide or Sulfonamide Substituted Thiazoles and Related Derivatives as Modulators For the Orphan Nuclear Receptor ROR[Gamma]</span>. WO Patent <span class="NLM_patent">WO2013178362A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Gege&author=C.+Steeneck&author=O.+Kinzel&author=G.+Kleymann&author=T.+Hoffmann&title=Carboxamide+or+Sulfonamide+Substituted+Thiazoles+and+Related+Derivatives+as+Modulators+For+the+Orphan+Nuclear+Receptor+ROR%5BGamma%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26atitle%3DCarboxamide%2520or%2520Sulfonamide%2520Substituted%2520Thiazoles%2520and%2520Related%2520Derivatives%2520as%2520Modulators%2520For%2520the%2520Orphan%2520Nuclear%2520Receptor%2520ROR%255BGamma%255D%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span>; <span class="NLM_string-name">Kinzel, O.</span>; <span class="NLM_string-name">Steeneck, C.</span>; <span class="NLM_string-name">Kleymann, G.</span>; <span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Carboxamide or Sulfonamide Substituted Nitrogen-Containing 5-Membered Heterocycles as Modulators For the Orphan Nuclear Receptor ROR Gamma</span>. WO Patent <span class="NLM_patent">WO2014023367A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Gege&author=O.+Kinzel&author=C.+Steeneck&author=G.+Kleymann&author=T.+Hoffmann&title=Carboxamide+or+Sulfonamide+Substituted+Nitrogen-Containing+5-Membered+Heterocycles+as+Modulators+For+the+Orphan+Nuclear+Receptor+ROR+Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26atitle%3DCarboxamide%2520or%2520Sulfonamide%2520Substituted%2520Nitrogen-Containing%25205-Membered%2520Heterocycles%2520as%2520Modulators%2520For%2520the%2520Orphan%2520Nuclear%2520Receptor%2520ROR%2520Gamma%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleymann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schluter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steeneck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Identification and biological evaluation of thiazole-based inverse agonists of RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1446</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.03.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2018.03.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29631962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1ejtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1446-1455&author=C.+Gegeauthor=M.+D.+Cummingsauthor=M.+Albersauthor=O.+Kinzelauthor=G.+Kleymannauthor=T.+Schluterauthor=C.+Steeneckauthor=M.+I.+Nelenauthor=C.+Milliganauthor=J.+Spurlinoauthor=X.+Xueauthor=K.+Leonardauthor=J.+P.+Edwardsauthor=A.+Fourieauthor=S.+D.+Goldbergauthor=T.+Hoffmann&title=Identification+and+biological+evaluation+of+thiazole-based+inverse+agonists+of+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2018.03.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological evaluation of thiazole-based inverse agonists of RORγt</span></div><div class="casAuthors">Gege, Christian; Cummings, Maxwell D.; Albers, Michael; Kinzel, Olaf; Kleymann, Gerald; Schlueter, Thomas; Steeneck, Christoph; Nelen, Marina I.; Milligan, Cindy; Spurlino, John; Xue, Xiaohua; Leonard, Kristi; Edwards, James P.; Fourie, Anne; Goldberg, Steven D.; Hoffmann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1446-1455</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nuclear receptor retinoic acid receptor-related orphan receptor gamma t (RORγt) is a transcription factor that drives Th17 cell differentiation and IL-17 prodn. in both innate and adaptive immune cells.  The IL-23/IL-17 pathway is implicated in major autoimmune and inflammatory diseases.  RORγt lies at the core of this pathway and represents an attractive opportunity for intervention with a small mol.  Despite diverse chem. series having been reported, combining high potency and nuclear receptor selectivity with good physicochem. properties remains a challenging endeavor in the field of RORγt drug discovery.  The authors describe the discovery and evaluation of a new class of potent and selective RORγt inverse agonists based on a thiazole core.  Acid analog 1j (Et 5-[4-[N-(tert-butyl)sulfamoyl]naphthalen-1-yl]-4-(cyclohexylmethyl)thiazole-2-carboxylate) demonstrated oral bioavailability in rats and was potent in a human whole blood assay, suggesting potential utility in treating autoimmune and inflammatory diseases such as psoriasis.  X-ray crystallog. data helped to elucidate the mol. mechanism for RORγt inhibition with this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8APFwgPE97Vg90H21EOLACvtfcHk0liKat3uUcQrJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1ejtLg%253D&md5=5eb11be2492120db73c94733d56ae126</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.03.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.03.093%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DKleymann%26aufirst%3DG.%26aulast%3DSchluter%26aufirst%3DT.%26aulast%3DSteeneck%26aufirst%3DC.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%26aulast%3DGoldberg%26aufirst%3DS.%2BD.%26aulast%3DHoffmann%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520biological%2520evaluation%2520of%2520thiazole-based%2520inverse%2520agonists%2520of%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1446%26epage%3D1455%26doi%3D10.1016%2Fj.bmcl.2018.03.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mcclure, K.</span>; <span class="NLM_string-name">Tanis, V.
M.</span>; <span class="NLM_string-name">Fennema, E. G.</span>; <span class="NLM_string-name">Lebsack, A. D.</span>; <span class="NLM_string-name">Martin, C. L.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Woods, C. R.</span></span> <span> </span><span class="NLM_article-title">6-Aminopyridin-3-yl Thiazoles as Modulators of RORγt</span>. WO Patent <span class="NLM_patent">WO2017189661A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Mcclure&author=V.%0AM.+Tanis&author=E.+G.+Fennema&author=A.+D.+Lebsack&author=C.+L.+Martin&author=H.+Venkatesan&author=X.+Xue&author=C.+R.+Woods&title=6-Aminopyridin-3-yl+Thiazoles+as+Modulators+of+ROR%CE%B3t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcclure%26aufirst%3DK.%26atitle%3D6-Aminopyridin-3-yl%2520Thiazoles%2520as%2520Modulators%2520of%2520ROR%25CE%25B3t%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span>; <span class="NLM_string-name">Leonard, K. A.</span></span> <span> </span><span class="NLM_article-title">Phenyl Linked Quinolinyl Modulators of ROR-Gamma-T</span>. WO Patent <span class="NLM_patent">WO2015057203A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&author=K.+A.+Leonard&title=Phenyl+Linked+Quinolinyl+Modulators+of+ROR-Gamma-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DPhenyl%2520Linked%2520Quinolinyl%2520Modulators%2520of%2520ROR-Gamma-T%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span>; <span class="NLM_string-name">Jones, W. M.</span>; <span class="NLM_string-name">Goldberg, S.</span></span> <span> </span><span class="NLM_article-title">Methylene Linked Quinolinyl Modulators of ROR-Gamma-T</span>. WO Patent <span class="NLM_patent">WO2015057205A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&author=W.+M.+Jones&author=S.+Goldberg&title=Methylene+Linked+Quinolinyl+Modulators+of+ROR-Gamma-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DMethylene%2520Linked%2520Quinolinyl%2520Modulators%2520of%2520ROR-Gamma-T%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span></span> <span> </span><span class="NLM_article-title">Secondary Alcohol Quinolinyl Modulators of RORγt</span>. WO Patent <span class="NLM_patent">WO2015057206A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&title=Secondary+Alcohol+Quinolinyl+Modulators+of+ROR%CE%B3t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DSecondary%2520Alcohol%2520Quinolinyl%2520Modulators%2520of%2520ROR%25CE%25B3t%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span>; <span class="NLM_string-name">Mcclure, K.</span>; <span class="NLM_string-name">Tanis, V.</span></span> <span> </span><span class="NLM_article-title">Quinolinyl Modulators of RORγt</span>. WO Patent <span class="NLM_patent">WO2015057626A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&author=K.+Mcclure&author=V.+Tanis&title=Quinolinyl+Modulators+of+ROR%CE%B3t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DQuinolinyl%2520Modulators%2520of%2520ROR%25CE%25B3t%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutter, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharoof, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanis, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span> <span> </span><span class="NLM_article-title">6-Substituted quinolines as RORγt inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5277</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2017.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29079472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5277-5283&author=J.+K.+Barbayauthor=M.+D.+Cummingsauthor=M.+Abadauthor=G.+Castroauthor=K.+D.+Kreutterauthor=D.+A.+Kummerauthor=U.+Maharoofauthor=C.+Milliganauthor=R.+Nishimuraauthor=J.+Pierceauthor=C.+Schalk-Hihiauthor=J.+Spurlinoauthor=V.+M.+Tanisauthor=M.+Urbanskiauthor=H.+Venkatesanauthor=A.+Wangauthor=C.+Woodsauthor=R.+Wolinauthor=X.+Xueauthor=J.+P.+Edwardsauthor=A.+M.+Fourieauthor=K.+Leonard&title=6-Substituted+quinolines+as+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmcl.2017.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">6-Substituted quinolines as RORγt inverse agonists</span></div><div class="casAuthors">Barbay, J. Kent; Cummings, Maxwell D.; Abad, Marta; Castro, Glenda; Kreutter, Kevin D.; Kummer, David A.; Maharoof, Umar; Milligan, Cynthia; Nishimura, Rachel; Pierce, Joan; Schalk-Hihi, Celine; Spurlino, John; Tanis, Virginia M.; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Woods, Craig; Wolin, Ronald; Xue, Xiaohua; Edwards, James P.; Fourie, Anne M.; Leonard, Kristi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5277-5283</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We identified 6-substituted quinolines as modulators of the retinoic acid receptor-related orphan receptor gamma t (RORγt).  The synthesis of this class of RORγt modulators is reported, and optimization of the substituents at the quinoline 6-position that produced compds. with high affinity for the receptor is detailed.  This effort identified mols. that act as potent, full inverse agonists in a RORγt-driven cell-based reporter assay.  The X-ray crystal structures of two full inverse agonists, I and II, from this chem. series bound to the RORγt ligand binding domain are disclosed, and we highlight the interaction of a hydrogen-bond acceptor on the 6-position substituent of the inverse agonist with Glu379:NH as a conserved binding contact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmNK7flW-DSbVg90H21EOLACvtfcHk0lh502zLCuoZKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO&md5=7df780bf52c1750414412d1c0067e280</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAbad%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DKreutter%26aufirst%3DK.%2BD.%26aulast%3DKummer%26aufirst%3DD.%2BA.%26aulast%3DMaharoof%26aufirst%3DU.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DR.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DTanis%26aufirst%3DV.%2BM.%26aulast%3DUrbanski%26aufirst%3DM.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWoods%26aufirst%3DC.%26aulast%3DWolin%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DLeonard%26aufirst%3DK.%26atitle%3D6-Substituted%2520quinolines%2520as%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5277%26epage%3D5283%26doi%3D10.1016%2Fj.bmcl.2017.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dulubova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannigan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visnick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigley, C.</span></span> <span> </span><span class="NLM_article-title">RTA 1701 is an orally-bioavailable, potent, and selective RORγt inhibitor that suppresses Th17 differentiation in vitro and is efficacious in mouse models of autoimmune disease</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">121.14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2018&pages=121.14&author=I.+Dulubovaauthor=X.+Jiangauthor=I.+Trevinoauthor=L.+McCauleyauthor=L.+Liuauthor=L.+Hanniganauthor=S.+A.+Reismanauthor=D.+Fergusonauthor=M.+Visnickauthor=C.+Wigley&title=RTA+1701+is+an+orally-bioavailable%2C+potent%2C+and+selective+ROR%CE%B3t+inhibitor+that+suppresses+Th17+differentiation+in+vitro+and+is+efficacious+in+mouse+models+of+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDulubova%26aufirst%3DI.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DTrevino%26aufirst%3DI.%26aulast%3DMcCauley%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHannigan%26aufirst%3DL.%26aulast%3DReisman%26aufirst%3DS.%2BA.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DVisnick%26aufirst%3DM.%26aulast%3DWigley%26aufirst%3DC.%26atitle%3DRTA%25201701%2520is%2520an%2520orally-bioavailable%252C%2520potent%252C%2520and%2520selective%2520ROR%25CE%25B3t%2520inhibitor%2520that%2520suppresses%2520Th17%2520differentiation%2520in%2520vitro%2520and%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520autoimmune%2520disease%26jtitle%3DJ.%2520Immunol.%26date%3D2018%26volume%3D200%26spage%3D121.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reisman, S.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-Y. I</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proksch, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span> <span> </span><span class="NLM_article-title">RTA 1701 is an oral RORγt inhibitor that suppresses the IL-17A response in non-human primates</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">175.22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2018&pages=175.22&author=S.%0AA.+Reismanauthor=C.-Y.+I+Leeauthor=J.+W.+Prokschauthor=M.+Sakamotoauthor=K.+W.+Ward&title=RTA+1701+is+an+oral+ROR%CE%B3t+inhibitor+that+suppresses+the+IL-17A+response+in+non-human+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReisman%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DC.-Y.%2BI%26aulast%3DProksch%26aufirst%3DJ.%2BW.%26aulast%3DSakamoto%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DK.%2BW.%26atitle%3DRTA%25201701%2520is%2520an%2520oral%2520ROR%25CE%25B3t%2520inhibitor%2520that%2520suppresses%2520the%2520IL-17A%2520response%2520in%2520non-human%2520primates%26jtitle%3DJ.%2520Immunol.%26date%3D2018%26volume%3D200%26spage%3D175.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Visnick, M.</span>; <span class="NLM_string-name">Jiang, X.</span>; <span class="NLM_string-name">Hotema, M. R.</span>; <span class="NLM_string-name">Lee, C.</span>; <span class="NLM_string-name">Caprathe, B. W.</span>; <span class="NLM_string-name">Roark, W. H.</span>; <span class="NLM_string-name">Bolton, G.</span></span> <span> </span><span class="NLM_article-title">C4-Modified Oleanolic Acid Derivatives For Inhibition of IL-17 And Other Uses</span>. WO Patent <span class="NLM_patent">WO2017053868A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+Visnick&author=X.+Jiang&author=M.+R.+Hotema&author=C.+Lee&author=B.+W.+Caprathe&author=W.+H.+Roark&author=G.+Bolton&title=C4-Modified+Oleanolic+Acid+Derivatives+For+Inhibition+of+IL-17+And+Other+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVisnick%26aufirst%3DM.%26atitle%3DC4-Modified%2520Oleanolic%2520Acid%2520Derivatives%2520For%2520Inhibition%2520of%2520IL-17%2520And%2520Other%2520Uses%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inker, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerspink, H. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Grady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnock, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: Post-hoc analyses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1159/000486398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1159%2F000486398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29402767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=40-47&author=M.+P.+Chinauthor=G.+L.+Bakrisauthor=G.+A.+Blockauthor=G.+M.+Chertowauthor=A.+Goldsberryauthor=L.+A.+Inkerauthor=H.+J.+L.+Heerspinkauthor=M.+O%E2%80%99Gradyauthor=P.+E.+Pergolaauthor=C.+Wannerauthor=D.+G.+Warnockauthor=C.+J.+Meyer&title=Bardoxolone+methyl+improves+kidney+function+in+patients+with+chronic+kidney+disease+stage+4+and+type+2+diabetes%3A+Post-hoc+analyses+from+bardoxolone+methyl+evaluation+in+patients+with+chronic+kidney+disease+and+type+2+diabetes+study&doi=10.1159%2F000486398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study</span></div><div class="casAuthors">Chin, Melanie P.; Bakris, George L.; Block, Geoffrey A.; Chertow, Glenn M.; Goldsberry, Angie; Inker, Lesley A.; Heerspink, Hiddo J. L.; O'Grady, Megan; Pergola, Pablo E.; Wanner, Christoph; Warnock, David G.; Meyer, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Increases in measured inulin clearance, measured creatinine clearance, and estd. glomerular filtration rate (eGFR) have been obsd. with bardoxolone Me in 7 studies enrolling approx. 2,600 patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).  The largest of these studies was Bardoxolone Me Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes (BEACON), a multinational, randomized, double-blind, placebo-controlled phase 3 trial which enrolled patients with T2D and CKD stage 4.  The BEACON trial was terminated after preliminary analyses showed that patients randomized to bardoxolone Me experienced significantly higher rates of heart failure events.  We performed post-hoc analyses to characterize changes in kidney function induced by bardoxolone Me.  Methods: Patients in -BEACON (n = 2,185) were randomized 1: 1 to receive once-daily bardoxolone Me (20 mg) or placebo.  We compared the effects of bardoxolone Me and placebo on a post-hoc composite renal endpoint consisting of ≥30% decline from baseline in eGFR, eGFR <15 mL/min/1.73 m2, and end-stage renal disease (ESRD) events (provision of dialysis or kidney transplantation).  Results: Consistent with prior studies, patients randomized to bardoxolone Me experienced mean increases in eGFR that were sustained through study week 48.  Moreover, increases in eGFR from baseline were sustained 4 wk after cessation of treatment.  Patients randomized to bardoxolone Me were significantly less likely to experience the composite renal endpoint (hazards ratio 0.48 [95% CI 0.36-0.64]; p < 0.0001).  Conclusions: Bardoxolone Me preserves kidney function and may delay the onset of ESRD in patients with T2D and stage 4 CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjOzptzThpbVg90H21EOLACvtfcHk0lheYZ-O6IEzig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D&md5=9351e5606902fd77cfe5dc042c833e66</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1159%2F000486398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000486398%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DM.%2BP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlock%26aufirst%3DG.%2BA.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DInker%26aufirst%3DL.%2BA.%26aulast%3DHeerspink%26aufirst%3DH.%2BJ.%2BL.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DM.%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWarnock%26aufirst%3DD.%2BG.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26atitle%3DBardoxolone%2520methyl%2520improves%2520kidney%2520function%2520in%2520patients%2520with%2520chronic%2520kidney%2520disease%2520stage%25204%2520and%2520type%25202%2520diabetes%253A%2520Post-hoc%2520analyses%2520from%2520bardoxolone%2520methyl%2520evaluation%2520in%2520patients%2520with%2520chronic%2520kidney%2520disease%2520and%2520type%25202%2520diabetes%2520study%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2018%26volume%3D47%26spage%3D40%26epage%3D47%26doi%3D10.1159%2F000486398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span>; <span class="NLM_string-name">Bender, C. F.</span>; <span class="NLM_string-name">Visnick, M.</span>; <span class="NLM_string-name">Hotema, M. R.</span>; <span class="NLM_string-name">Sheldon, Z. S.</span>; <span class="NLM_string-name">Lee, C.</span>; <span class="NLM_string-name">Caprathe, B. W.</span>; <span class="NLM_string-name">Bolton, G.</span>; <span class="NLM_string-name">Kornberg, B.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine Tricyclic Enone Derivatives For Inhibition of RORγ and Other Uses</span>. WO Patent <span class="NLM_patent">WO2018111315A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=X.+Jiang&author=C.+F.+Bender&author=M.+Visnick&author=M.+R.+Hotema&author=Z.+S.+Sheldon&author=C.+Lee&author=B.+W.+Caprathe&author=G.+Bolton&author=B.+Kornberg&title=Pyrimidine+Tricyclic+Enone+Derivatives+For+Inhibition+of+ROR%CE%B3+and+Other+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26atitle%3DPyrimidine%2520Tricyclic%2520Enone%2520Derivatives%2520For%2520Inhibition%2520of%2520ROR%25CE%25B3%2520and%2520Other%2520Uses%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGeehan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryson, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukhtiyarov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claremon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lala, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, R. E.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742, a RORγt antagonist, in healthy volunteers</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">71.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2016&pages=71.4&author=G.+M.+McGeehanauthor=S.+A.+Palmerauthor=C.+C.+Brysonauthor=Y.+Zhaoauthor=M.+Shiauthor=K.+K.+Lipinskiauthor=Y.+Bukhtiyarovauthor=J.+Guoauthor=D.+A.+Claremonauthor=D.+S.+Lalaauthor=R.+E.+Gregg&title=Safety%2C+tolerability%2C+pharmacokinetics+and+pharmacodynamics+of+VTP-43742%2C+a+ROR%CE%B3t+antagonist%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DPalmer%26aufirst%3DS.%2BA.%26aulast%3DBryson%26aufirst%3DC.%2BC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DLipinski%26aufirst%3DK.%2BK.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DGregg%26aufirst%3DR.%2BE.%26atitle%3DSafety%252C%2520tolerability%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520VTP-43742%252C%2520a%2520ROR%25CE%25B3t%2520antagonist%252C%2520in%2520healthy%2520volunteers%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D196%26spage%3D71.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span> <i>Vitae Pharmaceuticals Achieves Proof-of-Concept with First-in-Class
RORγt Inhibitor in Moderate to Severe Psoriasis</i>; <span class="NLM_publisher-name">Vitae Pharmaceuticals Inc.</span>: <span class="NLM_publisher-loc">Fort
Washington, PA</span>, March 16, 2016; press release <a href="http://ir.vitaepharma.com/phoenix.zhtml?c=219654&amp;p=irol-newsArticle&amp;ID=2149044" class="extLink">http://ir.vitaepharma.com/phoenix.zhtml?c=219654&p=irol-newsArticle&ID=2149044</a> (accessed March 26, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Vitae+Pharmaceuticals+Achieves+Proof-of-Concept+with+First-in-Class%0AROR%CE%B3t+Inhibitor+in+Moderate+to+Severe+Psoriasis%3B+Vitae+Pharmaceuticals+Inc.%3A+Fort%0AWashington%2C+PA%2C+March+16%2C+2016%3B+press+release+http%3A%2F%2Fir.vitaepharma.com%2Fphoenix.zhtml%3Fc%3D219654%26p%3Dirol-newsArticle%26ID%3D2149044+%28accessed+March+26%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DVitae%2520Pharmaceuticals%2520Achieves%2520Proof-of-Concept%2520with%2520First-in-Class%250AROR%25CE%25B3t%2520Inhibitor%2520in%2520Moderate%2520to%2520Severe%2520Psoriasis%26pub%3DVitae%2520Pharmaceuticals%2520Inc%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span> <i>Allergan writes off lead candidate from $640M Vitae buy, recorded
$535M impairment charge in Q1; shares down 2%</i>; <span class="NLM_publisher-name">Seeking Alpha</span>, April 30, <span class="NLM_year">2018</span>; press
release <a href="https://seekingalpha.com/news/3350282-allergan-writes-lead-candidate-640m-vitae-buy-recorded-535m-impairment-charge-q1-shares-2" class="extLink">https://seekingalpha.com/news/3350282-allergan-writes-lead-candidate-640m-vitae-buy-recorded-535m-impairment-charge-q1-shares-2</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Allergan+writes+off+lead+candidate+from+%24640M+Vitae+buy%2C+recorded%0A%24535M+impairment+charge+in+Q1%3B+shares+down+2%25%3B+Seeking+Alpha%2C+April+30%2C+2018%3B+press%0Arelease+https%3A%2F%2Fseekingalpha.com%2Fnews%2F3350282-allergan-writes-lead-candidate-640m-vitae-buy-recorded-535m-impairment-charge-q1-shares-2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DAllergan%2520writes%2520off%2520lead%2520candidate%2520from%2520%2524640M%2520Vitae%2520buy%252C%2520recorded%250A%2524535M%2520impairment%2520charge%2520in%2520Q1%253B%2520shares%2520down%25202%2525%26pub%3DSeeking%2520Alpha%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Mackensen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemetzki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freudenberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigger-Alberti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span> <span> </span><span class="NLM_article-title">A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK-2981278 ointment in a psoriasis plaque test</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">1427</span>– <span class="NLM_lpage">1429</span>, <span class="refDoi"> DOI: 10.1111/bjd.16131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1111%2Fbjd.16131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29150844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2018&pages=1427-1429&author=E.+G.+Kangauthor=S.+Wuauthor=A.+Guptaauthor=Y.+L.+von+Mackensenauthor=H.+Siemetzkiauthor=J.+M.+Freudenbergauthor=W.+Wigger-Albertiauthor=Y.+Yamaguchi&title=A+phase+I+randomized+controlled+trial+to+evaluate+safety+and+clinical+effect+of+topically+applied+GSK-2981278+ointment+in+a+psoriasis+plaque+test&doi=10.1111%2Fbjd.16131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test</span></div><div class="casAuthors">Kang E G; Wu S; Gupta A; Freudenberg J M; Yamaguchi Y; von Mackensen Y-L; Siemetzki H; Wigger-Alberti W</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1427-1429</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2LnZBzvo4YtFxYDaSSP8XfW6udTcc2eb8BSyTJglulrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D&md5=c480c28f5973de8ccba8f8e290d8e8ab</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fbjd.16131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjd.16131%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DE.%2BG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3Dvon%2BMackensen%26aufirst%3DY.%2BL.%26aulast%3DSiemetzki%26aufirst%3DH.%26aulast%3DFreudenberg%26aufirst%3DJ.%2BM.%26aulast%3DWigger-Alberti%26aufirst%3DW.%26aulast%3DYamaguchi%26aufirst%3DY.%26atitle%3DA%2520phase%2520I%2520randomized%2520controlled%2520trial%2520to%2520evaluate%2520safety%2520and%2520clinical%2520effect%2520of%2520topically%2520applied%2520GSK-2981278%2520ointment%2520in%2520a%2520psoriasis%2520plaque%2520test%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2018%26volume%3D178%26spage%3D1427%26epage%3D1429%26doi%3D10.1111%2Fbjd.16131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span> <i>GSK delivers further progress in Q2 and sets out
new priorities for
the Group</i>; <span class="NLM_publisher-name">GlaxoSmithKline</span>: <span class="NLM_publisher-loc">London</span>, July 26, <span class="NLM_year">2017</span>; press release <a href="https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group/" class="extLink">https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GSK+delivers+further+progress+in+Q2+and+sets+out%0Anew+priorities+for%0Athe+Group%3B+GlaxoSmithKline%3A+London%2C+July+26%2C+2017%3B+press+release+https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fgsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGSK%2520delivers%2520further%2520progress%2520in%2520Q2%2520and%2520sets%2520out%250Anew%2520priorities%2520for%250Athe%2520Group%26pub%3DGlaxoSmithKline%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIsaac, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce-Shaikh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristescu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudgett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piers, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltus, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehmet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawwari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of RORγT skews TCRα gene rearrangement and limits T cell repertoire diversity</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3206</span>– <span class="NLM_lpage">3218</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2016.11.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.celrep.2016.11.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28009290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGnsrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=3206-3218&author=Y.+Guoauthor=K.+D.+MacIsaacauthor=Y.+Chenauthor=R.+J.+Millerauthor=R.+Jainauthor=B.+Joyce-Shaikhauthor=H.+Fergusonauthor=I.+M.+Wangauthor=R.+Cristescuauthor=J.+Mudgettauthor=L.+Engstromauthor=K.+J.+Piersauthor=G.+A.+Baltusauthor=K.+Barrauthor=H.+Zhangauthor=H.+Mehmetauthor=L.+G.+Hegdeauthor=X.+Huauthor=L.+L.+Carterauthor=T.+D.+Aicherauthor=G.+Glickauthor=D.+Zallerauthor=A.+Hawwariauthor=C.+C.+Correllauthor=D.+C.+Jonesauthor=D.+J.+Cua&title=Inhibition+of+ROR%CE%B3T+skews+TCR%CE%B1+gene+rearrangement+and+limits+T+cell+repertoire+diversity&doi=10.1016%2Fj.celrep.2016.11.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity</span></div><div class="casAuthors">Guo, Yanxia; MacIsaac, Kenzie D.; Chen, Yi; Miller, Richard J.; Jain, Renu; Joyce-Shaikh, Barbara; Ferguson, Heidi; Wang, I-Ming; Cristescu, Razvan; Mudgett, John; Engstrom, Laura; Piers, Kyle J.; Baltus, Gretchen A.; Barr, Kenneth; Zhang, Hongjun; Mehmet, Huseyin; Hegde, Laxminarayan G.; Hu, Xiao; Carter, Laura L.; Aicher, Thomas D.; Glick, Gary; Zaller, Dennis; Hawwari, Abbas; Correll, Craig C.; Jones, Dallas C.; Cua, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3206-3218</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent studies have elucidated the mol. mechanism of RORγT transcriptional regulation of Th17 differentiation and function.  RORγT was initially identified as a transcription factor required for thymopoiesis by maintaining survival of CD4+CD8+ (DP) thymocytes.  While RORγ antagonists are currently being developed to treat autoimmunity, it remains unclear how RORγT inhibition may impact thymocyte development.  In this study, we show that in addn. to regulating DP thymocytes survival, RORγT also controls genes that regulate thymocyte migration, proliferation, and T cell receptor (TCR)α selection.  Strikingly, pharmacol. inhibition of RORγ skews TCRα gene rearrangement, limits T cell repertoire diversity, and inhibits development of autoimmune encephalomyelitis.  Thus, targeting RORγT not only inhibits Th17 cell development and function but also fundamentally alters thymic-emigrant recognition of self and foreign antigens.  The anal. of RORγ inhibitors has allowed us to gain a broader perspective of the diverse function of RORγT and its impact on T cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2YbVQ9dNS7Vg90H21EOLACvtfcHk0lgX8v8aBLUvhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGnsrjP&md5=6b3766d0673b02fbe6a6b0cc1a10f4a5</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.11.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.11.073%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMacIsaac%26aufirst%3DK.%2BD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DJoyce-Shaikh%26aufirst%3DB.%26aulast%3DFerguson%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DI.%2BM.%26aulast%3DCristescu%26aufirst%3DR.%26aulast%3DMudgett%26aufirst%3DJ.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPiers%26aufirst%3DK.%2BJ.%26aulast%3DBaltus%26aufirst%3DG.%2BA.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMehmet%26aufirst%3DH.%26aulast%3DHegde%26aufirst%3DL.%2BG.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DGlick%26aufirst%3DG.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DHawwari%26aufirst%3DA.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520ROR%25CE%25B3T%2520skews%2520TCR%25CE%25B1%2520gene%2520rearrangement%2520and%2520limits%2520T%2520cell%2520repertoire%2520diversity%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D17%26spage%3D3206%26epage%3D3218%26doi%3D10.1016%2Fj.celrep.2016.11.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORγ</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=901-909&author=E.+Uedaauthor=S.+Kurebayashiauthor=M.+Sakaueauthor=M.+Backlundauthor=B.+Kollerauthor=A.+M.+Jetten&title=High+incidence+of+T-cell+lymphomas+in+mice+deficient+in+the+retinoid-related+orphan+receptor+ROR%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DE.%26aulast%3DKurebayashi%26aufirst%3DS.%26aulast%3DSakaue%26aufirst%3DM.%26aulast%3DBacklund%26aufirst%3DM.%26aulast%3DKoller%26aufirst%3DB.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DHigh%2520incidence%2520of%2520T-cell%2520lymphomas%2520in%2520mice%2520deficient%2520in%2520the%2520retinoid-related%2520orphan%2520receptor%2520ROR%25CE%25B3%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D901%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liljevald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehnberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Söderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramnegård, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krutrök, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brändén, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjursell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjögren, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma</span>. <i>Autoimmun. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1016/j.autrev.2016.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.autrev.2016.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27491564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12nsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1062-1070&author=M.+Liljevaldauthor=M.+Rehnbergauthor=M.+S%C3%B6derbergauthor=M.+Ramneg%C3%A5rdauthor=J.+B%C3%B6rjessonauthor=D.+Lucianiauthor=N.+Krutr%C3%B6kauthor=L.+Br%C3%A4nd%C3%A9nauthor=C.+Johanssonauthor=X.+Xuauthor=M.+Bjursellauthor=A.+K.+Sj%C3%B6grenauthor=J.+Hornbergauthor=U.+Anderssonauthor=D.+Keelingauthor=J.+Jirholt&title=Retinoid-related+orphan+receptor+%CE%B3+%28ROR%CE%B3%29+adult+induced+knockout+mice+develop+lymphoblastic+lymphoma&doi=10.1016%2Fj.autrev.2016.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma</span></div><div class="casAuthors">Liljevald, Maria; Rehnberg, Maria; Soederberg, Magnus; Ramnegaard, Marie; Boerjesson, Jenny; Luciani, Donatella; Krutroek, Nina; Braenden, Lena; Johansson, Camilla; Xu, Xiufeng; Bjursell, Mikael; Sjoegren, Anna-Karin; Hornberg, Jorrit; Andersson, Ulf; Keeling, David; Jirholt, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Autoimmunity Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1062-1070</span>CODEN:
                <span class="NLM_cas:coden">ARUEBU</span>;
        ISSN:<span class="NLM_cas:issn">1568-9972</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RORγ is a nuclear hormone receptor which controls polarization of naive CD4+ T-cells into proinflammatory Th17 cells.  Pharmacol. antagonism of RORγ has therapeutic potential for autoimmune diseases; however, this mechanism may potentially carry target-related safety risks, as mice deficient in Rorc, the gene encoding RORγ, develop T-cell lymphoma with 50% frequency.  Due to the requirement of RORγ during development, the Rorc knockout (KO) animals lack secondary lymphoid organs and have a dysregulation in the generation of CD4 + and CD8 + T cells.  We wanted to extend the evaluation of RORγ deficiency to address the question whether lymphomas, similar to those obsd. in the Rorc KO, would develop in an animal with an otherwise intact adult immune system.  Accordingly, we designed a conditional RORγ knockout mouse (Rorc CKO) where the Rorc locus could be deleted in adult animals.  Based on these studies we can confirm that these animals also develop lymphoma in a similar time frame as embryonic Rorc knockouts.  This study also suggests that in animals where the gene deletion is incomplete, the thymus undergoes a rapid selection process replacing Rorc deficient cells with remnant thymocytes carrying a functional Rorc locus and that subsequently, these animals do not develop lymphoblastic lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi0KfNRXewvLVg90H21EOLACvtfcHk0lgIzIPnnpo6ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12nsLrP&md5=e58691ecc5983782269cd141548bf61d</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.autrev.2016.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autrev.2016.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DLiljevald%26aufirst%3DM.%26aulast%3DRehnberg%26aufirst%3DM.%26aulast%3DS%25C3%25B6derberg%26aufirst%3DM.%26aulast%3DRamneg%25C3%25A5rd%26aufirst%3DM.%26aulast%3DB%25C3%25B6rjesson%26aufirst%3DJ.%26aulast%3DLuciani%26aufirst%3DD.%26aulast%3DKrutr%25C3%25B6k%26aufirst%3DN.%26aulast%3DBr%25C3%25A4nd%25C3%25A9n%26aufirst%3DL.%26aulast%3DJohansson%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBjursell%26aufirst%3DM.%26aulast%3DSj%25C3%25B6gren%26aufirst%3DA.%2BK.%26aulast%3DHornberg%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DKeeling%26aufirst%3DD.%26aulast%3DJirholt%26aufirst%3DJ.%26atitle%3DRetinoid-related%2520orphan%2520receptor%2520%25CE%25B3%2520%2528ROR%25CE%25B3%2529%2520adult%2520induced%2520knockout%2520mice%2520develop%2520lymphoblastic%2520lymphoma%26jtitle%3DAutoimmun.%2520Rev.%26date%3D2016%26volume%3D15%26spage%3D1062%26epage%3D1070%26doi%3D10.1016%2Fj.autrev.2016.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deenick, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mele, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averbuch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzahrani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Muhsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halwani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soudais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzouqa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Barricarte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deswarte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabot-Hanin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrado, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlehamn, C. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossjohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villartay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moshous, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hambleton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latour, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkwright, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notarangelo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisson-Dupuis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sallusto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bustamante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tangye, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanova, J. L.</span></span> <span> </span><span class="NLM_article-title">Impairment of immunity to candida and mycobacterium in humans with bi-allelic RORC mutations</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1126/science.aaa4282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1126%2Fscience.aaa4282" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2015&pages=606-613&author=S.+Okadaauthor=J.+G.+Markleauthor=E.+K.+Deenickauthor=F.+Meleauthor=D.+Averbuchauthor=M.+Lagosauthor=M.+Alzahraniauthor=S.+Al-Muhsenauthor=R.+Halwaniauthor=C.+S.+Maauthor=N.+Wongauthor=C.+Soudaisauthor=L.+A.+Hendersonauthor=H.+Marzouqaauthor=J.+Shammaauthor=M.+Gonzalezauthor=R.+Martinez-Barricarteauthor=C.+Okadaauthor=D.+T.+Averyauthor=D.+Latorreauthor=C.+Deswarteauthor=F.+Jabot-Haninauthor=E.+Torradoauthor=J.+Fountainauthor=A.+Belkadiauthor=Y.+Itanauthor=B.+Boissonauthor=M.+Migaudauthor=C.+S.+L.+Arlehamnauthor=A.+Setteauthor=S.+Bretonauthor=J.+McCluskeyauthor=J.+Rossjohnauthor=J.+P.+de+Villartayauthor=D.+Moshousauthor=S.+Hambletonauthor=S.+Latourauthor=P.+D.+Arkwrightauthor=C.+Picardauthor=O.+Lantzauthor=D.+Engelhardauthor=M.+Kobayashiauthor=L.+Abelauthor=A.+M.+Cooperauthor=L.+D.+Notarangeloauthor=S.+Boisson-Dupuisauthor=A.+Puelauthor=F.+Sallustoauthor=J.+Bustamanteauthor=S.+G.+Tangyeauthor=J.+L.+Casanova&title=Impairment+of+immunity+to+candida+and+mycobacterium+in+humans+with+bi-allelic+RORC+mutations&doi=10.1126%2Fscience.aaa4282"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa4282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa4282%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DMarkle%26aufirst%3DJ.%2BG.%26aulast%3DDeenick%26aufirst%3DE.%2BK.%26aulast%3DMele%26aufirst%3DF.%26aulast%3DAverbuch%26aufirst%3DD.%26aulast%3DLagos%26aufirst%3DM.%26aulast%3DAlzahrani%26aufirst%3DM.%26aulast%3DAl-Muhsen%26aufirst%3DS.%26aulast%3DHalwani%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DC.%2BS.%26aulast%3DWong%26aufirst%3DN.%26aulast%3DSoudais%26aufirst%3DC.%26aulast%3DHenderson%26aufirst%3DL.%2BA.%26aulast%3DMarzouqa%26aufirst%3DH.%26aulast%3DShamma%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DMartinez-Barricarte%26aufirst%3DR.%26aulast%3DOkada%26aufirst%3DC.%26aulast%3DAvery%26aufirst%3DD.%2BT.%26aulast%3DLatorre%26aufirst%3DD.%26aulast%3DDeswarte%26aufirst%3DC.%26aulast%3DJabot-Hanin%26aufirst%3DF.%26aulast%3DTorrado%26aufirst%3DE.%26aulast%3DFountain%26aufirst%3DJ.%26aulast%3DBelkadi%26aufirst%3DA.%26aulast%3DItan%26aufirst%3DY.%26aulast%3DBoisson%26aufirst%3DB.%26aulast%3DMigaud%26aufirst%3DM.%26aulast%3DArlehamn%26aufirst%3DC.%2BS.%2BL.%26aulast%3DSette%26aufirst%3DA.%26aulast%3DBreton%26aufirst%3DS.%26aulast%3DMcCluskey%26aufirst%3DJ.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3Dde%2BVillartay%26aufirst%3DJ.%2BP.%26aulast%3DMoshous%26aufirst%3DD.%26aulast%3DHambleton%26aufirst%3DS.%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DArkwright%26aufirst%3DP.%2BD.%26aulast%3DPicard%26aufirst%3DC.%26aulast%3DLantz%26aufirst%3DO.%26aulast%3DEngelhard%26aufirst%3DD.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DAbel%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DA.%2BM.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DBoisson-Dupuis%26aufirst%3DS.%26aulast%3DPuel%26aufirst%3DA.%26aulast%3DSallusto%26aufirst%3DF.%26aulast%3DBustamante%26aufirst%3DJ.%26aulast%3DTangye%26aufirst%3DS.%2BG.%26aulast%3DCasanova%26aufirst%3DJ.%2BL.%26atitle%3DImpairment%2520of%2520immunity%2520to%2520candida%2520and%2520mycobacterium%2520in%2520humans%2520with%2520bi-allelic%2520RORC%2520mutations%26jtitle%3DScience%26date%3D2015%26volume%3D349%26spage%3D606%26epage%3D613%26doi%3D10.1126%2Fscience.aaa4282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Withers, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackley, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halford, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutton, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriott, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brucklacher-Waldert, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldhoen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldassano, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnenberg, G. F.</span></span> <span> </span><span class="NLM_article-title">Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing T<sub>H</sub>17 cells and preserving ILC3</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1038/nm.4046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fnm.4046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26878233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFKhsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=319-323&author=D.+R.+Withersauthor=M.+R.+Hepworthauthor=X.+Wangauthor=E.+C.+Mackleyauthor=E.+E.+Halfordauthor=E.+E.+Duttonauthor=C.+L.+Marriottauthor=V.+Brucklacher-Waldertauthor=M.+Veldhoenauthor=J.+Kelsenauthor=R.+N.+Baldassanoauthor=G.+F.+Sonnenberg&title=Transient+inhibition+of+ROR-%CE%B3t+therapeutically+limits+intestinal+inflammation+by+reducing+TH17+cells+and+preserving+ILC3&doi=10.1038%2Fnm.4046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells</span></div><div class="casAuthors">Withers, David R.; Hepworth, Matthew R.; Wang, Xinxin; Mackley, Emma C.; Halford, Emily E.; Dutton, Emma E.; Marriott, Clare L.; Brucklacher-Waldert, Verena; Veldhoen, Marc; Kelsen, Judith; Baldassano, Robert N.; Sonnenberg, Gregory F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-323</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">RAR-related orphan receptor-γt (ROR-γt) directs differentiation of proinflammatory T helper 17 (TH17) cells and is a potential therapeutic target in chronic autoimmune and inflammatory diseases.  However, ROR-γt-dependent group 3 innate lymphoid cells ILC3s provide essential immunity and tissue protection in the intestine, suggesting that targeting ROR-γt could also result in impaired host defense after infection or enhanced tissue damage.  Here, we demonstrate that transient chem. inhibition of ROR-γt in mice selectively reduces cytokine prodn. from TH17 but not ILCs in the context of intestinal infection with Citrobacter rodentium, resulting in preserved innate immunity.  Temporal deletion of Rorc (encoding ROR-γt) in mature ILCs also did not impair cytokine response in the steady state or during infection.  Finally, pharmacol. inhibition of ROR-γt provided therapeutic benefit in mouse models of intestinal inflammation and reduced the frequency of TH17 cells but not ILCs isolated from primary intestinal samples of individuals with inflammatory bowel disease (IBD).  Collectively, these results reveal differential requirements for ROR-γt in the maintenance of TH17 cell and ILC3 responses and suggest that transient inhibition of ROR-γt is a safe and effective therapeutic approach during intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6T-ucecrVJ7Vg90H21EOLACvtfcHk0lh7T1b5JXs1PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFKhsb4%253D&md5=4ef0467a7eee081460f34a42a9b26e8e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fnm.4046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4046%26sid%3Dliteratum%253Aachs%26aulast%3DWithers%26aufirst%3DD.%2BR.%26aulast%3DHepworth%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMackley%26aufirst%3DE.%2BC.%26aulast%3DHalford%26aufirst%3DE.%2BE.%26aulast%3DDutton%26aufirst%3DE.%2BE.%26aulast%3DMarriott%26aufirst%3DC.%2BL.%26aulast%3DBrucklacher-Waldert%26aufirst%3DV.%26aulast%3DVeldhoen%26aufirst%3DM.%26aulast%3DKelsen%26aufirst%3DJ.%26aulast%3DBaldassano%26aufirst%3DR.%2BN.%26aulast%3DSonnenberg%26aufirst%3DG.%2BF.%26atitle%3DTransient%2520inhibition%2520of%2520ROR-%25CE%25B3t%2520therapeutically%2520limits%2520intestinal%2520inflammation%2520by%2520reducing%2520TH17%2520cells%2520and%2520preserving%2520ILC3%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D319%26epage%3D323%26doi%3D10.1038%2Fnm.4046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniakis-Grivas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asher, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkington, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, J. S.</span></span> <span> </span><span class="NLM_article-title">Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1002/path.5013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fpath.5013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29210073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisl2jtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2018&pages=311-322&author=S.+Singhauthor=G.+Maniakis-Grivasauthor=U.+K.+Singhauthor=R.+M.+Asherauthor=F.+Mauriauthor=P.+T.+Elkingtonauthor=J.+S.+Friedland&title=Interleukin-17+regulates+matrix+metalloproteinase+activity+in+human+pulmonary+tuberculosis&doi=10.1002%2Fpath.5013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis</span></div><div class="casAuthors">Singh, Shivani; Maniakis-Grivas, George; Singh, Utpal K.; Asher, Radha M.; Mauri, Francesco; Elkington, Paul T.; Friedland, Jon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-322</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">1096-9896</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Tuberculosis (TB) is characterized by extensive pulmonary matrix breakdown.  Interleukin-17 (IL-17) is key in host defense in TB but its role in TB-driven tissue damage is unknown.  We investigated the hypothesis that respiratory stromal cell matrix metalloproteinase (MMP) prodn. in TB is regulated by T-helper 17 (TH-17) cytokines.  Biopsies of patients with pulmonary TB were analyzed by immunohistochem. (IHC), and patient bronchoalveolar lavage fluid (BALF) MMP and cytokine concns. were measured by Luminex assays.  Primary human airway epithelial cells were stimulated with conditioned medium from human monocytes infected with Mycobacterium tuberculosis (Mtb) and TH-17 cytokines.  MMP secretion, activity, and gene expression were detd. by ELISA, Luminex assay, zymog., RT-qPCR, and dual luciferase reporter assays.  Signalling pathways were examd. using phospho-western anal. and siRNA.  IL-17 is expressed in TB patient granulomas and MMP-3 is expressed in adjacent pulmonary epithelial cells.  IL-17 had a divergent, concn.-dependent effect on MMP secretion, increasing epithelial secretion of MMP-3 (p < 0.001) over 72 h, while decreasing that of MMP-9 (p < 0.0001); mRNA levels were similarly affected.  Both IL-17 and IL-22 increased fibroblast Mtb-dependent MMP-3 secretion but IL-22 did not modulate epithelial MMP-3 expression.  Both IL-17 and IL-22, but not IL-23, were significantly up-regulated in BALF from TB patients.  IL-17-driven MMP-3 was dependent on p38 MAP kinase and the PI3K p110α subunit.  In summary, IL-17 drives airway stromal cell-derived MMP-3, a mediator of tissue destruction in TB, alone and with monocyte-dependent networks in TB.  This is regulated by p38 MAP kinase and PI3K pathways. © 2017 The Authors.  The Journal of Pathol. published by John Wiley & Sons Ltd on behalf of Pathol. Society of Great Britain and Ireland.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEUiakeNvPHrVg90H21EOLACvtfcHk0lh7T1b5JXs1PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisl2jtrs%253D&md5=30d179727c8bfefa4a764d4298d45c32</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fpath.5013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.5013%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DManiakis-Grivas%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DU.%2BK.%26aulast%3DAsher%26aufirst%3DR.%2BM.%26aulast%3DMauri%26aufirst%3DF.%26aulast%3DElkington%26aufirst%3DP.%2BT.%26aulast%3DFriedland%26aufirst%3DJ.%2BS.%26atitle%3DInterleukin-17%2520regulates%2520matrix%2520metalloproteinase%2520activity%2520in%2520human%2520pulmonary%2520tuberculosis%26jtitle%3DJ.%2520Pathol.%26date%3D2018%26volume%3D244%26spage%3D311%26epage%3D322%26doi%3D10.1002%2Fpath.5013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Femke A. Meijer, Annet O.W.M. Saris, Richard G. Doveston, Guido J.M. Oerlemans, Rens M.J.M. de Vries, Bente A. Somsen, Anke Unger, Bert Klebl, Christian Ottmann, Peter J. Cossar, <span class="NLM_string-name hlFld-ContribAuthor">Luc Brunsveld</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Studies of Trisubstituted Isoxazoles as Selective Allosteric Ligands for the Retinoic-Acid-Receptor-Related Orphan Receptor γt. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00475%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BStudies%252Bof%252BTrisubstituted%252BIsoxazoles%252Bas%252BSelective%252BAllosteric%252BLigands%252Bfor%252Bthe%252BRetinoic-Acid-Receptor-Related%252BOrphan%252BReceptor%252B%2525CE%2525B3t%26aulast%3DMeijer%26aufirst%3DFemke%2BA.%26date%3D2021%26date%3D2021%26date%3D16032021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qingjie Liu, Hai-Yun Xiao, Douglas G. Batt, Zili Xiao, Yeheng Zhu, Michael G. Yang, Ning Li, Shiuhang Yip, Peng Li, Dawn Sun, Dauh-Rurng Wu, Max Ruzanov, John S. Sack, Carolyn A. Weigelt, Jinhong Wang, Sha Li, David J. Shuster, Jenny H. Xie, Yunling Song, Tara Sherry, Mary T. Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, Silvi Chacko, Purnima Khandelwal, Shailesh Dudhgaonkar, Anjuman Rudra, Jignesh Nagar, Venkata Murali, Arun Govindarajan, Rex Denton, Qihong Zhao, Nicholas A. Meanwell, Robert Borzilleri, <span class="NLM_string-name hlFld-ContribAuthor">T. G. Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and Psoriasis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 827-835. <a href="https://doi.org/10.1021/acsmedchemlett.1c00112" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00112%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAzatricyclic%252BInverse%252BAgonists%252Bof%252BROR%2525CE%2525B3t%252BThat%252BDemonstrate%252BEfficacy%252Bin%252BModels%252Bof%252BRheumatoid%252BArthritis%252Band%252BPsoriasis%26aulast%3DLiu%26aufirst%3DQingjie%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D22022021%26date%3D28042021%26date%3D30042021%26volume%3D12%26issue%3D5%26spage%3D827%26epage%3D835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Femke A. Meijer, Maxime C. M. van den Oetelaar, Richard G. Doveston, Ella N. R. Sampers, <span class="NLM_string-name hlFld-ContribAuthor">Luc Brunsveld</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Occlusion of the RORγt Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 631-639. <a href="https://doi.org/10.1021/acsmedchemlett.1c00029" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00029%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCovalent%252BOcclusion%252Bof%252Bthe%252BROR%2525CE%2525B3t%252BLigand%252BBinding%252BPocket%252BAllows%252BUnambiguous%252BTargeting%252Bof%252Ban%252BAllosteric%252BSite%26aulast%3DMeijer%26aufirst%3DFemke%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17012021%26date%3D03032021%26date%3D08032021%26volume%3D12%26issue%3D4%26spage%3D631%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian Harcken, Johanna Csengery, Michael Turner, Lifen Wu, Shuang Liang, Robert Sibley, Steven Brunette, Mark Labadia, Kathleen Hoyt, Anita Wayne, Thomas Wieckowski, Gregg Davis, Mark Panzenbeck, Donald Souza, Stanley Kugler, Donna Terenzio, Delphine Collin, Dustin Smith, Ryan M. Fryer, Yin-Chao Tseng, Jörg P. Hehn, Kim Fletcher, <span class="NLM_string-name hlFld-ContribAuthor">Robert O. Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 143-154. <a href="https://doi.org/10.1021/acsmedchemlett.0c00575" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00575%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252BPyrazinone%252BROR%2525CE%2525B3%252BAntagonists%252Band%252BIdentification%252Bof%252Bthe%252BClinical%252BCandidate%252BBI%252B730357%26aulast%3DHarcken%26aufirst%3DChristian%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D11112020%26date%3D11122020%26date%3D05012021%26volume%3D12%26issue%3D1%26spage%3D143%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qingjie Liu, Douglas G. Batt, Carolyn A. Weigelt, Shiuhang Yip, Dauh-Rurng Wu, Max Ruzanov, John S. Sack, Jinhong Wang, Melissa Yarde, Sha Li, David J. Shuster, Jenny H. Xie, Tara Sherry, Mary T. Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, Purnima Khandelwal, Joseph A. Tino, John E. Macor, Luisa Salter-Cid, Rex Denton, Qihong Zhao, <span class="NLM_string-name hlFld-ContribAuthor">T. G. Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening Approach. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (12)
                                     , 2510-2518. <a href="https://doi.org/10.1021/acsmedchemlett.0c00496" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00496%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BTricyclic%252BPyroglutamide%252BDerivatives%252Bas%252BPotent%252BROR%2525CE%2525B3t%252BInverse%252BAgonists%252BIdentified%252Busing%252Ba%252BVirtual%252BScreening%252BApproach%26aulast%3DLiu%26aufirst%3DQingjie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11092020%26date%3D03112020%26date%3D06112020%26volume%3D11%26issue%3D12%26spage%3D2510%26epage%3D2518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Cherney, Lyndon A. M. Cornelius, Anurag Srivastava, Carolyn A. Weigelt, David Marcoux, James J.-W. Duan, Qing Shi, Douglas G. Batt, Qingjie Liu, Shiuhang Yip, Dauh-Rurng Wu, Max Ruzanov, John Sack, Javed Khan, Jinhong Wang, Melissa Yarde, Mary Ellen Cvijic, Arvind Mathur, Sha Li, David Shuster, Purnima Khandelwal, Virna Borowski, Jenny Xie, Mary Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, Joseph A. Tino, John E. Macor, Luisa Salter-Cid, Rex Denton, Qihong Zhao, Percy H. Carter, <span class="NLM_string-name hlFld-ContribAuthor">T. G. Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1221-1227. <a href="https://doi.org/10.1021/acsmedchemlett.0c00063" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00063%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BBMS-986251%25253A%252BA%252BClinically%252BViable%25252C%252BPotent%25252C%252Band%252BSelective%252BROR%2525CE%2525B3t%252BInverse%252BAgonist%26aulast%3DCherney%26aufirst%3DRobert%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D05022020%26date%3D31032020%26date%3D10042020%26date%3D31032020%26volume%3D11%26issue%3D6%26spage%3D1221%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lauren E. Sirois, David Lao, Jie Xu, Rémy Angelaud, Jerry Tso, Brandon Scott, Paroma Chakravarty, Sushant Malhotra, <span class="NLM_string-name hlFld-ContribAuthor">Francis Gosselin</span>. </span><span class="cited-content_cbyCitation_article-title">Process Development Overcomes a Challenging Pd-Catalyzed C–N Coupling for the Synthesis of RORc Inhibitor GDC-0022. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (4)
                                     , 567-578. <a href="https://doi.org/10.1021/acs.oprd.0c00012" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00012%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252BOvercomes%252Ba%252BChallenging%252BPd-Catalyzed%252BC%2525E2%252580%252593N%252BCoupling%252Bfor%252Bthe%252BSynthesis%252Bof%252BRORc%252BInhibitor%252BGDC-0022%26aulast%3DSirois%26aufirst%3DLauren%2BE.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09012020%26date%3D30032020%26volume%3D24%26issue%3D4%26spage%3D567%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ryota Nakajima, Hiroyuki Oono, Sakae Sugiyama, Yohei Matsueda, Tomohide Ida, Shinji Kakuda, Jun Hirata, Atsushi Baba, Akito Makino, Ryo Matsuyama, Ryan D. White, Ryan Ρ. Wurz, Youngsook Shin, Xiaoshan Min, Angel Guzman-Perez, Zhulun Wang, Antony Symons, Sanjay K. Singh, Srinivasa Reddy Mothe, Sergei Belyakov, Anjan Chakrabarti, <span class="NLM_string-name hlFld-ContribAuthor">Satoshi Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of [1,2,4]Triazolo[1,5-a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 528-534. <a href="https://doi.org/10.1021/acsmedchemlett.9b00649" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00649%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyridine%252BDerivatives%252Bas%252BPotent%252Band%252BOrally%252BBioavailable%252BROR%2525CE%2525B3t%252BInverse%252BAgonists%26aulast%3DNakajima%26aufirst%3DRyota%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D24122019%26date%3D27022020%26date%3D03032020%26date%3D27022020%26volume%3D11%26issue%3D4%26spage%3D528%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hongjun Zhang, Blair T. Lapointe, Neville Anthony, Rita Azevedo, Jos Cals, Craig C. Correll, Matthew Daniels, Sujal Deshmukh, Hans van Eenenaam, Heidi Ferguson, Laxminarayan G. Hegde, Willem Jan Karstens, John Maclean, J. Richard Miller, Lily Y. Moy, Vladimir Simov, Sunil Nagpal, Arthur Oubrie, Rachel L. Palte, Gopal Parthasarathy, Nunzio Sciammetta, Mario van der Stelt, Janice D. Woodhouse, B. Wesley Trotter, <span class="NLM_string-name hlFld-ContribAuthor">Kenneth Barr</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (2)
                                     , 114-119. <a href="https://doi.org/10.1021/acsmedchemlett.9b00431" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00431%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-%252528Indazol-3-yl%252529piperidine-4-carboxylic%252BAcids%252Bas%252BROR%2525CE%2525B3t%252BAllosteric%252BInhibitors%252Bfor%252BAutoimmune%252BDiseases%26aulast%3DZhang%26aufirst%3DHongjun%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D18092019%26date%3D09012020%26date%3D14012020%26date%3D09012020%26volume%3D11%26issue%3D2%26spage%3D114%26epage%3D119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Femke A. Meijer, Richard G. Doveston, Rens M.J.M. de Vries, Gaël M. Vos, Alex A.A. Vos, Seppe Leysen, Marcel Scheepstra, Christian Ottmann, Lech-Gustav Milroy, <span class="NLM_string-name hlFld-ContribAuthor">Luc Brunsveld</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (1)
                                     , 241-259. <a href="https://doi.org/10.1021/acs.jmedchem.9b01372" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01372</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01372%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand-Based%252BDesign%252Bof%252BAllosteric%252BRetinoic%252BAcid%252BReceptor-Related%252BOrphan%252BReceptor%252B%2525CE%2525B3t%252B%252528ROR%2525CE%2525B3t%252529%252BInverse%252BAgonists%26aulast%3DMeijer%26aufirst%3DFemke%2BA.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D20082019%26date%3D24122019%26date%3D10122019%26volume%3D63%26issue%3D1%26spage%3D241%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Klemens Hoegenauer, Joerg Kallen, Eloísa Jiménez-Núñez, Ross Strang, Peter Ertl, Nigel G. Cooke, Samuel Hintermann, Markus Voegtle, Claudia Betschart, Daniel J. J. McKay, Juergen Wagner, Johannes Ottl, Christian Beerli, Andreas Billich, Janet Dawson, Klemens Kaupmann, Markus Streiff, Nathalie Gobeau, Stephanie Harlfinger, Rowan Stringer, <span class="NLM_string-name hlFld-ContribAuthor">Christine Guntermann</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based and Property-Driven Optimization of N-Aryl Imidazoles toward Potent and Selective Oral RORγt Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (23)
                                     , 10816-10832. <a href="https://doi.org/10.1021/acs.jmedchem.9b01291" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01291</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01291%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252Band%252BProperty-Driven%252BOptimization%252Bof%252BN-Aryl%252BImidazoles%252Btoward%252BPotent%252Band%252BSelective%252BOral%252BROR%2525CE%2525B3t%252BInhibitors%26aulast%3DHoegenauer%26aufirst%3DKlemens%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08082019%26date%3D03122019%26date%3D15112019%26volume%3D62%26issue%3D23%26spage%3D10816%26epage%3D10832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">David Marcoux, James J.-W. Duan, Qing Shi, Robert J. Cherney, Anurag S. Srivastava, Lyndon Cornelius, Douglas G. Batt, Qingjie Liu, Myra Beaudoin-Bertrand, Carolyn A. Weigelt, Purnima Khandelwal, Sureshbabu Vishwakrishnan, Kumaravel Selvakumar, Ananta Karmakar, Arun Kumar Gupta, Mushkin Basha, Sridharan Ramlingam, Naveen Manjunath, Sridhar Vanteru, Sukhen Karmakar, Nageswara Maddala, Muthalagu Vetrichelvan, Anuradha Gupta, Richard A. Rampulla, Arvind Mathur, Shiuhang Yip, Peng Li, Dauh-Rurng Wu, Javed Khan, Max Ruzanov, John S. Sack, Jinhong Wang, Melissa Yarde, Mary Ellen Cvijic, Sha Li, David J. Shuster, Virna Borowski, Jenny H. Xie, Kim W. McIntyre, Mary T. Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, John Hynes, Jr., Joseph A. Tino, John E. Macor, Luisa Salter-Cid, Rex Denton, Qihong Zhao, Percy H. Carter, <span class="NLM_string-name hlFld-ContribAuthor">T. G. Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt—Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (21)
                                     , 9931-9946. <a href="https://doi.org/10.1021/acs.jmedchem.9b01369" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01369%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRationally%252BDesigned%25252C%252BConformationally%252BConstrained%252BInverse%252BAgonists%252Bof%252BROR%2525CE%2525B3t%2525E2%252580%252594Identification%252Bof%252Ba%252BPotent%25252C%252BSelective%252BSeries%252Bwith%252BBiologic-Like%252Bin%252BVivo%252BEfficacy%26aulast%3DMarcoux%26aufirst%3DDavid%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19082019%26date%3D31102019%26date%3D22102019%26volume%3D62%26issue%3D21%26spage%3D9931%26epage%3D9946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stefan von Berg, Yafeng Xue, Mia Collins, Antonio Llinas, Roine I. Olsson, Torbjörn Halvarsson, Maria Lindskog, Jesper Malmberg, Johan Jirholt, Nina Krutrök, Marie Ramnegård, Marie Brännström, Anders Lundqvist, Matti Lepistö, Anna Aagaard, Jane McPheat, Eva L. Hansson, Rongfeng Chen, Yao Xiong, Thomas G. Hansson, <span class="NLM_string-name hlFld-ContribAuthor">Frank Narjes</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (6)
                                     , 972-977. <a href="https://doi.org/10.1021/acsmedchemlett.9b00158" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00158%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BOrally%252BBioavailable%252BInverse%252BAgonists%252Bof%252Bthe%252BRetinoic%252BAcid%252BReceptor-Related%252BOrphan%252BReceptor%252BC2%26aulast%3Dvon%2BBerg%26aufirst%3DStefan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D05042019%26date%3D29052019%26date%3D05062019%26date%3D29052019%26volume%3D10%26issue%3D6%26spage%3D972%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan Zhang, Xishan Wu, Xiaoqian Xue, Chenchang Li, Junjian Wang, Rui Wang, Cheng Zhang, Chao Wang, Yudan Shi, Lingjiao Zou, Qiu Li, Zenghong Huang, Xiaojuan Hao, Kerry Loomes, Donghai Wu, Hong-Wu Chen, Jinxin Xu, <span class="NLM_string-name hlFld-ContribAuthor">Yong Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4716-4730. <a href="https://doi.org/10.1021/acs.jmedchem.9b00327" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00327%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BCharacterization%252Bof%252BXY101%25252C%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BROR%2525CE%2525B3%252BInverse%252BAgonist%252Bfor%252BTreatment%252Bof%252BCastration-Resistant%252BProstate%252BCancer%26aulast%3DZhang%26aufirst%3DYan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20022019%26date%3D22042019%26date%3D09042019%26volume%3D62%26issue%3D9%26spage%3D4716%26epage%3D4730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Masayuki Kotoku, Takaki Maeba, Shingo Fujioka, Masahiro Yokota, Noriyoshi Seki, Keisuke Ito, Yoshihiro Suwa, Taku Ikenogami, Kazuyuki Hirata, Yasunori Hase, Yoshiaki Katsuda, Naoki Miyagawa, Kojo Arita, Kota Asahina, Masato Noguchi, Akihiro Nomura, Satoki Doi, Tsuyoshi Adachi, Paul Crowe, Haiyan Tao, Scott Thacher, Hiromasa Hashimoto, Takayoshi Suzuki, <span class="NLM_string-name hlFld-ContribAuthor">Makoto Shiozaki</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2837-2842. <a href="https://doi.org/10.1021/acs.jmedchem.8b01567" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01567</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01567%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSecond%252BGeneration%252BROR%2525CE%2525B3%252BInhibitors%252BComposed%252Bof%252Ban%252BAzole%252BScaffold%26aulast%3DKotoku%26aufirst%3DMasayuki%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D09102018%26date%3D01032019%26date%3D18022019%26volume%3D62%26issue%3D5%26spage%3D2837%26epage%3D2842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">James J.-W. Duan, Zhonghui Lu, Bin Jiang, Sylwia Stachura, Carolyn A. Weigelt, John S. Sack, Javed Khan, Max Ruzanov, Michael A. Galella, Dauh-Rurng Wu, Melissa Yarde, Ding-Ren Shen, David J. Shuster, Virna Borowski, Jenny H. Xie, Lisa Zhang, Sridhar Vanteru, Arun Kumar Gupta, Arvind Mathur, Qihong Zhao, William Foster, Luisa M. Salter-Cid, Percy H. Carter, <span class="NLM_string-name hlFld-ContribAuthor">T. G. Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 367-373. <a href="https://doi.org/10.1021/acsmedchemlett.9b00010" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00010%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252BDiscovery%252Bof%252BPhenyl%252B%2525283-Phenylpyrrolidin-3-yl%252529sulfones%252Bas%252BSelective%25252C%252BOrally%252BActive%252BROR%2525CE%2525B3t%252BInverse%252BAgonists%26aulast%3DDuan%26aufirst%3DJames%2BJ.-W.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D08012019%26date%3D25022019%26date%3D28022019%26date%3D26022019%26volume%3D10%26issue%3D3%26spage%3D367%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Buesking</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Mayes</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Combs</span>. </span><span class="cited-content_cbyCitation_article-title">Immuno‐Oncology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-30. <a href="https://doi.org/10.1002/0471266949.bmc272" title="DOI URL">https://doi.org/10.1002/0471266949.bmc272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc272%26sid%3Dliteratum%253Aachs%26atitle%3DImmuno%2525E2%252580%252590Oncology%26aulast%3DBuesking%26aufirst%3DAndrew%2BW.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D30%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Grabrijan</span>, <span class="hlFld-ContribAuthor ">Nika  Strašek</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>. </span><span class="cited-content_cbyCitation_article-title">Monocyclic beta–lactams for therapeutic uses: a patent overview (2010–2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (3)
                                     , 247-266. <a href="https://doi.org/10.1080/13543776.2021.1865919" title="DOI URL">https://doi.org/10.1080/13543776.2021.1865919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1865919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1865919%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DMonocyclic%252Bbeta%2525E2%252580%252593lactams%252Bfor%252Btherapeutic%252Buses%25253A%252Ba%252Bpatent%252Boverview%252B%2525282010%2525E2%252580%2525932020%252529%26aulast%3DGrabrijan%26aufirst%3DKatarina%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D3%26spage%3D247%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryota  Nakajima</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Oono</span>, <span class="hlFld-ContribAuthor ">Keiko  Kumazawa</span>, <span class="hlFld-ContribAuthor ">Tomohide  Ida</span>, <span class="hlFld-ContribAuthor ">Jun  Hirata</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Xiaoshan  Min</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Zhulun  Wang</span>, <span class="hlFld-ContribAuthor ">Antony  Symons</span>, <span class="hlFld-ContribAuthor ">Sanjay K.  Singh</span>, <span class="hlFld-ContribAuthor ">Srinivasa Reddy  Mothe</span>, <span class="hlFld-ContribAuthor ">Sergei  Belyakov</span>, <span class="hlFld-ContribAuthor ">Anjan  Chakrabarti</span>, <span class="hlFld-ContribAuthor ">Satoshi  Shuto</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 6-Oxo-4-phenyl-hexanoic acid derivatives as RORγt inverse agonists showing favorable ADME profile. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>36 </em>, 127786. <a href="https://doi.org/10.1016/j.bmcl.2021.127786" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127786</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127786%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B6-Oxo-4-phenyl-hexanoic%252Bacid%252Bderivatives%252Bas%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%252Bshowing%252Bfavorable%252BADME%252Bprofile%26aulast%3DNakajima%26aufirst%3DRyota%26date%3D2021%26volume%3D36%26spage%3D127786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo F.N.  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Cláudia  Cavadas</span>, <span class="hlFld-ContribAuthor ">Maria Manuel C.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule modulators of the circadian clock: Pharmacological potentials in circadian-related diseases. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>35 </em><a href="https://doi.org/10.1016/j.drudis.2021.03.015" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DSmall-molecule%252Bmodulators%252Bof%252Bthe%252Bcircadian%252Bclock%25253A%252BPharmacological%252Bpotentials%252Bin%252Bcircadian-related%252Bdiseases%26aulast%3DRibeiro%26aufirst%3DRodrigo%2BF.N.%26date%3D2021%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rens M. J. M.  de Vries</span>, <span class="hlFld-ContribAuthor ">Femke A.  Meijer</span>, <span class="hlFld-ContribAuthor ">Richard G.  Doveston</span>, <span class="hlFld-ContribAuthor ">Iris A.  Leijten-van de Gevel</span>, <span class="hlFld-ContribAuthor ">Luc  Brunsveld</span>. </span><span class="cited-content_cbyCitation_article-title">Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (6)
                                     , e2021287118. <a href="https://doi.org/10.1073/pnas.2021287118" title="DOI URL">https://doi.org/10.1073/pnas.2021287118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2021287118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2021287118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DCooperativity%252Bbetween%252Bthe%252Borthosteric%252Band%252Ballosteric%252Bligand%252Bbinding%252Bsites%252Bof%252BROR%2525CE%2525B3t%26aulast%3Dde%2BVries%26aufirst%3DRens%2BM.%2BJ.%2BM.%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D6%26spage%3De2021287118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hakim  Ben Abdallah</span>, <span class="hlFld-ContribAuthor ">Claus  Johansen</span>, <span class="hlFld-ContribAuthor ">Lars  Iversen</span>. </span><span class="cited-content_cbyCitation_article-title">Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Psoriasis: Targets and Therapy</span><span> <strong>2021,</strong> <em>Volume 11 </em>, 83-97. <a href="https://doi.org/10.2147/PTT.S294173" title="DOI URL">https://doi.org/10.2147/PTT.S294173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/PTT.S294173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FPTT.S294173%26sid%3Dliteratum%253Aachs%26jtitle%3DPsoriasis%253A%2520Targets%2520and%2520Therapy%26atitle%3DKey%252BSignaling%252BPathways%252Bin%252BPsoriasis%25253A%252BRecent%252BInsights%252Bfrom%252BAntipsoriatic%252BTherapeutics%26aulast%3DBen%2BAbdallah%26aufirst%3DHakim%26date%3D2021%26date%3D2021%26volume%3DVolume%252011%26spage%3D83%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-cheng  Yu</span>, <span class="hlFld-ContribAuthor ">Feng  Yang</span>, <span class="hlFld-ContribAuthor ">Xiao-yu  Ding</span>, <span class="hlFld-ContribAuthor ">Nan-nan  Sun</span>, <span class="hlFld-ContribAuthor ">Zheng-yuan  Jiang</span>, <span class="hlFld-ContribAuthor ">Ya-fei  Huang</span>, <span class="hlFld-ContribAuthor ">Yu-rong  Yan</span>, <span class="hlFld-ContribAuthor ">Chen  Zhu</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Zhi-feng  Chen</span>, <span class="hlFld-ContribAuthor ">Si-qi  Guo</span>, <span class="hlFld-ContribAuthor ">Hua-liang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kai-xian  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiao-min  Luo</span>, <span class="hlFld-ContribAuthor ">Shi-jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yong-hui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Crystallography-guided discovery of carbazole-based retinoic acid-related orphan receptor gamma-t (RORγt) modulators: insights into different protein behaviors with “short” and “long” inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>126 </em><a href="https://doi.org/10.1038/s41401-020-00552-w" title="DOI URL">https://doi.org/10.1038/s41401-020-00552-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-00552-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-00552-w%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DCrystallography-guided%252Bdiscovery%252Bof%252Bcarbazole-based%252Bretinoic%252Bacid-related%252Borphan%252Breceptor%252Bgamma-t%252B%252528ROR%2525CE%2525B3t%252529%252Bmodulators%25253A%252Binsights%252Binto%252Bdifferent%252Bprotein%252Bbehaviors%252Bwith%252B%2525E2%252580%25259Cshort%2525E2%252580%25259D%252Band%252B%2525E2%252580%25259Clong%2525E2%252580%25259D%252Binverse%252Bagonists%26aulast%3DYu%26aufirst%3DMing-cheng%26date%3D2020%26date%3D2020%26volume%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cervantes-Durán  Claudia</span>, <span class="hlFld-ContribAuthor ">Velázquez-Hernández  María-Elena</span>, <span class="hlFld-ContribAuthor ">Valentín-Escalera  Josué</span>, <span class="hlFld-ContribAuthor ">Bartolomé-Camacho  María-Carmen</span>, <span class="hlFld-ContribAuthor ">Rodríguez-Orozco  Alain-Raimundo</span>, <span class="hlFld-ContribAuthor ">García-Pérez  Martha-Estrella</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules under development for psoriasis: on the road to the individualized therapies. </span><span class="cited-content_cbyCitation_journal-name">Archives of Dermatological Research</span><span> <strong>2020,</strong> <em>312 </em>
                                    (9)
                                     , 611-627. <a href="https://doi.org/10.1007/s00403-020-02056-3" title="DOI URL">https://doi.org/10.1007/s00403-020-02056-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00403-020-02056-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00403-020-02056-3%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Dermatological%2520Research%26atitle%3DSmall%252Bmolecules%252Bunder%252Bdevelopment%252Bfor%252Bpsoriasis%25253A%252Bon%252Bthe%252Broad%252Bto%252Bthe%252Bindividualized%252Btherapies%26aulast%3DClaudia%26aufirst%3DCervantes-Dur%25C3%25A1n%26date%3D2020%26date%3D2020%26volume%3D312%26issue%3D9%26spage%3D611%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atrin  Toussi</span>, <span class="hlFld-ContribAuthor ">Natalia  Maverakis</span>, <span class="hlFld-ContribAuthor ">Stephanie T.  Le</span>, <span class="hlFld-ContribAuthor ">Soumajyoti  Sarkar</span>, <span class="hlFld-ContribAuthor ">Smriti K.  Raychaudhuri</span>, <span class="hlFld-ContribAuthor ">Siba P.  Raychaudhuri</span>. </span><span class="cited-content_cbyCitation_article-title">Updated therapies for the management of Psoriatic Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Clinical Immunology</span><span> <strong>2020,</strong> <em>220 </em>, 108536. <a href="https://doi.org/10.1016/j.clim.2020.108536" title="DOI URL">https://doi.org/10.1016/j.clim.2020.108536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.clim.2020.108536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.clim.2020.108536%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Immunology%26atitle%3DUpdated%252Btherapies%252Bfor%252Bthe%252Bmanagement%252Bof%252BPsoriatic%252BArthritis%26aulast%3DToussi%26aufirst%3DAtrin%26date%3D2020%26volume%3D220%26spage%3D108536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James J.-W.  Duan</span>, <span class="hlFld-ContribAuthor ">Bin  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhonghui  Lu</span>, <span class="hlFld-ContribAuthor ">Sylwia  Stachura</span>, <span class="hlFld-ContribAuthor ">Carolyn A.  Weigelt</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Javed  Khan</span>, <span class="hlFld-ContribAuthor ">Max  Ruzanov</span>, <span class="hlFld-ContribAuthor ">Dauh–Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Ding–Ren  Shen</span>, <span class="hlFld-ContribAuthor ">Qihong  Zhao</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter–Cid</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">T.G.  Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2,6–difluorobenzyl ether series of phenyl ((R)–3–phenylpyrrolidin–3–yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (19)
                                     , 127441. <a href="https://doi.org/10.1016/j.bmcl.2020.127441" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127441%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2%25252C6%2525E2%252580%252593difluorobenzyl%252Bether%252Bseries%252Bof%252Bphenyl%252B%252528%252528R%252529%2525E2%252580%2525933%2525E2%252580%252593phenylpyrrolidin%2525E2%252580%2525933%2525E2%252580%252593yl%252529sulfones%252Bas%252Bsurprisingly%252Bpotent%25252C%252Bselective%252Band%252Borally%252Bbioavailable%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%26aulast%3DDuan%26aufirst%3DJames%2BJ.-W.%26date%3D2020%26volume%3D30%26issue%3D19%26spage%3D127441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michio  Tokuyama</span>, <span class="hlFld-ContribAuthor ">Tomotaka  Mabuchi</span>. </span><span class="cited-content_cbyCitation_article-title">New Treatment Addressing the Pathogenesis of Psoriasis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (20)
                                     , 7488. <a href="https://doi.org/10.3390/ijms21207488" title="DOI URL">https://doi.org/10.3390/ijms21207488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21207488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21207488%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNew%252BTreatment%252BAddressing%252Bthe%252BPathogenesis%252Bof%252BPsoriasis%26aulast%3DTokuyama%26aufirst%3DMichio%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D20%26spage%3D7488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang-Jie  Zhu</span>, <span class="hlFld-ContribAuthor ">Sihao  Gong</span>, <span class="hlFld-ContribAuthor ">Deng-Bin  Ma</span>, <span class="hlFld-ContribAuthor ">Tao  Tao</span>, <span class="hlFld-ContribAuthor ">Wei-Qi  He</span>, <span class="hlFld-ContribAuthor ">Linqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Yun  Qian</span>, <span class="hlFld-ContribAuthor ">Han  Zhou</span>, <span class="hlFld-ContribAuthor ">Chi  Fan</span>, <span class="hlFld-ContribAuthor ">Pei  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Zhao</span>, <span class="hlFld-ContribAuthor ">Jie  Sun</span>, <span class="hlFld-ContribAuthor ">Huaqun  Chen</span>, <span class="hlFld-ContribAuthor ">Ye  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang  Gao</span>, <span class="hlFld-ContribAuthor ">Jian  Zuo</span>, <span class="hlFld-ContribAuthor ">Min-Sheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Xia  Gao</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Wan</span>, . </span><span class="cited-content_cbyCitation_article-title">Aldh inhibitor restores auditory function in a mouse model of human deafness. </span><span class="cited-content_cbyCitation_journal-name">PLOS Genetics</span><span> <strong>2020,</strong> <em>16 </em>
                                    (9)
                                     , e1009040. <a href="https://doi.org/10.1371/journal.pgen.1009040" title="DOI URL">https://doi.org/10.1371/journal.pgen.1009040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pgen.1009040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pgen.1009040%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Genetics%26atitle%3DAldh%252Binhibitor%252Brestores%252Bauditory%252Bfunction%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252Bhuman%252Bdeafness%26aulast%3DZhu%26aufirst%3DGuang-Jie%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D9%26spage%3De1009040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Yafei  Huang</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yunpeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Ji-An  Chen</span>, <span class="hlFld-ContribAuthor ">Chenyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Meiqi  Song</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>202 </em>, 112536. <a href="https://doi.org/10.1016/j.ejmech.2020.112536" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112536%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bcarboxyl-containing%252Bbiaryl%252Bureas%252Bas%252Bpotent%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%26aulast%3DSun%26aufirst%3DNannan%26date%3D2020%26volume%3D202%26spage%3D112536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">F.  Lestienne</span>, <span class="hlFld-ContribAuthor ">A.  Cousy</span>, <span class="hlFld-ContribAuthor ">V.  Mengeaud</span>, <span class="hlFld-ContribAuthor ">N.  Castex‐Rizzi</span>. </span><span class="cited-content_cbyCitation_article-title">Effective inhibition of Th17/Th22 pathway in 2D and 3D human models of psoriasis by Celastrol enriched plant cell culture extract. </span><span class="cited-content_cbyCitation_journal-name">Journal of the European Academy of Dermatology and Venereology</span><span> <strong>2020,</strong> <em>34 </em>
                                    (S6)
                                     , 3-9. <a href="https://doi.org/10.1111/jdv.16475" title="DOI URL">https://doi.org/10.1111/jdv.16475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jdv.16475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjdv.16475%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520European%2520Academy%2520of%2520Dermatology%2520and%2520Venereology%26atitle%3DEffective%252Binhibition%252Bof%252BTh17%25252FTh22%252Bpathway%252Bin%252B2D%252Band%252B3D%252Bhuman%252Bmodels%252Bof%252Bpsoriasis%252Bby%252BCelastrol%252Benriched%252Bplant%252Bcell%252Bculture%252Bextract%26aulast%3DNguyen%26aufirst%3DT.%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3DS6%26spage%3D3%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mian  Huang</span>, <span class="hlFld-ContribAuthor ">Shelby  Bolin</span>, <span class="hlFld-ContribAuthor ">Hannah  Miller</span>, <span class="hlFld-ContribAuthor ">Ho Leung  Ng</span>. </span><span class="cited-content_cbyCitation_article-title">RORγ Structural Plasticity and Druggability. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5329. <a href="https://doi.org/10.3390/ijms21155329" title="DOI URL">https://doi.org/10.3390/ijms21155329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155329%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DROR%2525CE%2525B3%252BStructural%252BPlasticity%252Band%252BDruggability%26aulast%3DHuang%26aufirst%3DMian%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iris A.  Leijten-van de Gevel</span>, <span class="hlFld-ContribAuthor ">Luc  Brunsveld</span>. </span><span class="cited-content_cbyCitation_article-title">Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2020,</strong> <em>295 </em>
                                    (27)
                                     , 9183-9191. <a href="https://doi.org/10.1074/jbc.RA120.013581" title="DOI URL">https://doi.org/10.1074/jbc.RA120.013581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA120.013581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA120.013581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDelineation%252Bof%252Bthe%252Bmolecular%252Bdeterminants%252Bof%252Bthe%252Bunique%252Ballosteric%252Bbinding%252Bsite%252Bof%252Bthe%252Borphan%252Bnuclear%252Breceptor%252BROR%2525CE%2525B3t%26aulast%3DLeijten-van%2Bde%2BGevel%26aufirst%3DIris%2BA.%26date%3D2020%26volume%3D295%26issue%3D27%26spage%3D9183%26epage%3D9191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christoph  Steeneck</span>, <span class="hlFld-ContribAuthor ">Christian  Gege</span>, <span class="hlFld-ContribAuthor ">Olaf  Kinzel</span>, <span class="hlFld-ContribAuthor ">Michael  Albers</span>, <span class="hlFld-ContribAuthor ">Gerald  Kleymann</span>, <span class="hlFld-ContribAuthor ">Thomas  Schlüter</span>, <span class="hlFld-ContribAuthor ">Andreas  Schulz</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Xue</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">Anne M.  Fourie</span>, <span class="hlFld-ContribAuthor ">Kristi A.  Leonard</span>, <span class="hlFld-ContribAuthor ">Brian  Scott</span>, <span class="hlFld-ContribAuthor ">James P.  Edwards</span>, <span class="hlFld-ContribAuthor ">Thomas  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Steven D.  Goldberg</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (12)
                                     , 127174. <a href="https://doi.org/10.1016/j.bmcl.2020.127174" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127174%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bnew%252Boxadiazole%252Bsubstituted%252Bthiazole%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%252Bthrough%252Ba%252Bbioisosteric%252Bamide%252Breplacement%252Bapproach%26aulast%3DSteeneck%26aufirst%3DChristoph%26date%3D2020%26volume%3D30%26issue%3D12%26spage%3D127174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Gege</span>, <span class="hlFld-ContribAuthor ">Michael  Albers</span>, <span class="hlFld-ContribAuthor ">Olaf  Kinzel</span>, <span class="hlFld-ContribAuthor ">Gerald  Kleymann</span>, <span class="hlFld-ContribAuthor ">Thomas  Schlüter</span>, <span class="hlFld-ContribAuthor ">Christoph  Steeneck</span>, <span class="hlFld-ContribAuthor ">Thomas  Hoffmann</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Xue</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">John  Spurlino</span>, <span class="hlFld-ContribAuthor ">Cynthia  Milligan</span>, <span class="hlFld-ContribAuthor ">Anne M.  Fourie</span>, <span class="hlFld-ContribAuthor ">James P.  Edwards</span>, <span class="hlFld-ContribAuthor ">Kristi  Leonard</span>, <span class="hlFld-ContribAuthor ">Kevin  Coe</span>, <span class="hlFld-ContribAuthor ">Brian  Scott</span>, <span class="hlFld-ContribAuthor ">Dan  Pippel</span>, <span class="hlFld-ContribAuthor ">Steven D.  Goldberg</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (12)
                                     , 127205. <a href="https://doi.org/10.1016/j.bmcl.2020.127205" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127205%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Band%252Bbiological%252Bevaluation%252Bof%252Bthiazole-bis-amide%252Binverse%252Bagonists%252Bof%252BROR%2525CE%2525B3t%26aulast%3DGege%26aufirst%3DChristian%26date%3D2020%26volume%3D30%26issue%3D12%26spage%3D127205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leo R.  Fitzpatrick</span>, <span class="hlFld-ContribAuthor ">Jeff  Small</span>, <span class="hlFld-ContribAuthor ">Robert  O’Connell</span>, <span class="hlFld-ContribAuthor ">George  Talbott</span>, <span class="hlFld-ContribAuthor ">Gordon  Alton</span>, <span class="hlFld-ContribAuthor ">Jim  Zapf</span>. </span><span class="cited-content_cbyCitation_article-title">VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease. </span><span class="cited-content_cbyCitation_journal-name">Inflammopharmacology</span><span> <strong>2020,</strong> <em>28 </em>
                                    (2)
                                     , 499-511. <a href="https://doi.org/10.1007/s10787-019-00643-z" title="DOI URL">https://doi.org/10.1007/s10787-019-00643-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10787-019-00643-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10787-019-00643-z%26sid%3Dliteratum%253Aachs%26jtitle%3DInflammopharmacology%26atitle%3DVPR-254%25253A%252Ban%252Binhibitor%252Bof%252BROR-gamma%252BT%252Bwith%252Bpotential%252Butility%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bbowel%252Bdisease%26aulast%3DFitzpatrick%26aufirst%3DLeo%2BR.%26date%3D2020%26date%3D2019%26volume%3D28%26issue%3D2%26spage%3D499%26epage%3D511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Jiang</span>, <span class="hlFld-ContribAuthor ">Irina  Dulubova</span>, <span class="hlFld-ContribAuthor ">Scott A.  Reisman</span>, <span class="hlFld-ContribAuthor ">Martha  Hotema</span>, <span class="hlFld-ContribAuthor ">Chun-Yue I.  Lee</span>, <span class="hlFld-ContribAuthor ">Liping  Liu</span>, <span class="hlFld-ContribAuthor ">Lyndsey  McCauley</span>, <span class="hlFld-ContribAuthor ">Isaac  Trevino</span>, <span class="hlFld-ContribAuthor ">Deborah A.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Yigitcan  Eken</span>, <span class="hlFld-ContribAuthor ">Angela K.  Wilson</span>, <span class="hlFld-ContribAuthor ">W. Christian  Wigley</span>, <span class="hlFld-ContribAuthor ">Melean  Visnick</span>. </span><span class="cited-content_cbyCitation_article-title">A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (6)
                                     , 126967. <a href="https://doi.org/10.1016/j.bmcl.2020.126967" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126967</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126967%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bnovel%252Bseries%252Bof%252Bcysteine-dependent%25252C%252Ballosteric%252Binverse%252Bagonists%252Bof%252Bthe%252Bnuclear%252Breceptor%252BROR%2525CE%2525B3t%26aulast%3DJiang%26aufirst%3DXin%26date%3D2020%26volume%3D30%26issue%3D6%26spage%3D126967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Ma</span>, <span class="hlFld-ContribAuthor ">Kaifeng  Zhou</span>, <span class="hlFld-ContribAuthor ">Chen  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhonglian  Cao</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111984. <a href="https://doi.org/10.1016/j.ejmech.2019.111984" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111984%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BN-sulfonamide-tetrahydroquinolines%252Bas%252Bpotent%252Bretinoic%252Bacid%252Breceptor-related%252Borphan%252Breceptor%252B%2525CE%2525B3t%252Binverse%252Bagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bautoimmune%252Bdiseases%26aulast%3DSun%26aufirst%3DNannan%26date%3D2020%26volume%3D187%26spage%3D111984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongqiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zenghong  Huang</span>, <span class="hlFld-ContribAuthor ">Christopher Z.  Chen</span>, <span class="hlFld-ContribAuthor ">Chengfei  Liu</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Evans</span>, <span class="hlFld-ContribAuthor ">Allen C.  Gao</span>, <span class="hlFld-ContribAuthor ">Fangjian  Zhou</span>, <span class="hlFld-ContribAuthor ">Hong-Wu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane via Coordinated Induction of Cell Death Programs. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2020,</strong> <em>19 </em>
                                    (2)
                                     , 364-374. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0327" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0327%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTherapeutic%252BTargeting%252Bof%252BMDR1%252BExpression%252Bby%252BROR%2525CE%2525B3%252BAntagonists%252BResensitizes%252BCross-Resistant%252BCRPC%252Bto%252BTaxane%252Bvia%252BCoordinated%252BInduction%252Bof%252BCell%252BDeath%252BPrograms%26aulast%3DWang%26aufirst%3DYongqiang%26date%3D2020%26date%3D2019%26volume%3D19%26issue%3D2%26spage%3D364%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shusuke  Suzuki</span>, <span class="hlFld-ContribAuthor ">Toshiya  Nakamura</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Saito</span>, <span class="hlFld-ContribAuthor ">Yuta  Terauchi</span>, <span class="hlFld-ContribAuthor ">Kentaro  Kawai</span>, <span class="hlFld-ContribAuthor ">Midori  Takimoto-Kamimura</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Kurita</span>. </span><span class="cited-content_cbyCitation_article-title">Structural change of retinoic-acid receptor-related orphan receptor induced by binding of inverse-agonist: Molecular dynamics and ab initio molecular orbital simulations. </span><span class="cited-content_cbyCitation_journal-name">Computational and Structural Biotechnology Journal</span><span> <strong>2020,</strong> <em>18 </em>, 1676-1685. <a href="https://doi.org/10.1016/j.csbj.2020.06.034" title="DOI URL">https://doi.org/10.1016/j.csbj.2020.06.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.csbj.2020.06.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.csbj.2020.06.034%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Structural%2520Biotechnology%2520Journal%26atitle%3DStructural%252Bchange%252Bof%252Bretinoic-acid%252Breceptor-related%252Borphan%252Breceptor%252Binduced%252Bby%252Bbinding%252Bof%252Binverse-agonist%25253A%252BMolecular%252Bdynamics%252Band%252Bab%252Binitio%252Bmolecular%252Borbital%252Bsimulations%26aulast%3DSuzuki%26aufirst%3DShusuke%26date%3D2020%26volume%3D18%26spage%3D1676%26epage%3D1685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayumu  Sato</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Fukase</span>, <span class="hlFld-ContribAuthor ">Mitsunori  Kono</span>, <span class="hlFld-ContribAuthor ">Atsuko  Ochida</span>, <span class="hlFld-ContribAuthor ">Tsuneo  Oda</span>, <span class="hlFld-ContribAuthor ">Yusuke  Sasaki</span>, <span class="hlFld-ContribAuthor ">Naoki  Ishii</span>, <span class="hlFld-ContribAuthor ">Yoshihide  Tomata</span>, <span class="hlFld-ContribAuthor ">Shoji  Fukumoto</span>, <span class="hlFld-ContribAuthor ">Yumi N.  Imai</span>, <span class="hlFld-ContribAuthor ">Keiko  Uga</span>, <span class="hlFld-ContribAuthor ">Akira  Shibata</span>, <span class="hlFld-ContribAuthor ">Masashi  Yamasaki</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Mikio  Shirasaki</span>, <span class="hlFld-ContribAuthor ">Robert  Skene</span>, <span class="hlFld-ContribAuthor ">Isaac  Hoffman</span>, <span class="hlFld-ContribAuthor ">Bi‐Ching  Sang</span>, <span class="hlFld-ContribAuthor ">Gyorgy  Snell</span>, <span class="hlFld-ContribAuthor ">Junya  Shirai</span>, <span class="hlFld-ContribAuthor ">Satoshi  Yamamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Conformationally Constrained RORγt Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (22)
                                     , 1917-1932. <a href="https://doi.org/10.1002/cmdc.201900416" title="DOI URL">https://doi.org/10.1002/cmdc.201900416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900416%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BConformationally%252BConstrained%252BROR%2525CE%2525B3t%252BInverse%252BAgonists%26aulast%3DSato%26aufirst%3DAyumu%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D22%26spage%3D1917%26epage%3D1932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of aryl-substituted indole and indoline derivatives as RORγt agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111589. <a href="https://doi.org/10.1016/j.ejmech.2019.111589" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111589%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Baryl-substituted%252Bindole%252Band%252Bindoline%252Bderivatives%252Bas%252BROR%2525CE%2525B3t%252Bagonists%26aulast%3DZhu%26aufirst%3DYan%26date%3D2019%26volume%3D182%26spage%3D111589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (9)
                                     , 663-674. <a href="https://doi.org/10.1080/13543776.2019.1655541" title="DOI URL">https://doi.org/10.1080/13543776.2019.1655541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1655541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1655541%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DRetinoic%252Bacid%252Breceptor-related%252Borphan%252Breceptor%252Bgamma-t%252B%252528ROR%2525CE%2525B3t%252529%252Binhibitors%252Bin%252Bclinical%252Bdevelopment%252Bfor%252Bthe%252Btreatment%252Bof%252Bautoimmune%252Bdiseases%25253A%252Ba%252Bpatent%252Breview%252B%2525282016-present%252529%26aulast%3DSun%26aufirst%3DNannan%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D9%26spage%3D663%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuyu  Lao</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Huanpeng  Chen</span>, <span class="hlFld-ContribAuthor ">Fengjiao  Wei</span>, <span class="hlFld-ContribAuthor ">Zhaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Chuan  Bai</span>. </span><span class="cited-content_cbyCitation_article-title">5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>90 </em>, 103077. <a href="https://doi.org/10.1016/j.bioorg.2019.103077" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103077%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3D5%25252C6%25252C7%25252C8-Tetrahydrobenzo%25255B4%25252C5%25255Dthieno%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Binhibitors%252Bof%252Bfull-length%252BROR%2525CE%2525B3t%26aulast%3DLao%26aufirst%3DChuyu%26date%3D2019%26volume%3D90%26spage%3D103077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhonghui  Lu</span>, <span class="hlFld-ContribAuthor ">James J.-W.  Duan</span>, <span class="hlFld-ContribAuthor ">Haiyun  Xiao</span>, <span class="hlFld-ContribAuthor ">James  Neels</span>, <span class="hlFld-ContribAuthor ">Dauh-Rurng  Wu</span>, <span class="hlFld-ContribAuthor ">Carolyn A.  Weigelt</span>, <span class="hlFld-ContribAuthor ">John S.  Sack</span>, <span class="hlFld-ContribAuthor ">Javed  Khan</span>, <span class="hlFld-ContribAuthor ">Max  Ruzanov</span>, <span class="hlFld-ContribAuthor ">Yongmi  An</span>, <span class="hlFld-ContribAuthor ">Melissa  Yarde</span>, <span class="hlFld-ContribAuthor ">Ananta  Karmakar</span>, <span class="hlFld-ContribAuthor ">Sureshbabu  Vishwakrishnan</span>, <span class="hlFld-ContribAuthor ">Venkata  Baratam</span>, <span class="hlFld-ContribAuthor ">Harisha  Shankarappa</span>, <span class="hlFld-ContribAuthor ">Sridhar  Vanteru</span>, <span class="hlFld-ContribAuthor ">Venkatesh  Babu</span>, <span class="hlFld-ContribAuthor ">Mushkin  Basha</span>, <span class="hlFld-ContribAuthor ">Arun  Kumar Gupta</span>, <span class="hlFld-ContribAuthor ">Selvakumar  Kumaravel</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Qihong  Zhao</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Salter-Cid</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">T.G.  Murali Dhar</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2265-2269. <a href="https://doi.org/10.1016/j.bmcl.2019.06.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bpotent%25252C%252Bselective%252Band%252Borally%252Bbioavailable%252Bphenyl%252B%252528%252528R%252529-3-phenylpyrrolidin-3-yl%252529sulfone%252Banalogues%252Bas%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%26aulast%3DLu%26aufirst%3DZhonghui%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2265%26epage%3D2269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadim S.  Shaikh</span>, <span class="hlFld-ContribAuthor ">Jitesh P.  Iyer</span>, <span class="hlFld-ContribAuthor ">Yogesh S.  Munot</span>, <span class="hlFld-ContribAuthor ">Partha P.  Mukhopadhyay</span>, <span class="hlFld-ContribAuthor ">Amol A.  Raje</span>, <span class="hlFld-ContribAuthor ">Ranganayaki  Nagaraj</span>, <span class="hlFld-ContribAuthor ">Vijay  Jamdar</span>, <span class="hlFld-ContribAuthor ">Ravindra  Gavhane</span>, <span class="hlFld-ContribAuthor ">Mahendra  Lohote</span>, <span class="hlFld-ContribAuthor ">Prasad  Sherkar</span>, <span class="hlFld-ContribAuthor ">Madhu  Bala</span>, <span class="hlFld-ContribAuthor ">Rajkanth  Petla</span>, <span class="hlFld-ContribAuthor ">Ashwinkumar  Meru</span>, <span class="hlFld-ContribAuthor ">Dhananjay  Umrani</span>, <span class="hlFld-ContribAuthor ">Sreekanth  Rouduri</span>, <span class="hlFld-ContribAuthor ">Sachin  Joshi</span>, <span class="hlFld-ContribAuthor ">Satyanarayan  Reddy</span>, <span class="hlFld-ContribAuthor ">Vishwottam  Kandikere</span>, <span class="hlFld-ContribAuthor ">Debnath  Bhuniya</span>, <span class="hlFld-ContribAuthor ">Bheemashankar  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Kasim A.  Mookhtiar</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and pharmacological evaluation of indole derivatives as potent and selective RORγt inverse agonist for multiple autoimmune conditions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2208-2217. <a href="https://doi.org/10.1016/j.bmcl.2019.06.044" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.06.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.06.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.06.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bindole%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BROR%2525CE%2525B3t%252Binverse%252Bagonist%252Bfor%252Bmultiple%252Bautoimmune%252Bconditions%26aulast%3DShaikh%26aufirst%3DNadim%2BS.%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2208%26epage%3D2217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jérôme  Amaudrut</span>, <span class="hlFld-ContribAuthor ">Maria A.  Argiriadi</span>, <span class="hlFld-ContribAuthor ">Martine  Barth</span>, <span class="hlFld-ContribAuthor ">Eric C.  Breinlinger</span>, <span class="hlFld-ContribAuthor ">Didier  Bressac</span>, <span class="hlFld-ContribAuthor ">Pierre  Broqua</span>, <span class="hlFld-ContribAuthor ">David J.  Calderwood</span>, <span class="hlFld-ContribAuthor ">Mohamed  Chatar</span>, <span class="hlFld-ContribAuthor ">Kevin P.  Cusack</span>, <span class="hlFld-ContribAuthor ">Stephen B.  Gauld</span>, <span class="hlFld-ContribAuthor ">Sébastien  Jacquet</span>, <span class="hlFld-ContribAuthor ">Rajesh V.  Kamath</span>, <span class="hlFld-ContribAuthor ">Michael E.  Kort</span>, <span class="hlFld-ContribAuthor ">Valérie  Lepais</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Luccarini</span>, <span class="hlFld-ContribAuthor ">Philippe  Masson</span>, <span class="hlFld-ContribAuthor ">Christian  Montalbetti</span>, <span class="hlFld-ContribAuthor ">Laurent  Mounier</span>, <span class="hlFld-ContribAuthor ">Dominique  Potin</span>, <span class="hlFld-ContribAuthor ">Olivia  Poupardin</span>, <span class="hlFld-ContribAuthor ">Sylvie  Rouaud</span>, <span class="hlFld-ContribAuthor ">Luc  Spitzer</span>, <span class="hlFld-ContribAuthor ">Craig D.  Wallace</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (14)
                                     , 1799-1806. <a href="https://doi.org/10.1016/j.bmcl.2019.05.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.05.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.05.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bquinoline%252Bsulphonamide%252Bderivatives%252Bas%252Bpotent%25252C%252Bselective%252Band%252Borally%252Bactive%252BROR%2525CE%2525B3%252Binverse%252Bagonists%26aulast%3DAmaudrut%26aufirst%3DJ%25C3%25A9r%25C3%25B4me%26date%3D2019%26volume%3D29%26issue%3D14%26spage%3D1799%26epage%3D1806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virginia M.  Tanis</span>, <span class="hlFld-ContribAuthor ">Hariharan  Venkatesan</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>, <span class="hlFld-ContribAuthor ">Michael  Albers</span>, <span class="hlFld-ContribAuthor ">J.  Kent Barbay</span>, <span class="hlFld-ContribAuthor ">Krystal  Herman</span>, <span class="hlFld-ContribAuthor ">David A.  Kummer</span>, <span class="hlFld-ContribAuthor ">Cynthia  Milligan</span>, <span class="hlFld-ContribAuthor ">Marina I.  Nelen</span>, <span class="hlFld-ContribAuthor ">Rachel  Nishimura</span>, <span class="hlFld-ContribAuthor ">Thomas  Schlueter</span>, <span class="hlFld-ContribAuthor ">Brian  Scott</span>, <span class="hlFld-ContribAuthor ">John  Spurlino</span>, <span class="hlFld-ContribAuthor ">Ronald  Wolin</span>, <span class="hlFld-ContribAuthor ">Craig  Woods</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Xue</span>, <span class="hlFld-ContribAuthor ">James P.  Edwards</span>, <span class="hlFld-ContribAuthor ">Anne M.  Fourie</span>, <span class="hlFld-ContribAuthor ">Kristi  Leonard</span>. </span><span class="cited-content_cbyCitation_article-title">3-Substituted Quinolines as RORγt Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1463-1470. <a href="https://doi.org/10.1016/j.bmcl.2019.04.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3-Substituted%252BQuinolines%252Bas%252BROR%2525CE%2525B3t%252BInverse%252BAgonists%26aulast%3DTanis%26aufirst%3DVirginia%2BM.%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1463%26epage%3D1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabetta  Bianchi</span>, <span class="hlFld-ContribAuthor ">Lars  Rogge</span>. </span><span class="cited-content_cbyCitation_article-title">The IL-23/IL-17 pathway in human chronic inflammatory diseases – new insight from genetics and targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Microbes and Infection</span><span> <strong>2019,</strong> <em>21 </em>
                                    (5-6)
                                     , 246-253. <a href="https://doi.org/10.1016/j.micinf.2019.06.009" title="DOI URL">https://doi.org/10.1016/j.micinf.2019.06.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.micinf.2019.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.micinf.2019.06.009%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobes%2520and%2520Infection%26atitle%3DThe%252BIL-23%25252FIL-17%252Bpathway%252Bin%252Bhuman%252Bchronic%252Binflammatory%252Bdiseases%252B%2525E2%252580%252593%252Bnew%252Binsight%252Bfrom%252Bgenetics%252Band%252Btargeted%252Btherapies%26aulast%3DBianchi%26aufirst%3DElisabetta%26date%3D2019%26volume%3D21%26issue%3D5-6%26spage%3D246%26epage%3D253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabetta  Bianchi</span>, <span class="hlFld-ContribAuthor ">Lars  Rogge</span>. </span><span class="cited-content_cbyCitation_article-title">The IL-23/IL-17 pathway in human chronic inflammatory diseases—new insight from genetics and targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Genes & Immunity</span><span> <strong>2019,</strong> <em>20 </em>
                                    (5)
                                     , 415-425. <a href="https://doi.org/10.1038/s41435-019-0067-y" title="DOI URL">https://doi.org/10.1038/s41435-019-0067-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41435-019-0067-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41435-019-0067-y%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%2520%2526%2520Immunity%26atitle%3DThe%252BIL-23%25252FIL-17%252Bpathway%252Bin%252Bhuman%252Bchronic%252Binflammatory%252Bdiseases%2525E2%252580%252594new%252Binsight%252Bfrom%252Bgenetics%252Band%252Btargeted%252Btherapies%26aulast%3DBianchi%26aufirst%3DElisabetta%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D5%26spage%3D415%26epage%3D425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinlong  Tian</span>, <span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Yu</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Gu</span>, <span class="hlFld-ContribAuthor ">Qiong  Xie</span>, <span class="hlFld-ContribAuthor ">Liming  Shao</span>, <span class="hlFld-ContribAuthor ">Jin  Liu</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-indanyl benzamides as potent RORγt inverse agonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 37-48. <a href="https://doi.org/10.1016/j.ejmech.2019.01.082" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.082%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-indanyl%252Bbenzamides%252Bas%252Bpotent%252BROR%2525CE%2525B3t%252Binverse%252Bagonists%26aulast%3DTian%26aufirst%3DJinlong%26date%3D2019%26volume%3D167%26spage%3D37%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florence  Ecoeur</span>, <span class="hlFld-ContribAuthor ">Jessica  Weiss</span>, <span class="hlFld-ContribAuthor ">Klemens  Kaupmann</span>, <span class="hlFld-ContribAuthor ">Samuel  Hintermann</span>, <span class="hlFld-ContribAuthor ">David  Orain</span>, <span class="hlFld-ContribAuthor ">Christine  Guntermann</span>. </span><span class="cited-content_cbyCitation_article-title">Antagonizing Retinoic Acid-Related-Orphan Receptor Gamma Activity Blocks the T Helper 17/Interleukin-17 Pathway Leading to Attenuated Pro-inflammatory Human Keratinocyte and Skin Responses. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fimmu.2019.00577" title="DOI URL">https://doi.org/10.3389/fimmu.2019.00577</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2019.00577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2019.00577%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DAntagonizing%252BRetinoic%252BAcid-Related-Orphan%252BReceptor%252BGamma%252BActivity%252BBlocks%252Bthe%252BT%252BHelper%252B17%25252FInterleukin-17%252BPathway%252BLeading%252Bto%252BAttenuated%252BPro-inflammatory%252BHuman%252BKeratinocyte%252Band%252BSkin%252BResponses%26aulast%3DEcoeur%26aufirst%3DFlorence%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nannan  Sun</span>, <span class="hlFld-ContribAuthor ">Congmin  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Ma</span>, <span class="hlFld-ContribAuthor ">Yonghui  Wang</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Gu</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3181. <a href="https://doi.org/10.3390/molecules23123181" title="DOI URL">https://doi.org/10.3390/molecules23123181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123181%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BMechanism%252Bof%252BAction%252Bof%252BROR%2525CE%2525B3t%252BAgonists%252Band%252BInverse%252BAgonists%25253A%252BInsights%252Bfrom%252BMolecular%252BDynamics%252BSimulation%26aulast%3DSun%26aufirst%3DNannan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Therapeutic targeting of the IL-23-Th17 axis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Early inhibitors of RORc.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Sulfonamides of cyclic amines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Acyclic sulfonamides and sultam derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of agonist ligand <b>12</b> (orange ribbon, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF">4WPF</a>) and inverse agonist ligand <b>10</b> (yellow ribbon, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP">4WQP</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Aryl sulfonyl compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Amide/Bis-amide derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Allosteric inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cocrystal structure of allosteric ligand <b>39</b> (MRL-871) and orthosteric ligand <b>1</b> (T0901317) with RORγt-LBD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Miscellaneous inhibitors (part 1).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/medium/jm-2018-00588n_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Miscellaneous inhibitors (part 2).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-24/acs.jmedchem.8b00588/20181226/images/large/jm-2018-00588n_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00588&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i19">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 120 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balagué, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunkel, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godessart, N.</span></span> <span> </span><span class="NLM_article-title">Understanding autoimmune disease: new targets for drug discovery</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">934</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2009.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.drudis.2009.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=19596080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFygs7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=926-934&author=C.+Balagu%C3%A9author=S.+L.+Kunkelauthor=N.+Godessart&title=Understanding+autoimmune+disease%3A+new+targets+for+drug+discovery&doi=10.1016%2Fj.drudis.2009.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding autoimmune disease: new targets for drug discovery</span></div><div class="casAuthors">Balague, Cristina; Kunkel, Steven L.; Godessart, Nuria</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">19/20</span>),
    <span class="NLM_cas:pages">926-934</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A more complete understanding of the mechanisms that drive autoimmune diseases has begun to be translated into therapeutic options with significant clin. consequences.  A clear example of this is the introduction of biol. therapies, which have provided new therapeutic avenues, as well as validated the mediators (TNFα, IL-6), mechanisms (T cell costimulation, leukocyte migration), and cellular players (T and B lymphocytes) of the disease process itself.  New discoveries into the role of Th17 and regulatory T cells and the epigenetic regulation of cytokine expression may offer novel intervention strategies to satisfy the unmet medical needs that still exist in these diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrE52gnwKpXrVg90H21EOLACvtfcHk0lgeXKMzjR4QzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFygs7fJ&md5=9716694fad8a281ab56c36cb48c47411</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2009.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2009.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DBalagu%25C3%25A9%26aufirst%3DC.%26aulast%3DKunkel%26aufirst%3DS.%2BL.%26aulast%3DGodessart%26aufirst%3DN.%26atitle%3DUnderstanding%2520autoimmune%2520disease%253A%2520new%2520targets%2520for%2520drug%2520discovery%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D926%26epage%3D934%26doi%3D10.1016%2Fj.drudis.2009.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansouri, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menter, A.</span></span> <span> </span><span class="NLM_article-title">A review of biologic therapies targeting IL-23 and IL-17 for use in moderate-to-severe plaque psoriasis</span>. <i>Dermatol Ther (Heidelb)</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1007/s13555-015-0092-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1007%2Fs13555-015-0092-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26714681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A280%3ADC%252BC28rlslejtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1-12&author=M.+Campaauthor=B.+Mansouriauthor=R.+Warrenauthor=A.+Menter&title=A+review+of+biologic+therapies+targeting+IL-23+and+IL-17+for+use+in+moderate-to-severe+plaque+psoriasis&doi=10.1007%2Fs13555-015-0092-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis</span></div><div class="casAuthors">Campa Molly; Menter Alan; Mansouri Bobbak; Warren Richard</div><div class="citationInfo"><span class="NLM_cas:title">Dermatology and therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn">2193-8210</span>.
    </div><div class="casAbstract">The development of several highly effective biologic drugs in the past decade has revolutionized the treatment of moderate-to-severe plaque psoriasis.  With increased understanding of the immunopathogenesis of psoriasis, the emphasis has turned toward more specific targets for psoriasis drugs.  Although the complex immunological pathway of psoriasis is not yet completely understood, current models emphasize the significant importance of interleukin (IL)-23 and IL-17.  Several biologic drugs targeting these cytokines are now in various stages of drug development.  Drugs targeting IL-23 include BI-655066, briakinumab, guselkumab, tildrakizumab, and ustekinumab.  Drugs targeting IL-17 include brodalumab, ixekizumab, and secukinumab.  While many of these have shown safety and good efficacy in clinical trials of moderate-to-severe plaque psoriasis, long-term safety is still to be established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQE6JaFL9P83pNiNltV31zlfW6udTcc2eaWccDfCsTiaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rlslejtA%253D%253D&md5=3937d9a24e1587e1d04d24f3dad6f48a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs13555-015-0092-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13555-015-0092-3%26sid%3Dliteratum%253Aachs%26aulast%3DCampa%26aufirst%3DM.%26aulast%3DMansouri%26aufirst%3DB.%26aulast%3DWarren%26aufirst%3DR.%26aulast%3DMenter%26aufirst%3DA.%26atitle%3DA%2520review%2520of%2520biologic%2520therapies%2520targeting%2520IL-23%2520and%2520IL-17%2520for%2520use%2520in%2520moderate-to-severe%2520plaque%2520psoriasis%26jtitle%3DDermatol%2520Ther%2520%2528Heidelb%2529%26date%3D2016%26volume%3D6%26spage%3D1%26epage%3D12%26doi%3D10.1007%2Fs13555-015-0092-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scala, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caiazzo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Caprio, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monfrecola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raimondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lembo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayala, F.</span></span> <span> </span><span class="NLM_article-title">Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders</span>. <i>Expert Opin. Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1363</span>– <span class="NLM_lpage">1374</span>, <span class="refDoi"> DOI: 10.1080/14712598.2017.1363884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1080%2F14712598.2017.1363884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28791896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSrt73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=1363-1374&author=A.+Balatoauthor=E.+Scalaauthor=N.+Balatoauthor=G.+Caiazzoauthor=R.+D.+Di+Caprioauthor=G.+Monfrecolaauthor=A.+Raimondoauthor=S.+Lemboauthor=F.+Ayala&title=Biologics+that+inhibit+the+Th17+pathway+and+related+cytokines+to+treat+inflammatory+disorders&doi=10.1080%2F14712598.2017.1363884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders</span></div><div class="casAuthors">Balato, Anna; Scala, Emanuele; Balato, Nicola; Caiazzo, Giuseppina; Di Caprio, Roberta; Monfrecola, Giuseppe; Raimondo, Annunziata; Lembo, Serena; Ayala, Fabio</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Biological Therapy</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1363-1374</span>CODEN:
                <span class="NLM_cas:coden">EOBTA2</span>;
        ISSN:<span class="NLM_cas:issn">1471-2598</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Advances in the understanding of TNF-α and IL-17 synergistic functions have recently led to the concept that patients who do not respond or who respond inadequately to TNF-α inhibitors may have IL-17-driven diseases, opening up the way for a new class of therapeutic development: Th17-inhibitors.  In this review, the authors discuss the central role that the IL-23/Th17 axis plays in the pathogenesis of several inflammatory diseases, such as psoriasis, highlighting its position as a relevant therapeutic target.  In particular, the authors start by giving a brief historical excursus on biol. agent development up until the success of TNF-α inhibitors, and continue with an overview of IL12/23 pathway inhibition.  Next, they describe Th17 cell biol., focusing on the role of IL-17 in host defense and in human immune-inflammatory diseases, discussing the use and side effects of IL-17 inhibitors.  The IL-23/Th17 signaling pathway plays a central role in the pathogenesis of several inflammatory diseases, such as psoriasis.  Recent data has demonstrated that biologics neutralizing IL-17 (ixekizumab, secukinumab) or its receptor (brodalumab) are highly effective with a pos. safety profile in treating moderate to severe psoriasis, offering new treatment possibilities, esp. for patients who do not respond adequately to anti-TNF-α therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppe7x_eAazOLVg90H21EOLACvtfcHk0lgSJ_Rr9PXrvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSrt73E&md5=2f344e96219286494f71e4aece68c52a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F14712598.2017.1363884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14712598.2017.1363884%26sid%3Dliteratum%253Aachs%26aulast%3DBalato%26aufirst%3DA.%26aulast%3DScala%26aufirst%3DE.%26aulast%3DBalato%26aufirst%3DN.%26aulast%3DCaiazzo%26aufirst%3DG.%26aulast%3DDi%2BCaprio%26aufirst%3DR.%2BD.%26aulast%3DMonfrecola%26aufirst%3DG.%26aulast%3DRaimondo%26aufirst%3DA.%26aulast%3DLembo%26aufirst%3DS.%26aulast%3DAyala%26aufirst%3DF.%26atitle%3DBiologics%2520that%2520inhibit%2520the%2520Th17%2520pathway%2520and%2520related%2520cytokines%2520to%2520treat%2520inflammatory%2520disorders%26jtitle%3DExpert%2520Opin.%2520Biol.%2520Ther.%26date%3D2017%26volume%3D17%26spage%3D1363%26epage%3D1374%26doi%3D10.1080%2F14712598.2017.1363884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byrne, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottman, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budelsky, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symons, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towne, J. E.</span></span> <span> </span><span class="NLM_article-title">Differential roles for interleukin-23 and interleukin-17 in intestinal immunoregulation</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">739</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2015.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.immuni.2015.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26431947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFyqt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=739-750&author=J.+R.+Maxwellauthor=Y.+Zhangauthor=W.+A.+Brownauthor=C.+L.+Smithauthor=F.+R.+Byrneauthor=M.+Fiorinoauthor=E.+Stevensauthor=J.+Biglerauthor=J.+A.+Davisauthor=J.+B.+Rottmanauthor=A.+L.+Budelskyauthor=A.+Symonsauthor=J.+E.+Towne&title=Differential+roles+for+interleukin-23+and+interleukin-17+in+intestinal+immunoregulation&doi=10.1016%2Fj.immuni.2015.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation</span></div><div class="casAuthors">Maxwell, Joseph R.; Zhang, Yu; Brown, William A.; Smith, Carole L.; Byrne, Fergus R.; Fiorino, Mike; Stevens, Erin; Bigler, Jeannette; Davis, John A.; Rottman, James B.; Budelsky, Alison L.; Symons, Antony; Towne, Jennifer E.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">739-750</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Interleukin-23 (IL-23) and IL-17 are cytokines currently being targeted in clin. trials.  Although inhibition of both of these cytokines is effective for treating psoriasis, IL-12 and IL-23 p40 inhibition attenuates Crohn's disease, whereas IL-17A or IL-17 receptor A (IL-17RA) inhibition exacerbates Crohn's disease.  This dichotomy between IL-23 and IL-17 was effectively modeled in the multidrug resistance-1a-ablated (Abcb1a-/-) mouse model of colitis.  IL-23 inhibition attenuated disease by decreasing colonic inflammation while enhancing regulatory T (Treg) cell accumulation.  Exacerbation of colitis by IL-17A or IL-17RA inhibition was assocd. with severe weakening of the intestinal epithelial barrier, culminating in increased colonic inflammation and accelerated mortality.  These data show that IL-17A acts on intestinal epithelium to promote barrier function and provide insight into mechanisms underlying exacerbation of Crohn's disease when IL-17A or IL-17RA is inhibited.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3yYoQqeahMrVg90H21EOLACvtfcHk0lgSJ_Rr9PXrvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFyqt7vI&md5=8108b2db081ce238b76827b938bbffbe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2015.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2015.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DJ.%2BR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DW.%2BA.%26aulast%3DSmith%26aufirst%3DC.%2BL.%26aulast%3DByrne%26aufirst%3DF.%2BR.%26aulast%3DFiorino%26aufirst%3DM.%26aulast%3DStevens%26aufirst%3DE.%26aulast%3DBigler%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DJ.%2BA.%26aulast%3DRottman%26aufirst%3DJ.%2BB.%26aulast%3DBudelsky%26aufirst%3DA.%2BL.%26aulast%3DSymons%26aufirst%3DA.%26aulast%3DTowne%26aufirst%3DJ.%2BE.%26atitle%3DDifferential%2520roles%2520for%2520interleukin-23%2520and%2520interleukin-17%2520in%2520intestinal%2520immunoregulation%26jtitle%3DImmunity%26date%3D2015%26volume%3D43%26spage%3D739%26epage%3D750%26doi%3D10.1016%2Fj.immuni.2015.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ivanov, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKenzie, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepelley, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafaille, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17<sup>+</sup> T helper cells</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2006.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.cell.2006.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=16990136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=1121-1133&author=I.+I.+Ivanovauthor=B.+S.+McKenzieauthor=L.+Zhouauthor=C.+E.+Tadokoroauthor=A.+Lepelleyauthor=J.+J.+Lafailleauthor=D.+J.+Cuaauthor=D.+R.+Littman&title=The+orphan+nuclear+receptor+ROR%CE%B3t+directs+the+differentiation+program+of+proinflammatory+IL-17%2B+T+helper+cells&doi=10.1016%2Fj.cell.2006.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells</span></div><div class="casAuthors">Ivanov, Ivaylo I.; McKenzie, Brent S.; Zhou, Liang; Tadokoro, Carlos E.; Lepelley, Alice; Lafaille, Juan J.; Cua, Daniel J.; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1121-1133</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">IL-17-producing T lymphocytes have been recently shown to comprise a distinct lineage of proinflammatory T helper cells, termed Th17 cells, that are major contributors to autoimmune disease.  The authors show here that the orphan nuclear receptor RORγt is the key transcription factor that orchestrates the differentiation of this effector cell lineage.  RORγt induces transcription of the genes encoding IL-17 and the related cytokine IL-17F in naive CD4+ T helper cells and is required for their expression in response to IL-6 and TGF-β, the cytokines known to induce IL-17.  Th17 cells are constitutively present throughout the intestinal lamina propria, express RORγt, and are absent in mice deficient for RORγt or IL-6.  Mice with RORγt-deficient T cells have attenuated autoimmune disease and lack tissue-infiltrating Th17 cells.  Together, these studies suggest that RORγt is a key regulator of immune homeostasis and highlight its potential as a therapeutic target in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsJd6RyFqWrVg90H21EOLACvtfcHk0lgSJ_Rr9PXrvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCnsrrE&md5=4f5693603c30dca4f6a2d0994aeaf9b0</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DI.%2BI.%26aulast%3DMcKenzie%26aufirst%3DB.%2BS.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DTadokoro%26aufirst%3DC.%2BE.%26aulast%3DLepelley%26aufirst%3DA.%26aulast%3DLafaille%26aufirst%3DJ.%2BJ.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DThe%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3t%2520directs%2520the%2520differentiation%2520program%2520of%2520proinflammatory%2520IL-17%252B%2520T%2520helper%2520cells%26jtitle%3DCell%26date%3D2006%26volume%3D126%26spage%3D1121%26epage%3D1133%26doi%3D10.1016%2Fj.cell.2006.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yosef, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahl, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Small molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.immuni.2014.04.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=477-489&author=S.+Xiaoauthor=N.+Yosefauthor=J.+Yangauthor=Y.+Wangauthor=L.+Zhouauthor=C.+Zhuauthor=C.+Wuauthor=E.+Balogluauthor=D.+Schmidtauthor=R.+Rameshauthor=M.+Loberaauthor=M.+S.+Sundrudauthor=P.+Y.+Tsaiauthor=Z.+Xiangauthor=J.+Wangauthor=Y.+Xuauthor=X.+Linauthor=K.+Kretschmerauthor=P.+B.+Rahlauthor=R.+A.+Youngauthor=Z.+Zhongauthor=D.+A.+Haflerauthor=A.+Regevauthor=S.+Ghoshauthor=A.+Marsonauthor=V.+K.+Kuchroo&title=Small+molecule+ROR%CE%B3t+antagonists+inhibit+T+helper+17+cell+transcriptional+network+by+divergent+mechanisms&doi=10.1016%2Fj.immuni.2014.04.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DYosef%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DTsai%26aufirst%3DP.%2BY.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKretschmer%26aufirst%3DK.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DMarson%26aufirst%3DA.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DSmall%2520molecule%2520ROR%25CE%25B3t%2520antagonists%2520inhibit%2520T%2520helper%252017%2520cell%2520transcriptional%2520network%2520by%2520divergent%2520mechanisms%26jtitle%3DImmunity%26date%3D2014%26volume%3D40%26spage%3D477%26epage%3D489%26doi%3D10.1016%2Fj.immuni.2014.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna-Roman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blevitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W. P.</span></span> <span> </span><span class="NLM_article-title">RORγt and RORα signature genes in human Th17 cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0181868</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0181868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1371%2Fjournal.pone.0181868" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0181868&author=G.+Castroauthor=X.+Liuauthor=K.+Ngoauthor=A.+De+Leon-Tabaldoauthor=S.+Zhaoauthor=R.+Luna-Romanauthor=J.+Yuauthor=T.+Caoauthor=R.+Kuhnauthor=P.+Wilkinsonauthor=K.+Hermanauthor=M.+I.+Nelenauthor=J.+Blevittauthor=X.+Xueauthor=A.+Fourieauthor=W.+P.+Fung-Leung&title=ROR%CE%B3t+and+ROR%CE%B1+signature+genes+in+human+Th17+cells&doi=10.1371%2Fjournal.pone.0181868"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0181868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0181868%26sid%3Dliteratum%253Aachs%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DNgo%26aufirst%3DK.%26aulast%3DDe%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLuna-Roman%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DT.%26aulast%3DKuhn%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DP.%26aulast%3DHerman%26aufirst%3DK.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DBlevitt%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DFourie%26aufirst%3DA.%26aulast%3DFung-Leung%26aufirst%3DW.%2BP.%26atitle%3DROR%25CE%25B3t%2520and%2520ROR%25CE%25B1%2520signature%2520genes%2520in%2520human%2520Th17%2520cells%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0181868%26doi%3D10.1371%2Fjournal.pone.0181868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span> <span> </span><span class="NLM_article-title">Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5871</span>– <span class="NLM_lpage">5892</span>, <span class="refDoi"> DOI: 10.1021/jm401901d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401901d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5871-5892&author=B.+P.+Fauberauthor=S.+Magnuson&title=Modulators+of+the+nuclear+receptor+retinoic+acid+receptor-related+orphan+receptor-%CE%B3+%28ROR%CE%B3+or+RORc%29&doi=10.1021%2Fjm401901d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)</span></div><div class="casAuthors">Fauber, Benjamin P.; Magnuson, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5871-5892</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  As the biol. surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunol. diseases.  Several major pharmaceutical and biotechnol. companies have disclosed RORc inhibitors or partnered with other players in the field.  In this perspective, we discuss both the biol. and the underlying structural biol. of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXhzxefrY4hLVg90H21EOLACvtfcHk0ljcNDtGEKJ3Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartbo%253D&md5=42b350bff7776d4b5689275eab214d86</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm401901d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401901d%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DMagnuson%26aufirst%3DS.%26atitle%3DModulators%2520of%2520the%2520nuclear%2520receptor%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B3%2520%2528ROR%25CE%25B3%2520or%2520RORc%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5871%26epage%3D5892%26doi%3D10.1021%2Fjm401901d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism</span>. <i>Nucl. Recept. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e003</span>, <span class="refDoi"> DOI: 10.1621/nrs.07003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1621%2Fnrs.07003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=19381306" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e003&author=A.+M.+Jetten&title=Retinoid-related+orphan+receptors+%28RORs%29%3A+critical+roles+in+development%2C+immunity%2C+circadian+rhythm%2C+and+cellular+metabolism&doi=10.1621%2Fnrs.07003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1621%2Fnrs.07003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1621%252Fnrs.07003%26sid%3Dliteratum%253Aachs%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoid-related%2520orphan%2520receptors%2520%2528RORs%2529%253A%2520critical%2520roles%2520in%2520development%252C%2520immunity%252C%2520circadian%2520rhythm%252C%2520and%2520cellular%2520metabolism%26jtitle%3DNucl.%2520Recept.%2520Signaling%26date%3D2009%26volume%3D7%26spage%3De003%26doi%3D10.1621%2Fnrs.07003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soroosh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Leon-Tabaldo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna-Roman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenkrants, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung-Leung, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria-Babi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlueter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budelsky, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">37977</span>, <span class="refDoi"> DOI: 10.1038/srep37977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fsrep37977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27905482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=37977&author=X.+Xueauthor=P.+Sorooshauthor=A.+De+Leon-Tabaldoauthor=R.+Luna-Romanauthor=M.+Sabladauthor=N.+Rozenkrantsauthor=J.+Yuauthor=G.+Castroauthor=H.+Banieauthor=W.-P.+Fung-Leungauthor=L.+Santamaria-Babiauthor=T.+Schlueterauthor=M.+Albersauthor=K.+Leonardauthor=A.+L.+Budelskyauthor=A.+M.+Fourie&title=Pharmacologic+modulation+of+ROR%CE%B3t+translates+to+efficacy+in+preclinical+and+translational+models+of+psoriasis+and+inflammatory+arthritis&doi=10.1038%2Fsrep37977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis</span></div><div class="casAuthors">Xue, Xiaohua; Soroosh, Pejman; De Leon-Tabaldo, Aimee; Luna-Roman, Rosa; Sablad, Marciano; Rozenkrants, Natasha; Yu, Jingxue; Castro, Glenda; Banie, Homayon; Fung-Leung, Wai-Ping; Santamaria-Babi, Luis; Schlueter, Thomas; Albers, Michael; Leonard, Kristi; Budelsky, Alison L.; Fourie, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37977</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The IL-23/IL-17 pathway is implicated in autoimmune diseases, particularly psoriasis, where biologics targeting IL-23 and IL-17 have shown significant clin. efficacy.  Retinoid-related orphan nuclear receptor gamma t (RORγt) is required for Th17 differentiation and IL-17 prodn. in adaptive and innate immune cells.  We identified JNJ-54271074, a potent and highly-selective RORγt inverse agonist, which dose-dependently inhibited RORγt-driven transcription, decreased co-activator binding and promoted interaction with co-repressor protein.  This compd. selectively blocked Th17 differentiation, significantly reduced IL-17A prodn. from memory T cells, and decreased IL-17A- and IL-22-producing human and murine γδ and NKT cells.  In a murine collagen-induced arthritis model, JNJ-54271074 dose-dependently suppressed joint inflammation.  Furthermore, JNJ-54271074 suppressed IL-17A prodn. in human PBMC from rheumatoid arthritis patients.  RORγt-deficient mice showed decreased IL-23-induced psoriasis-like skin inflammation and cytokine gene expression, consistent with dose-dependent inhibition in wild-type mice through oral dosing of JNJ-54271074.  In a translational model of human psoriatic epidermal cells and skin-homing T cells, JNJ-54271074 selectively inhibited streptococcus ext.-induced IL-17A and IL-17F.  JNJ-54271074 is thus a potent, selective RORγt modulator with therapeutic potential in IL-23/IL-17 mediated autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6V70xff8x77Vg90H21EOLACvtfcHk0lhV2_29lAKXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFWnsr3F&md5=2dea294b5db93b110af4818dbfcb589b</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsrep37977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep37977%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DX.%26aulast%3DSoroosh%26aufirst%3DP.%26aulast%3DDe%2BLeon-Tabaldo%26aufirst%3DA.%26aulast%3DLuna-Roman%26aufirst%3DR.%26aulast%3DSablad%26aufirst%3DM.%26aulast%3DRozenkrants%26aufirst%3DN.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DBanie%26aufirst%3DH.%26aulast%3DFung-Leung%26aufirst%3DW.-P.%26aulast%3DSantamaria-Babi%26aufirst%3DL.%26aulast%3DSchlueter%26aufirst%3DT.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DBudelsky%26aufirst%3DA.%2BL.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26atitle%3DPharmacologic%2520modulation%2520of%2520ROR%25CE%25B3t%2520translates%2520to%2520efficacy%2520in%2520preclinical%2520and%2520translational%2520models%2520of%2520psoriasis%2520and%2520inflammatory%2520arthritis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D37977%26doi%3D10.1038%2Fsrep37977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuruvilla, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corzo, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Antiobesity effect of a small molecule repressor of RORγ</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1124/mol.114.097485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1124%2Fmol.114.097485" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=48-56&author=M.+R.+Changauthor=Y.+Heauthor=T.+M.+Khanauthor=D.+S.+Kuruvillaauthor=R.+Garcia-Ordonezauthor=C.+A.+Corzoauthor=T.+J.+Ungerauthor=D.+W.+Whiteauthor=S.+Khanauthor=L.+Linauthor=M.+D.+Cameronauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Antiobesity+effect+of+a+small+molecule+repressor+of+ROR%CE%B3&doi=10.1124%2Fmol.114.097485"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.097485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.097485%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DT.%2BM.%26aulast%3DKuruvilla%26aufirst%3DD.%2BS.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%26aulast%3DCorzo%26aufirst%3DC.%2BA.%26aulast%3DUnger%26aufirst%3DT.%2BJ.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DM.%2BD.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DAntiobesity%2520effect%2520of%2520a%2520small%2520molecule%2520repressor%2520of%2520ROR%25CE%25B3%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D48%26epage%3D56%26doi%3D10.1124%2Fmol.114.097485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unutmaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner-Morton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mebius, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">Requirement of RORγ in thymocyte survival and lymphoid organ development</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">2369</span>– <span class="NLM_lpage">2373</span>, <span class="refDoi"> DOI: 10.1126/science.288.5475.2369</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1126%2Fscience.288.5475.2369" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2000&pages=2369-2373&author=Z.+Sunauthor=D.+Unutmazauthor=Y.-R.+Zouauthor=M.+J.+Sunshineauthor=A.+Pieraniauthor=S.+Brenner-Mortonauthor=R.+E.+Mebiusauthor=D.+R.+Littman&title=Requirement+of+ROR%CE%B3+in+thymocyte+survival+and+lymphoid+organ+development&doi=10.1126%2Fscience.288.5475.2369"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.288.5475.2369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.288.5475.2369%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DZ.%26aulast%3DUnutmaz%26aufirst%3DD.%26aulast%3DZou%26aufirst%3DY.-R.%26aulast%3DSunshine%26aufirst%3DM.%2BJ.%26aulast%3DPierani%26aufirst%3DA.%26aulast%3DBrenner-Morton%26aufirst%3DS.%26aulast%3DMebius%26aufirst%3DR.%2BE.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DRequirement%2520of%2520ROR%25CE%25B3%2520in%2520thymocyte%2520survival%2520and%2520lymphoid%2520organ%2520development%26jtitle%3DScience%26date%3D2000%26volume%3D288%26spage%3D2369%26epage%3D2373%26doi%3D10.1126%2Fscience.288.5475.2369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eberl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marmon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunshine, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rennert, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Littman, D. R.</span></span> <span> </span><span class="NLM_article-title">An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.1038/ni1022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fni1022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=14691482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=64-73&author=G.+Eberlauthor=S.+Marmonauthor=M.-J.+Sunshineauthor=P.+D.+Rennertauthor=Y.+Choiauthor=D.+R.+Littman&title=An+essential+function+for+the+nuclear+receptor+ROR%CE%B3t+in+the+generation+of+fetal+lymphoid+tissue+inducer+cells&doi=10.1038%2Fni1022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells</span></div><div class="casAuthors">Eberl, Gerard; Marmon, Shana; Sunshine, Mary-Jean; Rennert, Paul D.; Choi, Yongwon; Littman, Dan R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-73</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lymphoid tissue inducer (LTi) cells are assocd. with early development of lymph nodes and Peyer's patches.  The authors show here that during fetal life the nuclear hormone receptor RORγt is expressed exclusively in and is required for the generation of LTi cells.  RORγt+ LTi cells provide essential factors, among which lymphotoxin-α1β2 is necessary but not sufficient for activation of the mesenchyma in lymph node and Peyer's patch anlagen.  This early LTi cell-mediated activation of lymph node and Peyer's patch mesenchyma forms the necessary platform for the subsequent development of mature lymphoid tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon5WJaoOUVHLVg90H21EOLACvtfcHk0lhV2_29lAKXzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWhtr3N&md5=537f5f89b071b5b5a710d80a476d1b52</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fni1022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1022%26sid%3Dliteratum%253Aachs%26aulast%3DEberl%26aufirst%3DG.%26aulast%3DMarmon%26aufirst%3DS.%26aulast%3DSunshine%26aufirst%3DM.-J.%26aulast%3DRennert%26aufirst%3DP.%2BD.%26aulast%3DChoi%26aufirst%3DY.%26aulast%3DLittman%26aufirst%3DD.%2BR.%26atitle%3DAn%2520essential%2520function%2520for%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3t%2520in%2520the%2520generation%2520of%2520fetal%2520lymphoid%2520tissue%2520inducer%2520cells%26jtitle%3DNat.%2520Immunol.%26date%3D2004%26volume%3D5%26spage%3D64%26epage%3D73%26doi%3D10.1038%2Fni1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medvedev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptor γ (RORγ) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">10132</span>– <span class="NLM_lpage">10137</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.18.10132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1073%2Fpnas.97.18.10132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10132-10137&author=S.+Kurebayashiauthor=E.+Uedaauthor=M.+Sakaueauthor=D.+D.+Patelauthor=A.+Medvedevauthor=F.+Zhangauthor=A.+M.+Jetten&title=Retinoid-related+orphan+receptor+%CE%B3+%28ROR%CE%B3%29+is+essential+for+lymphoid+organogenesis+and+controls+apoptosis+during+thymopoiesis&doi=10.1073%2Fpnas.97.18.10132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.18.10132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.18.10132%26sid%3Dliteratum%253Aachs%26aulast%3DKurebayashi%26aufirst%3DS.%26aulast%3DUeda%26aufirst%3DE.%26aulast%3DSakaue%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DMedvedev%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DRetinoid-related%2520orphan%2520receptor%2520%25CE%25B3%2520%2528ROR%25CE%25B3%2529%2520is%2520essential%2520for%2520lymphoid%2520organogenesis%2520and%2520controls%2520apoptosis%2520during%2520thymopoiesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D10132%26epage%3D10137%26doi%3D10.1073%2Fpnas.97.18.10132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Enomoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujio, Y.</span></span> <span> </span><span class="NLM_article-title">RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0183584</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0183584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1371%2Fjournal.pone.0183584" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=e0183584&author=D.+Enomotoauthor=K.+Matsumotoauthor=T.+Yamashitaauthor=A.+Kobayashiauthor=M.+Maedaauthor=H.+Nakayamaauthor=M.+Obanaauthor=Y.+Fujio&title=ROR%CE%B3t-expressing+cells+attenuate+cardiac+remodeling+after+myocardial+infarction&doi=10.1371%2Fjournal.pone.0183584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0183584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0183584%26sid%3Dliteratum%253Aachs%26aulast%3DEnomoto%26aufirst%3DD.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DA.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DH.%26aulast%3DObana%26aufirst%3DM.%26aulast%3DFujio%26aufirst%3DY.%26atitle%3DROR%25CE%25B3t-expressing%2520cells%2520attenuate%2520cardiac%2520remodeling%2520after%2520myocardial%2520infarction%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26spage%3De0183584%26doi%3D10.1371%2Fjournal.pone.0183584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martynowski, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hydroxycholesterols a natural ligands of orphan nuclear receptor RORγ</span>. <i>Mol. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1210/me.2009-0507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1210%2Fme.2009-0507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=20203100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=923-929&author=L.+Jinauthor=D.+Martynowskiauthor=S.+Zhengauthor=T.+Wadaauthor=W.+Xieauthor=Y.+Li&title=Structural+basis+for+hydroxycholesterols+a+natural+ligands+of+orphan+nuclear+receptor+ROR%CE%B3&doi=10.1210%2Fme.2009-0507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORγ</span></div><div class="casAuthors">Jin, Lihua; Martynowski, Dariusz; Zheng, Songyang; Wada, Taira; Xie, Wen; Li, Yong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The retinoic acid-related orphan receptor γ (RORγ) has important roles in development and metabolic homeostasis.  Although the biol. functions of RORγ have been studied extensively, no ligands for RORγ have been identified, and no structure of RORγ has been reported.  In this study, we showed that hydroxycholesterols promote the recruitment of coactivators by RORγ using biochem. assays.  We also report the crystal structures of the RORγ ligand-binding domain bound with hydroxycholesterols.  The structures reveal the binding modes of various hydroxycholesterols in the RORγ pocket, with the receptors all adopting the canonical active conformation.  Mutations that disrupt the binding of hydroxycholesterols abolish the constitutive activity of RORγ.  Our observations suggest an important role for the endogenous hydroxycholesterols in modulating RORγ-dependent biol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6-ndP3ZSYebVg90H21EOLACvtfcHk0lgr9iraVSVrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlslOqurc%253D&md5=1651fa21702f2a06451377fa11aa80bc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0507%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DL.%26aulast%3DMartynowski%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DS.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520for%2520hydroxycholesterols%2520a%2520natural%2520ligands%2520of%2520orphan%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D923%26epage%3D929%26doi%3D10.1210%2Fme.2009-0507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izaac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Be, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arista, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span> <span> </span><span class="NLM_article-title">Structural states of RORγt: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1014</span>– <span class="NLM_lpage">1021</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201700278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28590087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1014-1021&author=J.+Kallenauthor=A.+Izaacauthor=C.+Beauthor=L.+Aristaauthor=D.+Orainauthor=K.+Kaupmannauthor=C.+Guntermannauthor=K.+Hoegenauerauthor=S.+Hintermann&title=Structural+states+of+ROR%CE%B3t%3A+X-ray+elucidation+of+molecular+mechanisms+and+binding+interactions+for+natural+and+synthetic+compounds&doi=10.1002%2Fcmdc.201700278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural States of RORγt: X-ray Elucidation of Molecular Mechanisms and Binding Interactions for Natural and Synthetic Compounds</span></div><div class="casAuthors">Kallen, Joerg; Izaac, Aude; Be, Celine; Arista, Luca; Orain, David; Kaupmann, Klemens; Guntermann, Christine; Hoegenauer, Klemens; Hintermann, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1014-1021</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The T-cell-specific retinoic acid receptor (RAR)-related orphan receptor-γ (RORγt) is a key transcription factor for the prodn. of pro-inflammatory Th17 cytokines, which are implicated in the pathogenesis of autoimmune diseases.  Over the years, several structurally diverse RORγt inverse agonists have been reported, but combining high potency and good physicochem. properties has remained a challenging task.  We recently reported a new series of inverse agonists based on an imidazopyridine core with good physicochem. properties and excellent selectivity.  Herein we report eight new X-ray crystal structures for different classes of natural and synthetic compds., including examples selected from the patent literature.  Anal. of their resp. binding modes revealed insight into the mol. mechanisms that lead to agonism, antagonism, or inverse agonism.  We report new mol. mechanisms for RORγt agonism and propose a sepn. of the inverse agonists into two classes: those that act via steric clash and those that act via other mechanisms (for the latter, co-crystn. with a co-activator peptide and helix 12 in the agonist position is still possible).  For the non-steric clash inverse agonists, we propose a new mechanism ("water trapping") which can be combined with other mechanisms (e.g., close contacts with H479).  In addn., we compare the interactions made for selected compds. in the "back pocket" near S404 and in the "sulfate pocket" near R364 and R367.  Taken together, these new mechanistic insights should prove useful for the design and optimization of further RORγt modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2bJdGLB1okrVg90H21EOLACvtfcHk0lgr9iraVSVrIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFamsrvK&md5=c49d7d9710f6c4f7baed7e7b207a0bf7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700278%26sid%3Dliteratum%253Aachs%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DIzaac%26aufirst%3DA.%26aulast%3DBe%26aufirst%3DC.%26aulast%3DArista%26aufirst%3DL.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DHintermann%26aufirst%3DS.%26atitle%3DStructural%2520states%2520of%2520ROR%25CE%25B3t%253A%2520X-ray%2520elucidation%2520of%2520molecular%2520mechanisms%2520and%2520binding%2520interactions%2520for%2520natural%2520and%2520synthetic%2520compounds%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D1014%26epage%3D1021%26doi%3D10.1002%2Fcmdc.201700278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span>Vitae Pharmaceuticals, Inc. <span> </span><span class="NLM_article-title">An Ascending
Multiple Dose Study With VTP-43742 in Healthy Volunteers and Psoriatic
Patients</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2016</span>;<a href="https://clinicaltrials.gov/ct2/show/NCT02555709?term=VTP43742&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02555709?term=VTP43742&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vitae+Pharmaceuticals%2C+Inc.+An+Ascending%0AMultiple+Dose+Study+With+VTP-43742+in+Healthy+Volunteers+and+Psoriatic%0APatients.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes+of+Health%3A+Bethesda%2C+MD%2C+2016%3Bhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02555709%3Fterm%3DVTP43742%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DAn%2520Ascending%250AMultiple%2520Dose%2520Study%2520With%2520VTP-43742%2520in%2520Healthy%2520Volunteers%2520and%2520Psoriatic%250APatients%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%2520of%2520Health%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span>GlaxoSmithKline. <span> </span><span class="NLM_article-title">A Study of GSK2981278
Ointment in Subjects With Plaque Psoriasis</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes
of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2018</span>;<a href="https://clinicaltrials.gov/ct2/show/NCT03004846?term=GSK2981278&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03004846?term=GSK2981278&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=GlaxoSmithKline.+A+Study+of+GSK2981278%0AOintment+in+Subjects+With+Plaque+Psoriasis.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes%0Aof+Health%3A+Bethesda%2C+MD%2C+2018%3Bhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03004846%3Fterm%3DGSK2981278%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%2520of%2520GSK2981278%250AOintment%2520in%2520Subjects%2520With%2520Plaque%2520Psoriasis%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%250Aof%2520Health%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span>Arrien Pharmaceuticals. <span> </span><span class="NLM_article-title">A Phase 1 Study
of ARN-6039 (ARN-6039)</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>;<a href="https://clinicaltrials.gov/ct2/show/NCT03237832?term=ARN-6039&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03237832?term=ARN-6039&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Arrien+Pharmaceuticals.+A+Phase+1+Study%0Aof+ARN-6039+%28ARN-6039%29.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3Bhttps%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03237832%3Fterm%3DARN-6039%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Phase%25201%2520Study%250Aof%2520ARN-6039%2520%2528ARN-6039%2529%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span>Takeda. <span> </span><span class="NLM_article-title">Safety, Tolerability and Pharmacokinetics
of Escalating Single Doses of TAK-828 in Healthy Participants</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National
Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2016</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT02706834?term=TAK828&amp;rank=2" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02706834?term=TAK828&rank=2</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Takeda.+Safety%2C+Tolerability+and+Pharmacokinetics%0Aof+Escalating+Single+Doses+of+TAK-828+in+Healthy+Participants.+ClinicalTrials.Gov%3B+U.S.+National%0AInsitutes+of+Health%3A+Bethesda%2C+MD%2C+2016%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02706834%3Fterm%3DTAK828%26rank%3D2+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DSafety%252C%2520Tolerability%2520and%2520Pharmacokinetics%250Aof%2520Escalating%2520Single%2520Doses%2520of%2520TAK-828%2520in%2520Healthy%2520Participants%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%250AInsitutes%2520of%2520Health%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span>AbbVie. <span> </span><span class="NLM_article-title">A Study to Evaluate the Pharmacokinetics,
Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects
With Psoriasis and Efficacy of ABBV-553 in Subjects With Psoriasis</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National
Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03145948?term=ABBV-553&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03145948?term=ABBV-553&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AbbVie.+A+Study+to+Evaluate+the+Pharmacokinetics%2C%0ASafety+and+Tolerability+of+ABBV-553+in+Healthy+Volunteers+and+in+Subjects%0AWith+Psoriasis+and+Efficacy+of+ABBV-553+in+Subjects+With+Psoriasis.+ClinicalTrials.Gov%3B+U.S.+National%0AInsitutes+of+Health%3A+Bethesda%2C+MD%2C+2017%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03145948%3Fterm%3DABBV-553%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520Study%2520to%2520Evaluate%2520the%2520Pharmacokinetics%252C%250ASafety%2520and%2520Tolerability%2520of%2520ABBV-553%2520in%2520Healthy%2520Volunteers%2520and%2520in%2520Subjects%250AWith%2520Psoriasis%2520and%2520Efficacy%2520of%2520ABBV-553%2520in%2520Subjects%2520With%2520Psoriasis%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%250AInsitutes%2520of%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span> <i>Phenex AG Announces Milestone
Payment from Janssen for the Entry
of RORgt Inhibitor into Phase I</i>; <span class="NLM_publisher-name">Phenex Pharmaceuticals
AG</span>: <span class="NLM_publisher-loc">Ludwigshafen, Germany</span>, July 10, <span class="NLM_year">2017</span>; press release, <a href="http://www.phenex-pharma.com/pdf/Phenex_Janssen_Ph1_eng_2017_final.pdf" class="extLink">http://www.phenex-pharma.com/pdf/Phenex_Janssen_Ph1_eng_2017_final.pdf</a> (accessed on July 10, 2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Phenex+AG+Announces+Milestone%0APayment+from+Janssen+for+the+Entry%0Aof+RORgt+Inhibitor+into+Phase+I%3B+Phenex+Pharmaceuticals%0AAG%3A+Ludwigshafen%2C+Germany%2C+July+10%2C+2017%3B+press+release%2C+http%3A%2F%2Fwww.phenex-pharma.com%2Fpdf%2FPhenex_Janssen_Ph1_eng_2017_final.pdf+%28accessed+on+July+10%2C+2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DPhenex%2520AG%2520Announces%2520Milestone%250APayment%2520from%2520Janssen%2520for%2520the%2520Entry%250Aof%2520RORgt%2520Inhibitor%2520into%2520Phase%2520I%26pub%3DPhenex%2520Pharmaceuticals%250AAG%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>AstraZeneca. <span> </span><span class="NLM_article-title">Study to Determine if AZD0284
is Effective and Safe in Treating Plaque Psoriasis (DERMIS)</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National
Insitutes of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2018</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03310320?term=AZD-0284&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03310320?term=AZD-0284&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=AstraZeneca.+Study+to+Determine+if+AZD0284%0Ais+Effective+and+Safe+in+Treating+Plaque+Psoriasis+%28DERMIS%29.+ClinicalTrials.Gov%3B+U.S.+National%0AInsitutes+of+Health%3A+Bethesda%2C+MD%2C+2018%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03310320%3Fterm%3DAZD-0284%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520to%2520Determine%2520if%2520AZD0284%250Ais%2520Effective%2520and%2520Safe%2520in%2520Treating%2520Plaque%2520Psoriasis%2520%2528DERMIS%2529%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%250AInsitutes%2520of%2520Health%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span>Akros Pharma (subsidiary
of Japan Tobacco). <span> </span><span class="NLM_article-title">Study to Evaluate Safety,
Tolerability, Pharmacodynamics & Pharmacokinetics
of JTE-451 in Active Plaque Psoriasis Subjects</span>.  <i>ClinicalTrials.Gov</i>; <span class="NLM_publisher-name">U.S. National Insitutes
of Health</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>, <span class="NLM_year">2017</span>; <a href="https://clinicaltrials.gov/ct2/show/NCT03018509?term=JTE-451&amp;rank=1" class="extLink">https://clinicaltrials.gov/ct2/show/NCT03018509?term=JTE-451&rank=1</a> (accessed March 13, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Akros+Pharma+%28subsidiary%0Aof+Japan+Tobacco%29.+Study+to+Evaluate+Safety%2C%0ATolerability%2C+Pharmacodynamics+%26+Pharmacokinetics%0Aof+JTE-451+in+Active+Plaque+Psoriasis+Subjects.+ClinicalTrials.Gov%3B+U.S.+National+Insitutes%0Aof+Health%3A+Bethesda%2C+MD%2C+2017%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT03018509%3Fterm%3DJTE-451%26rank%3D1+%28accessed+March+13%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DStudy%2520to%2520Evaluate%2520Safety%252C%250ATolerability%252C%2520Pharmacodynamics%2520%2526%2520Pharmacokinetics%250Aof%2520JTE-451%2520in%2520Active%2520Plaque%2520Psoriasis%2520Subjects%26jtitle%3DClinicalTrials.Gov%26pub%3DU.S.%2520National%2520Insitutes%250Aof%2520Health%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span> <i>Clinical Development as
of July 30, 2013</i>; <span class="NLM_publisher-name">Japan Tobacco Inc.</span>, <span class="NLM_year">2013</span>; <a href="http://www.jt.com/investors/results/S_information/pharmaceuticals/" class="extLink">http://www.jt.com/investors/results/S_information/pharmaceuticals/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Clinical+Development+as%0Aof+July+30%2C+2013%3B+Japan+Tobacco+Inc.%2C+2013%3B+http%3A%2F%2Fwww.jt.com%2Finvestors%2Fresults%2FS_information%2Fpharmaceuticals%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Development%2520as%250Aof%2520July%252030%252C%25202013%26pub%3DJapan%2520Tobacco%2520Inc%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span> <i>Reata Announces Initiation of a Phase 1 Trial of
RTA 1701, a Selective,
Oral Allosteric Inhibitor of RORγt</i>; <span class="NLM_publisher-name">Reata Pharmaceuticals</span>: <span class="NLM_publisher-loc">Irving, TX</span>, June 20, <span class="NLM_year">2018</span>; <a href="http://investors.reatapharma.com/news-releases/news-release-details/reata-announces-initiation-phase-1-trial-rta-1701-selective-oral" class="extLink">http://investors.reatapharma.com/news-releases/news-release-details/reata-announces-initiation-phase-1-trial-rta-1701-selective-oral</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Reata+Announces+Initiation+of+a+Phase+1+Trial+of%0ARTA+1701%2C+a+Selective%2C%0AOral+Allosteric+Inhibitor+of+ROR%CE%B3t%3B+Reata+Pharmaceuticals%3A+Irving%2C+TX%2C+June+20%2C+2018%3B+http%3A%2F%2Finvestors.reatapharma.com%2Fnews-releases%2Fnews-release-details%2Freata-announces-initiation-phase-1-trial-rta-1701-selective-oral."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DReata%2520Announces%2520Initiation%2520of%2520a%2520Phase%25201%2520Trial%2520of%250ARTA%25201701%252C%2520a%2520Selective%252C%250AOral%2520Allosteric%2520Inhibitor%2520of%2520ROR%25CE%25B3t%26pub%3DReata%2520Pharmaceuticals%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zbieg, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">RORγ antagonists and inverse agonists: a patent review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">101</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1080/13543776.2017.1236918</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1080%2F13543776.2017.1236918" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27629281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=101-112&issue=1&author=S.+M.+Bronnerauthor=J.+R.+Zbiegauthor=J.+J.+Crawford&title=ROR%CE%B3+antagonists+and+inverse+agonists%3A+a+patent+review&doi=10.1080%2F13543776.2017.1236918"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">RORγ antagonists and inverse agonists: a patent review</span></div><div class="casAuthors">Bronner, Sarah M.; Zbieg, Jason R.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-112</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The transcription factor RORγ plays a crit. role in the expression of pro-inflammatory cytokine interleukin IL-17 and is therefore an attractive target for the treatment of inflammatory diseases.  Interest in this mol. target has been heightened by the advancement of orally and topically administered RORγ modulators into clin. trials.  The present review seeks to summarize published patent applications from assignee companies that have disclosed Investigational New Drug (IND) filings for small mol. RORγ/RORγt antagonists and inverse agonists.  The field of RORγ research is extremely competitive, with the majority of companies targeting psoriasis as the primary disease indication.  Vitae Pharmaceuticals is currently the most advanced, with a potential first-in-class oral RORγ-modulator for the treatment of psoriasis.  Future efforts will likely expand into potential applications of RORγ-modulators in the lesser explored immune-related areas of rheumatoid arthritis, type 1 diabetes, lupus, and irritable bowel disorder, as well as cancer immunotherapy and castration-resistant prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj8lMzWsYVA7Vg90H21EOLACvtfcHk0lhj8fvW2yKpsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsbzP&md5=d80db6c4c948bc12c5d0ce4b41edd2fb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1080%2F13543776.2017.1236918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2017.1236918%26sid%3Dliteratum%253Aachs%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DZbieg%26aufirst%3DJ.%2BR.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DROR%25CE%25B3%2520antagonists%2520and%2520inverse%2520agonists%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2017%26volume%3D27%26issue%3D1%26spage%3D101%26epage%3D112%26doi%3D10.1080%2F13543776.2017.1236918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">764</span>– <span class="NLM_lpage">776</span>, <span class="refDoi"> DOI: 10.1039/c3md00005b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1039%2Fc3md00005b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=764-776&author=T.+M.+Kameneckaauthor=B.+Lydaauthor=M.+R.+Changauthor=P.+R.+Griffin&title=Synthetic+modulators+of+the+retinoic+acid+receptor-related+orphan+receptors&doi=10.1039%2Fc3md00005b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic modulators of the retinoic acid receptor-related orphan receptors</span></div><div class="casAuthors">Kamenecka, Theodore M.; Lyda, Brent; Chang, Mi Ra; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">764-776</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Nuclear receptors (NR) are ligand-regulated transcription factors that control the expression of target genes involved in a range of physiol. processes such as development, metab., and immunity.  The retinoic acid receptor-related orphan receptors alpha, beta, and gamma (RORA, RORB, and RORC) comprise a distinct subfamily of nuclear receptors and are considered orphan' receptors, as they have no known generally agreed upon endogenous ligands, although these receptors do bind to and are modulated by oxysterols.  Several recent reports have highlighted the potential role for RORs in human disease, and more importantly, studies have demonstrated that these receptors can be modulated by exogenous synthetic ligands.  The identification of potent and selective ROR ligands will allow for a better understanding of the roles of the ROR receptors in human disease, and potentially pave the way for development of novel therapeutics.  Here we review the current status of synthetic ligand development from both the primary and patent literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOh7XjR1TYObVg90H21EOLACvtfcHk0ljf7uWa8Lt6BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvVygsL0%253D&md5=1985ee3df0c0476b65bcd68f7e9bc126</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2Fc3md00005b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00005b%26sid%3Dliteratum%253Aachs%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DSynthetic%2520modulators%2520of%2520the%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptors%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D764%26epage%3D776%26doi%3D10.1039%2Fc3md00005b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cyr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, J. J.</span></span> <span> </span><span class="NLM_article-title">Recent progress on nuclear receptor RORc modulators</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">4387</span>– <span class="NLM_lpage">4393</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27542308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=4387-4393&author=P.+Cyrauthor=S.+M.+Bronnerauthor=J.+J.+Crawford&title=Recent+progress+on+nuclear+receptor+RORc+modulators&doi=10.1016%2Fj.bmcl.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress on nuclear receptor RORγ modulators</span></div><div class="casAuthors">Cyr, Patrick; Bronner, Sarah M.; Crawford, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4387-4393</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The retinoic acid receptor-related orphan receptor RORγ plays key roles in the development and differentiation of TH17 cells, and thus in IL-17 expression, thymocyte development and regulation of metab.  With the recent progression into phase 2 clin. trials of both oral and topically administered inverse agonists, and with others close behind, there is significant interest in the discovery of RORγ modulators.  This digest covers key developments around RORγ agonists, antagonists and inverse agonists; orthosteric and allosteric binders; and aims to summarize the available information concerning the potential utility of RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD6nrse0GiBLVg90H21EOLACvtfcHk0ljf7uWa8Lt6BQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7rL&md5=688885fc5c71ce01b86df6c9703b51ec</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DCyr%26aufirst%3DP.%26aulast%3DBronner%26aufirst%3DS.%2BM.%26aulast%3DCrawford%26aufirst%3DJ.%2BJ.%26atitle%3DRecent%2520progress%2520on%2520nuclear%2520receptor%2520RORc%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D4387%26epage%3D4393%26doi%3D10.1016%2Fj.bmcl.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, R.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Retinoic acid receptor-related orphan receptor γt (RORγt) agonists as potential small molecule therapeutics for cancer immunotherapy</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, DOI: <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01314</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+Qiu&author=Y.+Wang&title=Retinoic+acid+receptor-related+orphan+receptor+%CE%B3t+%28ROR%CE%B3t%29+agonists+as+potential+small+molecule+therapeutics+for+cancer+immunotherapy&doi=10.1021%2Facs.jmedchem.7b01314"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01314%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DR.%26atitle%3DRetinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%25CE%25B3t%2520%2528ROR%25CE%25B3t%2529%2520agonists%2520as%2520potential%2520small%2520molecule%2520therapeutics%2520for%2520cancer%2520immunotherapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.7b01314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conkright, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Istrate, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busby, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ordonez, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">The benzenesulfonamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-(trifluoromethyl)ethyl]phenyl] benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-α/γ inverse agonist</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1124/mol.109.060905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1124%2Fmol.109.060905" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=228-236&author=N.+Kumarauthor=L.+A.+Soltauthor=J.+J.+Conkrightauthor=Y.+Wangauthor=M.+A.+Istrateauthor=S.+A.+Busbyauthor=R.+D.+Garcia-Ordonezauthor=T.+P.+Burrisauthor=P.+R.+Griffin&title=The+benzenesulfonamide+T0901317+%5BN-%282%2C2%2C2-trifluoroethyl%29-N-%5B4-%5B2%2C2%2C2-trifluoro-1-hydroxy-%28trifluoromethyl%29ethyl%5Dphenyl%5D+benzenesulfonamide%5D+is+a+novel+retinoic+acid+receptor-related+orphan+receptor-%CE%B1%2F%CE%B3+inverse+agonist&doi=10.1124%2Fmol.109.060905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1124%2Fmol.109.060905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.109.060905%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DConkright%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DIstrate%26aufirst%3DM.%2BA.%26aulast%3DBusby%26aufirst%3DS.%2BA.%26aulast%3DGarcia-Ordonez%26aufirst%3DR.%2BD.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DThe%2520benzenesulfonamide%2520T0901317%2520%255BN-%25282%252C2%252C2-trifluoroethyl%2529-N-%255B4-%255B2%252C2%252C2-trifluoro-1-hydroxy-%2528trifluoromethyl%2529ethyl%255Dphenyl%255D%2520benzenesulfonamide%255D%2520is%2520a%2520novel%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor-%25CE%25B1%252F%25CE%25B3%2520inverse%2520agonist%26jtitle%3DMol.%2520Pharmacol.%26date%3D2010%26volume%3D77%26spage%3D228%26epage%3D236%26doi%3D10.1124%2Fmol.109.060905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Identification of SR2211: a potent synthetic RORγ-selective modulator</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">672</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.1021/cb200496y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb200496y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVGlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=672-677&author=N.+Kumarauthor=B.+Lydaauthor=M.+R.+Changauthor=J.+L.+Lauerauthor=L.+A.+Soltauthor=T.+P.+Burrisauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Identification+of+SR2211%3A+a+potent+synthetic+ROR%CE%B3-selective+modulator&doi=10.1021%2Fcb200496y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator</span></div><div class="casAuthors">Kumar, Naresh; Lyda, Brent; Chang, Mi Ra; Lauer, Janelle L.; Solt, Laura A.; Burris, Thomas P.; Kamenecka, Theodore M.; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">672-677</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nuclear receptors (NRs) are ligand-regulated transcription factors that display canonical domain structure with highly conserved DNA-binding and ligand-binding domains.  The identification of the endogenous ligands for several receptors remains elusive or is controversial, and thus these receptors are classified as orphans.  One such orphan receptor is the retinoic acid receptor-related orphan receptor γ (RORγ).  An isoform of RORγ, RORγt, has been shown to be essential for the expression of Interleukin 17 (IL-17) and the differentiation of Th17 cells.  Th17 cells have been implicated in the pathol. of several autoimmune diseases, including multiple sclerosis (MS) and rheumatoid arthritis (RA).  Genetic ablation of RORγ alone or in combination with RORα in mice led to impaired Th17 differentiation and protected the mice from development of exptl. autoimmune encephalomyelitis (EAE), a mouse model of MS.  Here we describe SR2211 (I), a selective RORγ modulator that potently inhibits prodn. of IL-17 in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUNURhZdOLSLVg90H21EOLACvtfcHk0lhiKnWJKLC-JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVGlsLo%253D&md5=3ef8a34687651a8fb7b3ab5a9b188abf</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcb200496y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200496y%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DLauer%26aufirst%3DJ.%2BL.%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DIdentification%2520of%2520SR2211%253A%2520a%2520potent%2520synthetic%2520ROR%25CE%25B3-selective%2520modulator%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D672%26epage%3D677%26doi%3D10.1021%2Fcb200496y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solt, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burris, T. P.</span></span> <span> </span><span class="NLM_article-title">Identification of a selective RORγ ligand that suppresses TH17 cells and stimulates T-regulatory cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1515</span>– <span class="NLM_lpage">1519</span>, <span class="refDoi"> DOI: 10.1021/cb3002649</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb3002649" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1515-1519&author=L.+A.+Soltauthor=N.+Kumarauthor=Y.+Heauthor=T.+M.+Kameneckaauthor=P.+R.+Griffinauthor=T.+P.+Burris&title=Identification+of+a+selective+ROR%CE%B3+ligand+that+suppresses+TH17+cells+and+stimulates+T-regulatory+cells&doi=10.1021%2Fcb3002649"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fcb3002649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3002649%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26aulast%3DBurris%26aufirst%3DT.%2BP.%26atitle%3DIdentification%2520of%2520a%2520selective%2520ROR%25CE%25B3%2520ligand%2520that%2520suppresses%2520TH17%2520cells%2520and%2520stimulates%2520T-regulatory%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D1515%26epage%3D1519%26doi%3D10.1021%2Fcb3002649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P. R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological repression of RORγ is therapeutic in the collagen-induced arthritis experimental model</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1002/art.38272</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fart.38272" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24574218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtl2gt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2014&pages=579-588&author=M.+R.+Changauthor=B.+Lydaauthor=T.+M.+Kameneckaauthor=P.+R.+Griffin&title=Pharmacological+repression+of+ROR%CE%B3+is+therapeutic+in+the+collagen-induced+arthritis+experimental+model&doi=10.1002%2Fart.38272"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic repression of retinoic acid receptor-related orphan nuclear receptor γ is therapeutic in the collagen-induced arthritis experimental model</span></div><div class="casAuthors">Chang, Mi Ra; Lyda, Brent; Kamenecka, Theodore M.; Griffin, Patrick R.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: The nuclear receptor retinoic acid receptor-related orphan nuclear receptor γ (RORγ; T cell-specific isoform RORγt) is a key regulator of Th17 cell differentiation, controlling the prodn. of the inflammatory cytokine interleukin-17 (IL-17).  Lipopolysaccharide (LPS) stimulation of monocytes leads to the induction of RORγ.  We previously showed that the potent and selective inverse agonist of RORγ, SR2211, was effective at suppressing IL-17 prodn. in EL4 cells.  The aim of this study was to examine the effects of SR2211 treatment on proinflammatory cytokine expression in LPS-stimulated RAW 264.7 cells as well as on joint inflammation in vivo in mice with collagen-induced arthritis (CIA).  Methods: Collagen was injected into the tail of DBA mice, followed by a booster inoculation 21 days later.  Three days prior to the booster inoculation, SR2211 was administered twice daily for 15 days.  Thymus, spleen, and draining lymph nodes (DLNs) were then harvested, and Th17 cell differentiation and DLN stimulation were performed.  Results: Treatment of Th17 cells with SR2211 suppressed the expression and prodn. of inflammatory cytokines.  Likewise, SR2211 reduced inflammatory cytokine prodn. in LPS-stimulated RAW 264.7 cells.  Mice with CIA that received SR2211 twice daily for 15 days exhibited a statistically significant redn. in joint inflammation as compared to mice that received only vehicle.  Interestingly, systemic Th1 cell activation was detected in SR2211-treated mice with CIA, as indicated by an increase in interferon-γ levels.  Conclusion: The findings of this study support the idea of targeting RORγ to therapeutically repress inflammatory T cell function and macrophage activation in humans with rheumatoid arthritis.  Compds. such as SR2211 have potential utility for the treatment of inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppuyw_Wu3pGbVg90H21EOLACvtfcHk0lhiKnWJKLC-JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtl2gt73M&md5=f58ea5bdd8276926161fee78e0c4f4a2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fart.38272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.38272%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DM.%2BR.%26aulast%3DLyda%26aufirst%3DB.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26aulast%3DGriffin%26aufirst%3DP.%2BR.%26atitle%3DPharmacological%2520repression%2520of%2520ROR%25CE%25B3%2520is%2520therapeutic%2520in%2520the%2520collagen-induced%2520arthritis%2520experimental%2520model%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2014%26volume%3D66%26spage%3D579%26epage%3D588%26doi%3D10.1002%2Fart.38272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6604</span>– <span class="NLM_lpage">6609</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2013.10.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24239186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslygtrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6604-6609&author=B.+P.+Fauberauthor=G.+de+Leon+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+Johnsonauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=O.+Ren%C3%A9author=H.+Wong&title=Structure-based+design+of+substituted+hexafluoroisopropanol-arylsulfonamides+as+modulators+of+RORc&doi=10.1016%2Fj.bmcl.2013.10.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc</span></div><div class="casAuthors">Fauber, Benjamin P.; de Leon Boenig, Gladys; Burton, Brenda; Eidenschenk, Celine; Everett, Christine; Gobbi, Alberto; Hymowitz, Sarah G.; Johnson, Adam R.; Liimatta, Marya; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Rene, Olivier; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6604-6609</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The structure-activity relationships of T0901317 analogs were explored as RORc inverse agonists using the principles of property- and structure-based drug design.  An X-ray co-crystal structure of T0901317 and RORc was obtained and provided mol. insight into why T0901317 functioned as an inverse agonist of RORc; whereas, the same ligand functioned as an agonist of FXR, LXR, and PXR.  The structural data was also used to design inhibitors with improved RORc biochem. and cellular activities.  The improved inhibitors possessed enhanced selectivity profiles (rationalized using the X-ray crystallog. data) against other nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxTcPky8JCMbVg90H21EOLACvtfcHk0lhiKnWJKLC-JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslygtrzL&md5=fb0331ebb12017c746f1a4f791e21637</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.054%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DStructure-based%2520design%2520of%2520substituted%2520hexafluoroisopropanol-arylsulfonamides%2520as%2520modulators%2520of%2520RORc%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6604%26epage%3D6609%26doi%3D10.1016%2Fj.bmcl.2013.10.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinstein, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stachura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haque, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karmakar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemagiri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raut, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sack, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pudzianowski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borowski, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dabros, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somerville, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murali
Dhar, T. G.</span></span> <span> </span><span class="NLM_article-title">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29233651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=85-93&author=H.+Gongauthor=D.+S.+Weinsteinauthor=Z.+Luauthor=J.+J.+Duanauthor=S.+Stachuraauthor=L.+Haqueauthor=A.+Karmakarauthor=H.+Hemagiriauthor=D.+K.+Rautauthor=A.+K.+Guptaauthor=J.+Khanauthor=D.+Camacauthor=J.+S.+Sackauthor=A.+Pudzianowskiauthor=D.+R.+Wuauthor=M.+Yardeauthor=D.+R.+Shenauthor=V.+Borowskiauthor=J.+H.+Xieauthor=H.+Sunauthor=C.+D%E2%80%99Arienzoauthor=M.+Dabrosauthor=M.+A.+Galellaauthor=F.+Wangauthor=C.+A.+Weigeltauthor=Q.+Zhaoauthor=W.+Fosterauthor=J.+E.+Somervilleauthor=L.+M.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=T.+G.+Murali%0ADhar&title=Identification+of+bicyclic+hexafluoroisopropyl+alcohol+sulfonamides+as+retinoic+acid+receptor-related+orphan+receptor+gamma+%28ROR%CE%B3%2FRORc%29+inverse+agonists.+Employing+structure-based+drug+design+to+improve+pregnane+X+receptor+%28PXR%29+selectivity&doi=10.1016%2Fj.bmcl.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity</span></div><div class="casAuthors">Gong, Hua; Weinstein, David S.; Lu, Zhonghui; Duan, James J.-W.; Stachura, Sylwia; Haque, Lauren; Karmakar, Ananta; Hemagiri, Hemalatha; Raut, Dhanya Kumar; Gupta, Arun Kumar; Khan, Javed; Camac, Dan; Sack, John S.; Pudzianowski, Andrew; Wu, Dauh-Rurng; Yarde, Melissa; Shen, Ding-Ren; Borowski, Virna; Xie, Jenny H.; Sun, Huadong; D'Arienzo, Celia; Dabros, Marta; Galella, Michael A.; Wang, Faye; Weigelt, Carolyn A.; Zhao, Qihong; Foster, William; Somerville, John E.; Salter-Cid, Luisa M.; Barrish, Joel C.; Carter, Percy H.; Dhar, T. G. Murali</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">85-93</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We disclose the optimization of a high throughput screening hit to yield benzothiazine and tetrahydroquinoline sulfonamides as potent RORγt inverse agonists.  However, a majority of these compds. showed potent activity against pregnane X receptor (PXR) and modest activity against liver X receptor α (LXRα).  Structure-based drug design (SBDD) led to the identification of benzothiazine and tetrahydroquinoline sulfonamide analogs which completely dialed out LXRα activity and were less potent at PXR.  Pharmacodynamic (PD) data for compd. 35 in an IL-23 induced IL-17 mouse model is discussed along with the implications of a high Ymax in the PXR assay for long term preclin. pharmacokinetic (PK) studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosFyMm8wpiSbVg90H21EOLACvtfcHk0ljnEH1AZjzSKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCqtr%252FJ&md5=be0dfef2d7494dca1979711a03ac7878</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DH.%26aulast%3DWeinstein%26aufirst%3DD.%2BS.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DDuan%26aufirst%3DJ.%2BJ.%26aulast%3DStachura%26aufirst%3DS.%26aulast%3DHaque%26aufirst%3DL.%26aulast%3DKarmakar%26aufirst%3DA.%26aulast%3DHemagiri%26aufirst%3DH.%26aulast%3DRaut%26aufirst%3DD.%2BK.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DKhan%26aufirst%3DJ.%26aulast%3DCamac%26aufirst%3DD.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPudzianowski%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DD.%2BR.%26aulast%3DYarde%26aufirst%3DM.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DBorowski%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%2BH.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%26aulast%3DDabros%26aufirst%3DM.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWeigelt%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DFoster%26aufirst%3DW.%26aulast%3DSomerville%26aufirst%3DJ.%2BE.%26aulast%3DSalter-Cid%26aufirst%3DL.%2BM.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DMurali%2BDhar%26aufirst%3DT.%2BG.%26atitle%3DIdentification%2520of%2520bicyclic%2520hexafluoroisopropyl%2520alcohol%2520sulfonamides%2520as%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520gamma%2520%2528ROR%25CE%25B3%252FRORc%2529%2520inverse%2520agonists.%2520Employing%2520structure-based%2520drug%2520design%2520to%2520improve%2520pregnane%2520X%2520receptor%2520%2528PXR%2529%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D85%26epage%3D93%26doi%3D10.1016%2Fj.bmcl.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4109</span>– <span class="NLM_lpage">4113</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.08.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4109-4113&author=B.+P.+Fauberauthor=A.+Gobbiauthor=P.+Savyauthor=B.+Burtonauthor=Y.+Dengauthor=C.+Everettauthor=H.+Laauthor=A.+R.+Johnsonauthor=P.+Lockeyauthor=M.+Normanauthor=H.+Wong&title=Identification+of+N-sulfonyl-tetrahydroquinolines+as+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.08.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DSavy%26aufirst%3DP.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520N-sulfonyl-tetrahydroquinolines%2520as%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4109%26epage%3D4113%26doi%3D10.1016%2Fj.bmcl.2015.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Berg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPheat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grindebacke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leffler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">Benzoxazepines achieve potent suppression of IL-17 release in human T-helper 17 (TH17) cells through an induced-fit binding mode to the nuclear receptor RORγ</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500432</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201500432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26553345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=207-216&author=R.+I.+Olssonauthor=Y.+Xueauthor=S.+von+Bergauthor=A.+Aagaardauthor=J.+McPheatauthor=E.+L.+Hanssonauthor=J.+Bernstr%C3%B6mauthor=P.+Hanssonauthor=J.+Jirholtauthor=H.+Grindebackeauthor=A.+Lefflerauthor=R.+Chenauthor=Y.+Xiongauthor=H.+Geauthor=T.+G.+Hanssonauthor=F.+Narjes&title=Benzoxazepines+achieve+potent+suppression+of+IL-17+release+in+human+T-helper+17+%28TH17%29+cells+through+an+induced-fit+binding+mode+to+the+nuclear+receptor+ROR%CE%B3&doi=10.1002%2Fcmdc.201500432"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ</span></div><div class="casAuthors">Olsson, Roine I.; Xue, Yafeng; von Berg, Stefan; Aagaard, Anna; McPheat, Jane; Hansson, Eva L.; Bernstroem, Jenny; Hansson, Pia; Jirholt, Johan; Grindebacke, Hanna; Leffler, Agnes; Chen, Rongfeng; Xiong, Yao; Ge, Hongbin; Hansson, Thomas G.; Narjes, Frank</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">207-216</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">RORγt, an isoform of the retinoic acid-related orphan receptor gamma (RORc, RORγ), has been identified as the master regulator of T-helper 17 (TH17) cell function and development, making it an attractive target for the treatment of autoimmune diseases.  Validation for this target comes from antibodies targeting interleukin-17 (IL-17), the signature cytokine produced by TH17 cells, which have shown impressive results in clin. trials.  Through focused screening of our compd. collection, we identified a series of N-sulfonylated benzoxazepines, which displayed micromolar affinity for the RORγ ligand-binding domain (LBD) in a radioligand binding assay.  Optimization of these initial hits resulted in potent binders, which dose-dependently decreased the ability of the RORγ-LBD to interact with a peptide derived from steroid receptor coactivator 1, and inhibited the release of IL-17 secretion from isolated and cultured human TH17 cells with nanomolar potency.  A cocrystal structure of inverse agonist 15 (2-chloro-6-fluoro-N-(4-{[3-(trifluoromethyl)phenyl]sulfonyl}-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl)benzamide) bound to the RORγ-LBD illustrated that both hydrophobic interactions, leading to an induced fit around the substituted benzamide moiety of 15, as well as a hydrogen bond from the amide NH to His479 seemed to be important for the mechanism of action.  This structure is compared with the structure of agonist 25 (N-(2-fluorophenyl)-4-[(4-fluorophenyl)sulfonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-6-amine ) and structures of other known RORγ modulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorSpjXrs3zSrVg90H21EOLACvtfcHk0ljnEH1AZjzSKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslyqtL3N&md5=ed6fa69d887818da7acd4f9abbd2ff93</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500432%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DR.%2BI.%26aulast%3DXue%26aufirst%3DY.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DMcPheat%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DE.%2BL.%26aulast%3DBernstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHansson%26aufirst%3DP.%26aulast%3DJirholt%26aufirst%3DJ.%26aulast%3DGrindebacke%26aufirst%3DH.%26aulast%3DLeffler%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DH.%26aulast%3DHansson%26aufirst%3DT.%2BG.%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DBenzoxazepines%2520achieve%2520potent%2520suppression%2520of%2520IL-17%2520release%2520in%2520human%2520T-helper%252017%2520%2528TH17%2529%2520cells%2520through%2520an%2520induced-fit%2520binding%2520mode%2520to%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D207%26epage%3D216%26doi%3D10.1002%2Fcmdc.201500432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Leon Boenig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3891</span>– <span class="NLM_lpage">3897</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2014.06.048" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3891-3897&author=B.+P.+Fauberauthor=O.+Ren%C3%A9author=G.+de+Leon+Boenigauthor=B.+Burtonauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=W.+Wangauthor=H.+Wong&title=Reduction+in+lipophilicity+improved+the+solubility%2C+plasma-protein+binding%2C+and+permeability+of+tertiary+sulfonamide+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2014.06.048"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3Dde%2BLeon%2BBoenig%26aufirst%3DG.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DReduction%2520in%2520lipophilicity%2520improved%2520the%2520solubility%252C%2520plasma-protein%2520binding%252C%2520and%2520permeability%2520of%2520tertiary%2520sulfonamide%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3891%26epage%3D3897%26doi%3D10.1016%2Fj.bmcl.2014.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boenig, G.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hymowitz, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiefer, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Minor structural change to tertiary sulfonamide RORc ligands led to opposite mechanisms of action</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1021/ml500420y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500420y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegurfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=276-281&author=O.+Ren%C3%A9author=B.+P.+Fauberauthor=G.-L.+Boenigauthor=B.+Burtonauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Gobbiauthor=S.+G.+Hymowitzauthor=A.+R.+Johnsonauthor=J.+R.+Kieferauthor=M.+Liimattaauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=H.+A.+Wallweberauthor=H.+Wong&title=Minor+structural+change+to+tertiary+sulfonamide+RORc+ligands+led+to+opposite+mechanisms+of+action&doi=10.1021%2Fml500420y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action</span></div><div class="casAuthors">Rene, Olivier; Fauber, Benjamin P.; Boenig, Gladys de Leon; Burton, Brenda; Eidenschenk, Celine; Everett, Christine; Gobbi, Alberto; Hymowitz, Sarah G.; Johnson, Adam R.; Kiefer, James R.; Liimatta, Marya; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Wallweber, Heidi A.; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">276-281</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A minor structural change to tertiary sulfonamide RORc ligands led to distinct mechanisms of action.  Co-crystal structures of two compds. revealed mechanistically consistent protein conformational changes.  Optimized phenylsulfonamides were identified as RORc agonists while benzylsulfonamides exhibited potent inverse agonist activity.  Compds. behaving as agonists in our biochem. assay also gave rise to an increased prodn. of IL-17 in human PBMCs whereas inverse agonists led to significant suppression of IL-17 under the same assay conditions.  The most potent inverse agonist compd. showed >180-fold selectivity over the ROR isoforms as well as all other nuclear receptors that were profiled.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI70iMUrA6ILVg90H21EOLACvtfcHk0lijB3U6M4zLSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegurfP&md5=0b4f24456aacce42db9f7a1843bb050b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fml500420y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500420y%26sid%3Dliteratum%253Aachs%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DBoenig%26aufirst%3DG.-L.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DWallweber%26aufirst%3DH.%2BA.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DMinor%2520structural%2520change%2520to%2520tertiary%2520sulfonamide%2520RORc%2520ligands%2520led%2520to%2520opposite%2520mechanisms%2520of%2520action%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D276%26epage%3D281%26doi%3D10.1021%2Fml500420y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">René, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5308</span>– <span class="NLM_lpage">5322</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00597</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00597" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5308-5322&author=B.+P.+Fauberauthor=O.+Ren%C3%A9author=Y.+Dengauthor=J.+DeVossauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=A.+Gobbiauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=J.+Leschauthor=P.+Lockeyauthor=M.+Normanauthor=W.+Ouyangauthor=S.+Summerhillauthor=H.+Wong&title=Discovery+of+1-%7B4-%5B3-fluoro-4-%28%283s%2C6r%29-3-methyl-1%2C1-dioxo-6-phenyl-%5B1%2C2%5Dthiazinan-2-ylmethyl%29-phenyl%5D-piperazin-1-yl%7D-ethanone+%28GNE-3500%29%3A+a+potent%2C+selective%2C+and+orally+bioavailable+retinoic+acid+receptor-related+orphan+receptor+C+%28RORc+or+ROR%CE%B3%29+inverse+agonist&doi=10.1021%2Facs.jmedchem.5b00597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1-{4-[3-Fluoro-4-((3S,6R)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C (RORc or RORγ) Inverse Agonist</span></div><div class="casAuthors">Fauber, Benjamin P.; Rene, Olivier; Deng, Yuzhong; DeVoss, Jason; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Gobbi, Alberto; Hawkins, Julie; Johnson, Adam R.; La, Hank; Lesch, Justin; Lockey, Peter; Norman, Maxine; Ouyang, Wenjun; Summerhill, Susan; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5308-5322</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Retinoic acid receptor-related orphan receptor C (RORc, RORγ, or NR1F3) is a nuclear receptor that plays a major role in the prodn. of interleukin (IL)-17.  Considerable efforts have been directed toward the discovery of selective RORc inverse agonists as potential treatments of inflammatory diseases such as psoriasis and rheumatoid arthritis.  Using the previously reported tertiary sulfonamide as a starting point, the authors engineered structural modifications that significantly improved human and rat metabolic stabilities while maintaining a potent and highly selective RORc inverse agonist profile.  The most advanced δ-sultam compd. I possessed favorable RORc cellular potency with 75-fold selectivity for RORc over other ROR family members and >200-fold selectivity over 25 addnl. nuclear receptors in a cell assay panel.  The favorable potency, selectivity, in vitro ADME properties, in vivo PK, and dose-dependent inhibition of IL-17 in a PK/PD model support the evaluation of I in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgSG0WeUAvc7Vg90H21EOLACvtfcHk0lijB3U6M4zLSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVansL3M&md5=86f291aa61281c4ec98a34cdd31963e0</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00597%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DRen%25C3%25A9%26aufirst%3DO.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DLesch%26aufirst%3DJ.%26aulast%3DLockey%26aufirst%3DP.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%25201-%257B4-%255B3-fluoro-4-%2528%25283s%252C6r%2529-3-methyl-1%252C1-dioxo-6-phenyl-%255B1%252C2%255Dthiazinan-2-ylmethyl%2529-phenyl%255D-piperazin-1-yl%257D-ethanone%2520%2528GNE-3500%2529%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520C%2520%2528RORc%2520or%2520ROR%25CE%25B3%2529%2520inverse%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D5308%26epage%3D5322%26doi%3D10.1021%2Facs.jmedchem.5b00597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bodil Van Niel, M.</span>; <span class="NLM_string-name">Fauber, B.</span>; <span class="NLM_string-name">Gaines, S.</span>; <span class="NLM_string-name">Gobbi, A.</span>; <span class="NLM_string-name">Rene, O.</span>; <span class="NLM_string-name">Vesey, D.</span>; <span class="NLM_string-name">Ward, S.</span></span> <span> </span><span class="NLM_article-title">Aryl Sultam Derivatives as RORc Modulators</span>. WO Patent <span class="NLM_patent">WO2014009447A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+Bodil+Van+Niel&author=B.+Fauber&author=S.+Gaines&author=A.+Gobbi&author=O.+Rene&author=D.+Vesey&author=S.+Ward&title=Aryl+Sultam+Derivatives+as+RORc+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBodil%2BVan%2BNiel%26aufirst%3DM.%26atitle%3DAryl%2520Sultam%2520Derivatives%2520as%2520RORc%2520Modulators%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birault, V.</span>; <span class="NLM_string-name">Campbell, A. J.</span>; <span class="NLM_string-name">Harrison, S. A.</span>; <span class="NLM_string-name">Le, J.</span></span> <span> </span><span class="NLM_article-title">Novel Compounds</span>. WO Patent <span class="NLM_patent">WO2015061515A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=V.+Birault&author=A.+J.+Campbell&author=S.+A.+Harrison&author=J.+Le&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBirault%26aufirst%3DV.%26atitle%3DNovel%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birault, V.</span>; <span class="NLM_string-name">Campbell, A. J.</span>; <span class="NLM_string-name">Harrison, S. A.</span>; <span class="NLM_string-name">Le, J.</span>; <span class="NLM_string-name">Shukla, L.</span></span> <span> </span><span class="NLM_article-title">Novel Compounds</span>. WO Patent <span class="NLM_patent">WO2013160418A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=V.+Birault&author=A.+J.+Campbell&author=S.+A.+Harrison&author=J.+Le&author=L.+Shukla&title=Novel+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBirault%26aufirst%3DV.%26atitle%3DNovel%2520Compounds%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peredo, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicodeme, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brusq, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birault, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viviani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofland, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote-Sierra, J.</span></span> <span> </span><span class="NLM_article-title">Development of a topical treatment for psoriasis targeting RORγ: From bench to skin</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0147979</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0147979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1371%2Fjournal.pone.0147979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26870941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XotlGltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0147979&author=S.+H.+Smithauthor=C.+E.+Peredoauthor=Y.+Takedaauthor=T.+Buiauthor=J.+Neilauthor=D.+Rickardauthor=E.+Millermanauthor=J.+P.+Therrienauthor=E.+Nicodemeauthor=J.+M.+Brusqauthor=V.+Biraultauthor=F.+Vivianiauthor=H.+Hoflandauthor=A.+M.+Jettenauthor=J.+Cote-Sierra&title=Development+of+a+topical+treatment+for+psoriasis+targeting+ROR%CE%B3%3A+From+bench+to+skin&doi=10.1371%2Fjournal.pone.0147979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a topical treatment for psoriasis targeting RORγ: from bench to skin</span></div><div class="casAuthors">Smith, Susan H.; Peredo, Carlos E.; Takeda, Yukimasa; Bui, Thi; Neil, Jessica; Rickard, David; Millerman, Elizabeth; Therrien, Jean-Philippe; Nicodeme, Edwige; Brusq, Jean-Marie; Birault, Veronique; Viviani, Fabrice; Hofland, Hans; Jetten, Anton M.; Cote-Sierra, Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e0147979/1-e0147979/18</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Psoriasis is a chronic inflammatory skin disorder involving marked immunol. changes.  IL-17-targeting biologics have been successful in reducing the disease burden of psoriasis patients with moderate-to-severe disease.  Unfortunately, the stratum corneum prevents penetration of large mol. wt. proteins, including monoclonal antibodies.  Thus, for the majority of psoriasis patients ineligible for systemic treatments, a small mol. targeting RORγt, the master regulator of IL-17 family cytokines, may represent an alternative topical medicine with biol.-like efficacy.  Methods and Findings: The preclin. studies described in this manuscript bridge the gap from bench to bedside to provide the scientific foundation for a compd. entering clin. trials for patients with mild to moderate psoriasis.  In addn. to several ex vivo reporter assays, primary T cell cultures, and the imiquimod mouse model, we demonstrate efficacy in a newly developed human ex vivo skin assay, where Th17-skewed cytokine expression is induced from skin-resident immune cells.  Importantly, the skin barrier remains intact allowing for the demonstration of topical drug delivery.  With the development of this novel assay, we demonstrate potent compd. activity in the target tissue: human skin.  Finally, target engagement by this small mol. was confirmed in ex vivo lesional psoriatic skin.  Conclusions: Our work describes a progressive series of assays to demonstrate the potential clin. value of a novel RORγ inverse agonist small mol. with high potency and selectivity, which will enter clin. trials in late 2015 for psoriasis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokk_sPVo8crbVg90H21EOLACvtfcHk0lj4ND3cLJBLEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotlGltLs%253D&md5=75b3d12e090eab85b79fa55312798dd1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0147979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0147979%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BH.%26aulast%3DPeredo%26aufirst%3DC.%2BE.%26aulast%3DTakeda%26aufirst%3DY.%26aulast%3DBui%26aufirst%3DT.%26aulast%3DNeil%26aufirst%3DJ.%26aulast%3DRickard%26aufirst%3DD.%26aulast%3DMillerman%26aufirst%3DE.%26aulast%3DTherrien%26aufirst%3DJ.%2BP.%26aulast%3DNicodeme%26aufirst%3DE.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DBirault%26aufirst%3DV.%26aulast%3DViviani%26aufirst%3DF.%26aulast%3DHofland%26aufirst%3DH.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26aulast%3DCote-Sierra%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520a%2520topical%2520treatment%2520for%2520psoriasis%2520targeting%2520ROR%25CE%25B3%253A%2520From%2520bench%2520to%2520skin%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0147979%26doi%3D10.1371%2Fjournal.pone.0147979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atrux-Tallau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bihl, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bondu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlavan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Defoin-Platel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deret, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forissier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froude, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hacini-Rachinel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervouet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huguet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafitte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozello, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peluchon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piwnica, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiesse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vatinel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vial, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of CD12681, a potent RORγ inverse agonist, preclinical candidate for the topical treatment of psoriasis</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201700758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29327456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1aksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=321-337&author=G.+Ouvryauthor=N.+Atrux-Tallauauthor=F.+Bihlauthor=A.+Bonduauthor=C.+Bouix-Peterauthor=I.+Carlavanauthor=O.+Christinauthor=M.+J.+Cuadradoauthor=C.+Defoin-Platelauthor=S.+Deretauthor=D.+Duvertauthor=C.+Feretauthor=M.+Forissierauthor=J.+F.+Fournierauthor=D.+Froudeauthor=F.+Hacini-Rachinelauthor=C.+S.+Harrisauthor=C.+Hervouetauthor=H.+Huguetauthor=G.+Lafitteauthor=A.+P.+Luzyauthor=B.+Musickiauthor=D.+Orfilaauthor=B.+Ozelloauthor=C.+Pascauauthor=J.+Pascauauthor=V.+Parnetauthor=G.+Peluchonauthor=R.+Pierreauthor=D.+Piwnicaauthor=C.+Raffinauthor=P.+Rossioauthor=D.+Spiesseauthor=N.+Taquetauthor=E.+Thoreauauthor=R.+Vatinelauthor=E.+Vialauthor=L.+F.+Hennequin&title=Discovery+and+characterization+of+CD12681%2C+a+potent+ROR%CE%B3+inverse+agonist%2C+preclinical+candidate+for+the+topical+treatment+of+psoriasis&doi=10.1002%2Fcmdc.201700758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis</span></div><div class="casAuthors">Ouvry, Gilles; Atrux-Tallau, Nicolas; Bihl, Franck; Bondu, Aline; Bouix-Peter, Claire; Carlavan, Isabelle; Christin, Olivier; Cuadrado, Marie-Josee; Defoin-Platel, Claire; Deret, Sophie; Duvert, Denis; Feret, Christophe; Forissier, Mathieu; Fournier, Jean-Francois; Froude, David; Hacini-Rachinel, Feriel; Harris, Craig Steven; Hervouet, Catherine; Huguet, Helene; Lafitte, Guillaume; Luzy, Anne-Pascale; Musicki, Branislav; Orfila, Danielle; Ozello, Benjamin; Pascau, Coralie; Pascau, Jonathan; Parnet, Veronique; Peluchon, Guillaume; Pierre, Romain; Piwnica, David; Raffin, Catherine; Rossio, Patricia; Spiesse, Delphine; Taquet, Nathalie; Thoreau, Etienne; Vatinel, Rodolphe; Vial, Emmanuel; Hennequin, Laurent Francois</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-337</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">With possible implications in multiple autoimmune diseases, the retinoic acid receptor-related orphan receptor RORγ has become a sought-after target in the pharmaceutical industry.  Herein are described the efforts to identify a potent RORγ inverse agonist compatible with topical application for the treatment of skin diseases.  These efforts culminated in the discovery of N-(2,4-dimethylphenyl)-N-isobutyl-2-oxo-1-[(tetrahydro-2H-pyran-4-yl)methyl]-2,3-dihydro-1H-benzo[d]imidazole-5-sulfonamide (CD12681), a potent inverse agonist with in vivo activity in an IL-23-induced mouse skin inflammation model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-4rMWerixL7Vg90H21EOLACvtfcHk0lj4ND3cLJBLEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1aksL4%253D&md5=443fc01d790536a34918f1b33f8fdba2</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700758%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DAtrux-Tallau%26aufirst%3DN.%26aulast%3DBihl%26aufirst%3DF.%26aulast%3DBondu%26aufirst%3DA.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DCarlavan%26aufirst%3DI.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DCuadrado%26aufirst%3DM.%2BJ.%26aulast%3DDefoin-Platel%26aufirst%3DC.%26aulast%3DDeret%26aufirst%3DS.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DFeret%26aufirst%3DC.%26aulast%3DForissier%26aufirst%3DM.%26aulast%3DFournier%26aufirst%3DJ.%2BF.%26aulast%3DFroude%26aufirst%3DD.%26aulast%3DHacini-Rachinel%26aufirst%3DF.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DHervouet%26aufirst%3DC.%26aulast%3DHuguet%26aufirst%3DH.%26aulast%3DLafitte%26aufirst%3DG.%26aulast%3DLuzy%26aufirst%3DA.%2BP.%26aulast%3DMusicki%26aufirst%3DB.%26aulast%3DOrfila%26aufirst%3DD.%26aulast%3DOzello%26aufirst%3DB.%26aulast%3DPascau%26aufirst%3DC.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DParnet%26aufirst%3DV.%26aulast%3DPeluchon%26aufirst%3DG.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DPiwnica%26aufirst%3DD.%26aulast%3DRaffin%26aufirst%3DC.%26aulast%3DRossio%26aufirst%3DP.%26aulast%3DSpiesse%26aufirst%3DD.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DThoreau%26aufirst%3DE.%26aulast%3DVatinel%26aufirst%3DR.%26aulast%3DVial%26aufirst%3DE.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520CD12681%252C%2520a%2520potent%2520ROR%25CE%25B3%2520inverse%2520agonist%252C%2520preclinical%2520candidate%2520for%2520the%2520topical%2520treatment%2520of%2520psoriasis%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26spage%3D321%26epage%3D337%26doi%3D10.1002%2Fcmdc.201700758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5293</span>– <span class="NLM_lpage">5302</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.07.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2015.07.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5293-5302&author=Y.+Wangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Maauthor=L.+Yangauthor=L.+Zhouauthor=Z.+Xiangauthor=Z.+Chengauthor=S.+Luauthor=L.+A.+Orband-Millerauthor=W.+Zhangauthor=Q.+Wuauthor=K.+Zhangauthor=Y.+Liauthor=J.-N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+N-%284-aryl-5-aryloxy-thiazol-2-yl%29-amides+as+potent+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmc.2015.07.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.07.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.07.068%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DXiang%26aufirst%3DJ.-N.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520N-%25284-aryl-5-aryloxy-thiazol-2-yl%2529-amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5293%26epage%3D5302%26doi%3D10.1016%2Fj.bmc.2015.07.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxdorf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">692</span>– <span class="NLM_lpage">702</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2013.12.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=692-702&author=Y.+Wangauthor=W.+Caiauthor=G.+Zhangauthor=T.+Yangauthor=Q.+Liuauthor=Y.+Chengauthor=L.+Zhouauthor=Y.+Maauthor=Z.+Chengauthor=S.+Luauthor=Y.+G.+Zhaoauthor=W.+Zhangauthor=Z.+Xiangauthor=S.+Wangauthor=L.+Yangauthor=Q.+Wuauthor=L.+A.+Orband-Millerauthor=Y.+Xuauthor=J.+Zhangauthor=R.+Gaoauthor=M.+Huxdorfauthor=J.+N.+Xiangauthor=Z.+Zhongauthor=J.+D.+Elliottauthor=S.+Leungauthor=X.+Lin&title=Discovery+of+novel+N-%285-%28arylcarbonyl%29thiazol-2-yl%29amides+and+N-%285-%28arylcarbonyl%29thiophen-2-yl%29amides+as+potent+ROR%CE%B3t+inhibitors&doi=10.1016%2Fj.bmc.2013.12.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DY.%2BG.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DR.%26aulast%3DHuxdorf%26aufirst%3DM.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%2520N-%25285-%2528arylcarbonyl%2529thiazol-2-yl%2529amides%2520and%2520N-%25285-%2528arylcarbonyl%2529thiophen-2-yl%2529amides%2520as%2520potent%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D692%26epage%3D702%26doi%3D10.1016%2Fj.bmc.2013.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlüter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5265</span>– <span class="NLM_lpage">5267</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.09.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2014.09.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=5265-5267&author=C.+Gegeauthor=T.+Schl%C3%BCterauthor=T.+Hoffmann&title=Identification+of+the+first+inverse+agonist+of+retinoid-related+orphan+receptor+%28ROR%29+with+dual+selectivity+for+ROR%CE%B2+and+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2014.09.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.09.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.09.053%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26aulast%3DSchl%25C3%25BCter%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DT.%26atitle%3DIdentification%2520of%2520the%2520first%2520inverse%2520agonist%2520of%2520retinoid-related%2520orphan%2520receptor%2520%2528ROR%2529%2520with%2520dual%2520selectivity%2520for%2520ROR%25CE%25B2%2520and%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D5265%26epage%3D5267%26doi%3D10.1016%2Fj.bmcl.2014.09.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of biaryl amides as potent, orally bioavailable, and CNS penetrant RORγt inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00122</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00122" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=787-792&author=Y.+Wangauthor=W.+Caiauthor=Y.+Chengauthor=T.+Yangauthor=Q.+Liuauthor=G.+Zhangauthor=Q.+Mengauthor=F.+Hanauthor=Y.+Huangauthor=L.+Zhouauthor=Z.+Xiangauthor=Y.+G.+Zhaoauthor=Y.+Xuauthor=Z.+Chengauthor=S.+Luauthor=Q.+Wuauthor=J.+N.+Xiangauthor=J.+D.+Elliottauthor=S.+Leungauthor=F.+Renauthor=X.+Lin&title=Discovery+of+biaryl+amides+as+potent%2C+orally+bioavailable%2C+and+CNS+penetrant+ROR%CE%B3t+inhibitors&doi=10.1021%2Facsmedchemlett.5b00122"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors</span></div><div class="casAuthors">Wang, Yonghui; Cai, Wei; Cheng, Yaobang; Yang, Ting; Liu, Qian; Zhang, Guifeng; Meng, Qinghua; Han, Fangbin; Huang, Yafei; Zhou, Ling; Xiang, Zhijun; Zhao, Yong-Gang; Xu, Yan; Cheng, Ziqiang; Lu, Sijie; Wu, Qianqian; Xiang, Jia-Ning; Elliott, John D.; Leung, Stewart; Ren, Feng; Lin, Xichen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">787-792</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of biaryl amides was identified as RORγt inhibitors through core replacement of a starting hit 1.  Structure-activity relation exploration on the biaryl moiety led to discovery of potent RORγt inhibitors with good oral bioavailability and CNS penetration.  Compds. 9a and 9g demonstrated excellent in vivo efficacy in EAE mice dose dependently with once daily oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRg-_IJY0l47Vg90H21EOLACvtfcHk0ljNn1e0_nXorw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGmtb8%253D&md5=0011aa5b6e6952ef2f7cfced6ee1b7fc</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00122%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DY.%2BG.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DJ.%2BD.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DRen%26aufirst%3DF.%26aulast%3DLin%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520biaryl%2520amides%2520as%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520CNS%2520penetrant%2520ROR%25CE%25B3t%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D787%26epage%3D792%26doi%3D10.1021%2Facsmedchemlett.5b00122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yosef, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretschmer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahl, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafler, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V. K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">489</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.immuni.2014.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24745332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2014&pages=477-489&author=S.+Xiaoauthor=N.+Yosefauthor=J.+Yangauthor=Y.+Wangauthor=L.+Zhouauthor=C.+Zhuauthor=C.+Wuauthor=E.+Balogluauthor=D.+Schmidtauthor=R.+Rameshauthor=M.+Loberaauthor=M.+S.+Sundrudauthor=P.+Y.+Tsaiauthor=Z.+Xiangauthor=J.+Wangauthor=Y.+Xuauthor=X.+Linauthor=K.+Kretschmerauthor=P.+B.+Rahlauthor=R.+A.+Youngauthor=Z.+Zhongauthor=D.+A.+Haflerauthor=A.+Regevauthor=S.+Ghoshauthor=A.+Marsonauthor=V.+K.+Kuchroo&title=Small-molecule+ROR%CE%B3t+antagonists+inhibit+T+helper+17+cell+transcriptional+network+by+divergent+mechanisms&doi=10.1016%2Fj.immuni.2014.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule RORγt Antagonists Inhibit T Helper 17 Cell Transcriptional Network by Divergent Mechanisms</span></div><div class="casAuthors">Xiao, Sheng; Yosef, Nir; Yang, Jianfei; Wang, Yonghui; Zhou, Ling; Zhu, Chen; Wu, Chuan; Baloglu, Erkan; Schmidt, Darby; Ramesh, Radha; Lobera, Mercedes; Sundrud, Mark S.; Tsai, Pei-Yun; Xiang, Zhijun; Wang, Jinsong; Xu, Yan; Lin, Xichen; Kretschmer, Karsten; Rahl, Peter B.; Young, Richard A.; Zhong, Zhong; Hafler, David A.; Regev, Aviv; Ghosh, Shomir; Marson, Alexander; Kuchroo, Vijay K.</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">477-489</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">We identified three retinoid-related orphan receptor gamma t (RORγt)-specific inhibitors that suppress T helper 17 (Th17) cell responses, including Th17-cell-mediated autoimmune disease.  We systemically characterized RORγt binding in the presence and absence of drugs with corresponding whole-genome transcriptome sequencing.  RORγt acts as a direct activator of Th17 cell signature genes and a direct repressor of signature genes from other T cell lineages; its strongest transcriptional effects are on cis-regulatory sites contg. the RORα binding motif.  RORγt is central in a densely interconnected regulatory network that shapes the balance of T cell differentiation.  Here, the three inhibitors modulated the RORγt-dependent transcriptional network to varying extents and through distinct mechanisms.  Whereas one inhibitor displaced RORγt from its target loci, the other two inhibitors affected transcription predominantly without removing DNA binding.  Our work illustrates the power of a system-scale anal. of transcriptional regulation to characterize potential therapeutic compds. that inhibit pathogenic Th17 cells and suppress autoimmunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23p8R83CDDbVg90H21EOLACvtfcHk0ljNn1e0_nXorw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsVKltr0%253D&md5=940074c565211bc00832179574e5231a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DS.%26aulast%3DYosef%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DC.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%2BS.%26aulast%3DTsai%26aufirst%3DP.%2BY.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DKretschmer%26aufirst%3DK.%26aulast%3DRahl%26aufirst%3DP.%2BB.%26aulast%3DYoung%26aufirst%3DR.%2BA.%26aulast%3DZhong%26aufirst%3DZ.%26aulast%3DHafler%26aufirst%3DD.%2BA.%26aulast%3DRegev%26aufirst%3DA.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DMarson%26aufirst%3DA.%26aulast%3DKuchroo%26aufirst%3DV.%2BK.%26atitle%3DSmall-molecule%2520ROR%25CE%25B3t%2520antagonists%2520inhibit%2520T%2520helper%252017%2520cell%2520transcriptional%2520network%2520by%2520divergent%2520mechanisms%26jtitle%3DImmunity%26date%3D2014%26volume%3D40%26spage%3D477%26epage%3D489%26doi%3D10.1016%2Fj.immuni.2014.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, F.</span></span> <span> </span><span class="NLM_article-title">From RORγt agonist to two types of RORγt inverse agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">120</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00476</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00476" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=120-124&author=Y.+Wangauthor=W.+Caiauthor=T.+Tangauthor=Q.+Liuauthor=T.+Yangauthor=L.+Yangauthor=Y.+Maauthor=G.+Zhangauthor=Y.+Huangauthor=X.+Songauthor=L.+A.+Orband-Millerauthor=Q.+Wuauthor=L.+Zhouauthor=Z.+Xiangauthor=J.+N.+Xiangauthor=S.+Leungauthor=L.+Shaoauthor=X.+Linauthor=M.+Loberaauthor=F.+Ren&title=From+ROR%CE%B3t+agonist+to+two+types+of+ROR%CE%B3t+inverse+agonists&doi=10.1021%2Facsmedchemlett.7b00476"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00476%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DZ.%26aulast%3DXiang%26aufirst%3DJ.%2BN.%26aulast%3DLeung%26aufirst%3DS.%26aulast%3DShao%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DRen%26aufirst%3DF.%26atitle%3DFrom%2520ROR%25CE%25B3t%2520agonist%2520to%2520two%2520types%2520of%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D120%26epage%3D124%26doi%3D10.1021%2Facsmedchemlett.7b00476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R.</span>; <span class="NLM_string-name">Kumar, S.
S.</span>; <span class="NLM_string-name">Pandya, V.</span>; <span class="NLM_string-name">Desai, J.</span>; <span class="NLM_string-name">Raval, S.</span></span> <span> </span><span class="NLM_article-title">Cyclopropyl Derivatives as ROR-gamma Modulators</span>. WO Patent<span class="NLM_patent">WO2018011746A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+Desai&author=S.%0AS.+Kumar&author=V.+Pandya&author=J.+Desai&author=S.+Raval&title=Cyclopropyl+Derivatives+as+ROR-gamma+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DR.%26atitle%3DCyclopropyl%2520Derivatives%2520as%2520ROR-gamma%2520Modulators%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of VTP-43742, a RORγt inverse agonist for the treatment of psoriasis</span>.  <i>13th Winter Conference on Medicinal and Bioorganic Chemistry, Steamboat Springs, CO. January 22–26</i>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=L.+Zhuang&title=Discovery+of+VTP-43742%2C+a+ROR%CE%B3t+inverse+agonist+for+the+treatment+of+psoriasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DZhuang%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520VTP-43742%252C%2520a%2520ROR%25CE%25B3t%2520inverse%2520agonist%2520for%2520the%2520treatment%2520of%2520psoriasis%26jtitle%3D13th%2520Winter%2520Conference%2520on%2520Medicinal%2520and%2520Bioorganic%2520Chemistry%252C%2520Steamboat%2520Springs%252C%2520CO.%2520January%252022%25E2%2580%259326%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGeehan, G. M.</span></span> <span> </span><span class="NLM_article-title">The RORγt blocker, VTP-43742, suppresses Th17 activity providing greater benefit than IL-17A blockade in an EAE model of autoimmunity</span>. Poster presented at  <i>Keystone Symposia on Mechanisms of Pro-Inflammatory Diseases, 23rd April</i>, <span class="NLM_year">2015</span>. <a href="http://www.keystonesymposia.org/15Z4" class="extLink">http://www.keystonesymposia.org/15Z4</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=G.+M.+McGeehan&title=The+ROR%CE%B3t+blocker%2C+VTP-43742%2C+suppresses+Th17+activity+providing+greater+benefit+than+IL-17A+blockade+in+an+EAE+model+of+autoimmunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26atitle%3DThe%2520ROR%25CE%25B3t%2520blocker%252C%2520VTP-43742%252C%2520suppresses%2520Th17%2520activity%2520providing%2520greater%2520benefit%2520than%2520IL-17A%2520blockade%2520in%2520an%2520EAE%2520model%2520of%2520autoimmunity%26jtitle%3DKeystone%2520Symposia%2520on%2520Mechanisms%2520of%2520Pro-Inflammatory%2520Diseases%252C%252023rd%2520April%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claremon, D. A.</span>; <span class="NLM_string-name">Dillard, L. W.</span>; <span class="NLM_string-name">Dong, C.</span>; <span class="NLM_string-name">Fan, Y.</span>; <span class="NLM_string-name">Jia, L.</span>; <span class="NLM_string-name">Lotesta, S. D.</span>; <span class="NLM_string-name">Marcus, A.</span>; <span class="NLM_string-name">Singh, S.
B.</span>; <span class="NLM_string-name">Tice, C.
M.</span>; <span class="NLM_string-name">Yuan, J.</span>; <span class="NLM_string-name">Zhao, W.</span>; <span class="NLM_string-name">Zheng, Y.</span>; <span class="NLM_string-name">Zhuang, L.</span></span> <span> </span><span class="NLM_article-title">Dihydropyrrolopyridine Inhibitors of ROR-gamma</span>. WO Patent <span class="NLM_patent">WO2016061160A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+A.+Claremon&author=L.+W.+Dillard&author=C.+Dong&author=Y.+Fan&author=L.+Jia&author=S.+D.+Lotesta&author=A.+Marcus&author=S.%0AB.+Singh&author=C.%0AM.+Tice&author=J.+Yuan&author=W.+Zhao&author=Y.+Zheng&author=L.+Zhuang&title=Dihydropyrrolopyridine+Inhibitors+of+ROR-gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DDihydropyrrolopyridine%2520Inhibitors%2520of%2520ROR-gamma%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khairatkar-Joshi, N.</span>; <span class="NLM_string-name">Kulkarni, A.</span>; <span class="NLM_string-name">Shah, D. M.</span>; <span class="NLM_string-name">Bhosale, V. M.</span>; <span class="NLM_string-name">Lodhiya, B. J.</span>; <span class="NLM_string-name">Thiraviam, A. M.</span>; <span class="NLM_string-name">Marathe, M.</span>; <span class="NLM_string-name">Hadambar, A. A.</span></span> <span> </span><span class="NLM_article-title">Treatment of Respiratory Disorders Using ROR-gamma Inhibitors</span>. WO Patent<span class="NLM_patent">WO2016193894A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=N.+Khairatkar-Joshi&author=A.+Kulkarni&author=D.+M.+Shah&author=V.+M.+Bhosale&author=B.+J.+Lodhiya&author=A.+M.+Thiraviam&author=M.+Marathe&author=A.+A.+Hadambar&title=Treatment+of+Respiratory+Disorders+Using+ROR-gamma+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKhairatkar-Joshi%26aufirst%3DN.%26atitle%3DTreatment%2520of%2520Respiratory%2520Disorders%2520Using%2520ROR-gamma%2520Inhibitors%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, J. R.</span></span> <span> </span><span class="NLM_article-title">Compounds Useful For Inhibiting ROR-Gamma-T</span>. WO Patent<span class="NLM_patent">WO2017044410A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=J.+R.+Morphy&title=Compounds+Useful+For+Inhibiting+ROR-Gamma-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26atitle%3DCompounds%2520Useful%2520For%2520Inhibiting%2520ROR-Gamma-T%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lever, S.</span>; <span class="NLM_string-name">Narjes, F.</span>; <span class="NLM_string-name">Olsson, R. I.</span>; <span class="NLM_string-name">Von Berg, S.</span></span> <span> </span><span class="NLM_article-title">Isoindole Compounds</span>. WO Patent <span class="NLM_patent">WO2017102784A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+Lever&author=F.+Narjes&author=R.+I.+Olsson&author=S.+Von+Berg&title=Isoindole+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLever%26aufirst%3DS.%26atitle%3DIsoindole%2520Compounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span> <span> </span><span class="NLM_article-title">The discovery of AZD0284, an inverse agonist of the nuclear receptor RORγ</span>.  <i>Drug Design and Delivery Symposium, October 26, 2017</i>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington DC</span>, <span class="NLM_year">2017</span>. <a href="https://www.acs.org/content/acs/en/acs-webinars/drug-discovery/psoriasis.html" class="extLink">https://www.acs.org/content/acs/en/acs-webinars/drug-discovery/psoriasis.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=F.+Narjes&title=The+discovery+of+AZD0284%2C+an+inverse+agonist+of+the+nuclear+receptor+ROR%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DNarjes%26aufirst%3DF.%26atitle%3DThe%2520discovery%2520of%2520AZD0284%252C%2520an%2520inverse%2520agonist%2520of%2520the%2520nuclear%2520receptor%2520ROR%25CE%25B3%26jtitle%3DDrug%2520Design%2520and%2520Delivery%2520Symposium%252C%2520October%252026%252C%25202017%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brunette, S. R.</span>; <span class="NLM_string-name">Csengery, J.</span>; <span class="NLM_string-name">Hughes, R. O.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Sibley, R.</span>; <span class="NLM_string-name">Turner, M. R.</span>; <span class="NLM_string-name">Xiong, Z.</span></span> <span> </span><span class="NLM_article-title">Pteridine Derivatives as Modulators of ROR Gamma</span>. WO Patent <span class="NLM_patent">WO2017058831A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+R.+Brunette&author=J.+Csengery&author=R.+O.+Hughes&author=X.+Li&author=R.+Sibley&author=M.+R.+Turner&author=Z.+Xiong&title=Pteridine+Derivatives+as+Modulators+of+ROR+Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrunette%26aufirst%3DS.%2BR.%26atitle%3DPteridine%2520Derivatives%2520as%2520Modulators%2520of%2520ROR%2520Gamma%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vloten, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guertin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchings, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taveras, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viney, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of biaryl carboxylamides as potent RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2991</span>– <span class="NLM_lpage">2997</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.05.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26048806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFGhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2991-2997&author=J.+Chaoauthor=I.+Enyedyauthor=K.+V.+Van+Vlotenauthor=D.+Marcotteauthor=K.+Guertinauthor=R.+Hutchingsauthor=N.+Powellauthor=H.+Jonesauthor=T.+Bohnertauthor=C.+C.+Pengauthor=L.+Silvianauthor=V.+S.+Hongauthor=K.+Littleauthor=D.+Banerjeeauthor=L.+Pengauthor=A.+Taverasauthor=J.+L.+Vineyauthor=J.+Fontenot&title=Discovery+of+biaryl+carboxylamides+as+potent+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of biaryl carboxylamides as potent RORγ inverse agonists</span></div><div class="casAuthors">Chao, Jianhua; Enyedy, Istvan; Van Vloten, Kurt; Marcotte, Douglas; Guertin, Kevin; Hutchings, Richard; Powell, Noel; Jones, Howard; Bohnert, Tonika; Peng, Chi-Chi; Silvian, Laura; Hong, Victor Sukbong; Little, Kevin; Banerjee, Daliya; Peng, Liaomin; Taveras, Arthur; Viney, Joanne L.; Fontenot, Jason</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2991-2997</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RORγt is a pivotal regulator of a pro-inflammatory gene expression program implicated in the pathol. of several major human immune-mediated diseases.  Evidence from mouse models demonstrates that genetic or pharmacol. inhibition of RORγ activity can block the prodn. of pathogenic cytokines, including IL-17, and convey therapeutic benefit.  We have identified and developed a biaryl-carboxylamide series of RORγ inverse agonists via a structure based design approach.  Co-crystal structures of compds. 16 and 48 supported the design approach and confirmed the key interactions with RORγ protein; the hydrogen bonding with His479 was key to the significant improvement in inverse agonist effect.  The results have shown this is a class of potent and selective RORγ inverse agonists, with demonstrated oral bioavailability in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8cho8P_anmrVg90H21EOLACvtfcHk0li1pwPqPgnTfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFGhtLs%253D&md5=6c8dc3982ef7203c3ae7390cccce99e4</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.026%26sid%3Dliteratum%253Aachs%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DVan%2BVloten%26aufirst%3DK.%2BV.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DGuertin%26aufirst%3DK.%26aulast%3DHutchings%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DN.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DPeng%26aufirst%3DC.%2BC.%26aulast%3DSilvian%26aufirst%3DL.%26aulast%3DHong%26aufirst%3DV.%2BS.%26aulast%3DLittle%26aufirst%3DK.%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DL.%26aulast%3DTaveras%26aufirst%3DA.%26aulast%3DViney%26aufirst%3DJ.%2BL.%26aulast%3DFontenot%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520biaryl%2520carboxylamides%2520as%2520potent%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2991%26epage%3D2997%26doi%3D10.1016%2Fj.bmcl.2015.05.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnert, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyedy, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guertin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talreja, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Vloten, K. V.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2985</span>– <span class="NLM_lpage">2990</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.05.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2985-2990&author=T.+Wangauthor=D.+Banerjeeauthor=T.+Bohnertauthor=J.+Chaoauthor=I.+Enyedyauthor=J.+Fontenotauthor=K.+Guertinauthor=H.+Jonesauthor=E.+Y.+Linauthor=D.+Marcotteauthor=T.+Talrejaauthor=K.+V.+Van+Vloten&title=Discovery+of+novel+pyrazole-containing+benzamides+as+potent+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.028%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBanerjee%26aufirst%3DD.%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DChao%26aufirst%3DJ.%26aulast%3DEnyedy%26aufirst%3DI.%26aulast%3DFontenot%26aufirst%3DJ.%26aulast%3DGuertin%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DH.%26aulast%3DLin%26aufirst%3DE.%2BY.%26aulast%3DMarcotte%26aufirst%3DD.%26aulast%3DTalreja%26aufirst%3DT.%26aulast%3DVan%2BVloten%26aufirst%3DK.%2BV.%26atitle%3DDiscovery%2520of%2520novel%2520pyrazole-containing%2520benzamides%2520as%2520potent%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2985%26epage%3D2990%26doi%3D10.1016%2Fj.bmcl.2015.05.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, F.</span>; <span class="NLM_string-name">Lei, H.</span>; <span class="NLM_string-name">Lin, X.</span>; <span class="NLM_string-name">Meng, Q.</span>; <span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Modulators of The Retinoid-Related Orphan Receptor Gamma (ROR-Gamma) For Use in The Treatment of Autoimmune and Inflammatory Diseases</span>. WO Patent <span class="NLM_patent">WO2014086894A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=F.+Han&author=H.+Lei&author=X.+Lin&author=Q.+Meng&author=Y.+Wang&title=Modulators+of+The+Retinoid-Related+Orphan+Receptor+Gamma+%28ROR-Gamma%29+For+Use+in+The+Treatment+of+Autoimmune+and+Inflammatory+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DF.%26atitle%3DModulators%2520of%2520The%2520Retinoid-Related%2520Orphan%2520Receptor%2520Gamma%2520%2528ROR-Gamma%2529%2520For%2520Use%2520in%2520The%2520Treatment%2520of%2520Autoimmune%2520and%2520Inflammatory%2520Diseases%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piaia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamel, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubic-Schneider, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Rio-Espinola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoegenauer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doelemeyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deurinck, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schümann, J.</span></span> <span> </span><span class="NLM_article-title">Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations</span>. <i>JCI Insight</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">e91127</span>, <span class="refDoi"> DOI: 10.1172/jci.insight.91127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1172%2Fjci.insight.91127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28289717" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=e91127&author=C.+Guntermannauthor=A.+Piaiaauthor=M.+L.+Hamelauthor=D.+Theilauthor=T.+Rubic-Schneiderauthor=A.+Del+Rio-Espinolaauthor=L.+Dongauthor=A.+Billichauthor=K.+Kaupmannauthor=J.+Dawsonauthor=K.+Hoegenauerauthor=D.+Orainauthor=S.+Hintermannauthor=R.+Stringerauthor=D.+D.+Patelauthor=A.+Doelemeyerauthor=M.+Deurinckauthor=J.+Sch%C3%BCmann&title=Retinoic-acid-orphan-receptor-C+inhibition+suppresses+Th17+cells+and+induces+thymic+aberrations&doi=10.1172%2Fjci.insight.91127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1172%2Fjci.insight.91127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci.insight.91127%26sid%3Dliteratum%253Aachs%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DPiaia%26aufirst%3DA.%26aulast%3DHamel%26aufirst%3DM.%2BL.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DRubic-Schneider%26aufirst%3DT.%26aulast%3DDel%2BRio-Espinola%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DHoegenauer%26aufirst%3DK.%26aulast%3DOrain%26aufirst%3DD.%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DD.%2BD.%26aulast%3DDoelemeyer%26aufirst%3DA.%26aulast%3DDeurinck%26aufirst%3DM.%26aulast%3DSch%25C3%25BCmann%26aufirst%3DJ.%26atitle%3DRetinoic-acid-orphan-receptor-C%2520inhibition%2520suppresses%2520Th17%2520cells%2520and%2520induces%2520thymic%2520aberrations%26jtitle%3DJCI%2520Insight%26date%3D2017%26volume%3D2%26spage%3De91127%26doi%3D10.1172%2Fjci.insight.91127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hintermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guntermann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carcache, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaupmann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stringer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orain, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new triazolo- and imidazolopyridine RORγt inverse agonists</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2640</span>– <span class="NLM_lpage">2648</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600500</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fcmdc.201600500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27902884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFKnu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=2640-2648&author=S.+Hintermannauthor=C.+Guntermannauthor=H.+Mattesauthor=D.+A.+Carcacheauthor=J.+Wagnerauthor=A.+Vulpettiauthor=A.+Billichauthor=J.+Dawsonauthor=K.+Kaupmannauthor=J.+Kallenauthor=R.+Stringerauthor=D.+Orain&title=Synthesis+and+biological+evaluation+of+new+triazolo-+and+imidazolopyridine+ROR%CE%B3t+inverse+agonists&doi=10.1002%2Fcmdc.201600500"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of New Triazolo- and Imidazolopyridine RORγt Inverse Agonists</span></div><div class="casAuthors">Hintermann, Samuel; Guntermann, Christine; Mattes, Henri; Carcache, David A.; Wagner, Juergen; Vulpetti, Anna; Billich, Andreas; Dawson, Janet; Kaupmann, Klemens; Kallen, Joerg; Stringer, Rowan; Orain, David</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2640-2648</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Retinoic-acid-related orphan receptor γt (RORγt) is a key transcription factor implicated in the prodn. of pro-inflammatory Th17 cytokines, which drive a no. of autoimmune diseases.  Despite diverse chem. series having been reported, combining high potency with a good physicochem. profile has been a very challenging task in the RORγt inhibitor field.  Based on available chem. structures and incorporating inhouse knowledge, a new series of triazolo- and imidazopyridine RORγt inverse agonists was designed.  In addn., replacement of the terminal cyclopentylamide metabolic soft spot by five-membered heterocycles was investigated.  From the efforts, the authors identified an optimal 6,7,8-substituted imidazo[1,2-a]pyridine core system and a 5-tert-butyl-1,2,4-oxadiazole as cyclopentylamide replacement leading to compds. I and II.  Both derivs. showed good pharmacol. potencies in biochem. and cell-based assays combined with excellent physicochem. properties, including low to medium plasma protein binding across species.  Finally, I and II were shown to be active in a rodent pharmacokinetic/pharmacodynamic (PK/PD) model after oral gavage at 15 mg kg-1, lowering IL-17 cytokine prodn. in ex vivo antigen recall assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWpnWp_eiIk7Vg90H21EOLACvtfcHk0ljS7fmjrnhAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFKnu77O&md5=8840fecf0dd72fb225ed6686c673a35d</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600500%26sid%3Dliteratum%253Aachs%26aulast%3DHintermann%26aufirst%3DS.%26aulast%3DGuntermann%26aufirst%3DC.%26aulast%3DMattes%26aufirst%3DH.%26aulast%3DCarcache%26aufirst%3DD.%2BA.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DBillich%26aufirst%3DA.%26aulast%3DDawson%26aufirst%3DJ.%26aulast%3DKaupmann%26aufirst%3DK.%26aulast%3DKallen%26aufirst%3DJ.%26aulast%3DStringer%26aufirst%3DR.%26aulast%3DOrain%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%2520triazolo-%2520and%2520imidazolopyridine%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D2640%26epage%3D2648%26doi%3D10.1002%2Fcmdc.201600500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimozato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, S.</span></span> <span> </span><span class="NLM_article-title">Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.jdermsci.2016.10.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.jdermsci.2016.10.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27726924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2017&pages=12-19&author=M.+Takaishiauthor=M.+Ishizakiauthor=K.+Suzukiauthor=T.+Isobeauthor=T.+Shimozatoauthor=S.+Sano&title=Oral+administration+of+a+novel+ROR%CE%B3t+antagonist+attenuates+psoriasis-like+skin+lesion+of+two+independent+mouse+models+through+neutralization+of+IL-17&doi=10.1016%2Fj.jdermsci.2016.10.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17</span></div><div class="casAuthors">Takaishi, Mikiro; Ishizaki, Masayuki; Suzuki, Keisuke; Isobe, Takashi; Shimozato, Takaichi; Sano, Shigetoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-19</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Targeting the IL-17 pathway represents a highly effective strategy for the treatment of psoriasis, using antibodies against IL-17A and IL-17 receptor, suggesting that Th17 cells essentially contribute to development of psoriasis.  Th17 differentiation depends on the key transcription factor, RORγt.  To develop a novel RORγt antagonist which is effective on psoriasis via oral administration.  A chem. library was screened using cell-based high-throughput methods, luciferase reporter assay, competitive binding assay, and T cell differentiation assay.  To evaluate in vivo effects of a novel RORγt antagonist, A213, we orally administrated it to two independent mouse models of psoriasis; IL-23-injection model and K5.Stat3C transgenic mouse.  Oral administration of A213 resulted in attenuation of skin inflammation in the both mouse models.  At the same time, increased levels of IL-17A expression were significantly reduced in the skin lesions and skin-draining lymph nodes.  These results implicate a new therapeutic application of RORγt antagonist for the treatment of psoriasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ-UL1F-id0bVg90H21EOLACvtfcHk0ljS7fmjrnhAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1GqsbvO&md5=e96213dec5048167e63a283d4cbe7a48</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2016.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2016.10.001%26sid%3Dliteratum%253Aachs%26aulast%3DTakaishi%26aufirst%3DM.%26aulast%3DIshizaki%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DShimozato%26aufirst%3DT.%26aulast%3DSano%26aufirst%3DS.%26atitle%3DOral%2520administration%2520of%2520a%2520novel%2520ROR%25CE%25B3t%2520antagonist%2520attenuates%2520psoriasis-like%2520skin%2520lesion%2520of%2520two%2520independent%2520mouse%2520models%2520through%2520neutralization%2520of%2520IL-17%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2017%26volume%3D85%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.jdermsci.2016.10.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flick, A. C.</span>; <span class="NLM_string-name">Jones, P.</span>; <span class="NLM_string-name">Kaila, N.</span>; <span class="NLM_string-name">Mente, S. R.</span>; <span class="NLM_string-name">Schnute, M. E.</span>; <span class="NLM_string-name">Trzupek, J. D.</span>; <span class="NLM_string-name">Vazquez, M. L.</span>; <span class="NLM_string-name">Xing, L.</span>; <span class="NLM_string-name">Zhang, L.</span>; <span class="NLM_string-name">Wennerstål, G.
M.</span>; <span class="NLM_string-name">Zamaratski, E.</span></span> <span> </span><span class="NLM_article-title">Methyl-And Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof</span>. WO Patent <span class="NLM_patent">WO2016046755A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+C.+Flick&author=P.+Jones&author=N.+Kaila&author=S.+R.+Mente&author=M.+E.+Schnute&author=J.+D.+Trzupek&author=M.+L.+Vazquez&author=L.+Xing&author=L.+Zhang&author=G.%0AM.+Wennerst%C3%A5l&author=E.+Zamaratski&title=Methyl-And+Trifluoromethyl-Substituted+Pyrrolopyridine+Modulators+of+RORC2+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlick%26aufirst%3DA.%2BC.%26atitle%3DMethyl-And%2520Trifluoromethyl-Substituted%2520Pyrrolopyridine%2520Modulators%2520of%2520RORC2%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2017.12.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=470-482&author=M.+Konoauthor=T.+Odaauthor=M.+Tawadaauthor=T.+Imadaauthor=Y.+Bannoauthor=N.+Tayaauthor=T.+Kawamotoauthor=H.+Tokuharaauthor=Y.+Tomataauthor=N.+Ishiiauthor=A.+Ochidaauthor=Y.+Fukaseauthor=T.+Yukawaauthor=S.+Fukumotoauthor=H.+Watanabeauthor=K.+Ugaauthor=A.+Shibataauthor=H.+Nakagawaauthor=M.+Shirasakiauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=J.+Shiraiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists.+Part+2%3A+Design%2C+synthesis%2C+and+biological+evaluation+of+novel+tetrahydroisoquinoline+derivatives&doi=10.1016%2Fj.bmc.2017.12.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DT.%26aulast%3DTawada%26aufirst%3DM.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DYukawa%26aufirst%3DT.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists.%2520Part%25202%253A%2520Design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520tetrahydroisoquinoline%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D470%26epage%3D482%26doi%3D10.1016%2Fj.bmc.2017.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span>; <span class="NLM_string-name">Shirai, J.</span>; <span class="NLM_string-name">Fukase, Y.</span>; <span class="NLM_string-name">Tomata, Y.</span>; <span class="NLM_string-name">Sato, A.</span>; <span class="NLM_string-name">Ochida, A.</span>; <span class="NLM_string-name">Yonemori, K.</span>; <span class="NLM_string-name">Nakagawa, H.</span></span> <span> </span><span class="NLM_article-title">Condensed Heterocyclic Compound</span>. WO Patent <span class="NLM_patent">WO 2013042782A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+Yamamoto&author=J.+Shirai&author=Y.+Fukase&author=Y.+Tomata&author=A.+Sato&author=A.+Ochida&author=K.+Yonemori&author=H.+Nakagawa&title=Condensed+Heterocyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DCondensed%2520Heterocyclic%2520Compound%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonemori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">483</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2017.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29262987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=483-500&author=J.+Shiraiauthor=Y.+Tomataauthor=M.+Konoauthor=A.+Ochidaauthor=Y.+Fukaseauthor=A.+Satoauthor=S.+Masadaauthor=T.+Kawamotoauthor=K.+Yonemoriauthor=R.+Koyamaauthor=H.+Nakagawaauthor=M.+Nakayamaauthor=K.+Ugaauthor=A.+Shibataauthor=K.+Kogaauthor=T.+Okuiauthor=M.+Shirasakiauthor=R.+Skeneauthor=B.+Sangauthor=I.+Hoffmanauthor=W.+Laneauthor=Y.+Fujitaniauthor=M.+Yamasakiauthor=S.+Yamamoto&title=Discovery+of+orally+efficacious+ROR%CE%B3t+inverse+agonists%2C+part+1%3A+Identification+of+novel+phenylglycinamides+as+lead+scaffolds&doi=10.1016%2Fj.bmc.2017.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds</span></div><div class="casAuthors">Shirai, Junya; Tomata, Yoshihide; Kono, Mitsunori; Ochida, Atsuko; Fukase, Yoshiyuki; Sato, Ayumu; Masada, Shinichi; Kawamoto, Tetsuji; Yonemori, Kazuko; Koyama, Ryoukichi; Nakagawa, Hideyuki; Nakayama, Masaharu; Uga, Keiko; Shibata, Akira; Koga, Keiko; Okui, Toshitake; Shirasaki, Mikio; Skene, Robert; Sang, Bi Ching; Hoffman, Isaac; Lane, Wes; Fujitani, Yasushi; Yamasaki, Masashi; Yamamoto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">483-500</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel phenylglycinamides as retinoic acid receptor-related orphan receptor-gamma t (RORγt) inverse agonists were discovered through optimization of a high-throughput screen hit 1.  (R)-N-(2-((3,5-Difluoro-4-(trimethylsilyl)phenyl) amino)-1-(4-methoxyphenyl)-2-oxoethyl)-3-hydroxy-N-methylisoxazole-5-carboxamide (22) was identified as one of the best of these compds.  It displayed higher subtype selectivity and specificity over other nuclear receptors and demonstrated in vivo potency to suppress the transcriptional activity of RORγt in a mouse PD (pharmacodynamic) model upon oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIW-zVUDTjKLVg90H21EOLACvtfcHk0liWVNDhQZ-wfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvF2nsLbJ&md5=649c3527a6f7e383456dd59551e35628</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DTomata%26aufirst%3DY.%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYonemori%26aufirst%3DK.%26aulast%3DKoyama%26aufirst%3DR.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DKoga%26aufirst%3DK.%26aulast%3DOkui%26aufirst%3DT.%26aulast%3DShirasaki%26aufirst%3DM.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DB.%26aulast%3DHoffman%26aufirst%3DI.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520orally%2520efficacious%2520ROR%25CE%25B3t%2520inverse%2520agonists%252C%2520part%25201%253A%2520Identification%2520of%2520novel%2520phenylglycinamides%2520as%2520lead%2520scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D483%26epage%3D500%26doi%3D10.1016%2Fj.bmc.2017.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagomi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span> <span> </span><span class="NLM_article-title">Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmc.2014.01.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1948-1959&author=H.+Toyamaauthor=M.+Nakamuraauthor=M.+Nakamuraauthor=Y.+Matsumotoauthor=M.+Nakagomiauthor=Y.+Hashimoto&title=Development+of+novel+silicon-containing+inverse+agonists+of+retinoic+acid+receptor-related+orphan+receptors&doi=10.1016%2Fj.bmc.2014.01.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DToyama%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DNakagomi%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520novel%2520silicon-containing%2520inverse%2520agonists%2520of%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1948%26epage%3D1959%26doi%3D10.1016%2Fj.bmc.2014.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonemori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yukawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tokuhara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchimori, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of [cis-3-({(5R)-5-[(7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic acid (TAK-828F) as a potent, selective, and orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2973</span>– <span class="NLM_lpage">2988</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00061</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00061" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjvFWns7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2973-2988&author=M.+Konoauthor=A.+Ochidaauthor=T.+Odaauthor=T.+Imadaauthor=Y.+Bannoauthor=N.+Tayaauthor=S.+Masadaauthor=T.+Kawamotoauthor=K.+Yonemoriauthor=Y.+Naraauthor=Y.+Fukaseauthor=T.+Yukawaauthor=H.+Tokuharaauthor=R.+Skeneauthor=B.+C.+Sangauthor=I.+D.+Hoffmanauthor=G.+P.+Snellauthor=K.+Ugaauthor=A.+Shibataauthor=K.+Igakiauthor=Y.+Nakamuraauthor=H.+Nakagawaauthor=N.+Tsuchimoriauthor=M.+Yamasakiauthor=J.+Shiraiauthor=S.+Yamamoto&title=Discovery+of+%5Bcis-3-%28%7B%285R%29-5-%5B%287-fluoro-1%2C1-dimethyl-2%2C3-dihydro-1H-inden-5-yl%29carbamoyl%5D-2-methoxy-7%2C8-dihydro-1%2C6-naphthyridin-6%285H%29-yl%7Dcarbonyl%29cyclobutyl%5Dacetic+acid+%28TAK-828F%29+as+a+potent%2C+selective%2C+and+orally+available+novel+retinoic+acid+receptor-related+orphan+receptor+%CE%B3t+inverse+agonist&doi=10.1021%2Facs.jmedchem.8b00061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of [cis-3-({(5R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist</span></div><div class="casAuthors">Kono, Mitsunori; Ochida, Atsuko; Oda, Tsuneo; Imada, Takashi; Banno, Yoshihiro; Taya, Naohiro; Masada, Shinichi; Kawamoto, Tetsuji; Yonemori, Kazuko; Nara, Yoshi; Fukase, Yoshiyuki; Yukawa, Tomoya; Tokuhara, Hidekazu; Skene, Robert; Sang, Bi-Ching; Hoffman, Isaac D.; Snell, Gyorgy P.; Uga, Keiko; Shibata, Akira; Igaki, Keiko; Nakamura, Yoshiki; Nakagawa, Hideyuki; Tsuchimori, Noboru; Yamasaki, Masashi; Shirai, Junya; Yamamoto, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2973-2988</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of tetrahydronaphthyridine derivs. as novel RORγt inverse agonists were designed and synthesized.  We reduced the lipophilicity of tetrahydroisoquinoline compd. 1 by replacement of the trimethylsilyl group and SBDD-guided scaffold exchange, which successfully afforded compd. 7 (VII) with a lower log D value and tolerable in vitro activity.  Consideration of LLE (lipophilic ligand efficiency) values in the subsequent optimization of the carboxylate tether led to the discovery of [cis-3-({(5R)-5-[(7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic acid, TAK-828F (10), which showed potent RORγt inverse agonistic activity, excellent selectivity against other ROR isoforms and nuclear receptors, and a good pharmacokinetic profile.  In animal studies, oral administration of compd. 10 exhibited robust and dose-dependent inhibition of IL-17A cytokine expression in a mouse IL23-induced gene expression assay.  Furthermore, development of clin. symptoms in a mouse exptl. autoimmune encephalomyelitis model was significantly reduced.  Compd. 10 was selected as a clin. compd. for the treatment of Th17-driven autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqraNPFfTkC1rVg90H21EOLACvtfcHk0li5PqUtWh67Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjvFWns7Y%253D&md5=966c20bbdf825d1ff6eb91c5950a33c8</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00061%26sid%3Dliteratum%253Aachs%26aulast%3DKono%26aufirst%3DM.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DOda%26aufirst%3DT.%26aulast%3DImada%26aufirst%3DT.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DTaya%26aufirst%3DN.%26aulast%3DMasada%26aufirst%3DS.%26aulast%3DKawamoto%26aufirst%3DT.%26aulast%3DYonemori%26aufirst%3DK.%26aulast%3DNara%26aufirst%3DY.%26aulast%3DFukase%26aufirst%3DY.%26aulast%3DYukawa%26aufirst%3DT.%26aulast%3DTokuhara%26aufirst%3DH.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DSang%26aufirst%3DB.%2BC.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DIgaki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DTsuchimori%26aufirst%3DN.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520%255Bcis-3-%2528%257B%25285R%2529-5-%255B%25287-fluoro-1%252C1-dimethyl-2%252C3-dihydro-1H-inden-5-yl%2529carbamoyl%255D-2-methoxy-7%252C8-dihydro-1%252C6-naphthyridin-6%25285H%2529-yl%257Dcarbonyl%2529cyclobutyl%255Dacetic%2520acid%2520%2528TAK-828F%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520available%2520novel%2520retinoic%2520acid%2520receptor-related%2520orphan%2520receptor%2520%25CE%25B3t%2520inverse%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2973%26epage%3D2988%26doi%3D10.1021%2Facs.jmedchem.8b00061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uga, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Igaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuchimori, N.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2018.01.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bcp.2018.01.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29369782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVentr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=35-45&author=A.+Shibataauthor=K.+Ugaauthor=T.+Satoauthor=M.+Sagaraauthor=K.+Igakiauthor=Y.+Nakamuraauthor=A.+Ochidaauthor=M.+Konoauthor=J.+Shiraiauthor=S.+Yamamotoauthor=M.+Yamasakiauthor=N.+Tsuchimori&title=Pharmacological+inhibitory+profile+of+TAK-828F%2C+a+potent+and+selective+orally+available+ROR%CE%B3t+inverse+agonist&doi=10.1016%2Fj.bcp.2018.01.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist</span></div><div class="casAuthors">Shibata, Akira; Uga, Keiko; Sato, Takayuki; Sagara, Masaki; Igaki, Keiko; Nakamura, Yoshiki; Ochida, Atsuko; Kono, Mitsunori; Shirai, Junya; Yamamoto, Satoshi; Yamasaki, Masashi; Tsuchimori, Noboru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">35-45</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Retinoic acid-related orphan receptor γt (RORγt) is a key master regulator of the differentiation and activation of IL-17 producing CD4+ Th17, CD8+ Tc17 and IL-17/IFN-γ co-producing cells (Th1/17 cells).  These cells play crit. roles in the pathogenesis of autoimmune diseases such as inflammatory bowel disease and multiple sclerosis.  Thus, RORγt is an attractive target for the treatment of these diseases.  The authors discovered TAK-828F, an orally available potent and selective RORγt inverse agonist.  The inhibitory effect on the activation and differentiation of Th17 cells by TAK-828F was evaluated in mouse and human primary cells.  TAK-828F inhibited IL-17 prodn. from mouse splenocytes and human peripheral blood mononuclear cells dose-dependently at concns. of 0.01-10 μM without affecting the prodn. of IFN-γ.  Addnl., TAK-828F strongly inhibited Th17, Tc17 and Th1/17 cells' differentiation from naive T cells and memory CD4+ T cells at 100 nM without affecting Th1 cells' differentiation.  In addn., TAK-828F improved Th17/Treg cells' population ratio by inhibiting Th17 cells' differentiation and up-regulating Treg cells.  Furthermore, TAK-828F, at 100 nM, reduced the prodn. of Th17-related cytokines (IL-17, IL-17F and IL-22) without affecting IFN-γ prodn. in whole blood.  These results demonstrate that TAK-828F has the potent and selective inhibitory activity against RORγt both in mouse and human cells.  Addnl., oral administration of TAK-828F showed promising efficacy in naive T cell transfer mouse colitis model.  TAK-828F may provide a novel therapeutic option to treat immune diseases by inhibiting Th17 and Th1/17 cells' differentiation and improving imbalance between Th17 and Treg cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ1ymVu1K7nbVg90H21EOLACvtfcHk0lgR4Mhrlt4-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVentr8%253D&md5=50e15bf2fbe1809db5d34d6f10ea77e7</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2018.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2018.01.023%26sid%3Dliteratum%253Aachs%26aulast%3DShibata%26aufirst%3DA.%26aulast%3DUga%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DSagara%26aufirst%3DM.%26aulast%3DIgaki%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DOchida%26aufirst%3DA.%26aulast%3DKono%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DM.%26aulast%3DTsuchimori%26aufirst%3DN.%26atitle%3DPharmacological%2520inhibitory%2520profile%2520of%2520TAK-828F%252C%2520a%2520potent%2520and%2520selective%2520orally%2520available%2520ROR%25CE%25B3t%2520inverse%2520agonist%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D150%26spage%3D35%26epage%3D45%26doi%3D10.1016%2Fj.bcp.2018.01.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span> </span><span class="NLM_article-title">FY2016 Full Year Results (released on May
10, 2017), Data Book</span>.  <i>Quarterly Results, Broker
Conferences, Special IR Events</i>; <span class="NLM_publisher-name">Takeda</span>: <span class="NLM_publisher-loc">Tokyo</span>, <span class="NLM_year">2017</span>; <a href="https://www.takeda.com/investors/reports/quarterly-announcements/" class="extLink">https://www.takeda.com/investors/reports/quarterly-announcements/</a> (accessed March 26, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=FY2016+Full+Year+Results+%28released+on+May%0A10%2C+2017%29%2C+Data+Book.+Quarterly+Results%2C+Broker%0AConferences%2C+Special+IR+Events%3B+Takeda%3A+Tokyo%2C+2017%3B+https%3A%2F%2Fwww.takeda.com%2Finvestors%2Freports%2Fquarterly-announcements%2F+%28accessed+March+26%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26atitle%3DFY2016%2520Full%2520Year%2520Results%2520%2528released%2520on%2520May%250A10%252C%25202017%2529%252C%2520Data%2520Book%26jtitle%3DQuarterly%2520Results%252C%2520Broker%250AConferences%252C%2520Special%2520IR%2520Events%26pub%3DTakeda%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoku, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirashima, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obika, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyagawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arita, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aratsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adachi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crowe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steensma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babine, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiozaki, M.</span></span> <span> </span><span class="NLM_article-title">SAR exploration guided by LE and Fsp3: Discovery of a selective and orally efficacious RORγ Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00253</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00253" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=23-27&author=K.+Hirataauthor=M.+Kotokuauthor=N.+Sekiauthor=T.+Maebaauthor=K.+Maedaauthor=S.+Hirashimaauthor=T.+Sakaiauthor=S.+Obikaauthor=A.+Horiauthor=Y.+Haseauthor=T.+Yamaguchiauthor=Y.+Katsudaauthor=T.+Hataauthor=N.+Miyagawaauthor=K.+Aritaauthor=Y.+Nomuraauthor=K.+Asahinaauthor=Y.+Aratsuauthor=M.+Kamadaauthor=T.+Adachiauthor=M.+Noguchiauthor=S.+Doiauthor=P.+Croweauthor=E.+Bradleyauthor=R.+Steensmaauthor=H.+Taoauthor=M.+Fennauthor=R.+Babineauthor=X.+Liauthor=S.+Thacherauthor=H.+Hashimotoauthor=M.+Shiozaki&title=SAR+exploration+guided+by+LE+and+Fsp3%3A+Discovery+of+a+selective+and+orally+efficacious+ROR%CE%B3+Inhibitor&doi=10.1021%2Facsmedchemlett.5b00253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor</span></div><div class="casAuthors">Hirata, Kazuyuki; Kotoku, Masayuki; Seki, Noriyoshi; Maeba, Takaki; Maeda, Katsuya; Hirashima, Shintaro; Sakai, Takayuki; Obika, Shingo; Hori, Akimi; Hase, Yasunori; Yamaguchi, Takayuki; Katsuda, Yoshiaki; Hata, Takahiro; Miyagawa, Naoki; Arita, Kojo; Nomura, Yukihiro; Asahina, Kota; Aratsu, Yusuke; Kamada, Masafumi; Adachi, Tsuyoshi; Noguchi, Masato; Doi, Satoki; Crowe, Paul; Bradley, Erin; Steensma, Ruo; Tao, Haiyan; Fenn, Morgan; Babine, Robert; Li, Xiaolin; Thacher, Scott; Hashimoto, Hiromasa; Shiozaki, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-27</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of RORγ inhibitors was identified starting with the HTS hit compd. 2-(5-(2,3-dihydro-1H-inden-2-yl)-4-ethyl-4-H-1,2,4-triazol-3-ylthio)-N-(naphthalen-1-yl)acetamide.  After SAR investigation based on a prospective consideration of two drug-likeness metrics, ligand efficiency (LE) and fraction of Sp3 carbon atoms (Fsp3), significant improvement of metabolic stability as well as redn. of CYP inhibition was obsd., which finally led to discovery of a selective and orally efficacious RORγ inhibitor (3R,4R)-1-acetyl-4-(4-cyclopropyl-5-(cis-3-isobutylcyclobutyl)-4H-1,2,4-triazol-3-yl)-M-(2,4-dimethylphenyl) pyrrolidine-3-carboxamide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojA7KFHVtsOrVg90H21EOLACvtfcHk0lgR4Mhrlt4-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslKlt77P&md5=fc2736f8baafee2084bb3adce7bb1a2e</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00253%26sid%3Dliteratum%253Aachs%26aulast%3DHirata%26aufirst%3DK.%26aulast%3DKotoku%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26aulast%3DMaeba%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DK.%26aulast%3DHirashima%26aufirst%3DS.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DObika%26aufirst%3DS.%26aulast%3DHori%26aufirst%3DA.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DKatsuda%26aufirst%3DY.%26aulast%3DHata%26aufirst%3DT.%26aulast%3DMiyagawa%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DK.%26aulast%3DAratsu%26aufirst%3DY.%26aulast%3DKamada%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DDoi%26aufirst%3DS.%26aulast%3DCrowe%26aufirst%3DP.%26aulast%3DBradley%26aufirst%3DE.%26aulast%3DSteensma%26aufirst%3DR.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DFenn%26aufirst%3DM.%26aulast%3DBabine%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DThacher%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DShiozaki%26aufirst%3DM.%26atitle%3DSAR%2520exploration%2520guided%2520by%2520LE%2520and%2520Fsp3%253A%2520Discovery%2520of%2520a%2520selective%2520and%2520orally%2520efficacious%2520ROR%25CE%25B3%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D23%26epage%3D27%26doi%3D10.1021%2Facsmedchemlett.5b00253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheepstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Almen, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piesvaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutilek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eenennaam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagpal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soisson, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kornienko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trotter, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Stelt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oubrie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parthasarathy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunsveld, L.</span></span> <span> </span><span class="NLM_article-title">Identification of an allosteric binding site for RORγt inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">8833</span>, <span class="refDoi"> DOI: 10.1038/ncomms9833</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fncomms9833" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26640126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8833&author=M.+Scheepstraauthor=S.+Leysenauthor=G.+C.+van+Almenauthor=J.+R.+Millerauthor=J.+Piesvauxauthor=V.+Kutilekauthor=H.+van+Eenennaamauthor=H.+Zhangauthor=K.+Barrauthor=S.+Nagpalauthor=S.+M.+Soissonauthor=M.+Kornienkoauthor=K.+Wileyauthor=N.+Elsenauthor=S.+Sharmaauthor=C.+C.+Correllauthor=B.+W.+Trotterauthor=M.+van+der+Steltauthor=A.+Oubrieauthor=C.+Ottmannauthor=G.+Parthasarathyauthor=L.+Brunsveld&title=Identification+of+an+allosteric+binding+site+for+ROR%CE%B3t+inhibition&doi=10.1038%2Fncomms9833"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an allosteric binding site for RORγt inhibition</span></div><div class="casAuthors">Scheepstra, Marcel; Leysen, Seppe; van Almen, Geert C.; Miller, J. Richard; Piesvaux, Jennifer; Kutilek, Victoria; van Eenennaam, Hans; Zhang, Hongjun; Barr, Kenneth; Nagpal, Sunil; Soisson, Stephen M.; Kornienko, Maria; Wiley, Kristen; Elsen, Nathaniel; Sharma, Sujata; Correll, Craig C.; Trotter, B. Wesley; van der Stelt, Mario; Oubrie, Arthur; Ottmann, Christian; Parthasarathy, Gopal; Brunsveld, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8833/1-8833/10</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">RORγt is crit. for the differentiation and proliferation of Th17 cells assocd. with several chronic autoimmune diseases.  We report the discovery of a novel allosteric binding site on the nuclear receptor RORγt.  Co-crystn. of the ligand binding domain (LBD) of RORγt with a series of small-mol. antagonists demonstrates occupancy of a previously unreported allosteric binding pocket.  Binding at this non-canonical site induces an unprecedented conformational reorientation of helix 12 in the RORγt LBD, which blocks cofactor binding.  The functional consequence of this allosteric ligand-mediated conformation is inhibition of function as evidenced by both biochem. and cellular studies.  RORγt function is thus antagonized in a manner molecularly distinct from that of previously described orthosteric RORγt ligands.  This brings forward an approach to target RORγt for the treatment of Th17-mediated autoimmune diseases.  The elucidation of an unprecedented modality of pharmacol. antagonism establishes a mechanism for modulation of nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNcktcUUFl77Vg90H21EOLACvtfcHk0lgR4Mhrlt4-Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFKit7zL&md5=409b08232ecdd3f3e82fa660585c989d</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fncomms9833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9833%26sid%3Dliteratum%253Aachs%26aulast%3DScheepstra%26aufirst%3DM.%26aulast%3DLeysen%26aufirst%3DS.%26aulast%3Dvan%2BAlmen%26aufirst%3DG.%2BC.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DPiesvaux%26aufirst%3DJ.%26aulast%3DKutilek%26aufirst%3DV.%26aulast%3Dvan%2BEenennaam%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DNagpal%26aufirst%3DS.%26aulast%3DSoisson%26aufirst%3DS.%2BM.%26aulast%3DKornienko%26aufirst%3DM.%26aulast%3DWiley%26aufirst%3DK.%26aulast%3DElsen%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DTrotter%26aufirst%3DB.%2BW.%26aulast%3Dvan%2Bder%2BStelt%26aufirst%3DM.%26aulast%3DOubrie%26aufirst%3DA.%26aulast%3DOttmann%26aufirst%3DC.%26aulast%3DParthasarathy%26aufirst%3DG.%26aulast%3DBrunsveld%26aufirst%3DL.%26atitle%3DIdentification%2520of%2520an%2520allosteric%2520binding%2520site%2520for%2520ROR%25CE%25B3t%2520inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8833%26doi%3D10.1038%2Fncomms9833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de
Wit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mossawi, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huhn, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arancibia-Carcamo, C. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendrick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gundle, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClanahan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powrie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowness, P. J.</span></span> <span> </span><span class="NLM_article-title">RORγt inhibitors suppress T(H)17 responses in inflammatory arthritis and inflammatory bowel disease</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">960</span>– <span class="NLM_lpage">963</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2015.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.jaci.2015.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26611672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVygs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2016&pages=960-963&author=J.+de%0AWitauthor=M.+H.+Al-Mossawiauthor=M.+H.+Huhnauthor=C.+V.+Arancibia-Carcamoauthor=K.+Doigauthor=B.+Kendrickauthor=R.+Gundleauthor=P.+Taylorauthor=T.+McClanahanauthor=E.+Murphyauthor=H.+Zhangauthor=K.+Barrauthor=J.+R.+Millerauthor=X.+Huauthor=T.+D.+Aicherauthor=R.+W.+Morganauthor=G.+D.+Glickauthor=D.+Zallerauthor=C.+Correllauthor=F.+Powrieauthor=P.+J.+Bowness&title=ROR%CE%B3t+inhibitors+suppress+T%28H%2917+responses+in+inflammatory+arthritis+and+inflammatory+bowel+disease&doi=10.1016%2Fj.jaci.2015.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease</span></div><div class="casAuthors">de Wit, Jelle; Al-Mossawi, M. Hussein; Huhn, Michael H.; Arancibia-Carcamo, Carolina V.; Doig, Karen; Kendrick, Benjamin; Gundle, Roger; Taylor, Peter; Mcclanahan, Terri; Murphy, Erin; Zhang, Hongjun; Barr, Ken; Miller, J. Richard; Hu, Xiao; Aicher, Thomas D.; Morgan, Rodney W.; Glick, Gary D.; Zaller, Dennis; Correll, Craig; Powrie, Fiona; Bowness, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">960-963</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The article investigated the role of MRL-248, MRL-367 as RORγt inhibitors suppressed TH17 responses in inflammatory arthritis and inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyjAsdh0dNRrVg90H21EOLACvtfcHk0li5EhVnisjZcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVygs7vP&md5=5671b3ecee05ca5a6c0faed3ce883478</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2015.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2015.09.048%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BWit%26aufirst%3DJ.%26aulast%3DAl-Mossawi%26aufirst%3DM.%2BH.%26aulast%3DHuhn%26aufirst%3DM.%2BH.%26aulast%3DArancibia-Carcamo%26aufirst%3DC.%2BV.%26aulast%3DDoig%26aufirst%3DK.%26aulast%3DKendrick%26aufirst%3DB.%26aulast%3DGundle%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DMcClanahan%26aufirst%3DT.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DJ.%2BR.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DMorgan%26aufirst%3DR.%2BW.%26aulast%3DGlick%26aufirst%3DG.%2BD.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DCorrell%26aufirst%3DC.%26aulast%3DPowrie%26aufirst%3DF.%26aulast%3DBowness%26aufirst%3DP.%2BJ.%26atitle%3DROR%25CE%25B3t%2520inhibitors%2520suppress%2520T%2528H%252917%2520responses%2520in%2520inflammatory%2520arthritis%2520and%2520inflammatory%2520bowel%2520disease%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2016%26volume%3D137%26spage%3D960%26epage%3D963%26doi%3D10.1016%2Fj.jaci.2015.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span>; <span class="NLM_string-name">Barr, K.
J.</span>; <span class="NLM_string-name">Lapointe, B. T.</span>; <span class="NLM_string-name">Gunaydin, H.</span>; <span class="NLM_string-name">Liu, K.</span>; <span class="NLM_string-name">Trotter, B. W.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl Substituted Benzoic Acids as RORgammaT Inhibitors and Uses Thereof</span>. WO Patent <span class="NLM_patent">WO2017075185A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=H.+Zhang&author=K.%0AJ.+Barr&author=B.+T.+Lapointe&author=H.+Gunaydin&author=K.+Liu&author=B.+W.+Trotter&title=Heteroaryl+Substituted+Benzoic+Acids+as+RORgammaT+Inhibitors+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DHeteroaryl%2520Substituted%2520Benzoic%2520Acids%2520as%2520RORgammaT%2520Inhibitors%2520and%2520Uses%2520Thereof%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidenschenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Everett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganguli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Summerhill, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2907</span>– <span class="NLM_lpage">2912</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2015.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26048793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=2907-2912&author=B.+P.+Fauberauthor=A.+Gobbiauthor=K.+Robargeauthor=A.+Zhouauthor=A.+Barnardauthor=J.+Caoauthor=Y.+Dengauthor=C.+Eidenschenkauthor=C.+Everettauthor=A.+Ganguliauthor=J.+Hawkinsauthor=A.+R.+Johnsonauthor=H.+Laauthor=M.+Normanauthor=G.+Salmonauthor=S.+Summerhillauthor=W.+Ouyangauthor=W.+Tangauthor=H.+Wong&title=Discovery+of+imidazo%5B1%2C5-a%5Dpyridines+and+-pyrimidines+as+potent+and+selective+RORc+inverse+agonists&doi=10.1016%2Fj.bmcl.2015.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists</span></div><div class="casAuthors">Fauber, Benjamin P.; Gobbi, Alberto; Robarge, Kirk; Zhou, Aihe; Barnard, Adrian; Cao, Jianhua; Deng, Yuzhong; Eidenschenk, Celine; Everett, Christine; Ganguli, Arunima; Hawkins, Julie; Johnson, Adam R.; La, Hank; Norman, Maxine; Salmon, Gary; Summerhill, Susan; Ouyang, Wenjun; Tang, Wei; Wong, Harvey</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2907-2912</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nuclear receptor (NR) retinoic acid receptor-related orphan receptor gamma (RORγ, RORc, or NR1F3) is a promising target for the treatment of autoimmune diseases.  RORc is a crit. regulator in the prodn. of the pro-inflammatory cytokine interleukin-17.  We discovered a series of potent and selective imidazo[1,5-a]pyridine and -pyrimidine RORc inverse agonists.  The most potent compds. displayed >300-fold selectivity for RORc over the other ROR family members, PPARγ, and NRs in our cellular selectivity panel.  The favorable potency, selectivity, and physiochem. properties of GNE-0946 (9) and GNE-6468 (28), in addn. to their potent suppression of IL-17 prodn. in human primary cells, support their use as chem. biol. tools to further explore the role of RORc in human biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIQTYB5nafXLVg90H21EOLACvtfcHk0li5EhVnisjZcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpt1yrtb0%253D&md5=d0e89e186488a9db8f7629fd86ed7ea0</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%2BP.%26aulast%3DGobbi%26aufirst%3DA.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DBarnard%26aufirst%3DA.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DEidenschenk%26aufirst%3DC.%26aulast%3DEverett%26aufirst%3DC.%26aulast%3DGanguli%26aufirst%3DA.%26aulast%3DHawkins%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DLa%26aufirst%3DH.%26aulast%3DNorman%26aufirst%3DM.%26aulast%3DSalmon%26aufirst%3DG.%26aulast%3DSummerhill%26aufirst%3DS.%26aulast%3DOuyang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520imidazo%255B1%252C5-a%255Dpyridines%2520and%2520-pyrimidines%2520as%2520potent%2520and%2520selective%2520RORc%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D2907%26epage%3D2912%26doi%3D10.1016%2Fj.bmcl.2015.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouix-Peter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciesielski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantalat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feret, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luzy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musicki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orfila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascau, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parnet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierre, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raffin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rival, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taquet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">5802</span>– <span class="NLM_lpage">5808</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2016.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27815118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=5802-5808&author=G.+Ouvryauthor=C.+Bouix-Peterauthor=F.+Ciesielskiauthor=L.+Chantalatauthor=O.+Christinauthor=C.+Cominoauthor=D.+Duvertauthor=C.+Feretauthor=C.+S.+Harrisauthor=L.+Lamyauthor=A.+P.+Luzyauthor=B.+Musickiauthor=D.+Orfilaauthor=J.+Pascauauthor=V.+Parnetauthor=A.+Perrinauthor=R.+Pierreauthor=G.+Polgeauthor=C.+Raffinauthor=Y.+Rivalauthor=N.+Taquetauthor=E.+Thoreauauthor=L.+F.+Hennequin&title=Discovery+of+phenoxyindazoles+and+phenylthioindazoles+as+ROR%CE%B3+inverse+agonists&doi=10.1016%2Fj.bmcl.2016.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists</span></div><div class="casAuthors">Ouvry, Gilles; Bouix-Peter, Claire; Ciesielski, Fabrice; Chantalat, Laurent; Christin, Olivier; Comino, Catherine; Duvert, Denis; Feret, Christophe; Harris, Craig S.; Lamy, Laurent; Luzy, Anne-Pascale; Musicki, Branislav; Orfila, Danielle; Pascau, Jonathan; Parnet, Veronique; Perrin, Agnes; Pierre, Romain; Polge, Gaelle; Raffin, Catherine; Rival, Yves; Taquet, Nathalie; Thoreau, Etienne; Hennequin, Laurent F.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5802-5808</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Targeting the IL17 pathway and more specifically the nuclear receptor RORγ is thought to be beneficial in multiple skin disorders.  The Letter describes the discovery of phenoxyindazoles and thiophenoxy indazoles as potent RORγ inverse agonists.  Optimization of the potency and efforts to mitigate the phototoxic liability of the series are presented.  Finally, crystn. of the lead compd. revealed that the series bound to an allosteric site of the nuclear receptor.  Such compds. could be useful as tool compds. for understanding the impact of topical treatment on skin disease models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX7Dguvi_h8LVg90H21EOLACvtfcHk0ligH0OnVmDl8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslynsr%252FM&md5=cd3aa2c246cfa35c98306096d823dccc</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DBouix-Peter%26aufirst%3DC.%26aulast%3DCiesielski%26aufirst%3DF.%26aulast%3DChantalat%26aufirst%3DL.%26aulast%3DChristin%26aufirst%3DO.%26aulast%3DComino%26aufirst%3DC.%26aulast%3DDuvert%26aufirst%3DD.%26aulast%3DFeret%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DC.%2BS.%26aulast%3DLamy%26aufirst%3DL.%26aulast%3DLuzy%26aufirst%3DA.%2BP.%26aulast%3DMusicki%26aufirst%3DB.%26aulast%3DOrfila%26aufirst%3DD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DParnet%26aufirst%3DV.%26aulast%3DPerrin%26aufirst%3DA.%26aulast%3DPierre%26aufirst%3DR.%26aulast%3DPolge%26aufirst%3DG.%26aulast%3DRaffin%26aufirst%3DC.%26aulast%3DRival%26aufirst%3DY.%26aulast%3DTaquet%26aufirst%3DN.%26aulast%3DThoreau%26aufirst%3DE.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%2520phenoxyindazoles%2520and%2520phenylthioindazoles%2520as%2520ROR%25CE%25B3%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D5802%26epage%3D5808%26doi%3D10.1016%2Fj.bmcl.2016.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skepner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trocha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baloglu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobera, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orband-Miller, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudjelal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundrud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1302190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.4049%2Fjimmunol.1302190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=24516202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslGls7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2014&pages=2564-2575&author=J.+Skepnerauthor=R.+Rameshauthor=M.+Trochaauthor=D.+Schmidtauthor=E.+Balogluauthor=M.+Loberaauthor=T.+Carlsonauthor=J.+Hillauthor=L.+A.+Orband-Millerauthor=A.+Barnesauthor=M.+Boudjelalauthor=M.+Sundrudauthor=S.+Ghoshauthor=J.+Yang&title=Pharmacologic+inhibition+of+ROR%CE%B3t+regulates+Th17+signature+gene+expression+and+suppresses+cutaneous+inflammation+in+vivo&doi=10.4049%2Fjimmunol.1302190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo</span></div><div class="casAuthors">Skepner, Jill; Ramesh, Radha; Trocha, Mark; Schmidt, Darby; Baloglu, Erkan; Lobera, Mercedes; Carlson, Thaddeus; Hill, Jonathan; Orband-Miller, Lisa A.; Barnes, Ashley; Boudjelal, Mohamed; Sundrud, Mark; Ghosh, Shomir; Yang, Jianfei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2564-2575</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">IL-17-producing CD4+Th17 cells, CD8+Tc17 cells, and γδ T cells play crit. roles in the pathogenesis of autoimmune psoriasis.  RORγt is required for the differentiation of Th17 cells and expression of IL-17.  In this article, we describe a novel, potent, and selective RORγt inverse agonist (TMP778), and its inactive diastereomer (TMP776).  This chem., for the first time to our knowledge, provides a unique and powerful set of tools to probe RORγt-dependent functions.  TMP778, but not TMP776, blocked human Th17 and Tc17 cell differentiation and also acutely modulated IL-17A prodn. and inflammatory Th17-signature gene expression (Il17a, Il17f, Il22, Il26, Ccr6, and Il23) in mature human Th17 effector/memory T cells.  In addn., TMP778, but not TMP776, inhibited IL-17A prodn. in both human and mouse γδ T cells.  IL-23-induced IL-17A prodn. was also blocked by TMP778 treatment.  In vivo targeting of RORγt in mice via TMP778 administration reduced imiquimod-induced psoriasis-like cutaneous inflammation.  Further, TMP778 selectively regulated Th17-signature gene expression in mononuclear cells isolated from both the blood and affected skin of psoriasis patients.  In summary, to our knowledge, we are the first to demonstrate that RORγt inverse agonists: (1) inhibit Tc17 cell differentiation, as well as IL-17 prodn. by γδ T cells and CD8+ Tc17 cells; (2) block imiquimod-induced cutaneous inflammation; (3) inhibit Th17 signature gene expression by cells isolated from psoriatic patient samples; and (4) block IL-23-induced IL-17A expression.  Thus, RORγt is a tractable drug target for the treatment of cutaneous inflammatory disorders, which may afford addnl. therapeutic benefit over existing modalities that target only IL-17A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu4CFK2lBK6bVg90H21EOLACvtfcHk0ligH0OnVmDl8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslGls7w%253D&md5=d72bc88b09a34874cf7b89f993977d35</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1302190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1302190%26sid%3Dliteratum%253Aachs%26aulast%3DSkepner%26aufirst%3DJ.%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DTrocha%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DBaloglu%26aufirst%3DE.%26aulast%3DLobera%26aufirst%3DM.%26aulast%3DCarlson%26aufirst%3DT.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DOrband-Miller%26aufirst%3DL.%2BA.%26aulast%3DBarnes%26aufirst%3DA.%26aulast%3DBoudjelal%26aufirst%3DM.%26aulast%3DSundrud%26aufirst%3DM.%26aulast%3DGhosh%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DJ.%26atitle%3DPharmacologic%2520inhibition%2520of%2520ROR%25CE%25B3t%2520regulates%2520Th17%2520signature%2520gene%2520expression%2520and%2520suppresses%2520cutaneous%2520inflammation%2520in%2520vivo%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D192%26spage%3D2564%26epage%3D2575%26doi%3D10.4049%2Fjimmunol.1302190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span>; <span class="NLM_string-name">Tilley, J.</span>; <span class="NLM_string-name">Blinn, J.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide Retinoic Acid Receptor-Related Orphan Receptor Modulators And Uses</span>. WO Patent <span class="NLM_patent">WO2016014910A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gaweco&author=J.+Tilley&author=J.+Blinn&title=Sulfonamide+Retinoic+Acid+Receptor-Related+Orphan+Receptor+Modulators+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26atitle%3DSulfonamide%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520Modulators%2520And%2520Uses%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span>; <span class="NLM_string-name">Tilley, J.</span>; <span class="NLM_string-name">Blinn, J.</span></span> <span> </span><span class="NLM_article-title">Azaindole Retinoic Acid Receptor-Related Orphan Receptor Modulators And Uses</span>. WO Patent <span class="NLM_patent">WO2016014916A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gaweco&author=J.+Tilley&author=J.+Blinn&title=Azaindole+Retinoic+Acid+Receptor-Related+Orphan+Receptor+Modulators+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26atitle%3DAzaindole%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520Modulators%2520And%2520Uses%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span>; <span class="NLM_string-name">Tilley, J.</span>; <span class="NLM_string-name">Blinn, J.</span></span> <span> </span><span class="NLM_article-title">Indazole Retinoic Acid Receptor-Related Orphan Receptor Modulators And Uses</span>. WO Patent<span class="NLM_patent">WO2016014913A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gaweco&author=J.+Tilley&author=J.+Blinn&title=Indazole+Retinoic+Acid+Receptor-Related+Orphan+Receptor+Modulators+And+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26atitle%3DIndazole%2520Retinoic%2520Acid%2520Receptor-Related%2520Orphan%2520Receptor%2520Modulators%2520And%2520Uses%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaweco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic efficacy of a promising oral INV-17 ROR gamma inverse agonist clinical lead compound in a mouse IMQ-psoriasis model</span>. <i>J. Am. Acad. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">AB259</span>, <span class="refDoi"> DOI: 10.1016/j.jaad.2017.04.1006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.jaad.2017.04.1006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2017&pages=AB259&author=A.+Gawecoauthor=K.+Adamauthor=O.+Herbinauthor=J.+Tilley&title=Therapeutic+efficacy+of+a+promising+oral+INV-17+ROR+gamma+inverse+agonist+clinical+lead+compound+in+a+mouse+IMQ-psoriasis+model&doi=10.1016%2Fj.jaad.2017.04.1006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2017.04.1006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2017.04.1006%26sid%3Dliteratum%253Aachs%26aulast%3DGaweco%26aufirst%3DA.%26aulast%3DAdam%26aufirst%3DK.%26aulast%3DHerbin%26aufirst%3DO.%26aulast%3DTilley%26aufirst%3DJ.%26atitle%3DTherapeutic%2520efficacy%2520of%2520a%2520promising%2520oral%2520INV-17%2520ROR%2520gamma%2520inverse%2520agonist%2520clinical%2520lead%2520compound%2520in%2520a%2520mouse%2520IMQ-psoriasis%2520model%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2017%26volume%3D76%26spage%3DAB259%26doi%3D10.1016%2Fj.jaad.2017.04.1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span> <i>Almirall and Nuevolution Enter into a Strategic
Collaboration to
Develop RORγt Inhibitors for Treatment of Dermatology Diseaes
and Psoriatic Arthritis</i>; <span class="NLM_publisher-name">Nuevolution</span>: <span class="NLM_publisher-loc">Copenhagen</span>, December 12, <span class="NLM_year">2016</span>; press release <a href="https://nuevolution.com/almirall-and-nuevolution-enter-into-a-strategic-collaboration" class="extLink">https://nuevolution.com/almirall-and-nuevolution-enter-into-a-strategic-collaboration</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Almirall+and+Nuevolution+Enter+into+a+Strategic%0ACollaboration+to%0ADevelop+ROR%CE%B3t+Inhibitors+for+Treatment+of+Dermatology+Diseaes%0Aand+Psoriatic+Arthritis%3B+Nuevolution%3A+Copenhagen%2C+December+12%2C+2016%3B+press+release+https%3A%2F%2Fnuevolution.com%2Falmirall-and-nuevolution-enter-into-a-strategic-collaboration."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DAlmirall%2520and%2520Nuevolution%2520Enter%2520into%2520a%2520Strategic%250ACollaboration%2520to%250ADevelop%2520ROR%25CE%25B3t%2520Inhibitors%2520for%2520Treatment%2520of%2520Dermatology%2520Diseaes%250Aand%2520Psoriatic%2520Arthritis%26pub%3DNuevolution%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder Glad, S.</span>; <span class="NLM_string-name">Birkebäk
Jensen, K.</span>; <span class="NLM_string-name">Grön
Nörager, N.</span>; <span class="NLM_string-name">Sarvary, I.</span>; <span class="NLM_string-name">Vestergaard, M.</span>; <span class="NLM_string-name">Haahr Gouliaev, A.</span>; <span class="NLM_string-name">Teuber, L.</span>; <span class="NLM_string-name">Stasi, L. P.</span></span> <span> </span><span class="NLM_article-title">Optionally Fused Heterocyclyl-Sustituted Derivatives of Pyrimidine Useful For the Treatment of Inflammatory, Metabolic, Oncologic And Autoimmune Diseases</span>. WO Patent <span class="NLM_patent">WO2016020295A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Schr%C3%B6der+Glad&author=K.+Birkeb%C3%A4k%0AJensen&author=N.+Gr%C3%B6n%0AN%C3%B6rager&author=I.+Sarvary&author=M.+Vestergaard&author=A.+Haahr+Gouliaev&author=L.+Teuber&author=L.+P.+Stasi&title=Optionally+Fused+Heterocyclyl-Sustituted+Derivatives+of+Pyrimidine+Useful+For+the+Treatment+of+Inflammatory%2C+Metabolic%2C+Oncologic+And+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%2BGlad%26aufirst%3DS.%26atitle%3DOptionally%2520Fused%2520Heterocyclyl-Sustituted%2520Derivatives%2520of%2520Pyrimidine%2520Useful%2520For%2520the%2520Treatment%2520of%2520Inflammatory%252C%2520Metabolic%252C%2520Oncologic%2520And%2520Autoimmune%2520Diseases%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuss, J.</span>; <span class="NLM_string-name">Harris, J.</span>; <span class="NLM_string-name">Mohan, R.</span></span> <span> </span><span class="NLM_article-title">ROR-Gamma Modulators</span>. WO Patent <span class="NLM_patent">WO2018081558A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+Nuss&author=J.+Harris&author=R.+Mohan&title=ROR-Gamma+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%26atitle%3DROR-Gamma%2520Modulators%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vankayalapati, H.</span>; <span class="NLM_string-name">Yerramreddy, V.</span></span> <span> </span><span class="NLM_article-title">Substituted 2,3-Dihydro-1<i>H</i>-Inden-1-one Retinoic Acid-Related Orphan Nuclear Receptor Antagonists For Treating Multiple Sclerosis</span>. WO Patent <span class="NLM_patent">WO2015038350A2</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=H.+Vankayalapati&author=V.+Yerramreddy&title=Substituted+2%2C3-Dihydro-1H-Inden-1-one+Retinoic+Acid-Related+Orphan+Nuclear+Receptor+Antagonists+For+Treating+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVankayalapati%26aufirst%3DH.%26atitle%3DSubstituted%25202%252C3-Dihydro-1H-Inden-1-one%2520Retinoic%2520Acid-Related%2520Orphan%2520Nuclear%2520Receptor%2520Antagonists%2520For%2520Treating%2520Multiple%2520Sclerosis%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J. W.</span>; <span class="NLM_string-name">Carlson, N. G.</span>; <span class="NLM_string-name">Yerramreddy, V.</span>; <span class="NLM_string-name">Appalaneni, R. P.</span>; <span class="NLM_string-name">Handler, J. A.</span>; <span class="NLM_string-name">Kancherla, R. R.</span>; <span class="NLM_string-name">Vankayalapati, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of ARN-6039 as a potent, orally available inverse agonist of RORγt for autoimmune neuroinflammatory demyelinating disease</span>. Poster presented at the  <i>68th AAN (American Academy of Neurology) Annual Meeting on April 15–21, 2016</i>; <span class="NLM_publisher-name">American Academy of Neurology</span>, <span class="NLM_year">2016</span>; <a href="https://tools.aan.com/annualmeeting/search/index.cfm?fuseaction=home.detail&amp;id=5109&amp;keyword=&amp;topic=81&amp;type=all" class="extLink">https://tools.aan.com/annualmeeting/search/index.cfm?fuseaction=home.detail&id=5109&keyword=&topic=81&type=all</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=J.+W.+Rose&author=N.+G.+Carlson&author=V.+Yerramreddy&author=R.+P.+Appalaneni&author=J.+A.+Handler&author=R.+R.+Kancherla&author=H.+Vankayalapati&title=Discovery+of+ARN-6039+as+a+potent%2C+orally+available+inverse+agonist+of+ROR%CE%B3t+for+autoimmune+neuroinflammatory+demyelinating+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DJ.%2BW.%26atitle%3DDiscovery%2520of%2520ARN-6039%2520as%2520a%2520potent%252C%2520orally%2520available%2520inverse%2520agonist%2520of%2520ROR%25CE%25B3t%2520for%2520autoimmune%2520neuroinflammatory%2520demyelinating%2520disease%26jtitle%3D68th%2520AAN%2520%2528American%2520Academy%2520of%2520Neurology%2529%2520Annual%2520Meeting%2520on%2520April%252015%25E2%2580%259321%252C%25202016%26pub%3DAmerican%2520Academy%2520of%2520Neurology%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Argiriadi, M. A.</span>; <span class="NLM_string-name">Breinlinger, E.</span>; <span class="NLM_string-name">Cusack, K. P.</span>; <span class="NLM_string-name">Hobson, A. D.</span>; <span class="NLM_string-name">Potin, D.</span>; <span class="NLM_string-name">Barth, M.</span>; <span class="NLM_string-name">Amaudrut, J.</span>; <span class="NLM_string-name">Poupardin, O.</span>; <span class="NLM_string-name">Mounier, L.</span>; <span class="NLM_string-name">Kort, M. E.</span></span> <span> </span><span class="NLM_article-title">ROR Nuclear Receptor Modulators</span>. WO Patent <span class="NLM_patent">WO2016198908A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=M.+A.+Argiriadi&author=E.+Breinlinger&author=K.+P.+Cusack&author=A.+D.+Hobson&author=D.+Potin&author=M.+Barth&author=J.+Amaudrut&author=O.+Poupardin&author=L.+Mounier&author=M.+E.+Kort&title=ROR+Nuclear+Receptor+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DArgiriadi%26aufirst%3DM.%2BA.%26atitle%3DROR%2520Nuclear%2520Receptor%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fauber, B.</span>; <span class="NLM_string-name">Bodil Van Niel, M.</span>; <span class="NLM_string-name">Cridland, A.</span>; <span class="NLM_string-name">Hurley, C.</span>; <span class="NLM_string-name">Killen, J.</span>; <span class="NLM_string-name">Ward, S.</span></span> <span> </span><span class="NLM_article-title">Pyridazine Derivatives as RORc Modulators</span>. WO Patent <span class="NLM_patent">WO2016177686A1</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=B.+Fauber&author=M.+Bodil+Van+Niel&author=A.+Cridland&author=C.+Hurley&author=J.+Killen&author=S.+Ward&title=Pyridazine+Derivatives+as+RORc+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFauber%26aufirst%3DB.%26atitle%3DPyridazine%2520Derivatives%2520as%2520RORc%2520Modulators%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steeneck, C.</span>; <span class="NLM_string-name">Kinzel, O.</span>; <span class="NLM_string-name">Gege, C.</span>; <span class="NLM_string-name">Kleymann, G.</span>; <span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Pyrrolo Carboxamides As Modulators of Orphan Nuclear Receptor RAR-Related Orphan Receptor-Gamma (RORγ, NR1F3) Activity and for the Treatment of Chronic Inflammatory and Autoimmune Diseases</span>. WO Patent <span class="NLM_patent">WO2013079223A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Steeneck&author=O.+Kinzel&author=C.+Gege&author=G.+Kleymann&author=T.+Hoffmann&title=Pyrrolo+Carboxamides+As+Modulators+of+Orphan+Nuclear+Receptor+RAR-Related+Orphan+Receptor-Gamma+%28ROR%CE%B3%2C+NR1F3%29+Activity+and+for+the+Treatment+of+Chronic+Inflammatory+and+Autoimmune+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSteeneck%26aufirst%3DC.%26atitle%3DPyrrolo%2520Carboxamides%2520As%2520Modulators%2520of%2520Orphan%2520Nuclear%2520Receptor%2520RAR-Related%2520Orphan%2520Receptor-Gamma%2520%2528ROR%25CE%25B3%252C%2520NR1F3%2529%2520Activity%2520and%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Inflammatory%2520and%2520Autoimmune%2520Diseases%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span>; <span class="NLM_string-name">Steeneck, C.</span>; <span class="NLM_string-name">Kinzel, O.</span>; <span class="NLM_string-name">Kleymann, G.</span>; <span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Carboxamide or Sulfonamide Substituted Thiazoles and Related Derivatives as Modulators For the Orphan Nuclear Receptor ROR[Gamma]</span>. WO Patent <span class="NLM_patent">WO2013178362A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Gege&author=C.+Steeneck&author=O.+Kinzel&author=G.+Kleymann&author=T.+Hoffmann&title=Carboxamide+or+Sulfonamide+Substituted+Thiazoles+and+Related+Derivatives+as+Modulators+For+the+Orphan+Nuclear+Receptor+ROR%5BGamma%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26atitle%3DCarboxamide%2520or%2520Sulfonamide%2520Substituted%2520Thiazoles%2520and%2520Related%2520Derivatives%2520as%2520Modulators%2520For%2520the%2520Orphan%2520Nuclear%2520Receptor%2520ROR%255BGamma%255D%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span>; <span class="NLM_string-name">Kinzel, O.</span>; <span class="NLM_string-name">Steeneck, C.</span>; <span class="NLM_string-name">Kleymann, G.</span>; <span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Carboxamide or Sulfonamide Substituted Nitrogen-Containing 5-Membered Heterocycles as Modulators For the Orphan Nuclear Receptor ROR Gamma</span>. WO Patent <span class="NLM_patent">WO2014023367A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+Gege&author=O.+Kinzel&author=C.+Steeneck&author=G.+Kleymann&author=T.+Hoffmann&title=Carboxamide+or+Sulfonamide+Substituted+Nitrogen-Containing+5-Membered+Heterocycles+as+Modulators+For+the+Orphan+Nuclear+Receptor+ROR+Gamma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26atitle%3DCarboxamide%2520or%2520Sulfonamide%2520Substituted%2520Nitrogen-Containing%25205-Membered%2520Heterocycles%2520as%2520Modulators%2520For%2520the%2520Orphan%2520Nuclear%2520Receptor%2520ROR%2520Gamma%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gege, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleymann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schluter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steeneck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelen, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, T.</span></span> <span> </span><span class="NLM_article-title">Identification and biological evaluation of thiazole-based inverse agonists of RORγt</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1446</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.03.093</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2018.03.093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29631962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnt1ejtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1446-1455&author=C.+Gegeauthor=M.+D.+Cummingsauthor=M.+Albersauthor=O.+Kinzelauthor=G.+Kleymannauthor=T.+Schluterauthor=C.+Steeneckauthor=M.+I.+Nelenauthor=C.+Milliganauthor=J.+Spurlinoauthor=X.+Xueauthor=K.+Leonardauthor=J.+P.+Edwardsauthor=A.+Fourieauthor=S.+D.+Goldbergauthor=T.+Hoffmann&title=Identification+and+biological+evaluation+of+thiazole-based+inverse+agonists+of+ROR%CE%B3t&doi=10.1016%2Fj.bmcl.2018.03.093"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and biological evaluation of thiazole-based inverse agonists of RORγt</span></div><div class="casAuthors">Gege, Christian; Cummings, Maxwell D.; Albers, Michael; Kinzel, Olaf; Kleymann, Gerald; Schlueter, Thomas; Steeneck, Christoph; Nelen, Marina I.; Milligan, Cindy; Spurlino, John; Xue, Xiaohua; Leonard, Kristi; Edwards, James P.; Fourie, Anne; Goldberg, Steven D.; Hoffmann, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1446-1455</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The nuclear receptor retinoic acid receptor-related orphan receptor gamma t (RORγt) is a transcription factor that drives Th17 cell differentiation and IL-17 prodn. in both innate and adaptive immune cells.  The IL-23/IL-17 pathway is implicated in major autoimmune and inflammatory diseases.  RORγt lies at the core of this pathway and represents an attractive opportunity for intervention with a small mol.  Despite diverse chem. series having been reported, combining high potency and nuclear receptor selectivity with good physicochem. properties remains a challenging endeavor in the field of RORγt drug discovery.  The authors describe the discovery and evaluation of a new class of potent and selective RORγt inverse agonists based on a thiazole core.  Acid analog 1j (Et 5-[4-[N-(tert-butyl)sulfamoyl]naphthalen-1-yl]-4-(cyclohexylmethyl)thiazole-2-carboxylate) demonstrated oral bioavailability in rats and was potent in a human whole blood assay, suggesting potential utility in treating autoimmune and inflammatory diseases such as psoriasis.  X-ray crystallog. data helped to elucidate the mol. mechanism for RORγt inhibition with this series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp8APFwgPE97Vg90H21EOLACvtfcHk0lh1dZTOCSFwAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnt1ejtLg%253D&md5=5eb11be2492120db73c94733d56ae126</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.03.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.03.093%26sid%3Dliteratum%253Aachs%26aulast%3DGege%26aufirst%3DC.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAlbers%26aufirst%3DM.%26aulast%3DKinzel%26aufirst%3DO.%26aulast%3DKleymann%26aufirst%3DG.%26aulast%3DSchluter%26aufirst%3DT.%26aulast%3DSteeneck%26aufirst%3DC.%26aulast%3DNelen%26aufirst%3DM.%2BI.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%26aulast%3DGoldberg%26aufirst%3DS.%2BD.%26aulast%3DHoffmann%26aufirst%3DT.%26atitle%3DIdentification%2520and%2520biological%2520evaluation%2520of%2520thiazole-based%2520inverse%2520agonists%2520of%2520ROR%25CE%25B3t%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26spage%3D1446%26epage%3D1455%26doi%3D10.1016%2Fj.bmcl.2018.03.093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mcclure, K.</span>; <span class="NLM_string-name">Tanis, V.
M.</span>; <span class="NLM_string-name">Fennema, E. G.</span>; <span class="NLM_string-name">Lebsack, A. D.</span>; <span class="NLM_string-name">Martin, C. L.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Woods, C. R.</span></span> <span> </span><span class="NLM_article-title">6-Aminopyridin-3-yl Thiazoles as Modulators of RORγt</span>. WO Patent <span class="NLM_patent">WO2017189661A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=K.+Mcclure&author=V.%0AM.+Tanis&author=E.+G.+Fennema&author=A.+D.+Lebsack&author=C.+L.+Martin&author=H.+Venkatesan&author=X.+Xue&author=C.+R.+Woods&title=6-Aminopyridin-3-yl+Thiazoles+as+Modulators+of+ROR%CE%B3t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcclure%26aufirst%3DK.%26atitle%3D6-Aminopyridin-3-yl%2520Thiazoles%2520as%2520Modulators%2520of%2520ROR%25CE%25B3t%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span>; <span class="NLM_string-name">Leonard, K. A.</span></span> <span> </span><span class="NLM_article-title">Phenyl Linked Quinolinyl Modulators of ROR-Gamma-T</span>. WO Patent <span class="NLM_patent">WO2015057203A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&author=K.+A.+Leonard&title=Phenyl+Linked+Quinolinyl+Modulators+of+ROR-Gamma-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DPhenyl%2520Linked%2520Quinolinyl%2520Modulators%2520of%2520ROR-Gamma-T%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span>; <span class="NLM_string-name">Jones, W. M.</span>; <span class="NLM_string-name">Goldberg, S.</span></span> <span> </span><span class="NLM_article-title">Methylene Linked Quinolinyl Modulators of ROR-Gamma-T</span>. WO Patent <span class="NLM_patent">WO2015057205A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&author=W.+M.+Jones&author=S.+Goldberg&title=Methylene+Linked+Quinolinyl+Modulators+of+ROR-Gamma-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DMethylene%2520Linked%2520Quinolinyl%2520Modulators%2520of%2520ROR-Gamma-T%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span></span> <span> </span><span class="NLM_article-title">Secondary Alcohol Quinolinyl Modulators of RORγt</span>. WO Patent <span class="NLM_patent">WO2015057206A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&title=Secondary+Alcohol+Quinolinyl+Modulators+of+ROR%CE%B3t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DSecondary%2520Alcohol%2520Quinolinyl%2520Modulators%2520of%2520ROR%25CE%25B3t%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, K.</span>; <span class="NLM_string-name">Edwards, J. P.</span>; <span class="NLM_string-name">Kreutter, K. D.</span>; <span class="NLM_string-name">Kummer, D. A.</span>; <span class="NLM_string-name">Maharoof, U.</span>; <span class="NLM_string-name">Nishimura, R.</span>; <span class="NLM_string-name">Urbanski, M.</span>; <span class="NLM_string-name">Venkatesan, H.</span>; <span class="NLM_string-name">Wang, A.</span>; <span class="NLM_string-name">Wolin, R. L.</span>; <span class="NLM_string-name">Woods, C. R.</span>; <span class="NLM_string-name">Fourie, A.</span>; <span class="NLM_string-name">Xue, X.</span>; <span class="NLM_string-name">Cummings, M. D.</span>; <span class="NLM_string-name">Mcclure, K.</span>; <span class="NLM_string-name">Tanis, V.</span></span> <span> </span><span class="NLM_article-title">Quinolinyl Modulators of RORγt</span>. WO Patent <span class="NLM_patent">WO2015057626A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=K.+Barbay&author=J.+P.+Edwards&author=K.+D.+Kreutter&author=D.+A.+Kummer&author=U.+Maharoof&author=R.+Nishimura&author=M.+Urbanski&author=H.+Venkatesan&author=A.+Wang&author=R.+L.+Wolin&author=C.+R.+Woods&author=A.+Fourie&author=X.+Xue&author=M.+D.+Cummings&author=K.+Mcclure&author=V.+Tanis&title=Quinolinyl+Modulators+of+ROR%CE%B3t"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DK.%26atitle%3DQuinolinyl%2520Modulators%2520of%2520ROR%25CE%25B3t%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barbay, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutter, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummer, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharoof, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanis, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbanski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fourie, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span> <span> </span><span class="NLM_article-title">6-Substituted quinolines as RORγt inverse agonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5277</span>– <span class="NLM_lpage">5283</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.10.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.bmcl.2017.10.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29079472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5277-5283&author=J.+K.+Barbayauthor=M.+D.+Cummingsauthor=M.+Abadauthor=G.+Castroauthor=K.+D.+Kreutterauthor=D.+A.+Kummerauthor=U.+Maharoofauthor=C.+Milliganauthor=R.+Nishimuraauthor=J.+Pierceauthor=C.+Schalk-Hihiauthor=J.+Spurlinoauthor=V.+M.+Tanisauthor=M.+Urbanskiauthor=H.+Venkatesanauthor=A.+Wangauthor=C.+Woodsauthor=R.+Wolinauthor=X.+Xueauthor=J.+P.+Edwardsauthor=A.+M.+Fourieauthor=K.+Leonard&title=6-Substituted+quinolines+as+ROR%CE%B3t+inverse+agonists&doi=10.1016%2Fj.bmcl.2017.10.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">6-Substituted quinolines as RORγt inverse agonists</span></div><div class="casAuthors">Barbay, J. Kent; Cummings, Maxwell D.; Abad, Marta; Castro, Glenda; Kreutter, Kevin D.; Kummer, David A.; Maharoof, Umar; Milligan, Cynthia; Nishimura, Rachel; Pierce, Joan; Schalk-Hihi, Celine; Spurlino, John; Tanis, Virginia M.; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Woods, Craig; Wolin, Ronald; Xue, Xiaohua; Edwards, James P.; Fourie, Anne M.; Leonard, Kristi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5277-5283</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We identified 6-substituted quinolines as modulators of the retinoic acid receptor-related orphan receptor gamma t (RORγt).  The synthesis of this class of RORγt modulators is reported, and optimization of the substituents at the quinoline 6-position that produced compds. with high affinity for the receptor is detailed.  This effort identified mols. that act as potent, full inverse agonists in a RORγt-driven cell-based reporter assay.  The X-ray crystal structures of two full inverse agonists, I and II, from this chem. series bound to the RORγt ligand binding domain are disclosed, and we highlight the interaction of a hydrogen-bond acceptor on the 6-position substituent of the inverse agonist with Glu379:NH as a conserved binding contact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmNK7flW-DSbVg90H21EOLACvtfcHk0lh2hKHSwNwwlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslejsbrO&md5=7df780bf52c1750414412d1c0067e280</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.10.027%26sid%3Dliteratum%253Aachs%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DAbad%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DG.%26aulast%3DKreutter%26aufirst%3DK.%2BD.%26aulast%3DKummer%26aufirst%3DD.%2BA.%26aulast%3DMaharoof%26aufirst%3DU.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DR.%26aulast%3DPierce%26aufirst%3DJ.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DTanis%26aufirst%3DV.%2BM.%26aulast%3DUrbanski%26aufirst%3DM.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWoods%26aufirst%3DC.%26aulast%3DWolin%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DEdwards%26aufirst%3DJ.%2BP.%26aulast%3DFourie%26aufirst%3DA.%2BM.%26aulast%3DLeonard%26aufirst%3DK.%26atitle%3D6-Substituted%2520quinolines%2520as%2520ROR%25CE%25B3t%2520inverse%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5277%26epage%3D5283%26doi%3D10.1016%2Fj.bmcl.2017.10.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dulubova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannigan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reisman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visnick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigley, C.</span></span> <span> </span><span class="NLM_article-title">RTA 1701 is an orally-bioavailable, potent, and selective RORγt inhibitor that suppresses Th17 differentiation in vitro and is efficacious in mouse models of autoimmune disease</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">121.14</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2018&pages=121.14&author=I.+Dulubovaauthor=X.+Jiangauthor=I.+Trevinoauthor=L.+McCauleyauthor=L.+Liuauthor=L.+Hanniganauthor=S.+A.+Reismanauthor=D.+Fergusonauthor=M.+Visnickauthor=C.+Wigley&title=RTA+1701+is+an+orally-bioavailable%2C+potent%2C+and+selective+ROR%CE%B3t+inhibitor+that+suppresses+Th17+differentiation+in+vitro+and+is+efficacious+in+mouse+models+of+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDulubova%26aufirst%3DI.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DTrevino%26aufirst%3DI.%26aulast%3DMcCauley%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DHannigan%26aufirst%3DL.%26aulast%3DReisman%26aufirst%3DS.%2BA.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DVisnick%26aufirst%3DM.%26aulast%3DWigley%26aufirst%3DC.%26atitle%3DRTA%25201701%2520is%2520an%2520orally-bioavailable%252C%2520potent%252C%2520and%2520selective%2520ROR%25CE%25B3t%2520inhibitor%2520that%2520suppresses%2520Th17%2520differentiation%2520in%2520vitro%2520and%2520is%2520efficacious%2520in%2520mouse%2520models%2520of%2520autoimmune%2520disease%26jtitle%3DJ.%2520Immunol.%26date%3D2018%26volume%3D200%26spage%3D121.14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reisman, S.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-Y. I</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proksch, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, K. W.</span></span> <span> </span><span class="NLM_article-title">RTA 1701 is an oral RORγt inhibitor that suppresses the IL-17A response in non-human primates</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">175.22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2018&pages=175.22&author=S.%0AA.+Reismanauthor=C.-Y.+I+Leeauthor=J.+W.+Prokschauthor=M.+Sakamotoauthor=K.+W.+Ward&title=RTA+1701+is+an+oral+ROR%CE%B3t+inhibitor+that+suppresses+the+IL-17A+response+in+non-human+primates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReisman%26aufirst%3DS.%2BA.%26aulast%3DLee%26aufirst%3DC.-Y.%2BI%26aulast%3DProksch%26aufirst%3DJ.%2BW.%26aulast%3DSakamoto%26aufirst%3DM.%26aulast%3DWard%26aufirst%3DK.%2BW.%26atitle%3DRTA%25201701%2520is%2520an%2520oral%2520ROR%25CE%25B3t%2520inhibitor%2520that%2520suppresses%2520the%2520IL-17A%2520response%2520in%2520non-human%2520primates%26jtitle%3DJ.%2520Immunol.%26date%3D2018%26volume%3D200%26spage%3D175.22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Visnick, M.</span>; <span class="NLM_string-name">Jiang, X.</span>; <span class="NLM_string-name">Hotema, M. R.</span>; <span class="NLM_string-name">Lee, C.</span>; <span class="NLM_string-name">Caprathe, B. W.</span>; <span class="NLM_string-name">Roark, W. H.</span>; <span class="NLM_string-name">Bolton, G.</span></span> <span> </span><span class="NLM_article-title">C4-Modified Oleanolic Acid Derivatives For Inhibition of IL-17 And Other Uses</span>. WO Patent <span class="NLM_patent">WO2017053868A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=M.+Visnick&author=X.+Jiang&author=M.+R.+Hotema&author=C.+Lee&author=B.+W.+Caprathe&author=W.+H.+Roark&author=G.+Bolton&title=C4-Modified+Oleanolic+Acid+Derivatives+For+Inhibition+of+IL-17+And+Other+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVisnick%26aufirst%3DM.%26atitle%3DC4-Modified%2520Oleanolic%2520Acid%2520Derivatives%2520For%2520Inhibition%2520of%2520IL-17%2520And%2520Other%2520Uses%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakris, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chertow, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsberry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inker, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heerspink, H. J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Grady, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pergola, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warnock, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, C. J.</span></span> <span> </span><span class="NLM_article-title">Bardoxolone methyl improves kidney function in patients with chronic kidney disease stage 4 and type 2 diabetes: Post-hoc analyses from bardoxolone methyl evaluation in patients with chronic kidney disease and type 2 diabetes study</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1159/000486398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1159%2F000486398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29402767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=40-47&author=M.+P.+Chinauthor=G.+L.+Bakrisauthor=G.+A.+Blockauthor=G.+M.+Chertowauthor=A.+Goldsberryauthor=L.+A.+Inkerauthor=H.+J.+L.+Heerspinkauthor=M.+O%E2%80%99Gradyauthor=P.+E.+Pergolaauthor=C.+Wannerauthor=D.+G.+Warnockauthor=C.+J.+Meyer&title=Bardoxolone+methyl+improves+kidney+function+in+patients+with+chronic+kidney+disease+stage+4+and+type+2+diabetes%3A+Post-hoc+analyses+from+bardoxolone+methyl+evaluation+in+patients+with+chronic+kidney+disease+and+type+2+diabetes+study&doi=10.1159%2F000486398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study</span></div><div class="casAuthors">Chin, Melanie P.; Bakris, George L.; Block, Geoffrey A.; Chertow, Glenn M.; Goldsberry, Angie; Inker, Lesley A.; Heerspink, Hiddo J. L.; O'Grady, Megan; Pergola, Pablo E.; Wanner, Christoph; Warnock, David G.; Meyer, Colin J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-47</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Increases in measured inulin clearance, measured creatinine clearance, and estd. glomerular filtration rate (eGFR) have been obsd. with bardoxolone Me in 7 studies enrolling approx. 2,600 patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).  The largest of these studies was Bardoxolone Me Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes (BEACON), a multinational, randomized, double-blind, placebo-controlled phase 3 trial which enrolled patients with T2D and CKD stage 4.  The BEACON trial was terminated after preliminary analyses showed that patients randomized to bardoxolone Me experienced significantly higher rates of heart failure events.  We performed post-hoc analyses to characterize changes in kidney function induced by bardoxolone Me.  Methods: Patients in -BEACON (n = 2,185) were randomized 1: 1 to receive once-daily bardoxolone Me (20 mg) or placebo.  We compared the effects of bardoxolone Me and placebo on a post-hoc composite renal endpoint consisting of ≥30% decline from baseline in eGFR, eGFR <15 mL/min/1.73 m2, and end-stage renal disease (ESRD) events (provision of dialysis or kidney transplantation).  Results: Consistent with prior studies, patients randomized to bardoxolone Me experienced mean increases in eGFR that were sustained through study week 48.  Moreover, increases in eGFR from baseline were sustained 4 wk after cessation of treatment.  Patients randomized to bardoxolone Me were significantly less likely to experience the composite renal endpoint (hazards ratio 0.48 [95% CI 0.36-0.64]; p < 0.0001).  Conclusions: Bardoxolone Me preserves kidney function and may delay the onset of ESRD in patients with T2D and stage 4 CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnjOzptzThpbVg90H21EOLACvtfcHk0ljuuBjiFzT_vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivVCiu7Y%253D&md5=9351e5606902fd77cfe5dc042c833e66</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1159%2F000486398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000486398%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DM.%2BP.%26aulast%3DBakris%26aufirst%3DG.%2BL.%26aulast%3DBlock%26aufirst%3DG.%2BA.%26aulast%3DChertow%26aufirst%3DG.%2BM.%26aulast%3DGoldsberry%26aufirst%3DA.%26aulast%3DInker%26aufirst%3DL.%2BA.%26aulast%3DHeerspink%26aufirst%3DH.%2BJ.%2BL.%26aulast%3DO%25E2%2580%2599Grady%26aufirst%3DM.%26aulast%3DPergola%26aufirst%3DP.%2BE.%26aulast%3DWanner%26aufirst%3DC.%26aulast%3DWarnock%26aufirst%3DD.%2BG.%26aulast%3DMeyer%26aufirst%3DC.%2BJ.%26atitle%3DBardoxolone%2520methyl%2520improves%2520kidney%2520function%2520in%2520patients%2520with%2520chronic%2520kidney%2520disease%2520stage%25204%2520and%2520type%25202%2520diabetes%253A%2520Post-hoc%2520analyses%2520from%2520bardoxolone%2520methyl%2520evaluation%2520in%2520patients%2520with%2520chronic%2520kidney%2520disease%2520and%2520type%25202%2520diabetes%2520study%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2018%26volume%3D47%26spage%3D40%26epage%3D47%26doi%3D10.1159%2F000486398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span>; <span class="NLM_string-name">Bender, C. F.</span>; <span class="NLM_string-name">Visnick, M.</span>; <span class="NLM_string-name">Hotema, M. R.</span>; <span class="NLM_string-name">Sheldon, Z. S.</span>; <span class="NLM_string-name">Lee, C.</span>; <span class="NLM_string-name">Caprathe, B. W.</span>; <span class="NLM_string-name">Bolton, G.</span>; <span class="NLM_string-name">Kornberg, B.</span></span> <span> </span><span class="NLM_article-title">Pyrimidine Tricyclic Enone Derivatives For Inhibition of RORγ and Other Uses</span>. WO Patent <span class="NLM_patent">WO2018111315A1</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=X.+Jiang&author=C.+F.+Bender&author=M.+Visnick&author=M.+R.+Hotema&author=Z.+S.+Sheldon&author=C.+Lee&author=B.+W.+Caprathe&author=G.+Bolton&author=B.+Kornberg&title=Pyrimidine+Tricyclic+Enone+Derivatives+For+Inhibition+of+ROR%CE%B3+and+Other+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26atitle%3DPyrimidine%2520Tricyclic%2520Enone%2520Derivatives%2520For%2520Inhibition%2520of%2520ROR%25CE%25B3%2520and%2520Other%2520Uses%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGeehan, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryson, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipinski, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukhtiyarov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claremon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lala, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregg, R. E.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742, a RORγt antagonist, in healthy volunteers</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>196</i></span>,  <span class="NLM_fpage">71.4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2016&pages=71.4&author=G.+M.+McGeehanauthor=S.+A.+Palmerauthor=C.+C.+Brysonauthor=Y.+Zhaoauthor=M.+Shiauthor=K.+K.+Lipinskiauthor=Y.+Bukhtiyarovauthor=J.+Guoauthor=D.+A.+Claremonauthor=D.+S.+Lalaauthor=R.+E.+Gregg&title=Safety%2C+tolerability%2C+pharmacokinetics+and+pharmacodynamics+of+VTP-43742%2C+a+ROR%CE%B3t+antagonist%2C+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DPalmer%26aufirst%3DS.%2BA.%26aulast%3DBryson%26aufirst%3DC.%2BC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DLipinski%26aufirst%3DK.%2BK.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26aulast%3DLala%26aufirst%3DD.%2BS.%26aulast%3DGregg%26aufirst%3DR.%2BE.%26atitle%3DSafety%252C%2520tolerability%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520VTP-43742%252C%2520a%2520ROR%25CE%25B3t%2520antagonist%252C%2520in%2520healthy%2520volunteers%26jtitle%3DJ.%2520Immunol.%26date%3D2016%26volume%3D196%26spage%3D71.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span> <i>Vitae Pharmaceuticals Achieves Proof-of-Concept with First-in-Class
RORγt Inhibitor in Moderate to Severe Psoriasis</i>; <span class="NLM_publisher-name">Vitae Pharmaceuticals Inc.</span>: <span class="NLM_publisher-loc">Fort
Washington, PA</span>, March 16, 2016; press release <a href="http://ir.vitaepharma.com/phoenix.zhtml?c=219654&amp;p=irol-newsArticle&amp;ID=2149044" class="extLink">http://ir.vitaepharma.com/phoenix.zhtml?c=219654&p=irol-newsArticle&ID=2149044</a> (accessed March 26, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Vitae+Pharmaceuticals+Achieves+Proof-of-Concept+with+First-in-Class%0AROR%CE%B3t+Inhibitor+in+Moderate+to+Severe+Psoriasis%3B+Vitae+Pharmaceuticals+Inc.%3A+Fort%0AWashington%2C+PA%2C+March+16%2C+2016%3B+press+release+http%3A%2F%2Fir.vitaepharma.com%2Fphoenix.zhtml%3Fc%3D219654%26p%3Dirol-newsArticle%26ID%3D2149044+%28accessed+March+26%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DVitae%2520Pharmaceuticals%2520Achieves%2520Proof-of-Concept%2520with%2520First-in-Class%250AROR%25CE%25B3t%2520Inhibitor%2520in%2520Moderate%2520to%2520Severe%2520Psoriasis%26pub%3DVitae%2520Pharmaceuticals%2520Inc%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span> <i>Allergan writes off lead candidate from $640M Vitae buy, recorded
$535M impairment charge in Q1; shares down 2%</i>; <span class="NLM_publisher-name">Seeking Alpha</span>, April 30, <span class="NLM_year">2018</span>; press
release <a href="https://seekingalpha.com/news/3350282-allergan-writes-lead-candidate-640m-vitae-buy-recorded-535m-impairment-charge-q1-shares-2" class="extLink">https://seekingalpha.com/news/3350282-allergan-writes-lead-candidate-640m-vitae-buy-recorded-535m-impairment-charge-q1-shares-2</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Allergan+writes+off+lead+candidate+from+%24640M+Vitae+buy%2C+recorded%0A%24535M+impairment+charge+in+Q1%3B+shares+down+2%25%3B+Seeking+Alpha%2C+April+30%2C+2018%3B+press%0Arelease+https%3A%2F%2Fseekingalpha.com%2Fnews%2F3350282-allergan-writes-lead-candidate-640m-vitae-buy-recorded-535m-impairment-charge-q1-shares-2."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DAllergan%2520writes%2520off%2520lead%2520candidate%2520from%2520%2524640M%2520Vitae%2520buy%252C%2520recorded%250A%2524535M%2520impairment%2520charge%2520in%2520Q1%253B%2520shares%2520down%25202%2525%26pub%3DSeeking%2520Alpha%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Mackensen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siemetzki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freudenberg, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wigger-Alberti, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, Y.</span></span> <span> </span><span class="NLM_article-title">A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK-2981278 ointment in a psoriasis plaque test</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">1427</span>– <span class="NLM_lpage">1429</span>, <span class="refDoi"> DOI: 10.1111/bjd.16131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1111%2Fbjd.16131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29150844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2018&pages=1427-1429&author=E.+G.+Kangauthor=S.+Wuauthor=A.+Guptaauthor=Y.+L.+von+Mackensenauthor=H.+Siemetzkiauthor=J.+M.+Freudenbergauthor=W.+Wigger-Albertiauthor=Y.+Yamaguchi&title=A+phase+I+randomized+controlled+trial+to+evaluate+safety+and+clinical+effect+of+topically+applied+GSK-2981278+ointment+in+a+psoriasis+plaque+test&doi=10.1111%2Fbjd.16131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test</span></div><div class="casAuthors">Kang E G; Wu S; Gupta A; Freudenberg J M; Yamaguchi Y; von Mackensen Y-L; Siemetzki H; Wigger-Alberti W</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of dermatology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1427-1429</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2LnZBzvo4YtFxYDaSSP8XfW6udTcc2ea2ZBmFovWwbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3isFWltg%253D%253D&md5=c480c28f5973de8ccba8f8e290d8e8ab</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fbjd.16131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbjd.16131%26sid%3Dliteratum%253Aachs%26aulast%3DKang%26aufirst%3DE.%2BG.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3Dvon%2BMackensen%26aufirst%3DY.%2BL.%26aulast%3DSiemetzki%26aufirst%3DH.%26aulast%3DFreudenberg%26aufirst%3DJ.%2BM.%26aulast%3DWigger-Alberti%26aufirst%3DW.%26aulast%3DYamaguchi%26aufirst%3DY.%26atitle%3DA%2520phase%2520I%2520randomized%2520controlled%2520trial%2520to%2520evaluate%2520safety%2520and%2520clinical%2520effect%2520of%2520topically%2520applied%2520GSK-2981278%2520ointment%2520in%2520a%2520psoriasis%2520plaque%2520test%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2018%26volume%3D178%26spage%3D1427%26epage%3D1429%26doi%3D10.1111%2Fbjd.16131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span> <i>GSK delivers further progress in Q2 and sets out
new priorities for
the Group</i>; <span class="NLM_publisher-name">GlaxoSmithKline</span>: <span class="NLM_publisher-loc">London</span>, July 26, <span class="NLM_year">2017</span>; press release <a href="https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group/" class="extLink">https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GSK+delivers+further+progress+in+Q2+and+sets+out%0Anew+priorities+for%0Athe+Group%3B+GlaxoSmithKline%3A+London%2C+July+26%2C+2017%3B+press+release+https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fgsk-delivers-further-progress-in-q2-and-sets-out-new-priorities-for-the-group%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DGSK%2520delivers%2520further%2520progress%2520in%2520Q2%2520and%2520sets%2520out%250Anew%2520priorities%2520for%250Athe%2520Group%26pub%3DGlaxoSmithKline%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIsaac, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce-Shaikh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cristescu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mudgett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engstrom, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piers, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltus, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehmet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aicher, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaller, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawwari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Correll, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of RORγT skews TCRα gene rearrangement and limits T cell repertoire diversity</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3206</span>– <span class="NLM_lpage">3218</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2016.11.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.celrep.2016.11.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=28009290" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFGnsrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=3206-3218&author=Y.+Guoauthor=K.+D.+MacIsaacauthor=Y.+Chenauthor=R.+J.+Millerauthor=R.+Jainauthor=B.+Joyce-Shaikhauthor=H.+Fergusonauthor=I.+M.+Wangauthor=R.+Cristescuauthor=J.+Mudgettauthor=L.+Engstromauthor=K.+J.+Piersauthor=G.+A.+Baltusauthor=K.+Barrauthor=H.+Zhangauthor=H.+Mehmetauthor=L.+G.+Hegdeauthor=X.+Huauthor=L.+L.+Carterauthor=T.+D.+Aicherauthor=G.+Glickauthor=D.+Zallerauthor=A.+Hawwariauthor=C.+C.+Correllauthor=D.+C.+Jonesauthor=D.+J.+Cua&title=Inhibition+of+ROR%CE%B3T+skews+TCR%CE%B1+gene+rearrangement+and+limits+T+cell+repertoire+diversity&doi=10.1016%2Fj.celrep.2016.11.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity</span></div><div class="casAuthors">Guo, Yanxia; MacIsaac, Kenzie D.; Chen, Yi; Miller, Richard J.; Jain, Renu; Joyce-Shaikh, Barbara; Ferguson, Heidi; Wang, I-Ming; Cristescu, Razvan; Mudgett, John; Engstrom, Laura; Piers, Kyle J.; Baltus, Gretchen A.; Barr, Kenneth; Zhang, Hongjun; Mehmet, Huseyin; Hegde, Laxminarayan G.; Hu, Xiao; Carter, Laura L.; Aicher, Thomas D.; Glick, Gary; Zaller, Dennis; Hawwari, Abbas; Correll, Craig C.; Jones, Dallas C.; Cua, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3206-3218</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent studies have elucidated the mol. mechanism of RORγT transcriptional regulation of Th17 differentiation and function.  RORγT was initially identified as a transcription factor required for thymopoiesis by maintaining survival of CD4+CD8+ (DP) thymocytes.  While RORγ antagonists are currently being developed to treat autoimmunity, it remains unclear how RORγT inhibition may impact thymocyte development.  In this study, we show that in addn. to regulating DP thymocytes survival, RORγT also controls genes that regulate thymocyte migration, proliferation, and T cell receptor (TCR)α selection.  Strikingly, pharmacol. inhibition of RORγ skews TCRα gene rearrangement, limits T cell repertoire diversity, and inhibits development of autoimmune encephalomyelitis.  Thus, targeting RORγT not only inhibits Th17 cell development and function but also fundamentally alters thymic-emigrant recognition of self and foreign antigens.  The anal. of RORγ inhibitors has allowed us to gain a broader perspective of the diverse function of RORγT and its impact on T cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS2YbVQ9dNS7Vg90H21EOLACvtfcHk0lgKslrP9SoQcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFGnsrjP&md5=6b3766d0673b02fbe6a6b0cc1a10f4a5</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2016.11.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2016.11.073%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DMacIsaac%26aufirst%3DK.%2BD.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DJoyce-Shaikh%26aufirst%3DB.%26aulast%3DFerguson%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DI.%2BM.%26aulast%3DCristescu%26aufirst%3DR.%26aulast%3DMudgett%26aufirst%3DJ.%26aulast%3DEngstrom%26aufirst%3DL.%26aulast%3DPiers%26aufirst%3DK.%2BJ.%26aulast%3DBaltus%26aufirst%3DG.%2BA.%26aulast%3DBarr%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMehmet%26aufirst%3DH.%26aulast%3DHegde%26aufirst%3DL.%2BG.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DCarter%26aufirst%3DL.%2BL.%26aulast%3DAicher%26aufirst%3DT.%2BD.%26aulast%3DGlick%26aufirst%3DG.%26aulast%3DZaller%26aufirst%3DD.%26aulast%3DHawwari%26aufirst%3DA.%26aulast%3DCorrell%26aufirst%3DC.%2BC.%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520ROR%25CE%25B3T%2520skews%2520TCR%25CE%25B1%2520gene%2520rearrangement%2520and%2520limits%2520T%2520cell%2520repertoire%2520diversity%26jtitle%3DCell%2520Rep.%26date%3D2016%26volume%3D17%26spage%3D3206%26epage%3D3218%26doi%3D10.1016%2Fj.celrep.2016.11.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurebayashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backlund, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koller, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jetten, A. M.</span></span> <span> </span><span class="NLM_article-title">High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORγ</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=901-909&author=E.+Uedaauthor=S.+Kurebayashiauthor=M.+Sakaueauthor=M.+Backlundauthor=B.+Kollerauthor=A.+M.+Jetten&title=High+incidence+of+T-cell+lymphomas+in+mice+deficient+in+the+retinoid-related+orphan+receptor+ROR%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUeda%26aufirst%3DE.%26aulast%3DKurebayashi%26aufirst%3DS.%26aulast%3DSakaue%26aufirst%3DM.%26aulast%3DBacklund%26aufirst%3DM.%26aulast%3DKoller%26aufirst%3DB.%26aulast%3DJetten%26aufirst%3DA.%2BM.%26atitle%3DHigh%2520incidence%2520of%2520T-cell%2520lymphomas%2520in%2520mice%2520deficient%2520in%2520the%2520retinoid-related%2520orphan%2520receptor%2520ROR%25CE%25B3%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D901%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liljevald, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehnberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Söderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramnegård, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Börjesson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luciani, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krutrök, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brändén, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjursell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjögren, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jirholt, J.</span></span> <span> </span><span class="NLM_article-title">Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma</span>. <i>Autoimmun. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1070</span>, <span class="refDoi"> DOI: 10.1016/j.autrev.2016.07.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1016%2Fj.autrev.2016.07.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=27491564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12nsLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1062-1070&author=M.+Liljevaldauthor=M.+Rehnbergauthor=M.+S%C3%B6derbergauthor=M.+Ramneg%C3%A5rdauthor=J.+B%C3%B6rjessonauthor=D.+Lucianiauthor=N.+Krutr%C3%B6kauthor=L.+Br%C3%A4nd%C3%A9nauthor=C.+Johanssonauthor=X.+Xuauthor=M.+Bjursellauthor=A.+K.+Sj%C3%B6grenauthor=J.+Hornbergauthor=U.+Anderssonauthor=D.+Keelingauthor=J.+Jirholt&title=Retinoid-related+orphan+receptor+%CE%B3+%28ROR%CE%B3%29+adult+induced+knockout+mice+develop+lymphoblastic+lymphoma&doi=10.1016%2Fj.autrev.2016.07.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Retinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma</span></div><div class="casAuthors">Liljevald, Maria; Rehnberg, Maria; Soederberg, Magnus; Ramnegaard, Marie; Boerjesson, Jenny; Luciani, Donatella; Krutroek, Nina; Braenden, Lena; Johansson, Camilla; Xu, Xiufeng; Bjursell, Mikael; Sjoegren, Anna-Karin; Hornberg, Jorrit; Andersson, Ulf; Keeling, David; Jirholt, Johan</div><div class="citationInfo"><span class="NLM_cas:title">Autoimmunity Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1062-1070</span>CODEN:
                <span class="NLM_cas:coden">ARUEBU</span>;
        ISSN:<span class="NLM_cas:issn">1568-9972</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RORγ is a nuclear hormone receptor which controls polarization of naive CD4+ T-cells into proinflammatory Th17 cells.  Pharmacol. antagonism of RORγ has therapeutic potential for autoimmune diseases; however, this mechanism may potentially carry target-related safety risks, as mice deficient in Rorc, the gene encoding RORγ, develop T-cell lymphoma with 50% frequency.  Due to the requirement of RORγ during development, the Rorc knockout (KO) animals lack secondary lymphoid organs and have a dysregulation in the generation of CD4 + and CD8 + T cells.  We wanted to extend the evaluation of RORγ deficiency to address the question whether lymphomas, similar to those obsd. in the Rorc KO, would develop in an animal with an otherwise intact adult immune system.  Accordingly, we designed a conditional RORγ knockout mouse (Rorc CKO) where the Rorc locus could be deleted in adult animals.  Based on these studies we can confirm that these animals also develop lymphoma in a similar time frame as embryonic Rorc knockouts.  This study also suggests that in animals where the gene deletion is incomplete, the thymus undergoes a rapid selection process replacing Rorc deficient cells with remnant thymocytes carrying a functional Rorc locus and that subsequently, these animals do not develop lymphoblastic lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpi0KfNRXewvLVg90H21EOLACvtfcHk0lh4UrHcTDOZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12nsLrP&md5=e58691ecc5983782269cd141548bf61d</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.autrev.2016.07.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autrev.2016.07.036%26sid%3Dliteratum%253Aachs%26aulast%3DLiljevald%26aufirst%3DM.%26aulast%3DRehnberg%26aufirst%3DM.%26aulast%3DS%25C3%25B6derberg%26aufirst%3DM.%26aulast%3DRamneg%25C3%25A5rd%26aufirst%3DM.%26aulast%3DB%25C3%25B6rjesson%26aufirst%3DJ.%26aulast%3DLuciani%26aufirst%3DD.%26aulast%3DKrutr%25C3%25B6k%26aufirst%3DN.%26aulast%3DBr%25C3%25A4nd%25C3%25A9n%26aufirst%3DL.%26aulast%3DJohansson%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DBjursell%26aufirst%3DM.%26aulast%3DSj%25C3%25B6gren%26aufirst%3DA.%2BK.%26aulast%3DHornberg%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DU.%26aulast%3DKeeling%26aufirst%3DD.%26aulast%3DJirholt%26aufirst%3DJ.%26atitle%3DRetinoid-related%2520orphan%2520receptor%2520%25CE%25B3%2520%2528ROR%25CE%25B3%2529%2520adult%2520induced%2520knockout%2520mice%2520develop%2520lymphoblastic%2520lymphoma%26jtitle%3DAutoimmun.%2520Rev.%26date%3D2016%26volume%3D15%26spage%3D1062%26epage%3D1070%26doi%3D10.1016%2Fj.autrev.2016.07.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markle, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deenick, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mele, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Averbuch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzahrani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Muhsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halwani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soudais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzouqa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shamma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Barricarte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latorre, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deswarte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabot-Hanin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrado, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkadi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migaud, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlehamn, C. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sette, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCluskey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossjohn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Villartay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moshous, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hambleton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latour, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkwright, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelhard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notarangelo, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boisson-Dupuis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sallusto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bustamante, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tangye, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casanova, J. L.</span></span> <span> </span><span class="NLM_article-title">Impairment of immunity to candida and mycobacterium in humans with bi-allelic RORC mutations</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1126/science.aaa4282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1126%2Fscience.aaa4282" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2015&pages=606-613&author=S.+Okadaauthor=J.+G.+Markleauthor=E.+K.+Deenickauthor=F.+Meleauthor=D.+Averbuchauthor=M.+Lagosauthor=M.+Alzahraniauthor=S.+Al-Muhsenauthor=R.+Halwaniauthor=C.+S.+Maauthor=N.+Wongauthor=C.+Soudaisauthor=L.+A.+Hendersonauthor=H.+Marzouqaauthor=J.+Shammaauthor=M.+Gonzalezauthor=R.+Martinez-Barricarteauthor=C.+Okadaauthor=D.+T.+Averyauthor=D.+Latorreauthor=C.+Deswarteauthor=F.+Jabot-Haninauthor=E.+Torradoauthor=J.+Fountainauthor=A.+Belkadiauthor=Y.+Itanauthor=B.+Boissonauthor=M.+Migaudauthor=C.+S.+L.+Arlehamnauthor=A.+Setteauthor=S.+Bretonauthor=J.+McCluskeyauthor=J.+Rossjohnauthor=J.+P.+de+Villartayauthor=D.+Moshousauthor=S.+Hambletonauthor=S.+Latourauthor=P.+D.+Arkwrightauthor=C.+Picardauthor=O.+Lantzauthor=D.+Engelhardauthor=M.+Kobayashiauthor=L.+Abelauthor=A.+M.+Cooperauthor=L.+D.+Notarangeloauthor=S.+Boisson-Dupuisauthor=A.+Puelauthor=F.+Sallustoauthor=J.+Bustamanteauthor=S.+G.+Tangyeauthor=J.+L.+Casanova&title=Impairment+of+immunity+to+candida+and+mycobacterium+in+humans+with+bi-allelic+RORC+mutations&doi=10.1126%2Fscience.aaa4282"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa4282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa4282%26sid%3Dliteratum%253Aachs%26aulast%3DOkada%26aufirst%3DS.%26aulast%3DMarkle%26aufirst%3DJ.%2BG.%26aulast%3DDeenick%26aufirst%3DE.%2BK.%26aulast%3DMele%26aufirst%3DF.%26aulast%3DAverbuch%26aufirst%3DD.%26aulast%3DLagos%26aufirst%3DM.%26aulast%3DAlzahrani%26aufirst%3DM.%26aulast%3DAl-Muhsen%26aufirst%3DS.%26aulast%3DHalwani%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DC.%2BS.%26aulast%3DWong%26aufirst%3DN.%26aulast%3DSoudais%26aufirst%3DC.%26aulast%3DHenderson%26aufirst%3DL.%2BA.%26aulast%3DMarzouqa%26aufirst%3DH.%26aulast%3DShamma%26aufirst%3DJ.%26aulast%3DGonzalez%26aufirst%3DM.%26aulast%3DMartinez-Barricarte%26aufirst%3DR.%26aulast%3DOkada%26aufirst%3DC.%26aulast%3DAvery%26aufirst%3DD.%2BT.%26aulast%3DLatorre%26aufirst%3DD.%26aulast%3DDeswarte%26aufirst%3DC.%26aulast%3DJabot-Hanin%26aufirst%3DF.%26aulast%3DTorrado%26aufirst%3DE.%26aulast%3DFountain%26aufirst%3DJ.%26aulast%3DBelkadi%26aufirst%3DA.%26aulast%3DItan%26aufirst%3DY.%26aulast%3DBoisson%26aufirst%3DB.%26aulast%3DMigaud%26aufirst%3DM.%26aulast%3DArlehamn%26aufirst%3DC.%2BS.%2BL.%26aulast%3DSette%26aufirst%3DA.%26aulast%3DBreton%26aufirst%3DS.%26aulast%3DMcCluskey%26aufirst%3DJ.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3Dde%2BVillartay%26aufirst%3DJ.%2BP.%26aulast%3DMoshous%26aufirst%3DD.%26aulast%3DHambleton%26aufirst%3DS.%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DArkwright%26aufirst%3DP.%2BD.%26aulast%3DPicard%26aufirst%3DC.%26aulast%3DLantz%26aufirst%3DO.%26aulast%3DEngelhard%26aufirst%3DD.%26aulast%3DKobayashi%26aufirst%3DM.%26aulast%3DAbel%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DA.%2BM.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26aulast%3DBoisson-Dupuis%26aufirst%3DS.%26aulast%3DPuel%26aufirst%3DA.%26aulast%3DSallusto%26aufirst%3DF.%26aulast%3DBustamante%26aufirst%3DJ.%26aulast%3DTangye%26aufirst%3DS.%2BG.%26aulast%3DCasanova%26aufirst%3DJ.%2BL.%26atitle%3DImpairment%2520of%2520immunity%2520to%2520candida%2520and%2520mycobacterium%2520in%2520humans%2520with%2520bi-allelic%2520RORC%2520mutations%26jtitle%3DScience%26date%3D2015%26volume%3D349%26spage%3D606%26epage%3D613%26doi%3D10.1126%2Fscience.aaa4282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Withers, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackley, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halford, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutton, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriott, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brucklacher-Waldert, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veldhoen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldassano, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonnenberg, G. F.</span></span> <span> </span><span class="NLM_article-title">Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing T<sub>H</sub>17 cells and preserving ILC3</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1038/nm.4046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1038%2Fnm.4046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=26878233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFKhsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=319-323&author=D.+R.+Withersauthor=M.+R.+Hepworthauthor=X.+Wangauthor=E.+C.+Mackleyauthor=E.+E.+Halfordauthor=E.+E.+Duttonauthor=C.+L.+Marriottauthor=V.+Brucklacher-Waldertauthor=M.+Veldhoenauthor=J.+Kelsenauthor=R.+N.+Baldassanoauthor=G.+F.+Sonnenberg&title=Transient+inhibition+of+ROR-%CE%B3t+therapeutically+limits+intestinal+inflammation+by+reducing+TH17+cells+and+preserving+ILC3&doi=10.1038%2Fnm.4046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells</span></div><div class="casAuthors">Withers, David R.; Hepworth, Matthew R.; Wang, Xinxin; Mackley, Emma C.; Halford, Emily E.; Dutton, Emma E.; Marriott, Clare L.; Brucklacher-Waldert, Verena; Veldhoen, Marc; Kelsen, Judith; Baldassano, Robert N.; Sonnenberg, Gregory F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">319-323</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">RAR-related orphan receptor-γt (ROR-γt) directs differentiation of proinflammatory T helper 17 (TH17) cells and is a potential therapeutic target in chronic autoimmune and inflammatory diseases.  However, ROR-γt-dependent group 3 innate lymphoid cells ILC3s provide essential immunity and tissue protection in the intestine, suggesting that targeting ROR-γt could also result in impaired host defense after infection or enhanced tissue damage.  Here, we demonstrate that transient chem. inhibition of ROR-γt in mice selectively reduces cytokine prodn. from TH17 but not ILCs in the context of intestinal infection with Citrobacter rodentium, resulting in preserved innate immunity.  Temporal deletion of Rorc (encoding ROR-γt) in mature ILCs also did not impair cytokine response in the steady state or during infection.  Finally, pharmacol. inhibition of ROR-γt provided therapeutic benefit in mouse models of intestinal inflammation and reduced the frequency of TH17 cells but not ILCs isolated from primary intestinal samples of individuals with inflammatory bowel disease (IBD).  Collectively, these results reveal differential requirements for ROR-γt in the maintenance of TH17 cell and ILC3 responses and suggest that transient inhibition of ROR-γt is a safe and effective therapeutic approach during intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6T-ucecrVJ7Vg90H21EOLACvtfcHk0lihgDKOjC_Hxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFKhsb4%253D&md5=4ef0467a7eee081460f34a42a9b26e8e</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1038%2Fnm.4046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4046%26sid%3Dliteratum%253Aachs%26aulast%3DWithers%26aufirst%3DD.%2BR.%26aulast%3DHepworth%26aufirst%3DM.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DMackley%26aufirst%3DE.%2BC.%26aulast%3DHalford%26aufirst%3DE.%2BE.%26aulast%3DDutton%26aufirst%3DE.%2BE.%26aulast%3DMarriott%26aufirst%3DC.%2BL.%26aulast%3DBrucklacher-Waldert%26aufirst%3DV.%26aulast%3DVeldhoen%26aufirst%3DM.%26aulast%3DKelsen%26aufirst%3DJ.%26aulast%3DBaldassano%26aufirst%3DR.%2BN.%26aulast%3DSonnenberg%26aufirst%3DG.%2BF.%26atitle%3DTransient%2520inhibition%2520of%2520ROR-%25CE%25B3t%2520therapeutically%2520limits%2520intestinal%2520inflammation%2520by%2520reducing%2520TH17%2520cells%2520and%2520preserving%2520ILC3%26jtitle%3DNat.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D319%26epage%3D323%26doi%3D10.1038%2Fnm.4046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maniakis-Grivas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asher, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkington, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, J. S.</span></span> <span> </span><span class="NLM_article-title">Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.1002/path.5013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=10.1002%2Fpath.5013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=29210073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisl2jtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2018&pages=311-322&author=S.+Singhauthor=G.+Maniakis-Grivasauthor=U.+K.+Singhauthor=R.+M.+Asherauthor=F.+Mauriauthor=P.+T.+Elkingtonauthor=J.+S.+Friedland&title=Interleukin-17+regulates+matrix+metalloproteinase+activity+in+human+pulmonary+tuberculosis&doi=10.1002%2Fpath.5013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-17 regulates matrix metalloproteinase activity in human pulmonary tuberculosis</span></div><div class="casAuthors">Singh, Shivani; Maniakis-Grivas, George; Singh, Utpal K.; Asher, Radha M.; Mauri, Francesco; Elkington, Paul T.; Friedland, Jon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-322</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">1096-9896</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Tuberculosis (TB) is characterized by extensive pulmonary matrix breakdown.  Interleukin-17 (IL-17) is key in host defense in TB but its role in TB-driven tissue damage is unknown.  We investigated the hypothesis that respiratory stromal cell matrix metalloproteinase (MMP) prodn. in TB is regulated by T-helper 17 (TH-17) cytokines.  Biopsies of patients with pulmonary TB were analyzed by immunohistochem. (IHC), and patient bronchoalveolar lavage fluid (BALF) MMP and cytokine concns. were measured by Luminex assays.  Primary human airway epithelial cells were stimulated with conditioned medium from human monocytes infected with Mycobacterium tuberculosis (Mtb) and TH-17 cytokines.  MMP secretion, activity, and gene expression were detd. by ELISA, Luminex assay, zymog., RT-qPCR, and dual luciferase reporter assays.  Signalling pathways were examd. using phospho-western anal. and siRNA.  IL-17 is expressed in TB patient granulomas and MMP-3 is expressed in adjacent pulmonary epithelial cells.  IL-17 had a divergent, concn.-dependent effect on MMP secretion, increasing epithelial secretion of MMP-3 (p < 0.001) over 72 h, while decreasing that of MMP-9 (p < 0.0001); mRNA levels were similarly affected.  Both IL-17 and IL-22 increased fibroblast Mtb-dependent MMP-3 secretion but IL-22 did not modulate epithelial MMP-3 expression.  Both IL-17 and IL-22, but not IL-23, were significantly up-regulated in BALF from TB patients.  IL-17-driven MMP-3 was dependent on p38 MAP kinase and the PI3K p110α subunit.  In summary, IL-17 drives airway stromal cell-derived MMP-3, a mediator of tissue destruction in TB, alone and with monocyte-dependent networks in TB.  This is regulated by p38 MAP kinase and PI3K pathways. © 2017 The Authors.  The Journal of Pathol. published by John Wiley & Sons Ltd on behalf of Pathol. Society of Great Britain and Ireland.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEUiakeNvPHrVg90H21EOLACvtfcHk0lihgDKOjC_Hxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisl2jtrs%253D&md5=30d179727c8bfefa4a764d4298d45c32</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2Fpath.5013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.5013%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DManiakis-Grivas%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DU.%2BK.%26aulast%3DAsher%26aufirst%3DR.%2BM.%26aulast%3DMauri%26aufirst%3DF.%26aulast%3DElkington%26aufirst%3DP.%2BT.%26aulast%3DFriedland%26aufirst%3DJ.%2BS.%26atitle%3DInterleukin-17%2520regulates%2520matrix%2520metalloproteinase%2520activity%2520in%2520human%2520pulmonary%2520tuberculosis%26jtitle%3DJ.%2520Pathol.%26date%3D2018%26volume%3D244%26spage%3D311%26epage%3D322%26doi%3D10.1002%2Fpath.5013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3L0L','PDB','3L0L'); return false;">PDB: 3L0L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NB6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4NB6','PDB','4NB6'); return false;">PDB: 4NB6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NTQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NTQ','PDB','5NTQ'); return false;">PDB: 5NTQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BN6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BN6','PDB','6BN6'); return false;">PDB: 6BN6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5APK','PDB','5APK'); return false;">PDB: 5APK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WQP','PDB','4WQP'); return false;">PDB: 4WQP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WPF','PDB','4WPF'); return false;">PDB: 4WPF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XT9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XT9','PDB','4XT9'); return false;">PDB: 4XT9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NU1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NU1','PDB','5NU1'); return false;">PDB: 5NU1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NTW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NTW','PDB','5NTW'); return false;">PDB: 5NTW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZJR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZJR','PDB','4ZJR'); return false;">PDB: 4ZJR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZOM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZOM','PDB','4ZOM'); return false;">PDB: 4ZOM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M96" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5M96','PDB','5M96'); return false;">PDB: 5M96</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B30" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B30','PDB','6B30'); return false;">PDB: 6B30</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BR3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BR3','PDB','6BR3'); return false;">PDB: 6BR3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AYG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5AYG','PDB','5AYG'); return false;">PDB: 5AYG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPQ','PDB','4YPQ'); return false;">PDB: 4YPQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LWP','PDB','5LWP'); return false;">PDB: 5LWP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CVH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6CVH','PDB','6CVH'); return false;">PDB: 6CVH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W4V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5W4V','PDB','5W4V'); return false;">PDB: 5W4V</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00588&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00588%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-24%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00588" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667981259c05d203","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
